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Abstract 
 
Measuring health system performance is essential for improving health and quality of 
care. It is relevant in any context, but especially in countries whose health care 
systems have undergone major changes. The 1989 transition from communism to 
democracy in Czechoslovakia followed by the 1993 split into two independent countries 
(the Czech Republic and Slovakia) have been studied extensively but little research has 
addressed the effects of these events on health and the quality of care provided. The 
overarching objective of this thesis is to examine pre- and post-transition health system 
performance at three levels: i) overall health and well-being,  ii) quality of the health 
care system, and iii) quality of outpatient care.  This is a policy piece intended to 
demonstrate the usefulness of various performance indicators, while applying a range 
of quantitative methods from different disciplines to unique datasets. The macro level 
findings suggest that the transition was not detrimental to overall health and well-
being in neither of the two countries as demonstrated by a small continued height 
increase. Slovakia showed a larger capacity to benefit from the transition. The overall 
quality of the health care systems is measured by ‘avoidable’ mortality and also shows 
improvements. For some ‘avoidable’ mortality conditions Slovakia continues to lag 
behind the Czech Republic, while for others it outperforms its neighbour. The thesis 
also provides evidence on the absence of a significant relationship between health care 
inputs and ‘avoidable’ mortality. Finally, the assessment of the quality of outpatient 
care in Slovakia, using preventable hospitalisations and selected processes of care, 
shows that inappropriate care may be provided for asthma and diabetes.  The findings 
also indicate a link between appropriate and inappropriate care and preventable 
hospitalisations. Overall, the results of this thesis provide the basis for policy makers 
to better understand the changes in health outcomes and quality of care in these two 
settings but also to inform future quality improvement efforts.   
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Chapter 1. Thesis motivation and background 
 
1.1. Introduction 
 
Measuring performance and quality is of great importance in any area, but especially 
so in health care where it is essential to know whether best possible care is being 
provided and steps are being taken to avoid unnecessary mistakes, illness or deaths. 
Probably the most important role of performance measurement is to hold the 
different stakeholders accountable by enabling them to make an informed decision 
(Smith, Mossialos, Papanicolas et al., 2009) and to enable health improvement 
initiatives. While there were some earlier efforts, it was the World Health Report 
(2000) on health system performance that drew wide attention to this important area 
and highlighted the complexities involved in performance measurement (Almeida, 
Braveman, Gold et al., 2001; Navarro, 2000; World Health Organization, 2000). 
Since the publishing of this report, performance measurement has become a rapidly 
growing aspect of health systems (Smith, Mossialos, Papanicolas, et al., 2009).  
 
Measuring health system performance and health outcomes is a complex task. The 
European Union (EU), the Organization for Economic Co-operation and 
Development (OECD), the World Health Organization (WHO) and other 
international bodies are actively involved in providing data and tools for 
policymakers in the countries to try to effectively measure, compare and 
consequently improve their health systems (Papanicolas & Smith, 2013).  In addition, 
there are increasingly more local performance assessment initiatives as well. 
Certainly, the most important ultimate goal is the overall health and well-being of 
individuals and populations, the distribution of these, and whether or not over time 
improvements can be observed. However, the fact that health and well-being are 
14 
broadly determined by a range of socio-economic, political, and environmental 
factors, as well as a person’s individual characteristics and behaviours, not only the 
quantity and quality of health care provided (World Health Organization), raises 
issues on how best to measure health, the contribution of health care systems to 
changes in health outcomes, and the quality of the health care system.  
 
Studying health system performance and quality of care is relevant in any context. 
However, it is especially important in countries whose health care systems are 
exposed to major institutional changes that can exert significant effects (improve or 
deteriorate) on well-being and population health. One such major historical, political, 
economic, social and institutional change was the 1989 transition to liberal 
democracy and market economy in the Eastern European region, and the Soviet 
Union, followed by many of the countries gaining independence for the first time. 
Overall, the transition created winners and losers amongst the countries and at the 
different levels of the society (McKee, 2004).  
 
The transition in the countries of central and Eastern Europe (e.g. Bulgaria, Czech 
Republic, Hungary, Poland, Romania, Slovakia and Slovenia) has been more 
successful than in the rest of the region, mainly because of different starting 
conditions including better infrastructure, economic growth, social cohesion, and 
greater exposure to the international scientific and policy community. Thus, where 
economic and political transition were more successful, so was the health transition 
(McKee, 2004). Nevertheless, during this period most of the countries initially 
experienced a deterioration in health outcomes (Cornia & Paniccià, 2000; Figueras, 
McKee, Cain et al., 2004) and struggled with structural changes, reduced budgets, 
lack of appropriately trained staff and rising poverty levels (Figueras, McKee, Cain, et 
al., 2004) before any significant improvements could be noticed. Given this context, 
the following questions arise: How have the health systems of these countries been 
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performing since the transition? Have they been providing high quality care to their 
populations?  The broader socio-economic and political transition as well the specific 
health care systems have become not only an important study area for researchers 
but also an essential area to be evaluated and understood by policy makers so that 
lessons can be learned across the entire region.  
 
1.2. Motivation and thesis objective 
 
Czechoslovakia is a particularly interesting case study and unique amongst the 
countries of central and Eastern Europe as it can be argued that the two countries - 
Slovakia and the Czech Republic – shared very similar health policies and health 
systems until the period of the two transitions: first, the fall of communism in 1989 
and then the separation in 1993 when they set out on their own paths.  Therefore, 
they also make a fascinating and important natural experiment that should allow us 
to better understand the impact of the transition, the different reform policies 
implemented and the move from one set of institutions to another. 
 
It was during this post-transition period when both Slovakia and the Czech Republic 
embarked on major reforms, including health care, and began to implement their 
own country-specific policies. In both countries, there was increased privatisation 
accompanied by increasing health expenditures, which makes one wonder how the 
two countries were performing in terms of achieving health outcomes and improving 
quality of care (Tomasik, 2012). Most of the reforms focused on health financing and 
service provision, with only limited evidence on how the different changes have been 
reflecting on the overall health of the population and quality of care provided, both at 
the aggregate and individual levels. This thesis is a policy piece that aims to 
contribute to the literature by addressing this gap using public health and health 
service research theories, a range of methods that draw on different disciplines (e.g. 
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epidemiology and demography, health economics and political science) and apply 
several unique datasets and performance indicators.  
 
The overarching goal of this thesis is to assess health performance and quality of care 
in Slovakia with respect to the Czech Republic since the ‘double transition’ (1989 and 
1993) using a selection of three methodologically more appropriate outcome 
indicators at the different levels of the health system. For clarity and consistency 
purposes, the analysis is guided by a conceptual health system performance 
framework. This framework should enable a common understanding of what is 
meant by a “health system”, encompass its different dimensions, and guide the 
selection of appropriate indicators from the macro to the micro level.  A fully 
comprehensive assessment of performance of any health care system would be truly 
far reaching. The framework followed here allows assessment to be undertaken at 
different levels, but cannot claim to be fully comprehensive. Following this 
framework it is nonetheless possible to assess different individual dimensions of the 
Czech and Slovakian health systems performance, providing invaluable information 
on the main direction of travel. The thesis starts from the macro assessment of 
overall health and well-being (Chapter 2), then narrows down to the assessment of 
the quality of the two health care systems (Chapter 3 and 4) and ends by an in-depth 
review of the quality of outpatient care in Slovakia (Chapter 5).  
 
Overall, this thesis provides an insight into the health system performance of 
Slovakia and Czech Republic since the two transitions, rather than an in-depth 
analysis of health reforms. This type of an assessment is especially timely as in the 
last decades, there has been a move away from assessing costs and activity to 
assessing quality with an emphasis on both efficient use of resources and on the 
effectiveness of health care (Campbell, Roland, & Buetow, 2000). The findings 
emerging from this piece of research will be a unique contribution to the body of 
17 
evidence addressing the health system effects since the two transitions. Furthermore, 
the results can serve as a useful information basis to policy makers not only to initiate 
future health performance assessment initiatives necessary to improve the quality of 
the health care systems, but also health and well-being overall.  
 
The next sections of this introductory chapter are structured as follows. First, a 
review of the 1989 socio-economic and political transition from communism to 
democracy and the 1993 independence is provided. This includes a summary of the 
key changes in the health systems of the two countries. Then a conceptual health 
system performance assessment framework is selected to guide the health system 
assessment process in Slovakia and the Czech Republic and facilitate the selection of 
health outcome indicators. Third, the in-depth literature review and rationale for the 
selection and use of three methodologically more appropriate indicators – height, 
‘avoidable’ mortality and hospitalisations for Ambulatory Care Sensitive Conditions 
(ACSCs) – is provided. Fourth, the data used in this thesis is reviewed. The chapter 
ends with an overview of the research questions and a thesis outline.   
 
1.3. The socio-economic and political transitions of Slovakia and 
the Czech Republic  
 
While the fall of the communist regime was similar across the region, 
Czechoslovakia’s separation into two countries and thus a double transition makes 
these countries a unique natural experiment and case studies.  Czechoslovakia fell 
under the Soviet influence, and hence became a socialist economy, in 1948. The latter 
implied a ban on civil and political liberties alongside media censorship and 
production plans and quotas (Janik, 2010). For about forty years, the population of 
Czechoslovakia lived under such a regime with some attempts to bring change after 
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the so-called Prague spring.1  However, in 1989 the communist regime fell all across 
Eastern Europe and the democratisation process began. Among the most important 
reforms were the introduction of a market economy by means of a set of regulations 
inspired by the principles of liberal economy including privatisation of large public 
enterprises and attempts to change the prevailing authoritarian culture.  
 
Although initially the steps taken in the two federations of Czechoslovakia were 
similar, in 1992 a peaceful secession process was designed by the two main political 
leaders to create two separate countries in 1993. Gradually the form and speed of the 
democratisation and liberalisation reforms began to differ. The Czech Republic 
initially implemented aggressive economic reforms in combination with socio-
economic entitlements, and the political system was stable and democratically sound. 
In Slovakia the first years after the break-up were characterised by authoritarian rule 
which left the country economically and politically isolated (Inglot, 2009; Meszaros, 
1999). By 1998 the rapid progress in the Czech Republic slowed down, while the 
reverse happened in Slovakia with the defeat of Meciar; it appeared that the Czech 
Republic was ready to join the EU while Slovakia’s chances appeared meagre. The 
period between 1989 and 2004 was characterized by some as the ‘transformation 
shock’ (Inglot, 2009). However, both countries reached an externally required level of 
political and economic transition and joined the EU in 2004. This confirms the view 
that “the two neighbours are not polar opposites, for the road to post-communist 
reform has proved unpredictable for both” (Meszaros, 1999).  
 
The degree of decentralization in Czechoslovakia was limited (Bookman, 1992). 
Czechoslovakia became a federation in 1969 with a constitutional agreement that 
regions would grant to the centre only those responsibilities they would be willing to 
                                                        
1 In 1968 the “Prague Spring” marked a short-lived period of liberalisation and 
democratization with reforms but quickly ended with the Warsaw Pact troops’ invasion; any 
attempts for reforms were crushed and oppression under Soviet Communism continued for 
the next 20 years (Janik 2010). 
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surrender. The economic jurisdiction, as well as social policies were shared between 
the regions and the centre.  However, in 1971 a new re-centralisation process emerged 
which implied that social welfare policies were returned and joined jurisdiction 
matters became under the power of the federal government.  The centralising trend 
continues until 1990 when regional decentralisation was enacted before the break up 
in 1992.  Czechs and Slovaks have small linguistic and cultural differences; however, 
economically Slovakia was always inferior to the Czech Republic; the Slovaks 
“perceive themselves as less developed than the Czechs and they blamed the union” 
(Bookman, 1992, p.92). Some argue that the secessionist movement was primarily 
motivated by economic factors (Bookman, 1992; Pavlínek, 1995) while others focused 
on the role of history, political culture and ethnic nationalism (Innes, 2001; 
Kirschbaum, 1993; Olson, 1993). 
 
The events if 1989 and 1992 can be regarded as a “double bang”, a rare case in history 
where two large forces coincided (Bookman, 1992). It was first a transition from 
centrally planned to a market economy and then the secession of Slovakia that 
happened virtually simultaneously. Some even suggest that it was a “triple 
transition”: democratisation, marketization, and a national transformation (Leff, 
1996). The institutional consolidation was rather smooth in the Czech Republic but 
less so in Slovakia. The Czech welfare state was relatively stable since 1993 given its 
solid institutional inheritance; Slovakia on the other hand was severely 
disadvantaged throughout the 1990s in terms of policy leadership and necessary 
social expertise, coupled with rapid institutional changes departing from those of 
Czechoslovakia’s past and in search of its new own national welfare state (Inglot, 
2009; Potucek & Radicova, 1997). Institutional reforms that come out of a transition 
to a market economy (Collins & Rodrik, 1991) lead to social changes which include 
stimulation of risk taking, altering the attitudes towards work under socialism, which 
encompass additional effects of globalisation and more generally increase in 
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standards of living.  Secession and transition, however, are argued to ease the pain of 
these processes as there is an overlap between them in the aftermath of the two 
events.  
 
The two transitions affected all parts of the economy, including the health care 
systems. In the following section an overview of Slovakia’s and the Czech Republic’s 
health care systems before and after the transition and independence is provided.   
 
1.4. The health care systems of Slovakia and the Czech Republic 
before and after the two transitions 
 
The different socio-economic and political transition processes have also reflected in 
changing policies and health systems in the two countries. The Slovak and the Czech 
health care systems were very similar before the fall of the regime and the split up, 
after which the two countries embarked on their own reform paths.  Up until 1990 
the health systems of the two federations had the same structure and were financed 
through a tax based system where all the services were provided by the state 
(Institute of Health Information and Statistics Czech Republic, 2006). During this 
period adoption of modern diagnostics and therapeutic practices, as well as access to 
innovative pharmaceuticals was limited and focus was mainly on improving 
structural indicators such as the numbers of hospitals, beds and physicians (Szalay, 
Pažitný, Szalayová et al., 2011).   
 
After 1989 both countries began to conceptualize a new health system with social 
health insurance (SHI) as the main pillar and with private provision (primary care, 
specialist care, pharmacies), provider choice, competition and decentralization as its 
key components. As the Slovak economy was in deep depression in the early 
transition years, the move to SHI was considered to be rather bold (Szalay, Pažitný, 
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Szalayová, et al., 2011).  The official goals in both countries continued to be 
universality, equity and free access to health services at the point of delivery with the 
ultimate goal of improving the health status of the population (Bryndova, Pavlokova, 
Roubal et al., 2009; Szalay, Pažitný, Szalayová, et al., 2011).  
 
Changes in the health systems between 1990 and 1992 were very similar in the two 
countries; only after the dissolution of the two federations in 1993 did they slowly 
began to differ. While Slovakia initially lagged behind the Czech Republic, both 
countries moved towards a compulsory SHI with multiple purchasing funds, financed 
by individuals, employers and the state, with voluntary health insurance and out-of-
pocket expenditure playing a small role (Bryndova, Pavlokova, Roubal, et al., 2009; 
Szalay, Pažitný, Szalayová, et al., 2011). Devolution and decentralization of public 
health functions and administration followed, even though at a slower pace 
(Bryndova, Pavlokova, Roubal, et al., 2009; Szalay, Pažitný, Szalayová, et al., 2011). 
The initial reforms led to the financial difficulties of insurance companies, mainly 
caused by the overutilisation of health services under the fee-for-service schemes, 
inadequate risk compensation schemes, insufficient contribution levels, and 
inefficiencies at all levels of the system. These financial difficulties continued through 
much of the 1990s and 2000s in both countries (Bryndova, Pavlokova, Roubal, et al., 
2009; Szalay, Pažitný, Szalayová, et al., 2011).  Below are some key specifics to the 
health systems of the Czech Republic and Slovakia. 
 
The Czech Republic 
 
In the early 1990s the Czech Republic was transitioning to the SHI system with 
numerous health insurance funds. Similar to Slovakia, the health insurance funds 
contracted providers on the fee-for-service basis which led to costs increasing 
unsustainably and changes in the contributions and provider payment mechanism. 
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Presently hospitals in the Czech Republic are reimbursed according to a combination 
of Diagnostic Related Groups (DRGs), individual contracts and global budgets. 
General Practitioners (GPs) do not act as true gatekeepers and are paid by a 
combination of capitation and fee-for-services, and outpatient specialists by fee-for-
service with a limit.  In 2003 large-scale decentralization of public administration 
occurred (Bryndova, Pavlokova, Roubal, et al., 2009). After 2005 some of the major 
changes introduced included risk-adjustment for redistribution of SHI contributions, 
an annual ceiling to SHI contributions for all, the introduction of user fees, increased 
transparency in pharmaceutical price setting, and highly specialized care into 
specially designed health care centres to improve the quality of care.  However, none 
of the reforms were of the scale and intensity as the overhaul of the 2002-2006 
reforms in Slovakia. 
 
Another step in the area of quality of care as of 2009 was the development of a 
national set of health care quality indicators and the Professional Forum’s (an 
advisory body to the Ministry of Health (MoH) and health insurance funds) task  to 
develop comprehensive sets of standards of clinical treatment, quality indicators, 
reimbursement, personnel  and technical matters, and patient impact analysis 
(Bryndova, Pavlokova, Roubal, et al., 2009). The future reforms in the Czech 
Republic aim to focus on patient rights, health care provision and further refinements 
to the SHI system in order to achieve financial sustainability and maintain high 
quality care in difficult economic times.  Overall, the Czech system is characterized by 
universal coverage, a broad benefits package, relatively low health expenditures as 
percentage of Gross Domestic Product (GDP) compared to Western Europe, low out 
of pocket (OOP) payments distributed relatively evenly across household income 
deciles, sufficient human resources even though with regional disparities, and high 
utilisation rates in ambulatory care as well as hospitals (Bryndova, Pavlokova, 
Roubal, et al., 2009).  
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Slovakia 
 
In Slovakia during the 1990s the institutional and regulatory frameworks were weak 
and plagued with corruption which led to debts and bankruptcies in the health 
insurance market. At the same time, hospital facilities were deteriorating and not 
reflecting the needs of the population. Physicians were dissatisfied with low wages 
which led to lower quality of care and increased corruption (Szalay, Pažitný, 
Szalayová, et al., 2011). During 2002-2006 debts were cleared and systematic 
reforms focusing on cost-stabilisation, limiting the scope of benefits, and increasing 
private spending were implemented. A reform package with six new laws was enacted 
in 2004 with an overall focus on individual responsibility for health, rather than the 
state’s (Szalay, Pažitný, Szalayová, et al., 2011).  
 
Unlike in the Czech Republic, the health care reforms in Slovakia during this period 
were part of broader reforms in public finances and the business environment – by 
some labeled as "Slovakia’s neo-liberal turn" (Fisher, Gould, & Haughton, 2007). The 
laws introduced new regulatory and institutional frameworks leading to adjustments 
in the financing, delivery and governance of the health system, and an overall change 
in the roles and relationships of all the health care actors (Szalay, Pažitný, Szalayová, 
et al., 2011).  User fees implemented in 2003 (abolished in 2006) seemed to have 
decreased physician visits and drug prescriptions without limiting access to necessary 
care, but little evidence is available whether access for necessary and appropriate 
treatment was truely maintained. The motivation and pay for health professionals 
continued to be unsatisfactory, putting to question the quality of care provided 
(Hlavačka, Wágner, & Riesberg, 2004).  
 
The 2006-2010 government shifted back towards more state involvement and 
responsibility. The institutional and regulatory framework was not really affected, but 
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user fees were abolished and health insurance companies were not allowed to make 
profit. The government between 2010-2012 was aligned with the goals of the 2002-
2006 government and built on their reform plans. Among other goals in the area of 
quality, the support of standard diagnostic and treatment protocols and evidence 
based medicine, as well as a hospital accreditation system was key (Szalay, Pažitný, 
Szalayová, et al., 2011).  
 
Ambulatory care providers in Slovakia negotiated individual contracts with insurance 
funds to determine the range and volume of services covered, as well as the fee for 
one point (each procedure has an assigned point value). General practitioners are 
paid by a combination of capitation and fee-for-service. The idea was that GPs act as 
gatekeepers to avoid unnecessary specialist visits as well as to ensure coordination of 
treatment and thus improve quality; however, capitation payments do not motivate 
GPs to coordinate and manage patients effectively (Szalay, Pažitný, Szalayová, et al., 
2011).  Specialists are paid with fee-for-service with a maximum volume of points2 
beyond which the specialist may not be reimbursed. In addition, differentiated prices 
depending on selected quality and effectiveness parameters have been introduced as 
well as a digressive fee per point. Quality initiatives in ambulatory care focus mainly 
on structural indicators such as education and premises, where processes are left to 
the discretion of the providers (Szalay, Pažitný, Szalayová, et al., 2011). Hospitals in 
Slovakia are paid by a form of the diagnostic related group (DRG) system based on 
the type of hospital and specialty.   
 
The recent Health System in Transition (HiT) report (Szalay, 2011) in Slovakia noted 
that the Slovak health system continues to be a “system in progress“ which is based 
on universal coverage, compulsory health insurance with selective contracting and 
                                                        
2 Every procedure is worth a certain amount of points. A point has a financial value given by 
the insurance company. The fee paid to the provider for a procedure is equal to the number of 
points of the procedures times the financial value of the point.   
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flexible pricing, and a broad benefits package. There continues to be high utilisation 
of ambulatory care services coupled with high hospital bed availability with relatively 
low occupancy rates. The technical infrastructure of hospitals is outmoded. Key 
challenges remain financial sustainability and the improvement of the health status 
of the Slovak population and quality of care. The authors of the HiT report note that 
this should be done through the implementation of clinical guidelines and protocols, 
and the development of useful quality of care indicators actively used for measuring 
quality. These could then make health provision more accountable, possibly link 
provider payment to quality and even make quality information publicly available so 
that patients can make informed decisions when selecting providers (Szalay, Pažitný, 
Szalayová, et al., 2011).  
 
A review of quality measurement and improvement concludes that in Slovakia 
“systematic approaches to quality of care are still at a basic stage of development”  
(Legido-Quigley, McKee, Nolte et al., 2008, p. 168) and securing quality of care while 
ensuring financial sustainability remains a challenge (Szalay, Pažitný, Szalayová, et 
al., 2011). While many clinical guidelines have been adopted, their uptake is sporadic 
and the extent to which quality of health care initiatives are implemented is not 
evaluated (Legido-Quigley, McKee, Nolte, et al., 2008). However, there were 
government intentions of supporting standard diagnostic and treatment protocols 
and evidence based medicine as well as recommendations to improve quality of care 
by implementing clinical guidelines (Szalay, Pažitný, Szalayová, et al., 2011).  
 
It is the historical context of Czechoslovakia,  the different health reform paths in the 
two countries and lack of focus on assessing the quality of  health care that motivate 
this thesis to assess how Slovakia’s health system has performed relative to the Czech 
Republic’s before and since the two transitions, as well as to study quality of care 
more specifically in Slovakia. Thus the goal in the first part of the thesis is to 
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understand how the two countries perform on overall health and well-being, as well 
as quality of care relative to each other. The second part of the thesis takes a more in-
depth look at the quality of care in Slovakia where these types of initiatives and 
evidence are limited. The next section provides a conceptual performance assessment 
framework to guide this research and the structure of the thesis.  
 
1.5. Framework for measuring health system performance 
 
A conceptual framework for measuring health system performance is necessary to 
guide the assessment in Slovakia and the Czech Republic before and after the 
transition period. Choosing a suitable framework for this research will facilitate the 
understanding and conceptualisation of a health system, its key goals and 
dimensions, and consequently the selection of appropriate performance indicators to 
assess how the two health systems are performing on selected goals and dimensions. 
In particular, the objective in this thesis is to assess overall health and well-being, 
together with quality of care at the different levels of the system. The framework 
selected in this section will help conceptualise how health and quality of care are 
linked in the context of the entire health system. 
 
As a first step, it is essential to define what is meant by a “health system” or “health 
care system” and its “key objectives” so that throughout the thesis it is clear what 
aspects of the two health systems are being assessed and compared. Various 
definitions are available for “health (care) system”, which go from the narrowest ones 
focusing only on the health care system to those encompassing broad determinants of 
health (i.e. the boundaries of the health system). Arah et al. (2006) defined a health 
system as “all activities and structures that impact or determine health in its broadest 
sense within a given society”, a definition that is consistent with the WHO’s definition 
of a health system (“all the activities whose primary purpose is to promote, restore or 
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maintain health”). Health care was defined more narrowly as the “combined 
functioning of public health and personal health care services”.  Parallel to these 
definitions, Arah et al. (2006) further defines health performance as a much broader 
concept where non-health care determinants, health care, contextual information are 
all considered to be important determinants of population health.  By many others as 
well as in this thesis, this is frequently referred to as ‘health system performance’. On 
the other hand, health care performance is only “the maintenance of an efficient and 
equitable system of health care without emphasizing an assessment of the non-health 
care determinants …that is, the direct functioning of the delivery system of health 
care is evaluated vis-à-vis its established public goals for the level and distribution of 
the benefits and costs of personal and public health care” (Arah, Westert, Hurst et al., 
2006).  This thesis will first assess health system performance in the two countries 
before and after the transitions to obtain a broad understanding of the developments 
in the two countries (Chapter 2). Then health care performance more specifically will 
be studied in the Czech Republic and Slovakia (Chapter 3 and 4), with a more in-
depth analysis of quality of care in Slovakia (Chapter 5).  
 
Reflecting the definitions of a health system and its boundaries, different 
conceptualisations of the health system are available. The most widely used 
international frameworks (Aday, Begley, Lairson et al., 1998; Arah, Westert, Hurst, et 
al., 2006; Atun & Menabde, 2008; Commonwealth Fund, 2006; Hsiao, 2003; Hurst 
& Jee-Hughes, 2001; IHP, 2008; Murray & Frenk, 2000; Sicotte, Champagne, 
Contandriopoulos et al., 1998; World Health Organization, 2000) were recently 
reviewed to assess their usefulness for health system performance assessment 
(Papanicolas, 2013).  The review shows that while some frameworks have a narrow 
focus on health care and others include non-health care determinants and the 
broader environment as well, all the frameworks agree on the broad objectives of a 
health system, as proposed by the WHO 2000 report – health, responsiveness, 
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financial protection, productive and efficient system – where improving health and 
well-being is the most important common goal of all.  However, there is more 
disagreement on other or intermediate goals (e.g. access, efficiency, equity, coverage, 
safety, quality etc.) where there are significant differences in conceptualisation, 
especially for quality of care, which is why it will be important to clearly define this 
dimension in this study.  Furthermore, the frameworks may differ in how they outline 
the organisational structure of the health care system. Again, the review concludes 
that there are five broad elements considered in all the frameworks: i) service 
provision; ii) financing; iii) resource allocation; iv) leadership/governance; and v) 
risk factors. The review concluded that over time, there has been convergence in how 
health systems are conceptualized with little gains from creating new frameworks. As 
a result, the framework that has been selected to guide this piece of research will also 
be based on one of these existing frameworks. 
 
There is no one perfect framework for health system performance assessment; 
however, based on the different criteria of the review and the purpose of this study, a 
modified version of the Aday framework (Aday, Begley, Lairson et al., 1993; Aday, 
Begley, Lairson, et al., 1998; Aday, Begley, Lairson et al., 2004) was considered to be 
the most suitable framework for several reasons (Figure 1).  First, it allows for 
conceptualizing the health system broadly where different non-health care factors 
(e.g. social, economic and other environmental) are considered to be potentially 
important determinants of well-being and population health (see Environment in 
Figure 1).3 As one of the goals in this thesis is to assess health performance at the 
macro level accounting for all the different determinants of health and well-being, 
this framework is appropriate. 
 
                                                        
3 The original version of this framework (Aday, 1993) did not recognize the influence of social 
and individual determinants of health (see shaded Environment and Health Risks in Figure 
1). 
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Second, the framework’s explicit ultimate goals are health and well-being, with the 
intermediate goals being effectiveness, efficiency and equity. This thesis aims to 
assess overall health and well-being, as well as effectiveness (or quality of care). 
Third, the framework is organised in terms of Donabedian’s structure (“availability, 
organisation, financing of health care programs; the characteristics of populations to 
be served by them; and the physical, social and economic environments to which they 
are exposed”), process (“transactions between patients and providers in the course of 
actual care delivery, as well as the environmental and behavioural transactions 
exacerbating health risks”) and outcomes (“the consequences of policies for the 
health and well-being of patients and the public”)  (Aday, Begley, Lairson, et al., 
2004). Given that the goal of this thesis to examine health system performance in 
Czech Republic and Slovakia at different levels going from macro to micro level, the 
structure – process - outcome elements of the framework allow for this type of an 
analysis with the appropriate indicators.  The macro level focuses on the population 
perspective and broad determinants of health and well-being, while the micro level 
has a clinical perspective studying the factors that influence a patient’s health at the 
system (i.e. health care system), institutional (i.e. organisational entity such as 
hospital, clinic or health maintenance organisation) or individual level (i.e. clinical 
decision making and treatment).  
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Figure 1. Framework for assessing health system performance 
 
 
Source: (Aday, Begley, Lairson, et al., 2004; Aday, Begley, Lairson et al., 1999; World Health 
Organization, 2012) 
 
The structure of the framework allows for a continuum in the assessment of 
performance. It shows how health policy in a given country is influenced by the 
health and well-being of the patients and population at large, and at the same time 
determines the structure of the health care system (see Delivery System in Figure 1) 
which interacts with other socio-economic and physical factors (see Environment in 
Figure 1). Public health responses are also included in the “Delivery System” 
component of the framework. These two structural aspects of the framework, interact 
with the “Population at Risk” element determined by various predisposing (e.g. 
genetics, age), enabling and need factors. The interaction of these various structural 
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elements give rise to two types of processes: realised access (utilisation, satisfaction) 
and health risks (behavioural and environmental) which then lead to three 
intermediate outcomes - effectiveness, efficiency and equity – with the effectiveness 
goal considered to be more important as it feeds into evaluating efficiency and equity.  
The ultimate goal is improved health and well-being of individuals and the 
community at large, which in turn should again determine the necessary health 
policies.  
 
It is important to clarify the relationship between health and well-being in this 
framework, as the first part of the thesis aims to measure well-being in the Czech 
Republic and Slovakia. The WHO defines health in broad terms as “a state of 
complete physical, mental and social well-being, not merely the absence of disease or 
infirmity”.  While the definition is broad, the focus in the previous years has been 
mainly on the health aspect of this definition; well-being as such was largely ignored 
(World Health Organization, 2013); however, since the WHO 2012 European health 
report, well-being has gained importance so that the objectives of Health 2020, the 
new European policy framework, “to improve the health and well-being of 
populations, reduce health inequities, and ensure sustainable people-centered health 
systems” can be achieved.  This new framework builds on the European health report 
from 2009, the focus of which was health system strengthening through cost-effective 
interventions and performance assessment (World Health Organization, 2013).  
 
Just like numerous definitions of health exist, well-being is also a complex concept 
determined by numerous factors. Well-being has an objective and a subjective 
element: the objective includes people’s living conditions and their opportunities to 
realize their potential and is measured through, for example, income, education or 
mortality rates, among others; the subjective element includes people’s experiences 
of their own lives measured with different methods that capture how people report 
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their own perceptions (World Health Organization, 2013).  The World Health 
Organization (2013) carried out a review of several different conceptualisations of 
well-being and found that in all the frameworks health was conceptualized as part of 
well-being, both as a determinant and an outcome. Also, both health and well-being 
are determined by health systems, as well as the broader political, economic and 
social contexts and other intermediary factors. In the context of our framework the 
“Environment” is an important determinant of well-being.   
 
The conceptualisation of effectiveness also deserves some attention so that confusion 
around the terminology is avoided in the thesis. In Aday’s  framework effectiveness is 
defined through Donabedian’s definition as “the degree to which improvements in 
health now attainable are actually attained” (Donabedian, 1993).  It is evaluated at 
the population (“improving the health of populations and communities through 
medical and/or nonmedical service”) and the clinical (“improving the health of 
individual patients through medical care services”) levels; so in other words, again at 
the macro and micro levels which can be assessed through different structure, 
process and outcome indicators. The clinical perspective is often focused on health 
care at the system, institution and patient level, in particular how the predisposing, 
enabling and need factors (“Population at Risk”) interact with the health care delivery 
system (e.g. availability, organisation) and result in particular medical interventions 
and outcomes.  The population perspective also accounts for all those individuals in 
the population who have not received medical care and focuses on how the 
interaction between policies at the individual and population level, and the medical 
and non-medical determinants of health affect the level and distribution of health  
(Aday, Begley, Lairson, et al., 2004).  
 
Aday et al. (2004) are mainly concerned with effectiveness as a broad concept 
referring to the degree to which potentially attainable health objectives are being 
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reached. So then quality is an attribute of the health care process and again 
effectiveness more specifically an attribute of the health outcome.  They define 
quality as “that part of the gap between efficacy, or what is achievable, and 
effectiveness, or what is achieved, that can reasonably be attributed to health care 
itself” (Aday, Begley, Lairson, et al., 2004, p.67) and note that “evidence-based 
medical care focuses on the use of the best available efficacy and effectiveness 
evidence to inform decisions about patient care and guide health care policy” (Lohr, 
Eleazer, & Mauskopf, 1998). Overall, “quality assessment deals with evaluating the 
process of health care in the service of ultimately improving health outcomes” and 
appropriateness is “the subset of quality that concerns determining whether the right 
thing was done for the patient” (Aday, Begley, Lairson, et al., 2004).   
 
It should be noted that there are many other definitions for quality of care. 
Definitions of quality may differ in the breadth and focus, or the dimensions that 
define it (Legido-Quigley, McKee, Nolte, et al., 2008) but they may all be suitable 
depending on the level of the system at which they are to be used and the nature and 
scope of the responsibilities of the person who is defining them (Donabedian, 1988). 
Donabedian, a pioneer in the area of quality of care, wrote in his last book that “some 
believe quality in health care is too abstract and nebulous a concept to be precisely 
defined or objectively measured” (Donabedian, 2003, p. xxxi).  Yet, he correctly 
stated that if quality was so difficult to define and measure, it would be difficult to 
“set it apart as a goal an individual or an organisation can aspire to”. Quality of care is 
usually defined through a range of dimensions including: effectiveness, efficiency, 
access, safety, equity, appropriateness, timeliness, acceptability, responsiveness, 
satisfaction, continuity, efficacy, relevance and others (Campbell, Roland, & Buetow, 
2000; Council of Europe, 1998; Department of Health, 1997; Donabedian, 1980; 
Institute of Medicine, 1990; Roberts, Hsiao, Berman et al., 2004; World Health 
Organization, 2000).  Hence effectiveness – or whether services and interventions 
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have the intended effect - is usually a key component of quality of care in most of 
these definitions. Sometimes these dimensions of quality of care are also viewed as 
key processes or intermediate goals of the health system, as highlighted in our 
framework. For example, in our framework access (see “Realised Access” in Figure 1) 
is a key process necessary to achieve effectiveness (intermediate outcome). In this 
way access is viewed as an element of effectiveness, just like it is often an element of 
quality of care.  
 
Therefore, quality of care can be viewed by some as a concept that is equal to 
effectiveness, and may be studied at the population level to assess the overall quality 
or performance of the health care system or at the individual level to assess clinical 
quality of care. The purpose of the above section was not to go into depth on this 
terminology but rather to highlight the different possible interpretations of the 
concepts in the literature and the importance of clarifying the focus for the purpose of 
this research. Thus, in this thesis quality of care and effectiveness also refer to the 
same broad concept. Quality of care (the term used predominantly throughout the 
thesis) is assessed at the population (or macro) level to capture health care 
performance (Chapter 3 and 4) and at the clinical (or micro) level capturing the 
quality of ambulatory care (Chapter 5).  Efficiency and equity are elements of quality 
of care at the population level.  
 
In order to assess overall health or health system performance, and quality of care at 
the different levels of the system, appropriate indicators need to be selected. The next 
section will therefore discuss what types of indicators can be used for this purpose, 
which are the ones that have been applied in Slovakia and the Czech Republic to date, 
their main weaknesses and why three alternative outcome indicators (height, 
‘avoidable’ mortality, hospitalisations for ACSCs) are methodologically more suitable 
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for gaining an insight into the performance of the two countries since the transition 
and independence.  
 
1.6. Rationale for indicator selection 
 
Outcome and process indicators 
 
A range of structure, process and outcome indicators are available to assess how a 
health system is performing on its key goals and dimensions, which all have 
important methodological advantages and disadvantages. One can either decide to 
combine a number of indicators into a composite indicator or study selected 
indicators together to evaluate the health system, as was also proposed by 
Donabedian in the 1970s (Donabedian, 2005 reprint of Donabedian, 1966). 
Donabedian’s contribution was to focus on measuring the outcomes (health status or 
survival), processes (the care supplied to the patient) or the structure (health care 
setting) of the health system (Donabedian, 2005). Outcome indicators usually suffer 
from the problem of attribution where changes in health outcomes are likely to be 
influenced by many factors outside the control of the health care system or 
organisation. As a result, adjusting for the various factors and risks whether at the 
population or clinical level is essential (Iezzoni, 2003); in addition, good or bad 
outcome may be achieved regardless of the particular (good or bad) process. 
However, as overall outcome indicators are more meaningful for stakeholders and 
can directly measure health goals (Smith, Mossialos, Papanicolas, et al., 2009), this 
thesis will largely apply these.  
 
Process indicators, on the other hand, may be too specific on particular aspects of 
care and ignore others, be easily manipulated or become outdated fast. However, they 
can be easily measured without major bias or error, are easier to interpret and overall 
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more sensitive to quality of care (Smith, Mossialos, Papanicolas, et al., 2009). 
Therefore, some process indicators will also be used in the last chapter of this thesis 
to examine specific aspects of quality of care. While both process and outcome 
indicators have their critics, if used together they can provide valid information about 
the effectiveness and quality of care provided (Brook, McGlynn, & Cleary, 1996). This 
thesis will rely mainly on health outcome and some process indicators to gain an 
insight into the health system performance and quality of care of the Czech Republic 
and Slovakia before and after the transition period.  
 
Outcome indicators are usually used to assess overall health system performance by 
examining health status and well-being. A broad range of methods and indicators 
exists to measure well-being which depend on the way well-being is conceptualised. 
For example, both the OECD and the United Nation’s (UN) work on well-being 
emerged from a long-standing debate that the traditional indicators such as GDP per 
capita may not be the most appropriate to measure well-being as higher average 
incomes may not necessarily result in improved well-being (World Health 
Organization, 2013). According to the 2011 OECD report, the most important aspects 
that shape people’s lives and well-being are: income and wealth, jobs and earnings, 
housing conditions, health status, work life-balance, education and skills, social 
connections, civic engagement and governance, environmental quality, personal 
security and subjective well-being. These domains are then measured through 
selected indicators. For example, income and wealth are captured through h0usehold 
net adjusted disposable income per person and household financial net wealth per 
person, while health is measured through life expectancy and self-report health status 
(Organization for Economic Cooperation and Development, 2011). Overall, however, 
the field of measuring well-being lacks clear definitions and rigorous assessment 
methods; at the same time it presents  numerous potential measures which results in 
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the inability to choose the most appropriate ones, as well the difficulty to combine 
and interpret these indicators (World Health Organization, 2013).  
 
Extensive literature has also been devoted to how to best measure population health. 
The main challenge is related to identifying indicators where changes in health 
outcomes can be directly attributed to changes in the quality of the health care 
system.  In order to properly capture the contribution of the health care system to 
changes in health outcomes, suitable data needs to be identified and secured, 
appropriate indicators selected and methods that control for variations outside the 
control of the health system applied. “One vitally important element in performance 
measurement therefore is how to attribute causality to observed outcomes or 
attribute responsibility for departures from approved standards of care” (Smith, 
Mossialos, Papanicolas, et al., 2009, pg.12). Only indicators that account for these 
challenges, and measure what they were designed to measure, can be considered 
credible and effective performance measures. In general, traditional population 
health measures (Table 1) such as standardised mortality rates or life expectancy 
suffer from the key methodological challenge of the difficulty of assessing the extent 
to which variations in the health outcome indicator can be  attributed to variations in 
the health system (Smith, Mossialos, Papanicolas, et al., 2009).  
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Table 1. Measures of population health 
 
Mortality Indicators Data and methodological issues 
  
Generic mortality-based indicators: 
• age-standardised death rates 
• life expectancy 
• Broad indicator of health 
• Mask contributions of specific causes 
• Exclude morbidity 
• Need further disaggregation by age and cause 
Age specific mortality indicators: 
• infant or perinatal mortality 
• Susceptible to variations in recording and 
reporting practices 
• Rely on precise definitions not always 
adhered to in practice (perinatal mortality) 
• Are influenced by factors outside the health 
system (infant mortality) 
• Are based on small numbers 
• Complex interpretation of underlying causes 
Cause-specific mortality indicators: 
• age-standardised mortality from 
specific causes (ischaemic heart 
disease, cancer etc.) 
• Data quality and coding 
• Capture influence of broader health 
determinants 
• Need to be interpreted in context of risk 
factor and disease prevalence, and policies in 
other sectors 
5-year survival: 
• cancer 
• Variations in coverage and diagnostic 
practices 
• Lead-time bias 
• Need to account for staging 
• Has to be viewed alongside mortality and 
incidence rates 
Summary measures: 
• HALE, DALYs, YLL 
• Controversial methodology (age and 
disability weighting) 
Source: Adopted from (Karanikolos, Khoshaba, Nolte et al., 2013) 
 
Overall, it is these standard indicators that have been usually monitored in the 
context of the Czech Republic and Slovakia. In the section that follows, these are 
reviewed to obtain a broad overview of health, well-being and quality of care 
developments in the two countries. 
 
Reviewing standard indicators in the Czech Republic and Slovakia 
 
Already during the communist period, the two countries differed in their level of 
economic and social development.  Life expectancy and mortality rates, suggest that 
despite both countries exhibiting improvements, Czechs continue to outperform the 
Slovaks even after the transition (Figure 2) (Ginter, Simko, & Wsolova, 2009). 
Improved life expectancy at birth has been influenced by improved living standards 
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and health services, as well as the absence of any major disruptive events  (e.g.  
regime change, revolution etc.) (Institute of Health Information and Statistics Czech 
Republic, 2006).  The same is suggested by the Human Development Index (HDI), 
which also includes income and education in addition to life expectancy, and ranks 
Slovakia closely behind the Czech Republic (United Nations Development 
Programme).  
 
Figure 2. Life expectancy at birth 
 
 
Source: OECD Health Data 2012 (http://stats.oecd.org/Index.aspx?DataSetCode=SHA) 
 
Basic economic indicators (Figure 3) suggest that the Czech Republic has been 
performing better during communism and has continued to outperform Slovakia in 
many well-being indicators. Overall, an analysis of the economic situation (income, 
inequality and poverty) found that in the initial years after the transition in both 
countries were painful and reflected in a decline of overall welfare (Cox & Mason, 
1999; Milanovic, 1998). Changes in income inequality between 1987-1988 and 1993-
95 measured by the GINI coefficient showed that inequality increased in the Czech 
Republic but did not change in Slovakia. The shape of the change also differed: in 
Slovakia no income quintile gained or lost more than 1 percentage point; in the Czech 
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Republic, the loss of 1-2 percentage points was concentrated in the bottom three 
quintiles, the fourth quintile experiencing a very small loss and the top quintile 
benefited the most. However, it has to be noted that given the overall income decline 
in both countries, the losers were losing more severely and the winners were not 
necessarily gaining in real income (Milanovic, 1998).  
 
Figure 3. Real GDP per capita, PPP$ 
 
 
Source: OECD Health Data 2012 (http://stats.oecd.org/Index.aspx?DataSetCode=SHA) 
 
While still lower than in many other European Union countries, health expenditure 
as a percentage of GDP (Figure 4) has been increasing in the last decades both in 
Slovakia (9.2% in 2009) and the Czech Republic (7.5% of GDP in 2009) (OECD, 
2010).  In the last years Slovakia has been spending more on health care as a 
percentage of GDP than the Czech Republic and has also shown a substantially 
sharper increase. Expenditures per capita have been increasing similarly in both 
countries, with Slovakia reaching US$2,000 per capita in the last years (Figure 5).   It 
has been argued that in Slovakia at these levels of expenditure, equal and universal 
access has been maintained with somewhat more limited access in rural areas and for 
the Roma living in remote settlements (Ecohost/ Masaryk University, 2000; 
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Hlavačka, Wágner, & Riesberg, 2004; The World Bank, 2002). In terms of the 
distribution of health expenditures, in the Czech Republic in 2008 hospital care 
(50.9%) followed by ambulatory care (25.5%) and drug expenditures (17.3%) 
represented the highest shares of total expenditure (Bryndova, Pavlokova, Roubal, et 
al., 2009). In Slovakia in 2010 expenditures were distributed quite differently: 
ambulatory care including diagnostics (34%), followed by drug expenditures (30%) 
and tertiary or inpatient care (27%) (Szalay, Pažitný, Szalayová, et al., 2011) . Overall, 
health expenditure data can reveal only a limited amount of information about the 
quality of care provided to patients. For many years in Slovakia the proportion going 
to drugs represented the highest portion of the budget.  Drug expenditures have been 
high both because of patient demands for the most modern, and usually expensive 
drugs, and overprescribing by providers under the aggressive influence of 
pharmaceutical companies and their advertising (Hlavačka, Wágner, & Riesberg, 
2004).  While drugs expenditures as a proportion of total health expenditures have 
now decreased it is dififcult to conclude how the quality of care provided was affected. 
 
Figure 4. Total expenditure on health as % of GDP 
 
 
Source: OECD Health Data 2012 (http://stats.oecd.org/Index.aspx?DataSetCode=SHA) 
Note: Data for the initial years for Slovakia were not available from the OECD 
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Figure 5. Health expenditures per capita 
 
 
Source: OECD Health Data 2012 (http://stats.oecd.org/Index.aspx?DataSetCode=SHA) 
 
A limited number of indicators have been used in Slovakia and the Czech Republic to 
capture the overall quality of the health care system. In Slovakia, some argue that the 
reforms seem to have been “implemented without significant adverse effects on the 
population’s health” (Hlavačka, Wágner, & Riesberg, 2004). However, there is only 
little evidence that analyses trends in health outcomes and processes as the focus has 
been on structural indicators. Standard health outcome indicators have been 
monitored (Figure 6) where declines in infant and neonatal deaths suggest possible 
improvements in the quality of care provided.  The top causes of death in both 
countries - diseases of the circulatory system,  malignant neoplasms, mortality 
attributable to external causes (injury and poisoning) and diseases of the respiratory 
system (Figure  7 and 8) – have also been declining in both countries, with Czech 
Republic performing better than Slovakia. These mortality indicators as well as other 
standardly available ones, while informative, do not provide in depth insight of the 
extent to which declines can be attributed to changes in the quality of health care.   
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Figure 6. Infant deaths per 1000 births and neonatal deaths per 1,000 live births 
 
 
Source: WHO European Health for All Database 
 
Figure 7. Diseases of circulatory system and malignant neoplasms, 0-64, age-
standardised death rate per 100,000 
 
 
Source: WHO European Health for All Database 
 
Figure 8. External cause (injury and poison) 0-64; and diseases of the 
respiratory system, all ages, age-standardised death rate per 100,000 
 
Source: WHO European Health for All Database 
 
Due to the weaknesses discussed above and other methodological challenges (Komlos 
& Snowdon, 2005; Masseria, Allin, Sorenson, Papanicolas, & Mossialos, 2007; 
Milanovic, 1998; Murray, Salomon, & Mathers, 2000), this thesis will draw on three  
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alternative indicators – height, ‘avoidable’ mortality and hospitalisations for ACSCs – 
to measure overall health and well-being and quality of care. The rational for these is  
briefly discussed in the next section before an in-depth literature review on their 
application is provided.  
 
Alternative indicators  
 
First, this thesis will use adult height as a possible alternative measure of health and 
well-being to GDP or life expectancy. As height is determined during childhood and 
adolescence, average adult height mainly captures a population’s health conditions 
during childhood (Hatton, 2013). While biologists have been interested in the 
indicators for a long time, increasingly heights are of interest to economists and 
demographers as well.  Throughout the 20th century an extensive amount of studies 
of human growth were carried out (Steckel, 2009). It is considered to be an indicator 
of life-time health and given that taller populations are also generally richer, it has 
been used to understand  their standards of living (Bozzoli, Deaton, & Quintana-
Domeque, 2009). A separate body of literature looks at well-being through the 
concept of “biological standard of living”, defined by Komlos in the 1990s, where a 
population’s biological processes are affected by socioeconomic and epidemiological 
factors. Similarly to the OECD and the UN, this approach is also built on the fact that 
quality of life is determined by more than just economic power, focusing in particular 
on health (Koch, 2012). In this context, physical stature has been used to measure the 
biological status of the population as it is regarded an indicator of “how well the 
human organism fared during childhood and adolescence in its socio-economic and 
epidemiological environment” (Komlos & Snowdon, 2005). Human height may 
therefore be used as a retrospective marker of wellbeing and living standards both 
over long term intervals as well as short term cyclical variations, and thus serve as a 
complement to conventional indicators (Cvrcek, 2006; Komlos, 2009; Komlos & 
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Baten, 1998; Komlos & Snowdon, 2005; Persico, Postlewaite, & Silverman, 2004) as 
it can address some of their weaknesses.  
 
Height captures a wide range of determinants and is frequently used in the area of 
economic development and economic history to assess changes in overall standard of 
living. Heights are available in settings were standard income data, mortality or 
morbidity information is lacking or of dubious quality (Deaton, 2007; Steckel, 1995).  
Information derived from average adult heights is particularly reliable because the 
person’s height reflects his or her living conditions from conception to maturity and 
is not simply a snapshot during particular years; furthermore, height data is usually 
available for the neglected groups and lends itself to international comparisons as it 
is uniformly measured (Koch, 2012; Komlos & Kriwy, 2002).  Evidence suggests that 
authoritarian regimes such as the former East Germany reported conventional 
standard of living information such as income unreliably (Koch, 2012). Information 
on height was not politically sensitive (unlike, e.g. infant mortality) and may have 
been the only exact indicator of welfare strain in Czechoslovakia under early 
communism (Cvrcek, 2006). Nevertheless, issues with measurement of height or use 
of self-reported height need to also be carefully considered. In the context of the 
framework in Figure 1, height measures overall health system performance by 
capturing health and well-being together, and all its broad determinants.  In this 
thesis it is therefore proposed as an all-encompassing indicator of retrospective 
health and well-being in the Czech Republic and Slovakia, both before and after the 
transition and independence.  
 
Next, the thesis proposes the use of ‘avoidable’ mortality’ indicators which capture 
premature deaths for certain conditions that are considered to be largely avoidable if 
timely and effective health care is provided (Holland, 1988; Nolte & McKee, 2004).  
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The application of the concept of ‘avoidability’ dates back to at least the early 20th 
century when, in the United Kingdom, in 1928 confidential enquiries were made into 
maternal deaths to first identify errors and areas where improvements could be made 
to avoid unnecessary deaths (Holland, 2009); in the United States similar enquiries 
were carried out in the early 1930s and also led to important reductions in maternal 
mortality rates (New York Academy of Medicine, 1933).  The WHO in a report 
describing the methods of investigation of maternal mortality and morbidity stated 
that while there is no formal proof of the effectiveness of such enquiries ‘the lessons 
derived will enable health care practitioners and health planners to learn from the 
past’ (Holland, 2009; World Health Organization, 2004). The concept was later 
expanded by Rutstein and colleagues in 1976 (Rutstein, Berenberg, Chalmers et al., 
1976), who suggested measuring quality of care through untimely deaths which 
should not occur in the presence of timely and good quality care.  ‘Avoidable’ 
mortality indicators have increasingly been used to address the main weakness of 
standard population measures where changes in health outcomes cannot be directly 
attributed to changes in the quality of care provided.  Therefore, ‘avoidable’ mortality 
indicators will be used to capture health care performance or overall quality of care at 
the system level.  
 
As changes in ‘avoidable’ mortality only provide a macro snapshot of the quality of 
the entire health care system, it will be important to study quality of care provided at 
the micro levels of the system. The focus in this thesis will be the further examination 
of quality of care in Slovakia, where evidence is almost entirely lacking. This is 
necessary as only with more in-depth analysis can we gain a better understanding of 
where there are gaps in quality and room for improvement.  Most of the literature has 
been focused on measuring the quality of primary care (Lester & Roland, 2009) or 
the hospital sector (McKee & Healy, 2002).  Recently, given the rising burden of 
chronic diseases, increasing attention has also been paid to the domain of chronic 
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care (McKee, Bain, & Nolte, 2009). However, only little attention has been on the 
quality of ambulatory care overall, including primary and specialist outpatient 
services for both acute and chronic conditions.  
 
Measuring the quality of ambulatory (or outpatient) care is important for several 
reasons. First, health care is generally more expensive to provide in inpatient than 
outpatient settings and there are potential savings that can be made from reduced 
hospital admissions (Kovner & Knickman, 2008); the hospital sector usually absorbs 
as much as 50% of national expenditure of the health care system (Rechel, Wright, 
Edwards et al., 2009).  Besides the cost of hospital care, a hospital admission is likely 
to cause disruptions in the patient’s life, as well as in his or her family’s (Rechel, 
Wright, Edwards, et al., 2009).  Also, repeated hospitalisations may lead to the 
overall deterioration of the patient’s condition (Chu, Chan, Lin et al., 2004). 
Therefore, quality ambulatory care and reduced hospital admissions is not only a 
potential cost-reduction strategy but also an obligation towards the patients by those 
who design and regulate the health care system. 
 
Most of the process and outcome indicators that measure the performance of some 
domains of the health system do not capture the performance of ambulatory care in 
its entirety (Table 2). The purpose of the final chapter of this thesis will therefore be 
on one particular indicator – hospitalisations for ambulatory care sensitive 
conditions (ACSCs) – that has received only little attention in earlier research.  
ACSCs are conditions for which timely and effective ambulatory care can help reduce 
the risks of hospitalisation by preventing the onset of an illness or condition, 
controlling an acute episodic illness or condition, or managing a chronic disease or 
condition (Ansari, 2007a).   
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Table 2. Examples of process and outcome indicators for different areas of care 
 
Area of Care Process Indicators Outcome 
Indicators 
 
Primary Care Diet and exercise counselling  
(diabetes) 
 
Patients with diabetes should have 
an annual eye and visual exam 
(diabetes) 
 
Pharmacotherapy for uncontrolled 
mild hypertension (hypertension) 
The percentage of 
patients with 
diabetes whose 
last blood pressure 
was 145/85 mgHg or 
less 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chronic Care 
(Includes 
primary, 
specialist and 
inpatient care) 
Frequency of regular HbA1c tests 
(diabetes) 
 
Long-acting agents for patients with 
frequent use of short-acting beta-
agonists (asthma) 
Rate of diabetes 
related blindness or 
amputation 
 
The percentage of 
patients age 16 years 
and over on 
drug treatment for 
epilepsy who have 
been convulsion 
free for last 12 
months recorded in 
last 15 months 
 
Avoidable 
admission for 
chronic conditions 
Specialist 
Outpatient 
Care 
Inhaled corticosteroids for patients 
receiving long term systemic 
corticosteroid therapy (asthma) 
 
Screening for high-risk patients 
starting at age 40 years of age 
(colorectal cancer) 
 
Women who have a hysterectomy 
for post-menopausal bleeding 
should have been offered a biopsy 
of the endometrium within 6 
months prior to the procedure 
(hysterectomy) 
 
Rule out cancer, fracture, infection, 
cauda equina syndrome, and 
neurologic causes (Acute low back 
pain) 
Rate of diabetes 
related blindness or 
amputation 
 
Hospitalisations for 
acute and chronic 
conditions 
 
Hospital Care Aspirin at arrival (AMI) 
 
Initial antibiotic timing (within 4 
hours) (Pneumonia) 
 
30-day mortality 
 
Emergency 
readmission within 
28 days of discharge 
 
 
Source: (McGlynn, 2009; McGlynn, Asch, Adams et al., 2003; McKee, Bain, & Nolte, 2009; 
McKee & Healy, 2002; Nolte & McKee, 2008b) 
 
 
In the next sections an in-depth literature review on the three performance indicators 
used in this thesis to assess health system performance in the Czech Republic and 
Hospitalisations for 
ambulatory care 
sensitive conditions 
(acute, chronic, vaccine 
preventable) 
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Slovakia is provided. These indicators should be viewed as complementary indicators 
which may address some of the weaknesses of standard health and well-being 
performance indicators. However, as all indicators, these also have their flaws.   
 
1.6.1. Height: an indicator of well-being and overall health system 
performance 
 
The concept 
 
Physical stature is regarded an indicator of “how well the human organism fared 
during childhood and adolescence in its socio-economic and epidemiological 
environment” (Komlos & Snowdon, 2005). Thus the rate of growth of children is a 
reflection of the health of a population (Eveleth & Tanner, 1990), or the “mirror of the 
society” (Tanner, 1986).  Height is determined by cumulative net nutrition during the 
period of growth, where net nutrition is the difference between the intake of nutrition 
(food) and the output through activity and disease (Bogin, 2001; Bozzoli, Deaton, & 
Quintana-Domeque, 2009; Eveleth & Tanner, 1990; Silventoinen, 2003). In turn, the 
caloric and protein intake during one’s childhood and youth is also associated with 
income and the price of food (Komlos, 2009). Thus overall, “adult height is an 
indicator of both the economic and disease environment in childhood and as such at 
least a partial indicator of the health component of well-being”(Deaton, 2007, 
p.13232). However, whether or not adult height will be affected, depends on the 
complex interaction of factors, the period of growth during which they occur and how 
they influence nutritional intake (Steckel, 2009). A growing literature on economic 
and biological sciences reveals that in genetically stable societies, changes in adult 
height proxy the physical returns to psycho-socially beneficial health environments 
(Steckel, 1995). Indeed, improvements in certain socio-economic conditions could in 
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turn create the conditions to allow individuals during the years of growth to maximise 
their height potential.  
 
Louis-Rene Villerme, a public health expert in France, made an observation in 1829  
that captures the importance of environmental factors on height: “Human height 
becomes greater and growth takes place more rapidly, other things being equal in 
proportion as the country is richer, comfort more general, houses, clothes and 
nourishment better and labour, fatigue and privation during infancy and youth 
less; in other words, the circumstances which accompany poverty delay the age at 
which complete stature is reached and stunt adult height.” (Tanner, 1981). Changes 
in height reflect the interaction between genetic and environmental factors during the 
period of growth (Eveleth & Tanner, 1976). Yet, although genes are important 
determinants of individual height, changes in average height across most populations 
are largely attributable to environmental factors (Steckel, 1995). More specifically, it 
has been estimated that approximately 20 percent of variation in height is due to 
environmental factors (Silventoinen, Kaprio, Lahelma et al., 2000; Stunkard, Foch, & 
Hrubec, 1986).  
 
A review of the literature by Steckel (2009) summarises recent developments in 
height research and highlights the many factors investigated and the numerous 
debates on the interpretations of empirical findings within height research across the 
different disciplines (Steckel, 2009).  The environmental factors include changes in 
the diet, disease, work intensity, maintenance, genetics (i.e. proximate determinants), 
as well as broader socioeconomic effects such as income, social inequality, public 
health, personal hygiene, disease environment, technology, labour organisation, 
cultural values, and food prices (i.e. socioeconomic determinants) (Steckel, 1995) 
(See Figure 9).  Thus, as highlighted in the figure below, apart from genetics, an 
important causal pathway for changes in height includes improvements in the 
51 
proximate determinants, especially nutrition through reduced barriers to food, 
improved disease environment, and reduced work intensity resulting from positive 
changes in the social, political or economic environment.    
 
Figure 9. Relationships involving stature 
 
Source: Adopted from Steckel (1995) 
 
The focus of this research is whether and how the changes in the broad political, 
economic and institutional environment in the former Czechoslovakia (i.e. 
“socioeconomic determinants” in Figure 9) are associated with changes in adult 
height.  
 
Empirical evidence: institutional change and heights 
 
There is evidence of a direct link through an improved diet in the Eastern European 
region. Prior to the transition, poor nutrition was a problem due to seasonal 
unavailability of certain foods and the opening of the boarders enabled easier access 
to fruits and vegetable consumption (McKee, 2004). This has been linked to declining 
deaths from cardiovascular diseases in the region, and Czechoslovakia in particular 
(Bobak, Skodova, Pisa et al., 1997). One can also envision institutional triggers that 
can result in improvement in heights (Sunder, 2003). Institutional effects are 
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generation specific influences reflecting exposure to similar contemporary time or 
space limitations (e.g. social norms, restrictions on freedom, etc.). Eveleth and 
Tanner (1976) in their summary of growth studies suggest “if a particular stimulus is 
lacking at a time when it is essential for the child…the child’s development may be 
shunted…” (Eveleth & Tanner, 1976, p.222). However, there is evidence that for 
deprivation to have an effect on adult height, it has to be severe and long-term during 
key periods of growth as after short nutritional shocks normal height is usually 
restored (Steckel, 2009). In particular, evidence from developing countries on the 
environmental determinants suggests that unlike in developed countries, there is no 
relationship between child mortality or living conditions and adult height; the 
example of the African paradox is provided where low incomes, high disease 
environment and inappropriate nutrition is usual (Bozzoli, Deaton, & Quintana-
Domeque, 2009; Deaton, 2007). Deaton (2007, p.13232), therefore, concludes that 
the relationship between population height and income (or income and health 
generally) is “inconsistent and unreliable”. It is in this context that Chapter 2 aims to 
test whether in the Czech Republic and Slovakia the number of years a person has 
spent growing up under democracy and as part of an independent country (as 
opposed to communism and Czechoslovakia), after adjusting for income and other 
key variables, resulted in health and well-being benefits, and thus would show to be 
an important determinant of adult height.  
 
A country’s democratisation reshapes the institutional framework within which the 
economic actors manage their lives (North, 1991). Therefore, the introduction of 
structural reforms in a country’s organisation might induce environmental health 
effects and ultimately enhance a positive effect on well-being in the long run (Costa-
Font & Gil, 2008). More specifically, it can be reasonably expected that democracy 
should lead to institutional and environmental improvements that make children and 
adolescences’ existence safer and healthier, and thus are expected to be positively 
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associated with height. As Amartya Sen also put it, a country should become fit 
through democracy (Sen, 1999). Consistently, adverse socio-economic developments 
in the society may lead to stagnation or deterioration in height, and such negative 
developments can also occur in democratic regimes. For example, in the United 
States in the second half of the 20th century, the American population went from 
being the tallest in the world to being among the most overweight, despite higher per 
capita income; the latter is largely attributed to the greater social inequality, 
incomplete health care insurance and fewer social safety nets than in Western and 
Northern Europe (Komlos & Baur, 2004).   
 
Disentangling the effects of institutional changes in human height calls for the 
examination of some natural experiments. One of these experiments is the process of 
reunification of Germany and democratisation (Heineck, 2006; Hiermeyer, 2008; 
Komlos & Baur, 2004).  Research carried out on living standards in East and West 
Germany had two important findings: i) despite proclamations of an officially 
classless society, important social differences in stature were identified in East 
Germany (Komlos & Kriwy, 2003); ii) West Germans were taller than East Germans 
(by approx. 1cm) throughout the second half of the twentieth century and the 
difference widened after the Berlin Wall was built (Komlos & Snowdon, 2005). Even 
though the difference in height is small, it was concluded that the West German 
welfare state with a mixed economy provided a superior biological  standard of living 
to its children and youth than socialist East Germany (Hiermeyer, 2008; Komlos & 
Snowdon, 2005). Since unification there has been convergence between East and 
West German males but not females (Komlos & Kriwy, 2003). Other research show 
how  height can be employed to assess whether there is convergence or divergence 
between regions or countries capturing changes in social welfare (A’hearn, Peracchi, 
& Vecchi, 2009; Arcaleni, 2006; Baten & Blum, 2012; Chanda, Craig, & Treme, 2008; 
Komlos, 2007; Meisel & Vega, 2007; Salvatore, 2004; Steckel, 2009).  
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The case of Czechoslovakia stands out as a unique natural experiment with the 
processes of democratisation followed by the country democratically splitting in two 
independent communities. It can be argued that both processes potentially improve 
well-being overall as they underpin an expansion collective self-determination, which 
would be expected to reshape each community’s institutions. These new institutions 
would be tailored to their own specific welfare needs, foster freedoms and hence 
improve the environmental and institutional settings individuals grow up in, as well 
as further stability and conflict reduction.  Whether the latter is indeed the case is an 
empirical question where the effect on height, the indicator of health and well-being, 
may reveal interesting similarities or differences between the Czech Republic and 
Slovakia. In this respect, this research adds to the body of evidence on the ability of 
political and economic liberalisation to improve health (Costa-Font & Gil, 2008; 
Nobles, Brown, & Catalano, 2010). 
 
1.6.2. ‘Avoidable’ mortality: an indicator of health care performance 
or overall quality of care 
 
The concept4 
 
Explicitly the concept of ‘avoidable’ deaths was proposed by Rutstein and colleagues 
in 1976 (Rutstein, Berenberg, Chalmers, et al., 1976). The group outlined the method 
of measuring the quality of medical care5 that counts cases of unnecessary disease, 
                                                        
4 A version of this section has been published as the Methodological Note for the European 
Commission co-authored with Walter Holland (LSE Health), Ellen Nolte (RAND Europe) and 
Martin McKee (LSHTM).) The views expressed are those of the authors and do not necessarily 
represent those of the European Commission. The Methodological Note and this section draw 
on the extensive review prepared by Nolte and McKee (2004) and summarise some of its 
main findings. 
5 Rutstein and colleagues (1976) defined “quality” as the effect of care on the health of the 
individual and of the population (outcome). Improvement in the quality of care should be 
reflected in better health.  
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disability and untimely deaths. Rutstein and colleagues (1976) defined medical care 
in its broadest sense as “the application of all relevant medical knowledge, the basic 
and applied research to increase that knowledge and make it more precise, the 
services of all medical and allied health personnel, institutions and laboratories, the 
resources of governmental, voluntary and social agencies, and the co-operative 
responsibilities of the individual himself”.  Their list included around 90 conditions 
which they considered as sentinel health events. When selecting the conditions, they 
“assumed that if everything had gone well, the condition would have been prevented 
or managed”.  As Rutstein and colleagues acknowledged, “the chain of responsibility 
to prevent the occurrence of any unnecessary disease, disability, or untimely death 
may be long and complex; the failure of any single link may precipitate an 
unnecessary undesirable health event” (Rutstein, Berenberg, Chalmers, et al., 1976). 
As a result, often it may be difficult to establish who is responsible. For example, they 
cited deaths from diphtheria, measles and poliomyelitis for which the responsibility 
may lie in the state which may not have provided the necessary funding, the health 
officer who did not implement the program, the medical society that opposed 
community clinics, the physician who did not immunise the patient, the religious 
views of the family, or the mother who did not care to bring her child for 
immunisation (Rutstein, Berenberg, Chalmers, et al., 1976). However, they thought 
that in each death considered unnecessary and untimely the physician had the “initial 
and also some continuing responsibility”. Similar examples can be derived for many 
other conditions. It was Rutstein’s work that provided the basis for the concept and 
was followed by numerous publications, which applied the concept empirically, 
reviewed the list of conditions, adjusted the definition of medical care and its scope, 
as well as the age limits.   
 
After the initial work carried out on maternal mortality in the early 20th century, and 
Rutstein and colleagues’ extension of the concept of ‘avoidable’ mortality in 1976, the 
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concept and application of the indicator continued to be expanded (Appendix A).  
Interestingly there was no attempt to use Rutstein’s methodology in the United States 
(Holland, 2009). Charlton and colleagues (Charlton, Hartley, Silver et al., 1983) in 
the United Kingdom narrowed the concept by excluding conditions which were 
considered to be outside the scope of medical care, e.g. road traffic accidents, and 
tobacco policy. They were the first to apply ‘avoidable’ mortality empirically at the 
population level and to examine national and international trends (Nolte & McKee, 
2004), as well as the importance of disease incidence and social factors. At the same 
time they introduced an upper age limit for some conditions at 65 years.  
 
In 1986 a major project was undertaken in the European Community (EC) which 
resulted in the publication ‘European Community Atlas of ‘Avoidable Death’’ under 
the EC Concerted Action Project on Health Services and  ‘Avoidable Deaths’ (Holland, 
1988, 1991, 1993, 1997).  This project extended the work of Charlton and colleagues 
(1983) and used a definition of health services, which were interpreted to include 
primary care, hospital care and collective health services such as screening and public 
health services, e.g. immunisation. The original list also included conditions whose 
control mainly depended on primary prevention or health policies, which were 
outside the direct control of health services, e.g. lung cancer, liver cirrhosis or motor 
vehicle accidents; these were excluded from the most recent edition (Nolte & McKee, 
2004).  
 
Several country specific analyses resulted from the EC Atlas carried out by 
participating researchers, as well as in non-EC countries (Nolte & McKee, 2004).  
However, studies used different lists of ‘avoidable’ conditions, with varying age limits 
and methods of analysis. Lack of suitable data or insufficient numbers of deaths for 
some of the conditions may explain the differences in the methods applied 
(Mackenbach, Bouvier-Colle, & Jougla, 1990). In the 1980s, Mackenbach and 
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colleagues analysed the possible contribution of medical care innovations to mortality 
changes by analysing trends in mortality from selected conditions and found that 
“although the exact contribution of medical care innovations to changes in mortality 
cannot be determined, the impact of medical care on post-1950 mortality in the 
Netherlands could well have been substantial” (Mackenbach, Looman, Kunst et al., 
1988). They used a stricter definition of medical care defining it as “the application of 
biomedical knowledge through a personal service system” building on Rutstein’s list 
of conditions. 
 
Further work has focused explicitly on differentiating and comparing levels of 
‘avoidable’ mortality attributable to the health care system and to wider health 
policies usually not within the direct control of health services. While this distinction 
had been made in earlier publications (Holland, 1986; Rutstein, Berenberg, 
Chalmers, et al., 1976), this time, conditions were clearly split as indicators for the 
different areas of health care (Westerling, 1993; Westerling, Gullberg, & Rosén, 1996; 
Westerling & Smedby, 1992).  Tobias and Jackson (2001), following an expert 
consensus exercise in New Zealand, partitioned  the relative avoidability of death 
from conditions into proportions which are avoidable by primary, secondary, and 
tertiary actions (Tobias & Jackson, 2001). For example, avoidability of deaths from 
asthma was partitioned into primary, secondary and tertiary interventions with 
weights 0.1, 0.7, and 0.2, respectively, while tuberculosis received weights of 0.6, 
0.35, and 0.05, respectively. According to this approach, death from tuberculosis is 
considered, largely, avoidable by primary prevention while death from asthma is 
primarily avoidable by secondary prevention through early detection and treatment.  
Finally, the work of Nolte & McKee (2004) looked at ‘avoidable’ mortality and 
changing life expectancy in the European Union in the 1980s and 1990s using an 
updated list of conditions taking into consideration advances in medical knowledge 
and technology.  
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Empirical evidence 
 
As shown by Nolte and McKee (2004) numerous studies have applied the concept of 
‘avoidable’ mortality empirically. As noted above, these studies vary in the selection 
of conditions which are considered avoidable by health care, definitions of medical 
care and/or health services, and age limits, thus limiting comparability of findings 
(Nolte & McKee, 2004). While some only looked at trends in ‘avoidable’ mortality 
others attempted to identify factors that might explain these trends or any variations. 
Given that the indicator is assumed to measure the effectiveness of health services, it 
might be expected that variations in ‘avoidable’ deaths could be linked to health care 
inputs; however, of those studies that did attempt to establish such link, most tended 
to capture only quantity but not the quality of health services and, perhaps 
unsurprisingly, could not establish a clear association between health care input and 
(population) health outcome. Nolte and McKee (2004) reviewed over 70 studies and 
grouped them into three categories as follows: 
 
• Studies that examine geographic variation. These suggest that there is little 
association between geographical variation in ‘avoidable’ mortality and 
differences in quality or quantity of health services, as measured by routine 
data; geographical variations seem to be more closely related to 
socioeconomic conditions. 
• Studies that examine variation between social groups. These suggest that 
population groups classified as being at social disadvantage because of 
ethnicity or socioeconomic characteristics tend to be at higher risk of death 
from ‘avoidable’ conditions. 
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• Studies that examine variation in ‘avoidable’ mortality over time. These tend 
to show consistent declines in ‘avoidable’ mortality that have been more rapid 
than declines in mortality from causes not considered ‘avoidable’. 
 
Only a handful of studies have focused on ‘avoidable’ mortality in Eastern Europe. 
These have found that amenable mortality was falling about 1-2 percent per year 
between mid-1970s and mid-1980s while non-amenable mortality remained more or 
less stable or even increased in Hungary, Poland and Lithuania (Gaizauskiene & 
Gurevicius, 1995; Nolte, Scholz, Shkolnikov et al., 2002).  A study that looked at 
changes in ‘avoidable’ mortality in East Germany before and after the transition in 
1990 found that in both periods amenable mortality was falling faster than non-
amenable mortality; however, in Poland mortality from other causes fell faster in the 
90s than in the 80s but also more rapidly than ‘avoidable’ mortality (Nolte, Scholz, 
Shkolnikov, et al., 2002).  Nolte et al (2004) noted that while East Germany was 
going through rapid changes after unification, in Poland health care improvements in 
the country were substantially slower.  One study that compared ‘avoidable’ mortality 
rates between 1979 and 1988 in Hungary with other countries, including 
Czechoslovakia, found that amenable mortality in the Western countries fell faster 
than mortality for all other causes in these two countries. In Hungary and the Czech 
Republic death rates from both groups of causes increased in the first part of the 
period studied and a decline in mortality from both types of causes could be observed 
from 1985; all-cause mortality declined more slowly and stayed stable toward the end 
of the period (Bojan, Hajdu, & Belicza, 1991). 
 
Another study compared trends in ‘avoidable’ mortality between 1980 and 1997 in the 
Czech Republic and 15 countries of the EU (Treurniet, Boshuizen, & Harteloh, 2004). 
While the differences in trends in avoidable and non-avoidable mortality before and 
after 1989 were not statistically significant, both avoidable and non-avoidable 
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mortality declined with non-avoidable mortality at an increased annual rate after 
1989 (from 1.8% to 2.7%) but still somewhat slower than ‘avoidable’ mortality (from 
2.1% to 2.8%).  The only study that analysed trends in ‘avoidable’ mortality by 
separate conditions in both the Czech and the Slovak Republic, including on the 
regional level, was the Atlas of Leading and Avoidable Causes of Death in Country of 
Central and Eastern Europe but only between 1985 and 1989 (Jozan & Prokhorskas, 
1997). No study has been identified which would have analysed ‘avoidable’ mortality 
rates of the Czech and Slovak Republic before and after 1989 or in relation to the split 
of the Czech and Slovak Federation into two new countries; neither at the aggregate 
level nor by individual conditions. While most studies found that ‘avoidable’ 
mortality declines faster than mortality from other conditions, the  study in Poland 
(Nolte, Scholz, Shkolnikov, et al., 2002) where ‘avoidable’ mortality declined at a 
slower rate than mortality from all other causes in the 90s provides the basis for the 
hypotheses that ‘avoidable’ mortality in the Czech Republic and Slovakia has 
decreased since 1989 but at a slower pace than mortality from other conditions.  
Furthermore, because the Czech Republic has higher life expectancy and performs 
better on standard mortality indicators, we further hypothesise that ‘avoidable’ 
mortality has decreased faster in the Czech Republic than in Slovakia since 1993.  
 
1.6.3. Hospitalisations for Ambulatory Care Sensitive Conditions: an 
indicator of the quality of ambulatory care  
 
The concept 
 
ACSCs are “conditions for which hospitalisation is thought to be avoidable with the 
application of preventive care and early disease management usually delivered in the 
ambulatory setting. In theory, timely and effective ambulatory care can help reduce 
the risks of hospitalisation by preventing the onset of an illness or condition, 
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controlling an acute episodic illness or condition, or managing a chronic disease or 
condition. This has led to the concept of preventable or avoidable hospitalisation as 
an indicator of health outcomes for evaluating the quality of primary health care.  
ACSC rates have also been proposed as a measure of access to health care” (Ansari, 
2007a).  In this thesis, hospitalisations for ambulatory care sensitive conditions 
(ACSHs) will be used synonymously with preventable hospitalisations. 
 
The above definition of ACSCs refers to both the role of ambulatory and primary care 
in preventing unnecessary hospitalisations. However, much of the available literature 
uses ACSH rates as a measure of access to primary care without providing a clear 
definition of primary care. It is therefore important to clarify that someone’s chances 
of being hospitalised may depend on factors which are not only in the responsibility 
of primary care providers but a consequence of all the care provided by other 
outpatient specialists and health care staff, as well as appropriate coordination across 
the different levels of care, continuity, patient management and other factors. The 
definition of ambulatory care used here includes all the services provided on an 
outpatient basis, requiring no overnight hospital stay, including i) primary care, ii) 
emergency care and iii) ambulatory specialty care as well as diagnostics services, 
provided by a range of health care professionals (Kovner & Knickman, 2008).  At the 
same time, it is an indicator that apart from access captures a range of quality of care 
dimensions such as effectiveness, efficacy, appropriateness and equity. This indicator 
is conceptually related to and has been developed on the basis of an indicator of 
population health – ‘avoidable’ mortality (Millman, 1993).  Both ‘avoidable’ mortality 
and ACSHs are meant to be used as “screening tools” for potential problems in the 
health system to be further investigated; in other words, to provide a “snapshot” on 
the quality of the health system overall, or ambulatory care more specifically.   
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The first list of ACSCs was developed in the early 1990s in the United States by 
Weissman (Weissman, Gatsonis, & Epstein, 1992) with 12 conditions and Billings 
(Billings, Zeitel, Lukomnik et al., 1993) with 28 conditions when the Institute of 
Medicine (IOM) suggested that ACSHs be used as a measure of access to primary care 
(Millman, 1993). In general, ACSCs have been identified through consensus 
processes with panels of clinicians, using various methodologies and decision criteria 
(Ansari, 2007a).  ACSCs can be classified into three broad categories: i)  vaccine-
preventable ACSCs where the vaccine prevents the occurrence of the condition (not 
actually the hospitalisation) and thus the incidence of preventable diseases (e.g. 
measles, rubella etc.); ii) acute ACSCs for which timely and appropriate care reduces 
morbidity and pain (e.g. dehydration/gastroenteritis, perforated ulcer, pelvic 
inflammatory disease, kidney infection etc.); and iii) chronic ACSCs where 
appropriate outpatient care reduces the effect of particular chronic disease and 
prolongs life (e.g. asthma, hypertension, angina, congestive heart failure, diabetes 
etc.).  In addition to ambulatory care sensitive conditions, there are also “marker” 
conditions for which hospitalisations should not vary according to access and quality 
of outpatient care (e.g. appendicitis) (Appendix A, Table 39).  
 
Many countries including Canada, the United States, United Kingdom, Italy, Spain 
and Australia have already developed their country specific lists and have been 
monitoring ACSHs during the last decade (Ansari, Laditka, & Laditka, 2006; Billings, 
Anderson, & Newman, 1996; Caminal, Starfield, Sanchez et al., 2004; CIFHI, 2008; 
Giuffrida, Gravelle, & Roland, 1999; Magan, Otero, Alberquilla et al., 2008; Rizza, 
Bianco, Pavia et al., 2007).  While countries differ in how the indicator is applied and 
the lists of conditions being monitored, the fact that easily accessible and cheap 
administrative data may be used makes this indicator attractive to health policy and 
decision makers equally.  
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Admissions for individual ambulatory care sensitive conditions have been carefully 
evaluated and proposed as area level indicators by the Agency for Healthcare 
Research and Quality (AHRQ) in the United States as part of the Healthcare Cost and 
Utilization Project, an on-going Federal-State-private sector collaboration to build 
uniform databases from administrative hospital based data (AHRQ, 2001). The 
AHRQ evaluated the validity of admissions for all the ambulatory care sensitive 
conditions together6 along several dimensions (Appendix A, Table 40). Given the 
limitations of the measure, the AHRQ recommended that ACSHs be used alongside 
other quality indicators as a “quality screen” which can provide initial information 
about potential problem in the health system that should be analysed in more depth 
(AHRQ, 2001 and 2004).  
 
It is difficult to establish the appropriate rate of hospitalisations for ambulatory care 
sensitive conditions but a rate which is too high may indicate poor access to, 
underuse or inappropriate outpatient care or low threshold for admissions by the 
admitting physician. Overall, it is important to explore the causes of variations in 
admissions rates where the best benchmark would be comparisons with national, 
regional, or peer group means (AHRQ, 2001).  Wennberg and colleagues (Wennberg, 
1999, 2004; Wennberg, Fisher, Stukel et al., 2004) have extensively studied 
variations in health care utilisation and expenditures in the United States and showed 
the importance of understanding the factors that explain such variations, in 
particular, how the care provided for the same condition differs across regions. For 
example, if high rates persist in some regions over time, there may be some 
systematic differences in access to and appropriateness of the treatment. Overall, it is 
                                                        
6 Most evidence applies to sets of conditions. The indicators included are: Perforated 
appendix, Diabetes short-term complication, Diabetes long-term complication, Chronic 
obstructive pulmonary disease, Hypertension, Congestive heart silure, Low Birth Weight, 
Dehydration, bacterial pneumonia, urinary tract infection, angina without procedure, 
uncontrolled diabetes, adult asthma and rate of lower-extremity amputation among patients 
with diabetes 
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essential to identify variations, and determine its causes so that unwarranted 
variation can be reduced by either increasing or decreasing utilisation.  
 
Many of the ACSCs have clinical practice guidelines and studies have shown that 
better outpatient care can reduce patient complication rates of existing disease, 
including the complications leading to hospital admissions. Empirically, most of the 
hospital admission rates for ACSCs are correlated with each other, suggesting that 
common underlying factors influence many of the rates (AHRQ, 2007). However, 
exploring concrete aspects of clinical quality of care and how these are linked to 
hospitalisation levels requires a condition specific analysis. Yet, studies which look at 
sets of several ACSCs together have not been able to include clinical quality of care 
variables such as appropriate treatment.  
 
Preventable hospitalisations have primarily been proposed as a single outcome-based 
measure of access, after acknowledging that evaluating all the different dimensions of 
access (availability, accessibility, affordability etc.) is often not feasible  (Ansari, 
2007b).  In fact, most of the available literature focuses on ACSH rates as a measure 
of access to health care where different factors, predominantly socioeconomic, are 
used as a proxy of access to health care; an inverse relationship with ACSH rates 
suggests reduced access. In addition, the relationship of other variables (e.g. lifestyle 
factors, prevalence, environment etc.) and ACSHs have also been explored. The large 
amount of non-health system factors that have a relationship with ACSH rates may 
suggest that the reporting of ACSHs figures is not likely to foster change in the quality 
of services provided. However, if all the different factors are appropriately accounted 
for, changes in ACSH rates are likely to at least indicate potential weak areas in the 
health system and provide the initial motivation for further enquiries and potential 
for improvement.   
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Empirical evidence 
 
A systematic review (see Appendix A for the full review) has been carried out to bring 
together the existing body of evidence on the factors that explain ACSH rates. In this 
section the key findings and implications for the research carried out in Chapter 5 are 
briefly summarised.  In the process of carrying out the initial literature search of the 
systematic review, a comprehensive literature review7 (Ansari, 2007) has been 
identified which covers evidence from 1970 till August, 2005. The review explores the 
validity of ACSC admissions as proxy indicators of access to primary health care, and 
summarises all the different factors that are associated with ACSHs rates across 
geographic areas and population groups. The author of the review grouped the 
evidence along several areas: demographics, socio-economic status, “rurality”, health 
system factors, prevalence, lifestyle factors, environment, adherence to medication, 
severity of illness and propensity to seek care. The results and main effects are 
summarised in Appendix A and further details can be found in the original article 
(Ansari, 2007).  
 
Ansari concludes that ACSC admissions are valid proxy indicators of access to 
primary health care. ACSHs result from a number of key reasons including 
insufficiency and mal-distribution of primary health care resources, evidence of the 
existence of barriers to accessing primary care services (e.g. socioeconomic), 
problems with continuity of care and inefficient use of resources (e.g. may occur if the 
patient finds it easier or cheaper to go directly to the hospital instead of getting care 
in an ambulatory setting) (Ansari, 2007). Overall, the review reveals that 
socioeconomic factors seem to be the most important predictors of ACSHs. While 
some factors are addressed much more extensively (e.g. supply of physicians), others 
such as lifestyle, prevalence, adherence to medication, and in more general terms, 
                                                        
7 From here onwards this literature review may be referred to as “Ansari review” only.   
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utilisation and clinical quality of care that patients are covered to a more limited 
extent.  The Ansari review was systematically updated to encompass new evidence 
from 2005 until March 2009 to see whether an effect of any additional factors that 
influence ACSHs has since been identified. The results from the Ansari review as well 
as the systematic review were summarised in light of a conceptual framework which 
demonstrates the range of factors that may influence ACSHs (Figure 10).  
 
 
Figure 10. Conceptual framework for ACSHs 
 
Source: Adjusted based on (Andersen, 1995; Andersen, McCutcheon, Aday et al., 1983; Basu, 
Friedman, & Burstin, 2004; Chang, Mirvis, & Waters, 2008; The World Bank) 
 
The fourteen new studies selected in the review focused on the same variables of 
interest8 as in the Ansari review, as well as some new factors including age, gender, 
race, socioeconomic status (insurance status, poverty etc.), rurality, self-rated access, 
                                                        
8 Variables controlled for/confounding variables are not included. 
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continuity of care, presence of rural clinic, physician supply, and physician visits. 
Overall, the variety of settings and chosen variables of interest, differences in ACSCs 
used, the target population, number and type of confounders, study designs, methods 
and data sources made it difficult to compare and assess the quality of studies, and to 
draw sound conclusions about the overall effects and strengths of associations of the 
different factors and ACSHs. However, despite these limitations, this systematic 
review together with the Ansari review provide interesting findings for future 
research and policy application of the ACSHs indicator. The newly identified studies 
again focused on demographic, socioeconomic and a few health system factors. 
Again, the focus was on factors which are easier to assess and measure rather than a  
complex approach using a conceptual framework. This may not be a problem as such, 
but may lead to incomplete conclusions about ACSHs as a measure of the quality of 
care.  When the results are analysed against the factors included in the conceptual 
framework, the literature predominantly deals with predisposing factors, personal 
enabling factors and health system factors and how these explain ACSH rates, while 
other factors are not addressed.  
 
Besides one study which included physician visits, no new evidence has been 
identified which would consider health services utilisation (intensity) and clinical 
quality of care variables, such as appropriate drug treatment for a specific condition9 
or adherence to the treatment prescribed.  Yet it is important to acknowledge that 
including these types of variables may only be possible if ACSCs are monitored 
individually at the patient level. This has been done in condition specific studies, for 
example diabetes or asthma, where it has been established that hospitalisations for 
these conditions can be controlled with appropriate care. Also, none of the studies 
looked at the relationship between all the key factors together - predisposing (e.g. 
age, gender), enabling (e.g. income, insurance), behaviour and risk (e.g. adherence, 
                                                        
9 Literature on determinants of hospitalisations for individual conditions has not been 
reviewed 
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smoking), utilisation (e.g. primary and specialist visits) and quality of care (e.g. type 
of drug treatment) – and ACSHs.  Finally, the indicator of ACSHs continued to be 
applied mainly in the United States, as well as Canada, Australia and Spain but not in 
new country contexts such as the Eastern European region.  
 
The systematic literature review revealed that the application of this indicator 
requires additional in depth research, especially, studies that focus on the effect of 
variables whose association with ACSHs is not well understood.  In this review the 
focus was not on the condition specific literature (e.g. diabetes, asthma, and 
hypertension) which may identify a range of additional, especially clinical, factors 
associated with preventable hospitalisations. These may include, for example, 
appropriateness of clinical care according to evidence-based guidelines, adherence or 
others. Therefore, the focus of Chapter 5 will be on individual ambulatory care 
sensitive conditions and the relevant literature.  
 
As has been mentioned above, Slovakia has gone through numerous health care 
reforms with only little assessment of the quality of care provided to patients. Based 
on variations in the availability of physician posts, some have argued that there is a 
little difference in accessibility or quality of care between rural and urban areas 
(Hlavačka, Wágner, & Riesberg, 2004). However, availability and proximity to 
services does not yet guarantee access and utilisation of effective care.  The Slovak 
Government has only recently approved new quality indicators for hospital (e.g. 
readmission, repeat surgery etc.) and outpatient care (e.g. utilisation of preventive 
services) but their application is still in infancy (Legido-Quigley, McKee, Nolte, et al., 
2008).  This is despite the availability of linked administrative data that could be 
used to gain a better understanding of the medical care patients are accessing. Given 
the high utilisation of the health care system and the expenditure distribution, it is 
important to understand whether the ambulatory care patients currently receive is 
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effective in preventing adverse hospitalisations for ACSCs. Chapter 5 will therefore 
look at trends in hospitalisations for ACSCs, asthma and diabetes in particular, to see 
if they are unnecessarily high and may reflect on poor access to effective outpatient 
care. Based on the gap in the reviewed literature, the focus will be on appropriate care 
as a key determinant of unnecessary hospitalisations.  
 
1.7. Data  
 
The data used to carry out the analysis come from different data sources. Table 3 
below provides an overview. The data sources will be briefly summarised below and 
then discussed in depth in the individual chapters. First, Chapter 2 used data from 
the 2003 World Health Survey (WHS), which is the baseline household survey for 
health status of populations and outcomes related to investments and functioning of 
health systems. The survey has information on self-reported height of individuals as 
well as information on other important variables that are controlled for including 
education, income, rural or urban location, employment and others. Next, in Chapter 
3 and 4 mortality data classified by individual or small groups of diagnosis and age 
groups between 1971 and 2008 were obtained from the Statistical Office of the Slovak 
Republic and the Czech Statistical Office. For years 1971 to 1993 mortality data had to 
be collected manually from the Archives of the Statistical Office of the Slovak 
Republic. Data for the control variables at the regional level (GPD per capita, 
unemployment, pollution etc.) and instruments (number of dwellings completed in a 
year, number of car accidents per operated cars) were also obtained from the same 
organisations. Finally, data on health care inputs (number of beds, physicians, 
nurses) were obtained from the Institute of Health Information and Statistics of the 
Czech Republic (IHIS) and the National Health Information Center of Slovakia 
(NHIC). In Chapter 5 nationally representative administrative data from the largest 
public health insurance company (the General Health Insurance Company (GHIC)) 
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in Slovakia from 2001 to 2008 is used. Patients were included in the study population 
if they received medical treatment (outpatient, inpatient, diagnostic) with the 
principal diagnosis for diabetes and asthma in 2002 were disease free in the previous 
year. All the patients have a unique identifier and were followed for the period of 
2002-2008.  
 
Table 3. Overview of data sources and variables 
 
 Data Source Year Dependent  
variable 
Variables of 
interest and  
controls 
Chapter 2 World Health Survey  
 
Centre for Systematic Peace 
 
Eurobarometer (sensitivity 
analysis) 
2003 Height  Gender 
Age 
Education 
Job 
Income 
Polity IV index 
Language 
Country 
Chapter 3 Statistical Office of the Slovak 
Republic  
 
Czech Statistical Office 
1971-
2008 
Age-standardised 
mortality 
 
Chapter 4 Statistical Office of the Slovak 
Republic  
 
Czech Statistical Office 
 
Institute of Health 
Information and Statistics of 
the Czech Republic  
 
The National Health 
Information Center of Slovakia  
1996-
2007 
Age-standardised 
mortality 
 
 
Beds 
Nurses 
Doctors 
GDP  
Pollution 
Unemployment 
Country 
Chapter 5 Administrative data from the 
General Health Insurance 
Company  
2002-
2008 
Number of 
hospitalisations 
Age  
Sex 
Comorbidities 
HbA1c tests 
Urine tests 
Ophthalmologic 
visits 
Doctor visits 
Cholesterol tests 
Antidiabetic 
medication 
Corticoids 
SABA 
Antibiotics 
Flu shot 
Spirometry 
Asthma 
medication 
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1.8. Research questions and thesis contribution 
 
To summarise, the main research question the thesis sets out to answer is: How have 
the health systems of Slovakia and the Czech Republic performed since the transition 
in 1989 and independence in 1993?  The additional sub-research questions of the 
thesis are summarised in Table 4.   
 
Based on the reviewed literature, the overall hypothesis of the thesis is that health, 
health system performance and quality of care in both countries have been improving 
since the transition. The thesis supports that the two transitions have resulted in a 
health and well-being benefit in both the Czech Republic and Slovakia reflected in a 
gain in height. Furthermore, this thesis hypothesises that health care performance, or 
quality of care in particular as measured by ‘avoidable’ mortality has also improved 
since the double transition in both countries where Slovakia falls behind the 
performance of the Czech Republic.  Moreover, the thesis expects to find that the 
human and economic development that has occurred since 1989 will have resulted in 
declines in non-avoidable mortality; however, ‘avoidable’ mortality will have declined 
at a slower pace. Also, the thesis expects to find a relationship between health care 
inputs and ‘avoidable’ mortality, a better indicator of the contribution of health care 
to health outcomes. Finally, the thesis hypothesises that appropriate and 
inappropriate care are associated with hospitalisations for ambulatory care sensitive 
conditions.   
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Table 4. Summary of research questions 
 
Overall research question: How have the health systems of Slovakia and the 
Czech Republic performed before and since the transition in 1989 and 
independence in 1993? 
Chapter  Research Goal Sub-Questions 
Chapter 2 Determine overall health 
system performance in 
Slovakia and the Czech 
Republic since the transition to 
democracy and independence 
using the indicator of height 
Is there a height increase for 
those who grew up after the 
1989 transition? 
 
Is there a height difference 
between the Czechs and the 
Slovaks? Who benefited 
more? 
 
Is there a height difference 
between females and males? 
Chapter 3 Determine health care 
performance (overall quality of 
care) in Slovakia and the Czech 
Republic since the transition to 
democracy and independence 
using the indicator of 
‘avoidable’ mortality 
Has overall ‘avoidable’ 
mortality declined since the 
transitions reflecting 
improvements in quality of 
care?  
 
Has overall ‘avoidable’ 
mortality declined more 
rapidly than non-avoidable 
mortality?  
 
Has there been divergence or 
convergence between 
Slovakia and the Czech 
Republic?  
 
Are there regional variations 
in ‘avoidable’ mortality? 
Chapter 4 Determine relationship 
between health care inputs and 
‘avoidable’ mortality in 
Slovakia and the Czech 
Republic 
Is there a negative 
relationship between health 
care inputs and ‘avoidable’ 
mortality? 
 
Do improved analytic 
methods provide more 
robust and consistent 
results? 
Chapter 5 Determine quality of outpatient 
care in Slovakia using ACSHs 
and its associations with 
appropriate care 
Are there variations in 
ACSHs? 
 
Do diabetic patients receive 
appropriate care as defined 
by clinical guidelines? 
 
Do asthma patients receive 
appropriate care as defined 
by clinical guidelines? 
 
Are selected process 
indicators for asthma and 
diabetes care negatively 
associated with ACSHs? 
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Chapter 1 is the background chapter which highlights the importance of measuring 
health system performance, especially in the context of the 1989 transition countries, 
and Czechoslovakia as a unique case study and natural experiment which split into 
two countries. The chapter provides the country context for Slovakia and the Czech 
Republic and their health systems, a conceptual framework to guide the 
measurement of health system performance in these two countries, and finally the 
rationale for selecting and using three more appropriate indicators to measure health 
system and health care system performance by examining changes in health, well-
being and quality of care.  
 
Chapter 2 examines changes in overall health system performance in the Czech 
Republic and Slovakia before and after the 1989 and 1993 transition. This chapter 
sets the stage for the entire thesis as its goal is to see whether the last twenty years 
have potentially resulted in any health and well-being improvements, and if so, what 
differences can be observed between the two countries.   Evidence from developed 
countries suggests that changes in adult population heights can be regarded as 
indicators of health and well-being improvements in psycho-social environments 
during childhood. Heights also address the data and methodological challenges of 
other well-being indicators. Processes of transition to democracy and country break 
up stand out as ideal experiments to estimate the impact of changes in such 
environments on adult heights. The health care system is only one of the many 
determinants of change in height, so the focus of this chapter is to capture all the 
broad determinants of health, not only health care.  A unique dataset containing 
records on individual heights in the Czech Republic and Slovakia is exploited to 
ascertain the retrospective welfare effects of the two distinct patterns of transition to 
liberal democracy and capitalism both countries followed after the split up of 
Czechoslovakia. The goal is to understand whether there has been a height gain for 
individuals who grew up under liberal democracy as opposed to communism. 
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Equally, the chapter aims to understand whether there is a height difference between 
the Czech and the Slovaks, as well as males and females, and the extent to which 
transition was an important determinant of these identified height gaps.  
 
Chapter 3 aims to single out the contribution of the health care system and its 
quality to changes in health outcomes using the methodologically more appropriate 
indicator of ‘avoidable’ mortality in the two countries between 1971 and 2008.  Age-
standardised mortality rates for mortality from ‘avoidable’ and other (non-avoidable) 
causes have been calculated through indirect standardisation to study national and 
regional trends between 1971 and 2008. The chapter investigates a hypothesis of an 
overall decline in ‘avoidable’ mortality relative to non-avoidable mortality, as well as 
condition specific trends. Specifically, whether there has been convergence or 
divergence in trends between Slovakia and Czech Republic as an indicator of the 
quality and effectiveness of their health care systems. Finally, given the countries’ 
regional heterogeneity, the chapter examines regional variations in ‘avoidable’ 
mortality and seeks to provide condition specific explanations for bad performance.  
 
Chapter 4 focuses on the relationship between health care resources and ‘avoidable’ 
mortality. The consensus in the literature points out that health care resources do not 
consistently explain variations in health outcomes and instead other socio-economic 
and life-style variables should be investigated. However, the health outcome 
measures usually used in these studies capture a range of determinants where the 
quality of health care provision is only one of the many factors. This chapter sets out 
to test whether ‘avoidable’ mortality is an improved health outcome indicator that 
better captures the contribution of the health care system to see whether a negative 
relationship with health care inputs can be established. Some earlier evidence on the 
link between health care inputs and ‘avoidable’ mortality is inconclusive. This may 
reflect the fact that the potential endogeneity of physician supply and time 
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dependence of mortality rates have not been taken into consideration. Investigating 
the association between health care inputs and ‘avoidable’ mortality by using 
instrumental variables and dynamic panel modelling circumvents this problem. 
‘Avoidable’ mortality rates were used as the health outcome measure, and the number 
of physicians, nurses and beds were used to capture health care inputs at the regional 
level.  
 
Chapter 5 studies one particular aspect of health care performance, namely the 
quality of ambulatory care in Slovakia by examining potentially preventable 
hospitalisations for two ACSCs (asthma and diabetes) and the relationship with 
appropriate care.  Anonymous patient level panel data from 2001-2008 from the 
administrative database of the largest public health insurance company in Slovakia is 
used. All newly diagnosed patients in 2002 and disease free in 2001 with asthma and 
diabetes are selected and followed for six years. Descriptive statistics are carried out 
to identify deficiencies in processes of care constructed on the basis of clinical 
guidelines. Then multilevel methods are applied to see whether appropriate and 
inappropriate processes of care are associated with variations in preventable 
hospitalisations for diabetes and asthma.  
 
Chapter 6 concludes by summarising the overarching findings and contributions of 
the thesis, followed by results of individual chapters.  It then provides 
recommendations for research and policy, and notes the limitations of this research. 
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Chapter 2. Using height to assess overall well-being and 
health system performance before and after 
Czechoslovakia’s transition and break up  
 
2.1. Introduction 
 
The impact of the regime change from communism to democracy in 1989 and the 
split of Czechoslovakia in 1993 have usually been assessed with standard economic 
and health outcome indicators. The review of the literature in Chapter 1 found that 
the indicator of height is increasingly used to assess the overall well-being in a 
country as it is considered to be the “mirror of the society” (Tanner, 1986).  It has 
been used to assess the impact of political regime change in several countries, 
including East and West Germany or Spain. This chapter therefore empirically 
examines the effect of political and economic liberalisation (and more specifically the 
transition from communism to a liberal democracy and further country break up of 
Czechoslovakia10) on a retrospective measure of health and well-being – adult human 
heights. The goal is to understand how institutional reforms have reflected in the 
expansion of overall standard of living, and how individual and political rights fared 
in Slovakia and the Czech Republic by studying changes in human stature. The 
assumption is that political and economic changes that occurred after 1989 in 
Czechoslovakia have overall benefited the society and should be reflected in a height 
increase. Heights are examined by income terciles and a number of covariates 
including gender, education, employment and others are controlled for. Furthermore, 
the goal is to explore whether there is a height difference between Slovaks and 
Czechs.  
                                                        
10 For simplicity purposes, in the remaining of the chapter we will be using the term 
“democracy” even though we are referring more broadly to political and economic 
liberalisation. 
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However, testing for the height effects of wider political and economic liberalisation 
processes (such as the adoption of a liberal democracy and political break up) is a 
task that can be contentious on several grounds. First, the benefits from transition to 
a liberal democratic society as well as separation of Czechoslovakia are likely to come 
with a lag, in part because the effect of height enhancing processes is intermediated 
by other reforms (e.g., the development of social protection, implementation of 
liberalisation reforms etc). Evidence shows that during the time of transition, a 
deterioration in living standards was occurring in Eastern Europe before any visible 
improvements took place (Adeyi, Chellaraj, Goldstein, Preker, & Ringold, 1997; 
Garner & Terrell, 1998; Milanovic, 1998; Stillman, 2006; Svejnar, 2002).  Second, 
identifying the effect of the break up is complex even though one could argue that 
both Slovakia and the Check Republic benefited (or suffered) from it.  Both countries 
lost some scale benefits and at the same time they may have overcome the 
complexities of public decision making in multinational environments.  In addition, 
the emergence of new countries in Easter Europe, including the Czech Republic and 
Slovakia, implied huge needs for institutional build-up since their national 
institutions were likely to be underdeveloped and with little experience of running 
their own affairs (Milanovic, 1998). Hence, the direction of the effect is  empirically 
contested.  
 
The literature comparing Czech Republic and Slovakia post-secession focuses mainly 
on the degree of similarity or difference in the political context and economy 
(Bartosova & Zelinsky, 2013; Meszaros, 1999) as well as social and health outcomes 
post 1993 (Potucek & Radicova, 1997). However, most of the analyses consider 
democratisation and secession effects together, which leads us to the third issue, the 
problem of correctly identifying the effect of the break up from that of 
democratisation as both have coincided. Instead, how the trajectories of both 
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countries differed after the transition to democracy and independence can be 
identified. Just like the literature on secession, the evidence on the democratic 
transition and its effects is even more extensive, covering all areas from economic 
welfare and institutional changes (Hausner, Jessop, & Nielsen, 1995; Inglot, 2008, 
2009; Kostecki, Zukrowska, & Goralczyk, 2000; Milanovic, 1998; Whitefield, 1993; 
Winiecki & Kondratowicz, 1993) to health effects (Bobak & Feachem, 1992; Cornia & 
Paniccià, 2000; Ginter, Simko, & Wsolova, 2009; Lawson & Nemec, 2003; Stillman, 
2006). Broadly speaking, the evidence points to the difficult transition years with 
Czech Republic having performed better than Slovakia on a range of aspects. Finally, 
an inescapable issue lies in distinguishing the effects of economic liberalisation which 
may bring reforms that improve access to food sources and new technologies from 
the introduction of democratic decision-making systems (Tavares & Wacziarg, 
2001).11 Difference by income terciles would be expected to contain some information 
that allows us to ascertain whether one effect over the other prevailed.  
 
The next section contains detailed information on data and methods. Section four 
reports on the results and robustness checks. Finally, section five presents the 
discussion and conclusions of the chapter. 
 
2.2. Data and methods 
 
Data and variables 
 
This study uses the data from the 2003 World Health Survey (WHS) which is the 
baseline household survey for health status of populations and outcomes related to 
investments and functioning of health systems. The survey identified all adult 
                                                        
11 Indeed, while political liberalisation is assumed to involve those individuals who uphold 
democratic values in collective decision-making, economic liberalisation refers solely to the 
areas of economic activity and commerce. 
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population over age 18 years old as the sample and employed a probability sampling 
design where every single person had a known non-zero chance of being selected into 
the survey sample; either with single or multi-stage random cluster sampling. 
Individual probability sampling weights were applied to adjust for the probability of 
selection into the sample  (World Health Organization, 2003). According to the WHS 
individual country reports provided by the WHO, the number of interviewed 
households was 935 (total 3913 - 24% of selected households) in the Czech Republic 
and 1811 (total of 2539 - 71% of selected households) in Slovakia; the number of 
interviewed individuals was 935 (total selected 949 – 99% of selected individuals) 
and 2461 (total selected 2471 – 99% of selected individuals), respectively. The 
household level figures for Czech Republic suggest that there may have been an 
important selection bias and therefore the sample may not correctly represent the 
Czech population. In particular, non-response bias may be the key concern where 
those who participated (potentially the healthier population) are different from non-
participants (Delgado-Rodríguez & Llorca, 2004).   
 
However, according to the official WHS country report of the Czech Republic, 
prepared by the Institute of Health Information and Statistics Czech Republic 
(Institute of Health Information and Statistics Czech Republic, 2004), the sample is 
representative of the population. The findings of the report were confirmed by the 
Director of the Institute through personal correspondence (Ing. Jiri Holub, March 14, 
2014). According to this report, 1918 individuals were finally eligible and contacted, 
and responses were obtained from 935, resulting in a response rate of 55.1% 
(excluding individuals who could not be contacted for objective reasons), which is 
higher than the response rate in the report provided by the WHO. The same report 
states that while the structure of the respondents differs in some characteristics from 
the structure of the adult Czech population, it confirms previous findings and none of 
the important population groups were significantly under or overestimated. The 
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following differences were identified when compared to the overall Czech population. 
With respect to sex, there were somewhat more women and less men in the sample 
than the overall population (55.2% compared to 52% and 44.8% compared to 48%, 
respectively); with respect to age, women and men younger than 30 and men 
between 40-49 were somewhat underrepresented, while men over the age of 70 were 
somewhat overrepresented. Similarly, the report compares the WHS sample to the 
overall population for regional representation, ethnicity, family status, education, 
economic activity and employment, household composition and finds that the sample 
is broadly similar to the overall population. Perhaps, the most important finding is 
that lowest participation in the survey is seen by the least educated who may be 
suffering from worse health.  
 
Furthermore, the report identifies the proportions of individuals out of a total of 1918 
individuals who did not respond to the survey and the underlying reasons: the 
individual or the household was unwilling to participate (26.5%); the individual was 
not at home (13.2%); the individual was unsuitable (1.2%); the individual did not live 
at the address (6.2%); the individual could not be contacted (1%); the individual died 
(1.4%); and individuals were not contacted at all (1.8%). In addition, an analysis of 
homogeneity between the responders and the non-responders was carried out. More 
women, less men, more older people and citizens of smaller towns responded to the 
survey. While these differences can be adjusted for by using sampling weights, it 
remains difficult to adjust for other non-observable differences between respondents 
and non-respondents. For example, the healthiest or the least healthy may have been 
those who did not participate (Institute of Health Information and Statistics Czech 
Republic, 2004). In addition, the report notes that the complexity of the survey in 
terms of topics covered and time required to complete it, as well as implementation 
issues are potentially other relevant reasons for 26.5% unwilling to participate.  
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Therefore, the actual sample used in this study (after accounting for missing 
observations for height) contains 1806 Slovak and 920 Czech individuals. 
Distribution by age groups can be seen in Figure 11.  
 
Figure 11. Distribution of the population by age categories 
 
 
 
The survey includes information on self-reported height of the individuals as well as 
information on other important variables that are controlled for including education, 
income, rural or urban location, employment and others. The control variables are 
based on the conceptual framework of determinants of height defined by Steckel 
(1995).  Table 5 below summarises the descriptive statistics for all the variables used 
in the analysis.  
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Table 5. Variable description 
 
Variable Variable description Obs 
height =adult height in cm 2726 
gend =1 if male; 0 if female 2726 
co =1 if Czech Republic; 0 if Slovakia 2726 
popul_cz = number of Czechs 920 
popul_sk = number of Slovaks 1806 
age70_98 =1 if the individual was born between 1910-1933; 0 
otherwise 
2726 
age60_69 =1 if the individual was born between 1934-1943; 0 
otherwise 
2726 
age50_59 =1 if the individual was born between 1944-1953; 0 
otherwise 
2726 
age40_49 =1 if the individual was born between 1954-1963; 0 
otherwise 
2726 
age30_39 =1 if the individual was born between 1964-1973; 0 
otherwise 
2726 
age18_29 =1 if the individual was born between 1974-1985; 0 
otherwise 
2726 
educ1 =1 if individual has primary education or less; 0 otherwise 2724 
educ2 =1 if individual completed secondary education; 0 
otherwise 
2724 
educ3 =1 if individual completed high school/equivalent 
education; 0 otherwise 
2724 
educ4 =1 if individual completed college or higher level 
education; 0 otherwise 
2724 
job1 =1 if individual is working; 0 otherwise 2702 
income estimated permanent income of individual 2596 
qincome1 bottom income tercile 2596 
qincome2 middle income tercile 2596 
qincome3 top income tercile 2596 
demage Years spent under democracy before the age of 20 2726 
indage Years spent under independence before the age of 20 2726 
demd =1 if individual was raised at least 1 year under democracy 
before age 20; 0 otherwise 
2726 
indd =1 if individual was raised at least 1 year in independent 
country before age 20; 0 otherwise 
2726 
dempolity Years spent under democracy from 1993-2003, adjusted 
for the “quality of democracy” with the Polity IV 
democracy score 
2726 
language =1 if individual reported a language; 0 otherwise 2726 
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Predicted permanent income (income) is used as a proxy for wealth or socio-
economic development (Filmer & Pritchett, 1999; Komlos & Baur, 2004; Persico, et 
al., 2004) as the dataset did not contain other suitable income variable.  A variable of 
income was created using factor analysis from a series of questions on the ownership 
of particular household objects (e.g. number of cars, TVs, rooms, ownership of phone, 
video camera, computer, access to internet etc.). Polychoric correlation was first 
carried out as the variables are constructed as counts or dummies followed by factor 
analysis to reduce the several correlated variables into one variable. The key steps in 
factor analysis are choosing the relevant variables and determining the number of 
factors. The ownership of the following variables were used as these are expected to 
better predict income:  car, television, bike, video player, stereo, DVD player, washing 
machine, dishwasher, vacuum cleaner, fridge, cell phone, computer and internet. 
Several other variables were excluded due to high uniqueness values or because there 
was very little variation. The predicted income variable was then standardised and 
converted into three income thirds (poorest third, middle third and rich third). Given 
that nutrition is a function of income, a positive association between height and 
income is expected; however, it should also be noted that the height-income 
relationship is not stable in the face of epidemiological conditions; at a given income, 
improvements in public health, personal life style and childcare practices, the 
prevalence of disease may be reduced and physical growth enhanced (Peracchi, 2008; 
Steckel, 2009). Furthermore, the literature suggests that there are diminishing 
returns to nutrient intake suggesting that the height of the rich is expected to increase 
by less than is the decline in the height of the poor; this results in a net negative effect 
where holding income constant, increased inequalities imply that average height 
diminishes (Komlos, 2009).  Therefore, it can be expected that the richest individuals 
benefited less from the transition than the poorest group.  
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Education (educ) is used as a proxy of individual abilities and a predictor of an 
individual’s efficiency in health production (Costa-Font & Gil, 2008; D.S. Kenkel, 
1991). It is presented in four categories from those with less than primary education 
completed all the way to those with a post-graduate degree completed. In addition, 
we control for urban and rural differences in height as those in urban areas are more 
likely to have easy access to resources (Costa-Font & Gil, 2008). The variable job 
captures the employment category of the individual which was aggregated into two 
major groups: employed and unemployed. A dummy variable was included to capture 
the country effect (co) – Slovakia and Czech Republic. Six age categories represent 
the effect of the different birth cohorts, where the 1974-1985 birth cohort was selected 
as the reference category. Finally, the variable language is a proxy variable for 
ethnicity. The variable cannot be interpreted as it stands given the large number of 
missing values which may not be missing randomly but instead may be capturing 
individuals belonging to one of the important ethnic minorities in Czech Republic 
and Slovakia (e.g. Roma, Hungarians). However, it was still considered important to 
be controlled for and was included as a dummy variable with the value of 1 if a 
language was reported by the individual and zero for all the missing values.  
 
The key dependent variables are represented by the number of years a person has 
lived under democracy (damage) and independence (indage) before they reach 20 
years of age.  For democracy (1989), these are individuals aged 18 to 33 year in year 
2003 (birth cohorts 1970 - 1985) who lived their first 20 years between 14 to 1 year 
under democracy (4 to 19 years under communism). All the older individuals lived all 
the years before they reach 20 years of age under communism. Similarly for 
independence (1993), individuals aged 18 to 30 in year 2003 (birth cohorts 1973-
1985) lived their first 20 years between 11 to 1 year as part of an independent country 
(or 7 to 19 years as part of Czechoslovakia). These variables were first included as 
dummy variables with a value of 0 for those who were raised zero years under 
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democracy (demd) independent (indd) country and 1 otherwise. The purpose is to see 
whether being raised any amount of years under a democracy/ independence as 
opposed to none matters or it’s rather the increasing number of years that has an 
impact.  
 
Furthermore, the “quality” of the democratic years is also controlled for when an 
adjusted democracy variable is included to see whether the results are consistent. The 
type of democracy the two countries had immediately after the change of the regime 
versus several years later may change depending on the political situation and 
reforms implemented. Therefore the Polity IV12 institutionalised democracy variable 
(dempolity) was used to adjust for the “quality” of the democratic years after 1993 for 
independent Slovakia and Czech Republic. In other words, whether someone was a 
child during the 1993-1997 democratic years may not be the same as growing up 
under the 2000-2003 democratic years and later. Under the Polity IV project, 
institutionalised democracy consists of three key elements: i) presence of institutions 
and procedures through which citizens can express effective preferences about 
alternative policies and leader; ii) the existence of institutionalized constraints on the 
exercise of power by the executive; iii) the guarantee of civil liberties to all citizens in 
their daily lives and in acts of political participation. Other aspects of plural 
democracy, such as the rule of law, systems of checks and balances, freedom of the 
press, and so on are means to, or specific manifestations of, these general principles 
(Center for Systemic Peace). The “Polity Score” ranges from -10 (hereditary 
monarchy) to 10 (consolidated democracy) in any given year and was used to weigh 
the years spent under democracy. Both for Slovakia and the Czech Republic the 
scores were positive (7 and above) for the entire period under study so the weights 
                                                        
12 The goal of the Polity IV project is to code the authority characteristics of states in the world 
system for purposes of comparative, quantitative analysis. It has become the most widely used 
resource for monitoring regime change and studying the effects of regime authority (Center 
for Systemic Peace). 
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used were between 0.7 and 1. These weighted years were then added up to obtain an 
adjusted democracy variable. For both types of democracy variables and 
independence variable a positive association with height was expected. However, as 
the independence and democracy variables are likely to be confounded and the 
changes the occurred as a result of one or the other transition cannot be 
appropriately controlled for, these are included in separate regressions.  
 
Finally, the following interaction terms are also included: two-way interaction 
variables between country and years under democracy/independence, income and 
years under democracy/independence, income and country, as well as a three-way 
interaction between income terciles, years under democracy/independence. The goal 
is to see whether the effect of democracy was country or income group dependent, 
especially given the fact the Czech Republic was initially performing significantly 
better on many grounds than Slovakia. As the direct interpretation of three-way 
interactions is complicated, where the term is significant, additional visual analysis is 
carried out. This was done by graphing the slopes of height by one of the continuous 
variables, while allowing for the other two categorical variables to differ. Then the 
slopes were calculated followed by a test of differences in slopes (Institute of 
Research and Digital Education, 2013).  
 
Methods 
 
A classical ordinary least squares (OLS) regression model is applied to identify the 
effect of democracy and independence on the mean height of the population, as well 
as the other control variables on height.  The model for the effect of democracy is as 
follows:  
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H = f (democracy, gender, country, age, education, job, income, language) 
 
Alternatively, for independence it is: 
 
H = f (independence, gender, country, age, education, job, income, language) 
 
More specifically, the models can be expressed as: 
 
++++++= iiiiii jobeducagegenddemocracyHeight 543210 ββββββ    (1)
  
iiii languagecoincome εβββ ++++ 876  
 
Or  
 
++++++= iiiiii jobeducagegendceindependenHeight 543210 ββββββ    (2)
  
iiii languagecoincome εβββ ++++ 876  
 
for observations i = 1…n, where democracy and independence are either a continuous 
variable (demage or indage) or a dummy variable (demd or indd) as described above;  
  itε  is the unobserved random error which captures random factors that may affect 
height.   
 
2.3. Results 
 
A height difference can be observed between males and females as well as between 
the Slovak and the Czech population by age cohorts (Figure 12).  There is an 
increasing height trend across the age cohorts, where older generations are shorter 
than the younger ones. The largest difference between the two countries for males 
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appears to be for those aged 60-69 (born between 1934-1943) and then again for ages 
30-39 (born 1964-1973); for females it is ages 79-98 (born between 1905-1933) and 
ages 40-49 (born between 1954-1963). Overall, the difference over age cohorts 
appears to be more important than the difference between the two countries.  
 
Figure 12. Height by age cohorts, gender and country in 2003 
 
 
 
The average height figures by age groups, gender and country used in Figure 12 are 
presented in Table 6.  The range for Slovak males between the oldest and the 
youngest age groups is as much as 8.79cm, followed by Czech males (8.41cm), Slovak 
females (6.99cm) and Czech females (5.97).  
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Table 6. Mean height by gender and country, 2003 
 
 SLOVAKIA  CZECH  
 Mean height Std. Dev. Mean height Std. Dev. 
WOMEN     
18_29 167.69 5.68 168.55 6.53 
30_39 166.32 5.66 166.17 6.38 
40_49 164.63 5.98 166.39 7.28 
50_59 164.09 5.74 164.35 5.35 
60_69 161.83 5.80 162.70 5.53 
70_98 160.70 5.30 162.58 5.81 
MEN     
18_29 180.79 7.44 180.24 7.46 
30_39 178.88 7.27 180.84 6.95 
40_49 178.61 6.85 178.52 7.45 
50_59 175.82 5.67 176.09 6.51 
60_69 171.67 9.67 174.92 6.16 
70_98 172.00 6.91 171.83 6.14 
Note: No adjustment with weights was carried out 
 
 
The average height also differs across the income terciles within and across countries 
(Table 7 and Figure 13). The average height of the Slovak females in the lowest tercile 
is only 164.6cm, increasing to 166.1cm in the mid and top terciles. Slovak males’ 
height gradually increases across tercile from 176.8cm to 178.6cm and 180.3cm 
respectively.  Czech females are 164.4cm in the lowest tercile, 164.8cm in the mid and 
increases to 167.1cm in the top group. Finally, the poorest Czech males are 175.3cm, 
increasing to 177cm and 180.2cm in the mid and highest income terciles respectively.  
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Table 7. Average height by terciles, gender and country 
 
Variable Obs Mean Std. Dev. Min Max 
      
q1_female_SK 408 164.6237 2.242089 160.5122 167.4286 
q1_male_SK 143 176.7851 3.970725 166.125 180.2407 
q1_female_CZ 190 164.4199 2.497327 161.3428 168.36 
q1_male_CZ 133 175.2617 4.065685 169.8333 181.9 
      
q2_female_SK 352 166.1261 2.048122 163.0667 168.2391 
q2_male_SK 202 178.599 1.371597 173 179.9302 
q2_female_CZ 185 164.82 1.472075 162.7586 166.7778 
q2_male_CZ 140 177.014 2.228076 173.9583 179.8182 
      
q3_female_SK 380 166.0745 1.223809 159.6667 167.6667 
q3_male_SK 234 180.312 1.734207 174.6667 181.3617 
q3_female_CZ 123 167.0809 2.448351 162.8 170.75 
q3_male_CZ 130 180.2097 2.761017 173.7778 183.4333 
Note: No adjustment with weights was carried out 
 
Figure 13 graphs the height difference across terciles by age cohorts where it can be 
seen that regardless of the income tercile, height increases from the oldest to the 
youngest generations. The graphs also suggest some variation in the mean height for 
males and females across the age cohorts and income terciles, with the richest Czechs 
being the tallest across cohorts.  
 
Figure 13. Height by income tercile, age group, gender and country, 2003. 
Poorest (q1), middle (q2), top (q3) 
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First the results where the key independent variable democracy is included in the 
analysis as a dummy variable (=1  for those who spent at least 1 year growing up 
under democracy and  zero otherwise) are presented (Table 8).  It can be seen that 
the sign and the significance of the variable changes depending on the model 
specification but is only positively significant in Models 3 and 7, similarly to the 
country effect.  However, there is a significant income, gender and age cohort effect in 
all the models. As expected, the results show that males are taller than females, older 
generations are shorter relative to the youngest generation and income has a positive 
effect on height. The cohort effects show that anyone born before 1973 is significantly 
shorter than the youngest cohort born between 1974 and 1985 that we used as the 
reference category.  When income was studied in income terciles (Model 6), height of 
the respondents in the poorest tercile and mid tercile is 1.97cm and 2.23cm less than 
the height of the richest tercile. Next, a range of different interactions were included 
(Model 3-7). In Model 3 the interaction between country and democracy was studied 
and results show that for Slovaks, height for those who were raised under democracy 
as opposed to communism is 1.504cm more; for Czechs, on the other hand, the height 
of those raised under democracy is 0.4cm less that for those raised under 
communism.  Another way of interpreting this interaction is to say that under 
communism, height of Czechs was 1.4cm more than the height of Slovaks; for those 
who grew up under democracy, height of the Czechs is 0.5cm less than the height of 
Slovaks. In other words, these results seem to suggest that the Slovaks have benefited 
more from democracy. 
 
In Model 4 the significant interaction between income and democracy was studied 
which shows that with a unit increase in income, height increases by 1.2cm for those 
under communism and only by 0.6 for those growing up under democracy; or that 
height is 0.3cm more for those growing up under democracy as opposed to 
communism when income equals zero and this difference decreases by 0.6 for each 
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additional unit of income. These results suggest that while for a given income height 
is more under democracy then communism, higher income benefits an individual 
more under communism.  In Model 5 the interaction between income and country 
was studied and there was no significant effect.  Finally, in Model 7 all the controls 
are included together and there is positive significant effect of democracy and country 
(Czechs), as well as gender, language, education and age cohorts, while the three-way 
interaction term is not significant. Increase in the years of education is associated 
with a significant increase in height when compared to the reference group of people 
with primary and less years of schooling. The log-likelihood ratio test comparing the 
restricted models to the less restricted models showed that adding interactions as 
well as controlling for education and employment resulted in a statistically significant 
improvement in the model fit compared to a model where only income is controlled 
for.  
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Table 8. OLS regressions of years lived under democracy as a dummy variable on 
height with different controls 
 
 (1) (2) (3) (4) (5) (6) (7) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 Eq.5 Eq.6 Eq.7 
        
demd 0.166 0.0363 1.504** 0.268 0.0554 -0.0204 1.631** 
 (0.558) (0.575) (0.726) (0.586) (0.575) (0.573) (0.742) 
co 0.389 0.388 1.415*** 0.356 0.288 0.481 1.641*** 
 (0.291) (0.296) (0.429) (0.297) (0.314) (0.296) (0.433) 
income  0.938*** 0.912*** 1.180*** 0.744***  0.717* 
  (0.145) (0.145) (0.191) (0.248)  (0.388) 
demd_co   -1.940***    -1.812*** 
   (0.588)    (0.631) 
demd_inc    -0.574*   -0.831 
    (0.293)   (0.509) 
inc_co     0.287  0.453 
     (0.298)  (0.434) 
demd_inc_co       0.398 
       (0.619) 
language       1.029 
       (4.310) 
gend 13.19*** 13.05*** 13.01*** 13.04*** 13.04*** 13.04*** 12.59*** 
 (0.249) (0.254) (0.254) (0.254) (0.254) (0.253) (0.251) 
geog       0.232 
       (0.323) 
age30_39 -1.364*** -1.266*** -1.039** -1.289*** -1.276*** -1.436*** -1.188** 
 (0.456) (0.467) (0.471) (0.466) (0.467) (0.465) (0.471) 
age40_49 -1.762*** -1.685** -1.428** -1.719** -1.678** -1.763** -1.325* 
 (0.675) (0.692) (0.695) (0.692) (0.692) (0.691) (0.688) 
age50_59 -5.323*** -5.148*** -5.042*** -5.095*** -5.131*** -5.256*** -4.838*** 
 (0.697) (0.716) (0.715) (0.716) (0.716) (0.712) (0.704) 
age60_69 -5.707*** -5.219*** -5.195*** -5.117*** -5.191*** -5.415*** -4.734*** 
 (0.742) (0.762) (0.761) (0.764) (0.763) (0.758) (0.764) 
age70_98 -7.588*** -6.836*** -6.833*** -6.707*** -6.800*** -7.083*** -6.015*** 
 (0.704) (0.727) (0.725) (0.729) (0.728) (0.721) (0.736) 
educ2       1.534*** 
       (0.403) 
educ3       1.376*** 
       (0.391) 
educ4       1.999*** 
       (0.523) 
job1       0.306 
       (0.313) 
qincome1      -1.977***  
      (0.327)  
qincome2      -2.252***  
      (0.304)  
Constant 167.6*** 167.3*** 166.3*** 167.2*** 167.3*** 169.0*** 163.5*** 
 (0.621) (0.641) (0.701) (0.641) (0.645) (0.664) (4.403) 
        
Observations 2,726 2,596 2,596 2,596 2,596 2,596 2,572 
R-squared 0.567 0.575 0.577 0.576 0.575 0.578 0.576 
 
 
The complete sets of regressions where democracy is included as a continuous 
variable are summarised in Table 9.  The results show that with an additional year 
spent under democracy while growing up there is a small significant positive 
association with height, contrary to the findings above where democracy was 
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included as a dummy variable. The effect of the other variables (education, gender, 
income) is still significant in the same direction even though the size of the 
coefficients differs somewhat. However, age cohort is only significantly negatively 
associated with the height of the youngest age cohort for individuals born before 
1953.  In other words, there is no significant difference in height between the three 
youngest cohorts, all of which grew up predominantly under communism. Again, the 
country effect is not consistently significant across the models and Model 6 shows 
that there is a significant effect by income terciles where the bottom and middle 
tercile are shorter than the top tercile. Also, there is a significant effect of job where 
those employed are significantly taller than the unemployed, and a significant 
education effect.  Interactions are again included in models 3, 4 and 5 and only the 
interaction between country and democracy is significant (Model 3). Now democracy 
is a continuous variable so the interpretation is slightly different from before. With an 
additional year spent under democracy while growing up, height increases by 
0.286cm for Slovaks and 0.148cm for Czechs. In other words, height is 1.141cm more 
for Czechs than Slovaks if a person spent zero years under democracy and this 
difference in height becomes smaller for each additional year under democracy 
(1.141-0.138*demage).  Similarly as before, results indicate that democracy seems to 
be benefiting the Slovaks more than the Czechs. In Model 7 the three-way interaction 
is significant and the model is also preferred to the model with income only, based on 
the results of the likelihood ratio test.  
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Table 9. OLS regressions of years lived under democracy as a continuous 
variable on height with different controls 
 (1) (2) (3) (4) (5) (6) (7) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 Eq.5 Eq.6 Eq.7 
        
demage 0.264*** 0.217*** 0.286*** 0.221*** 0.222*** 0.202*** 0.432*** 
 (0.0714) (0.0735) (0.0783) (0.0754) (0.0737) (0.0734) (0.110) 
1.co#c.demage       -0.251** 
       (0.105) 
2.qincome       0.643 
       (0.840) 
3.qincome       1.353 
       (0.843) 
1o.co#1b.qincome       0 
       (0) 
1.co#2.qincome       -0.135 
       (0.920) 
1.co#3.qincome       0.358 
       (0.933) 
2.qincome#c.demage       -0.291*** 
       (0.112) 
3.qincome#c.demage       -0.286** 
       (0.111) 
1o.co#1b.qincome#co
.demage 
      0 
       (0) 
1.co#2.qincome#c.de
mage 
      0.0340 
       (0.140) 
1.co#3.qincome#c.de
mage 
      0.379*** 
       (0.137) 
gend 13.12*** 12.99*** 12.97*** 13.00*** 12.98*** 12.98*** 12.49*** 
 (0.249) (0.254) (0.254) (0.255) (0.255) (0.254) (0.251) 
language       1.065 
       (4.279) 
geog       0.196 
       (0.322) 
age30_39 0.933 0.662 0.521 0.668 0.685 0.390 -0.226 
 (0.739) (0.758) (0.759) (0.759) (0.758) (0.758) (0.756) 
age40_49 0.822 0.535 0.394 0.542 0.572 0.357 -0.149 
 (0.834) (0.856) (0.857) (0.857) (0.857) (0.854) (0.855) 
age50_59 -2.752*** -
2.950*** 
-3.191*** -
2.934*** 
-2.901*** -3.154*** -3.625*** 
 (0.848) (0.868) (0.872) (0.871) (0.869) (0.867) (0.874) 
age60_69 -3.145*** -
3.036*** 
-
3.330*** 
-3.013*** -2.974*** -3.324*** -3.417*** 
 (0.882) (0.902) (0.909) (0.906) (0.904) (0.901) (0.945) 
age70_98 -5.017*** -
4.648*** 
-
4.958*** 
-
4.623*** 
-4.577*** -
4.986*** 
-4.715*** 
 (0.853) (0.874) (0.882) (0.880) (0.876) (0.873) (0.929) 
educ2       1.505*** 
       (0.405) 
educ3       1.409*** 
       (0.397) 
educ4       2.063*** 
       (0.528) 
job1       0.630** 
       (0.318) 
dem_co   -0.138**     
   (0.0543)     
co 0.458 0.458 1.141*** 0.454 0.342 0.542* 1.335** 
 (0.290) (0.296) (0.400) (0.297) (0.313) (0.296) (0.637) 
income  0.909*** 0.894*** 0.937*** 0.679***   
  (0.145) (0.145) (0.179) (0.248)   
dem_inc    -0.00755    
    (0.0284)    
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inc_co     0.340   
     (0.298)   
qincome1      -1.924***  
      (0.326)  
qincome2      -2.184***  
      (0.305)  
Constant 165.0*** 165.0*** 164.7*** 165.0*** 165.1*** 166.9*** 161.8*** 
 (0.801) (0.825) (0.834) (0.827) (0.826) (0.853) (4.439) 
        
Observations 2,726 2,596 2,596 2,596 2,596 2,596 2,572 
R-squared 0.569 0.576 0.577 0.576 0.577 0.579 0.583 
 
 
The fact that the interaction term between country, years under democracy and 
income terciles is significant, suggests that the slopes of height on years under 
democracy are not the same across countries and terciles (Figure 14). Many different 
comparisons can be made across the slopes, but only a few important ones are 
highlighted as follows. In Slovakia, there is a significant difference in the effect of 
years under democracy on height between the bottom and mid as well as the bottom 
and top tercile; the difference between the mid and top terciles is not significant. For 
the Czechs the difference is significant between the bottom and mid tercile, and the 
mid and top tercile. In the poor and mid terciles the Slovaks benefit more with 
increasing years of democracy while in the top tercile there is not difference between 
the two countries. These findings suggest that the effect of years spent under 
democracy has reflected in different height effects depending on the country and 
income tercile, where interestingly the flattest slopes can be observed for the mid-
tercile.  
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Figure 14. Slopes of height on years under democracy in Czech Republic and 
Slovakia across income terciles 
 
 
 
When the regression is decomposed by sex, the effects are quite different for men and 
women (Table 10 and 11).  The interaction terms were excluded for the purpose of 
simplicity.  For males, years under democracy is significantly associated with a height 
increase in all the models. The country effect shows that the Czech males are shorter 
than Slovak males. A large positive significant income effect both as a continuous 
variable and when included in income terciles can be noted, and there is significant 
positive education effect as years of completed education increase.  However, the 
results for the birth cohorts show an important difference where actually the birth 
cohorts 1954-1963 and 1964-1973 are significantly taller than the youngest birth 
cohort 1974-1985; the oldest birth cohort is significantly shorter than the youngest 
birth cohort. In other words, there appears to be height gain between the youngest 
age cohort growing up under democracy and the previous generation.  
 
1
6
5
1
7
0
1
7
5
1
8
0
1
6
5
1
7
0
1
7
5
1
8
0
0 5 10 15 0 5 10 15 0 5 10 15
0, 1 0, 2 0, 3
1, 1 1, 2 1, 3
F
it
te
d
 v
a
lu
e
s
Years spent under democracy before the age of 20
Graphs by country (=0 if Slovakia, 1 if Czech Republic) and terciles (1=bottom, 2=mid; 3=top)
98 
Table 10. OLS regressions of years lived under democracy on height with 
different controls – male 
 
 (1) (2) (3) (4) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 
     
demage 0.428*** 0.317** 0.301** 0.273** 
 (0.125) (0.127) (0.127) (0.134) 
co -1.538*** -1.729*** -1.592*** -0.785 
 (0.539) (0.537) (0.531) (0.542) 
income  1.968***  1.742*** 
  (0.251)  (0.251) 
geog    0.632 
    (0.597) 
language    6.520 
    (7.379) 
age30_39 3.473** 3.238** 3.039** 2.253* 
 (1.350) (1.365) (1.354) (1.356) 
age40_49 3.876*** 2.989** 2.727* 2.584* 
 (1.501) (1.518) (1.504) (1.531) 
age50_59 -1.816 -2.268 -2.452 -2.788* 
 (1.538) (1.552) (1.550) (1.584) 
age60_69 -1.386 -1.384 -1.833 -1.485 
 (1.637) (1.653) (1.644) (1.754) 
age70_98 -4.168*** -3.565** -3.895** -3.087* 
 (1.520) (1.535) (1.525) (1.682) 
educ2    2.277*** 
    (0.753) 
educ3    1.383* 
    (0.720) 
educ4    2.559*** 
    (0.905) 
job1    1.109* 
    (0.573) 
qincome1   -4.743***  
   (0.553)  
qincome2   -3.716***  
   (0.510)  
Constant 177.7*** 177.8*** 181.3*** 168.1*** 
 (1.446) (1.475) (1.513) (7.592) 
     
Observations 1,025 976 976 967 
R-squared 0.222 0.266 0.284 0.261 
 
 
For women (Table 11), years spent under democracy while growing up is not 
significantly associated with a height increase in any of the regressions, while again 
there is a significant country effect; however, it is the Czech women who are taller 
than the Slovak women. Education also has a significant effect on height but whether 
or not women are employed does not seem to affect height. Here income is not 
significantly associated with an increase in height and when included in income 
terciles, it is only the middle tercile that is significantly shorter than the top tercile. 
All the cohorts of women born before 1953 are significantly shorter than the youngest 
cohort but there is no significant difference between the youngest cohort and the next 
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two older cohorts. So to summarise the gender specific results, it is democracy, 
income and job that matters for men while for women there is no income or 
democracy effect, but a strong country effect.  
 
Table 11. OLS regressions of years lived under democracy on height with 
different controls – female 
 
 (1) (2) (3) (4) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 
     
demage 0.0967 0.0851 0.0971 0.107 
 (0.0824) (0.0849) (0.0847) (0.0883) 
co 1.725*** 1.811*** 1.894*** 2.107*** 
 (0.319) (0.329) (0.329) (0.342) 
income  0.0962  0.00384 
  (0.167)  (0.170) 
geog    0.0157 
    (0.360) 
language    -1.899 
    (5.031) 
age30_39 -1.018 -1.123 -1.185 -1.066 
 (0.820) (0.843) (0.842) (0.864) 
age40_49 -1.493 -1.494 -1.357 -1.205 
 (0.937) (0.962) (0.960) (0.990) 
age50_59 -3.742*** -3.950*** -3.935*** -3.620*** 
 (0.946) (0.970) (0.966) (0.995) 
age60_69 -4.861*** -4.915*** -5.062*** -4.543*** 
 (0.973) (0.997) (0.993) (1.063) 
age70_98 -5.563*** -5.580*** -5.843*** -4.960*** 
 (0.963) (0.990) (0.986) (1.062) 
educ2    0.884* 
    (0.452) 
educ3    1.710*** 
    (0.438) 
educ4    1.885*** 
    (0.631) 
job1    -0.153 
    (0.370) 
qincome1   0.422  
   (0.381)  
qincome2   -0.775**  
   (0.364)  
Constant 165.8*** 165.8*** 165.9*** 166.1*** 
 (0.895) (0.921) (0.951) (5.185) 
     
Observations 1,701 1,620 1,620 1,605 
R-squared 0.131 0.133 0.140 0.141 
 
 
Finally, the complete sets of regressions where democracy is included as a continuous 
variable adjusted with the Polity IV score are summarised in Table 12.  The results are 
very similar to those presented earlier without the adjustment. The significance of the 
coefficients does not change, only somewhat the magnitude depending on the Model.  
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Table 12. OLS regressions of years lived under democracy as a continuous 
variable adjusted for “quality” of democracy 
 
 (1) (2) (3) (4) (5) (6) (7) 
VARIABL
ES 
Eq.1 Eq.2 Eq.3 Eq.4 Eq.5 Eq.6 Eq.7 
        
dempolity 0.280*** 0.230*** 0.425*** 0.217** 0.231*** 0.217** 0.660*** 
 (0.0833) (0.0854) (0.108) (0.0881) (0.0854) (0.0852) (0.173) 
1.co#c.de
mpolity 
      -0.448*** 
       (0.168) 
2.qincome       0.375 
       (0.798) 
3.qincome       1.246 
       (0.795) 
1o.co#1b.q
income 
      0 
       (0) 
1.co#2.qin
come 
      0.0567 
       (0.878) 
1.co#3.qin
come 
      0.379 
       (0.885) 
2.qincome
#c.dempol
ity 
      -0.431** 
       (0.186) 
3.qincome
#c.dempol
ity 
      -0.465** 
       (0.184) 
1o.co#1b.q
income#c
o.dempoli
ty 
      0 
       (0) 
1.co#2.qin
come#c.d
empolity 
      0.0892 
       (0.218) 
1.co#3.qin
come#c.d
empolity 
      0.663*** 
       (0.213) 
gend 13.12*** 13.00*** 12.96*** 12.99*** 12.99*** 12.99*** 12.44*** 
 (0.250) (0.255) (0.254) (0.255) (0.255) (0.254) (0.251) 
language       1.168 
       (4.275) 
geog       0.231 
       (0.322) 
age30_39 0.405 0.231 0.437 0.224 0.215 0.00724 -0.222 
 (0.661) (0.675) (0.678) (0.675) (0.675) (0.675) (0.674) 
age40_49 -0.0402 -0.173 0.0888 -0.178 -0.182 -0.283 -0.326 
 (0.678) (0.692) (0.696) (0.692) (0.692) (0.690) (0.692) 
age50_59 -3.585*** -3.632*** -3.475*** -3.658*** -3.630*** -3.767*** -3.799*** 
 (0.702) (0.716) (0.717) (0.717) (0.716) (0.715) (0.715) 
age60_69 -3.964*** -3.704*** -3.603*** -3.741*** -3.690*** -3.923*** -3.575*** 
 (0.747) (0.762) (0.761) (0.764) (0.762) (0.761) (0.793) 
age70_98 -5.833*** -5.311*** -5.225*** -5.354*** -5.290*** -5.581*** -4.872*** 
 (0.712) (0.729) (0.729) (0.733) (0.730) (0.729) (0.773) 
educ2       1.533*** 
       (0.405) 
educ3       1.399*** 
       (0.395) 
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educ4       2.096*** 
       (0.528) 
job1       0.657** 
       (0.317) 
dempolity
_co 
  -0.242***     
   (0.0827)     
co 0.256 0.287 0.982*** 0.296 0.185 0.381 1.116* 
 (0.293) (0.298) (0.381) (0.298) (0.315) (0.298) (0.615) 
income  0.918*** 0.895*** 0.861*** 0.721***   
  (0.145) (0.145) (0.171) (0.248)   
dempolity
_inc 
   0.0259    
    (0.0415)    
inc_co     0.292   
     (0.298)   
qincome1      -1.954***  
      (0.326)  
qincome2      -2.198***  
      (0.305)  
Constant 166.0*** 165.9*** 165.1*** 165.9*** 165.9*** 167.6*** 162.1*** 
 (0.599) (0.615) (0.661) (0.616) (0.620) (0.642) (4.394) 
        
Observati
ons 
2,726 2,596 2,596 2,596 2,596 2,596 2,572 
R-squared 0.569 0.576 0.578 0.576 0.576 0.579 0.584 
 
 
The complete sets of regressions that look at the effect of years lived under 
independence are summarised in Table 13.  The independence dummy (zero as 
opposed to at least 1 year spent in an independent country) does not have a 
significant effect on height in any of the models. A significant positive country effect 
can be observed only in Models 3 and 7. Similarly to years spend under democracy, 
the results show that all the generations born before 1973 are significantly shorter 
than the youngest generation. With increased education, there is a significant positive 
effect on height, while job is not significant. There is a positive overall income effect 
on height (Model 2-5), as well as by income terciles where those in the bottom and 
mid terciles are significantly shorter than people in the top tercile. Only the 
interaction term between years under independence and country is significant 
(Model 3) and the three-way interaction between country, independence and income 
(Model 7).  The interaction in Model 3 suggests that for Slovaks, height for those who 
were raised in independent Slovakia as opposed to Czechoslovakia is 0.8cm more; for 
Czechs, on the contrary, the height of those raised in independent Czech Republic is 
1cm less that for those raised in Czechoslovakia.  Another way of interpreting this 
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interaction is to say that being raised in Czechoslovakia, height of Czechs was 1.23cm 
more than the height of Slovaks; for those who grew up in independent countries, 
height of the Czechs was 0.5cm less than the height of Slovaks. So again, as with 
democracy, the Czechs seem to have lost out more from independence than Slovaks.  
 
Table 13. OLS regressions of years lived under independence as a dummy 
variable on height with different controls 
 
 (1) (2) (3) (4) (5) (6) (7) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 Eq.5 Eq.6 Eq.7 
        
indd -0.0933 -0.520 0.780 -0.394 -0.526 -0.764 0.888 
 (0.727) (0.746) (0.863) (0.763) (0.746) (0.746) (0.877) 
co 0.393 0.389 1.230*** 0.379 0.289 0.481 1.478*** 
 (0.290) (0.296) (0.408) (0.296) (0.314) (0.295) (0.413) 
income  0.944*** 0.929*** 1.029*** 0.750***  0.838** 
  (0.145) (0.145) (0.181) (0.248)  (0.367) 
indd_co   -1.753***    -1.857*** 
   (0.587)    (0.642) 
indd_inc    -0.237   -1.048** 
    (0.302)   (0.502) 
inc_co     0.288  0.141 
     (0.298)  (0.411) 
indd_inc_co       1.279** 
       (0.633) 
gend 13.19*** 13.05*** 13.02*** 13.05*** 13.04*** 13.03*** 12.60*** 
 (0.249) (0.254) (0.254) (0.254) (0.254) (0.253) (0.251) 
language       0.805 
       (4.317) 
geog       0.246 
       (0.324) 
age30_39 -1.521** -1.709** -1.553** -1.690** -1.733** -2.052*** -1.726** 
 (0.702) (0.717) (0.717) (0.717) (0.717) (0.717) (0.712) 
age40_49 -2.021** -2.237*** -2.017** -2.224*** -2.256*** -2.503*** -1.950** 
 (0.817) (0.836) (0.838) (0.837) (0.837) (0.836) (0.831) 
age50_59 -5.583*** -5.699*** -5.599*** -5.655*** -5.706*** -5.990*** -5.465*** 
 (0.834) (0.853) (0.852) (0.855) (0.853) (0.850) (0.844) 
age60_69 -5.967*** -5.769*** -5.735*** -5.708*** -5.765*** -6.148*** -5.341*** 
 (0.871) (0.890) (0.889) (0.894) (0.890) (0.887) (0.897) 
age70_98 -7.848*** -7.384*** -7.368*** -7.315*** -7.373*** -7.815*** -6.634*** 
 (0.839) (0.860) (0.858) (0.864) (0.860) (0.856) (0.875) 
educ2       1.576*** 
       (0.403) 
educ3       1.346*** 
       (0.392) 
educ4       1.962*** 
       (0.523) 
job1       0.349 
       (0.314) 
qincome1      -2.007***  
      (0.327)  
qincome2      -2.277***  
      (0.305)  
Constant 167.9*** 167.8*** 167.0*** 167.8*** 167.9*** 169.8*** 164.4*** 
 (0.780) (0.799) (0.840) (0.801) (0.804) (0.831) (4.458) 
        
Observations 2,726 2,596 2,596 2,596 2,596 2,596 2,572 
R-squared 0.567 0.575 0.576 0.575 0.575 0.578 0.576 
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The significant interaction term between country, independence and income suggests 
that the slopes of height on income are not the same across countries and years under 
independence (Figure 15).  Our calculations and the graphs below suggest that there 
is a significant difference in slopes of income on height for Slovaks under 
Czechoslovakia as opposed to an independent Slovakia; the difference is not 
significant for Czechs. Also, there is a significant difference between Slovaks and 
Czechs after independence, with a more important gain in height for Czechs as 
income increases. So once income is interacted with country and independence, the 
Czechs are benefiting more; when income was not accounted for, the Slovaks seem to 
have benefited more.  The difference in slopes under Czechoslovakia between the 
Czech and Slovaks was not significant.  
  
Figure 15. Slopes of height on income by country and whether or not the person 
spent time growing up under independence  
 
Note: Top row represents Slovakia, bottom row Czech Republic. 
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Results where independence is included as a continuous variable are summarised in 
Table 14.  Again it can be seen that with an additional year spent in independent 
Slovakia or Czech Republic while growing up there is a significant positive effect on 
height, contrary to the earlier findings where independence was included as a dummy 
variable. These results resemble the results for democracy. The effect of the other 
variables (education, gender, income, income terciles) is still significant in the same 
direction even though the size of the coefficients differs somewhat. Here again age 
cohort is only significantly negatively associated with the height of the youngest age 
cohort for those born before 1953. In other words, there is again no significant 
difference in height between the youngest generation growing up almost entirely in 
an independent country and those growing up under Czechoslovakia.  The only 
interactions that are significant are the ones in Models 3 and the three-way 
interaction in Model 7. The interaction between independence and country in Model 
3 shows that with an additional year spent in independent countries while growing 
up, height increases by 0.4cm for Slovaks and 0.2cm for Czechs. In other words, 
height is 1cm more for Czechs than Slovaks if a person spent zero years under 
independence and this difference in height becomes smaller by 0.153 for each 
additional year under independence (1-0.153*indage).  In Model 7 the three-way 
interaction is significant and the model is also preferred to the model with income 
only, based on the results of the likelihood ratio test.  
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Table 14. OLS regressions of years lived under independence as a continuous 
variable on height with different controls 
 
 (1) (2) (3) (4) (5) (6) (7) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 Eq.5 Eq.6 Eq.7 
        
indage 0.318*** 0.269*** 0.345*** 0.262*** 0.274*** 0.257*** 0.534*** 
 (0.0790) (0.0809) (0.0882) (0.0836) (0.0810) (0.0807) (0.137) 
1.co#c.indag
e 
      -0.314** 
       (0.140) 
2.qincome       0.439 
       (0.805) 
3.qincome       1.262 
       (0.802) 
1o.co#1b.qin
come 
      0 
       (0) 
1.co#2.qinco
me 
      -0.00719 
       (0.884) 
1.co#3.qinco
me 
      0.366 
       (0.891) 
2.qincome#c
.indage 
      -0.352** 
       (0.147) 
3.qincome#c
.indage 
      -0.368** 
       (0.145) 
1o.co#1b.qin
come#co.ind
age 
      0 
       (0) 
1.co#2.qinco
me#c.indage 
      0.0109 
       (0.186) 
1.co#3.qinco
me#c.indage 
      0.567*** 
       (0.180) 
gend 13.10*** 12.98*** 12.96*** 12.98*** 12.97*** 12.97*** 12.44*** 
 (0.249) (0.255) (0.254) (0.255) (0.255) (0.254) (0.251) 
geog       0.231 
       (0.322) 
language       1.169 
       (4.274) 
age30_39 0.848 0.645 0.509 0.639 0.660 0.426 -0.150 
 (0.677) (0.691) (0.694) (0.692) (0.691) (0.691) (0.690) 
age40_49 0.429 0.267 0.165 0.262 0.291 0.162 -0.252 
 (0.699) (0.712) (0.713) (0.712) (0.712) (0.710) (0.709) 
age50_59 -3.149*** -3.223*** -3.400*** -3.238*** -3.187*** -3.352*** -3.727*** 
 (0.714) (0.728) (0.732) (0.730) (0.729) (0.727) (0.731) 
age60_69 -3.545*** -3.312*** -3.530*** -3.332*** -3.263*** -3.525*** -3.503*** 
 (0.755) (0.769) (0.775) (0.772) (0.770) (0.768) (0.807) 
age70_98 -5.415*** -4.922*** -5.152*** -4.945*** -4.864*** -5.185*** -4.800*** 
 (0.720) (0.736) (0.743) (0.740) (0.738) (0.735) (0.787) 
educ2       1.535*** 
       (0.405) 
educ3       1.396*** 
       (0.395) 
educ4       2.095*** 
       (0.528) 
job1       0.655** 
       (0.317) 
ind_co   -0.153**     
   (0.0711)     
co 0.483* 0.481 1.001*** 0.485 0.364 0.565* 1.157* 
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 (0.290) (0.297) (0.382) (0.297) (0.314) (0.296) (0.617) 
income  0.908*** 0.895*** 0.880*** 0.675***   
  (0.145) (0.145) (0.172) (0.248)   
ind_inc    0.0109    
    (0.0375)    
inc_co     0.343   
     (0.298)   
qincome1      -1.930***  
      (0.326)  
qincome2      -2.182***  
      (0.304)  
Constant 165.4*** 165.3*** 165.0*** 165.3*** 165.4*** 167.0*** 162.0*** 
 (0.659) (0.675) (0.685) (0.677) (0.678) (0.704) (4.398) 
        
Observation
s 
2,726 2,596 2,596 2,596 2,596 2,596 2,572 
R-squared 0.570 0.577 0.578 0.577 0.577 0.580 0.584 
 
 
The fact that the interaction term between country, years under independence and 
income terciles is significant, suggests that the slopes of height on years under 
independence are not the same across countries and terciles (Figure 16 below).  
Again, several different comparisons can be made across the slopes. The analysis and 
the graphs show that for Slovaks, there is a significant difference of years under 
independence on height between the poorest and the mid and top terciles. For 
Czechs, there is a significant difference between the poorest and the middle tercile, as 
well as the middle and the top, but the poorest and the top tercile is only significant at 
10%. When Czechs and Slovaks are compared by each income tercile, the slopes are 
significantly different in all cases, with the Slovaks having a steeper slope except in 
the top tercile where Czech gain more in height with increasing years of 
independence.  
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Figure 16. Slopes of height on years under independence in Czech Republic and 
Slovakia across income terciles 
 
 
When the regression is decomposed by sex, similarly to the case of democracy, the 
effects are quite different for men and women (Table 15 and 16). For males, years 
under independence is significantly associated with a height increase in all the 
models. The country effect shows that the Czech males are significantly shorter than 
Slovak males, except in Model 4. A large positive significant income effect both as a 
continuous variable and when included in terciles can be noted. There is also an 
education and job effect where those who are employed and have completed more 
years of education are significantly taller than the unemployed and with only primary 
education or less. Again, the results for the birth cohorts have changed where it can 
be seen that the two birth cohorts born between 1954-1963 and 1964-1973 are 
significantly taller than the youngest birth cohort used as the reference category. On 
the other hand, the oldest birth cohort is significantly shorter than the youngest 
cohort.  
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Table 15. OLS regressions of years lived under independence on height with 
different controls – male 
 
 (1) (2) (3) (4) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 
     
Indage 0.550*** 0.418*** 0.402*** 0.382*** 
 (0.137) (0.138) (0.137) (0.147) 
Co -1.489*** -1.694*** -1.558*** -0.773 
 (0.539) (0.537) (0.531) (0.541) 
Income  1.946***  1.721*** 
  (0.250)  (0.251) 
Geog    0.647 
    (0.597) 
Language    6.571 
    (7.369) 
age30_39 3.626*** 3.426*** 3.262*** 2.517** 
 (1.236) (1.237) (1.227) (1.226) 
age40_49 3.542*** 2.825** 2.614** 2.573** 
 (1.257) (1.257) (1.245) (1.264) 
age50_59 -2.151* -2.441* -2.565** -2.788** 
 (1.301) (1.299) (1.298) (1.321) 
age60_69 -1.722 -1.561 -1.950 -1.427 
 (1.417) (1.418) (1.410) (1.511) 
age70_98 -4.506*** -3.747*** -4.018*** -3.011** 
 (1.281) (1.280) (1.271) (1.424) 
educ2    2.272*** 
    (0.751) 
educ3    1.403* 
    (0.719) 
educ4    2.566*** 
    (0.903) 
job1    1.247** 
    (0.576) 
qincome1   -4.716***  
   (0.552)  
qincome2   -3.665***  
   (0.510)  
Constant 178.0*** 177.9*** 181.3*** 167.9*** 
 (1.191) (1.200) (1.244) (7.527) 
     
Observations 1,025 976 976 967 
R-squared 0.225 0.269 0.286 0.264 
 
 
Finally, for women, years spent under independence is not significantly associated 
with a height increase in any of the models while a significant positive country effect 
with Czech women being taller than Slovak women in all models can be observed. 
There is again a significant education effect while job is not significant for females. 
Income is not significantly associated with height only when it is included as income 
terciles where the women in the middle tercile are significantly shorter than the top 
tercile. The effect of the birth cohort is the same as in the aggregate model where all 
the cohorts are significantly shorter than the youngest cohort.  
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Table 16. OLS regressions of years lived under independence on height with 
different controls – female 
 
 (1) (2) (3) (4) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 
     
Indage 0.0772 0.0645 0.0767 0.0804 
 (0.0919) (0.0948) (0.0945) (0.0986) 
Co 1.723*** 1.808*** 1.891*** 2.101*** 
 (0.319) (0.330) (0.330) (0.343) 
Income  0.101  0.0105 
  (0.167)  (0.170) 
Geog    0.0277 
    (0.360) 
Language    -2.035 
    (5.030) 
age30_39 -1.323* -1.414* -1.497* -1.425* 
 (0.752) (0.772) (0.771) (0.793) 
age40_49 -1.920** -1.893** -1.791** -1.693** 
 (0.783) (0.804) (0.802) (0.833) 
age50_59 -4.169*** -4.346*** -4.364*** -4.111*** 
 (0.794) (0.815) (0.812) (0.838) 
age60_69 -5.287*** -5.310*** -5.490*** -5.052*** 
 (0.826) (0.847) (0.845) (0.907) 
age70_98 -5.989*** -5.975*** -6.269*** -5.469*** 
 (0.815) (0.840) (0.837) (0.906) 
educ2    0.892** 
    (0.453) 
educ3    1.707*** 
    (0.438) 
educ4    1.850*** 
    (0.633) 
job1    -0.183 
    (0.369) 
qincome1   0.403  
   (0.381)  
qincome2   -0.787**  
   (0.363)  
Constant 166.2*** 166.2*** 166.3*** 166.8*** 
 (0.733) (0.756) (0.782) (5.136) 
     
Observations 1,701 1,620 1,620 1,605 
R-squared 0.131 0.133 0.139 0.141 
 
 
 
Robustness checks 
 
Two main robustness checks are carried out. First, a reduced sample excluding 
individuals who are over the age of 50 was analysed as at older ages people’s height 
begins to shrink. As a result the coefficients obtained may have been overestimated. 
The older individuals are also those who grew up their entire childhood and youth 
under communism. This double effect may have been biasing the results. The results 
show that with every additional year growing up under democracy there is a small 
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associated height increase, even when the older tail of the sample is excluded (Table 
17). With every additional year growing up under democracy, there is between a 0.17 
and 0.37cm height increase. As expected, the coefficients are somewhat lower in this 
analysis.  Furthermore confirming our earlier results, while there is a small height 
increase with every additional year spent under democracy, there is no significant 
height difference between the youngest age cohort and the two oldest cohorts. The 
significance of all the other results is consistent with the main results and the 
magnitude is only slightly different.  
 
Table 17. OLS regressions of years lived under democracy as a continuous 
variable on height with different controls – individuals aged 50 and less 
 
 (1) (2) (3) (4) (5) (6) (7) 
VARIABLES Eq.1 Eq.2 Eq.3 Eq.4 Eq.5 Eq.6 Eq.7 
        
demage 0.171*** 0.199*** 0.285*** 0.207*** 0.204*** 0.174** 0.356*** 
 (0.0294) (0.0762) (0.0828) (0.0781) (0.0762) (0.0757) (0.123) 
1.co#c.dema
ge 
      -0.295** 
       (0.125) 
2.qincome       -0.497 
       (1.065) 
3.qincome       0.822 
       (1.023) 
1o.co#1b.qin
come 
      0 
       (0) 
1.co#2.qinco
me 
      -0.446 
       (1.255) 
1.co#3.qinco
me 
      0.0390 
       (1.218) 
2.qincome#c
.demage 
      -0.188 
       (0.127) 
3.qincome#c
.demage 
      -0.233* 
       (0.123) 
1o.co#1b.qin
come#co.de
mage 
      0 
       (0) 
1.co#2.qinco
me#c.demag
e 
      0.0854 
       (0.163) 
1.co#3.qinco
me#c.demag
e 
      0.397** 
       (0.156) 
gend 14.20*** 14.09*** 14.04*** 14.10*** 14.08*** 14.13*** 13.53*** 
 (0.307) (0.315) (0.315) (0.315) (0.315) (0.312) (0.311) 
language       1.019 
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       (4.268) 
geog       0.580 
       (0.406) 
age30_39  0.717 0.563 0.727 0.744 0.294 -0.283 
  (0.780) (0.781) (0.781) (0.780) (0.778) (0.780) 
age40_49  0.478 0.348 0.488 0.517 0.257 -0.236 
  (0.883) (0.882) (0.883) (0.882) (0.877) (0.886) 
educ2       1.097* 
       (0.614) 
educ3       1.033* 
       (0.601) 
educ4       1.323* 
       (0.764) 
job1       0.578 
       (0.373) 
dem_co   -0.160***     
   (0.0608)     
co 0.266 0.298 1.282** 0.291 0.0177 0.385 1.657* 
 (0.323) (0.333) (0.500) (0.333) (0.370) (0.330) (0.946) 
income  0.884*** 0.872*** 0.964*** 0.521*   
  (0.171) (0.171) (0.237) (0.272)   
dem_inc    -0.0156    
    (0.0320)    
inc_co     0.599*   
     (0.349)   
qincome1      -1.203***  
      (0.400)  
qincome2      -2.641***  
      (0.350)  
Constant 165.6*** 164.7*** 164.2*** 164.7*** 164.9*** 166.6*** 162.2*** 
 (0.333) (0.862) (0.884) (0.866) (0.866) (0.892) (4.504) 
        
Observation
s 
1,917 1,816 1,816 1,816 1,816 1,816 1,805 
R-squared 0.551 0.556 0.558 0.556 0.557 0.563 0.564 
 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 
Data from the 2005 Eurobarometer survey (Eurobarometer 64.3: Foreign Languages, 
Biotechnology, Organized Crime, and Health Items, November - December, 2005) 
was used to see whether the results show largely similar effects (See Appendix B).  
The Eurobarometer (EB) survey is a series of cross-national and cross-temporal 
comparative social science research that started in the early seventies. Representative 
national samples are interviewed in the European Union member states twice a year. 
The goal of the EB is to provide data for monitoring of public social and political 
attitudes in the European Union13 (Economic and Social Data Service, 2005).  This 
round of the EB survey asked respondents on foreign languages, biotechnology, 
                                                        
13 For more information see the Leibniz Institute for the Social Sciences, Data Archive for the 
Social Sciences (GESIS) Eurobarometer Survey Series web pages.  
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organised crime and corruption, health consciousness, smoking, AIDS prevention, 
medical errors, and consumer rights. For the purpose of the analysis, the relevant 
data came from the demographic and other background information section, 
including the respondents’ self-reported height, age, gender, occupation and 
urban/rural residence.   The variables included are similar to the variables used in the 
analysis; however there was no data that would allow for a better proxy of income or 
wealth of the individuals. As a result, only the results from the basic model (Model 1) 
will be compared. Descriptive statistics can be found in Appendix B. Below the main 
results are summarised.   
 
In the model where democracy is included as a dummy variable again no significant 
relationship was identified. In this model gender has a strong significant relationship 
just like with the WHS data.  Contrary to the WHS results, there is a positive 
significant relationship for country in all the models, suggesting that the Czechs are 
taller than the Slovaks.  When democracy is included as a continuous variable, there 
is again a positive significant association with height for every additional year lived 
under democracy. Confirming the main results, the age cohort effect is again only 
significant for the older generations starting for individuals born before 1955. Results 
were different in the analysis by gender where a significant height increase can be 
observed for women rather than men. When independence is examined, results 
follow the same pattern as for democracy with respect to the WHS results.  Overall, 
the minor difference, especially the gender and the country effect, is likely to be 
explained by the difference in samples resulting from a different sampling method 
used by the EB survey where either multi-stage national probability samples or 
national stratified quota samples are implemented, as opposed to stratified random 
sampling in the WHS.    
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2.4. Discussion and conclusion 
 
This chapter has looked at the changes in stature of the Czech and Slovak population 
after two important political, social, economic and institutional changes of the 
twentieth century Eastern Europe - the 1989 transition from the communist regime 
to democracy, and disintegration of Czechoslovakia in 1993 into two independent 
countries. Changes in height by gender groups were also examined. Overall, there 
results suggest that while there has been a significant height increase for every 
additional year spent under democracy (0.2-0.4cm; 0.18-0.36cm for sample younger 
than 50 to account for shrinkage) or as independent countries, this increase cannot 
be clearly attributed to the transition but rather to potential secular trends in height. 
Especially, as all those who grew up under democracy fall into the youngest age 
cohort and there was no significant difference in height between these individuals 
and the following two older age cohorts who grew up almost entirely under 
communism. So even though it cannot be inferred  that political and economic 
liberalisation were directly beneficial, as perhaps shown in other studies in East and 
West Germany, and Spain among others (Costa-Font & Gil, 2008; Hiermeyer, 2008; 
Komlos & Kriwy, 2002; Komlos & Snowdon, 2005), the results suggest that the 
transition period did not have a detrimental effect on health and standard of living as 
heights have continued to increase in both countries. Given the difficulty of 
disentangling the effects of transition to democracy and the break up, the remaining 
of the discussion focuses on the results for democracy; results for independence were 
very similar.  Most of the findings hold even when democracy is adjusted with the 
Polity IV index or the analysis is carried out with a different data set 
(Eurobarometer). 
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Even though Slovakia was under authoritarian rule in the initial years of democracy, 
the effect on height was still positive. The lack of significance when democracy was 
included as a dummy variable demonstrates that the height difference between those 
individuals who grew up entirely under communism and those who grew up between 
1 to 14 years under democracy is not important. Despite the existing evidence of an 
initial deterioration in the standard of living in the transition countries (Leff, 1996; 
Milanovic, 1998), our results demonstrate that starting from 1990 there continues to 
be a  small positive effect on well-being as measured by an increase in height.  
 
Consistent with other studies in the region (Vignerová, Brabec, & Bláha, 2006) height 
also increased across the generations from the oldest to the youngest birth cohort, 
where older generations are shorter than the younger generations in both countries.  
In other words, over the course of the twentieth century, people have become on 
average taller. The effect is strongest for the birth cohorts born before 1953 where 
individuals are significantly shorter, suggesting that the inter-war period and the first 
decade after World War II had the strong negative effect on adult stature, consistent 
with the findings of other studies (Hatton, 2013).  
 
When examining the results by income terciles height increases from the poorest to 
the richest tercile, for both men and women, implying that similarly to Germany 
(Komlos & Kriwy, 2003), social differences in height exist in both the Czech Republic 
and Slovakia. These findings are also consistent with the extensive evidence 
suggesting that inequalities were present already under communism and continued 
to widen in both countries after 1989 (Cox & Mason, 1999; Milanovic, 1998; Simai, 
2006; Szamuely, 1996). There is also a significant education and gender effect. The 
level of education achieved is an important determinant of the individual’s height. It 
is important to note that most of the height literature focuses on parental education 
as a key determinant (Christiaensen & Alderman, 2004; Fedorov & Sahn, 2005) so 
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the education of the individual in this context was a proxy for the individual’s 
capabilities and the importance of schooling on health behaviour (Costa-Font & Gil, 
2008; Donald S. Kenkel, 1991). There is no consistent country effect across the 
models.  
 
The statistically significant interaction between country and years spent under 
democracy implies that the democracy effect was not the same in the two countries. 
While the Czechs are on average taller, the Slovaks seemed to have benefited more 
from the transition to democracy. This result confirms the general hypothesis that the 
one performing worse has a bigger capacity to benefit. Slovakia was the poorer 
federation during communism and also had a rougher transition in the initial years 
under authoritarian rule (Meszaros, 1999). Nevertheless, the Slovaks seem to have 
benefited from this transition more than the Czechs, which over years has brought an 
increase in their well-being and standard of living as measured by height.  
 
The other interaction term between country, years spent under democracy and 
permanent income was also significant. The significance of this term and 
consequently the study of the different slopes imply that the years spent under 
democracy had a different effect on height depending on the country and income 
tercile. When comparing across countries, the Slovaks benefited more than the 
Czechs in the bottom and mid tercile with no difference in the top group. 
Furthermore, with increasing number of years under democracy the poorest in 
Slovakia benefited more in height than both the mid and top tercile. In the Czech 
Republic, the bottom tercile benefited more than the middle, and the middle less than 
the top tercile.  As noted above, evidence of inequalities and poverty since transition 
has been documented. The transition brought along significant social changes where 
particular groups benefited – especially those who were benefiting under the previous 
regime – while others such as pensioners, workers, ethnic groups or women were 
116 
able to benefit much less; the cost of transition weighed most heavily on ordinary 
citizens who felt that they had too little influence on the political decisions that 
affected them (Leff, 1996; Simai, 2006). While the transition years may have 
impacted negatively on the most disadvantaged, they were still able to benefit in 
terms height, and more so than the richer groups.  
 
The analysis revealed interesting findings when carried out separately for women and 
men. For men, the years spent growing up under democracy are significantly 
positively associated with height, even after controlling for different factors; for 
women there is no significant effect. The lack of a significant democracy effect for 
women actually suggests that the institutional and environmental effects during the 
transition did not bring substantial improvements for women compared to their 
position in the society under communism; in fact, women felt the erosion of their 
economic position after the transition with unemployment disproportionately 
affecting the females (Leff, 1996). Finally, education was an important determinant 
for both males and females, while income and employment are only significant for 
men.  
 
There are several limitations to this study. First, the low response rate in the WHS 
data used for the Czech population may have introduced bias in the results, as non-
response bias where responders may be significantly different from responders, is 
difficult to account for. At the same time, there may be small number bias (especially 
for some age cohorts) which could have affected the significance of the results. 
However, findings using the Eurobarometer data are largely consistent with the key 
findings and therefore mitigate this problem to some extent.  Second, as has already 
been discussed earlier, using self-reported height allows for reporting bias. 
Overestimation of height may vary with a person’s age and gender (Cavelaars et al., 
2000; Ezzati, Martin, Skjold, Hoorn, & Murray, 2006; Giles & Hutchinson, 1991; Hill 
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& Roberts, 1998). In general, height is overestimated by both men and women, but 
especially by shorter individuals, men, heavier women and the error in reported 
height increases with age (Spencer, Appleby, Davey et al., 2002). There have been a 
range of studies examining the accuracy of self-reported height with varying 
conclusions; there seems to be wide individual variation between reported and 
measured heights in both sexes which makes it essential that heights are accurately 
measured in clinical practice and recorded (Cizmecioglu, Doherty, Paterson et al., 
2005). Despite the potential for reporting error, the sample was not corrected for as 
precise information on the magnitude of the bias was not available, similarly to 
earlier studies (Costa-Font & Gil, 2008). In future studies, measured height should be 
used rather than self-reported height where possible. Third, accounting for shrinkage 
in the sensitivity analysis showed that while results were fully consistent with main 
results, the coefficients were somewhat overestimated. Therefore, future analysis 
should appropriately adjust for shrinkage in all the analysis. Fourth, as has already 
been mentioned, it was not possible to disentangle the effects of the 1989 transition 
to democracy and the 1993 disintegration of Czechoslovakia, even though both 
appeared to have a positive effect on stature. Finally, it is possible that any positive or 
negative effect from the political change came with a several years delay, and 
accounting for this lag in future analysis may result in somewhat different findings.  
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Chapter 3.  Using ‘avoidable’ mortality to measure health 
care performance in the Czech Republic and Slovakia 
between 1971 and 2008 
 
3.1. Introduction 
 
The findings of Chapter 2 revealed that overall both Czech and Slovaks have benefited 
from the transition as their health and well-being has reflected in a height gain.  
However, this indicator, similarly to other health outcome indicators discussed in 
Chapter 1 captures country health system performance broadly, rather than the 
contribution of the health care system.  As has been noted already, the effect of the 
regime change in 1989 and the breakup of Czechoslovakia in 1993 have been studied 
from numerous perspectives, including changes in the health status of the population 
and health outcomes (Bauer & Charlton, 1986; Bobak & Feachem, 1992; Bobak, 
Skodova, Pisa, et al., 1997; Ginter, 1996, 1998; Institute of Health Information and 
Statistics Czech Republic, 2006; Nemec & Lawson, 2005). However,  most of this 
research uses standard health outcome indicators such as life expectancy at birth, 
infant mortality or overall mortality rates which suffer from the difficulty of 
attributing any improvements to health care system activities directly (Smith, 
Mossialos, Papanicolas, et al., 2009).  Little research (Blazek & Dzurova, 2000; 
Burcin, 2009; Burcin & Kucera, 2008) has been carried out evaluating the quality 
and performance of the Czech and Slovak health care systems post 1989 and 1993 
attempting to isolate the influence of other determinants such as socio-economic 
development or environmental changes.  Therefore, this chapter applies the indicator 
of ‘avoidable’ mortality, which captures premature deaths for certain conditions that 
are considered to be largely avoidable if timely and effective health care is provided 
(Holland, 1988; Nolte & McKee, 2004) and where the role of other mortality 
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determinants are considered to be minor. While not all deaths can be avoided, the 
contribution of health services may avert a substantial proportion of deaths for the 
selected conditions.  
 
As Chapter 1 has shown, only a handful of aggregate level studies have focused on 
‘avoidable’ mortality in Eastern Europe for different periods between the 1950s and 
1990s and have produced mixed results with regards to trends and rates of changes in 
‘avoidable’ and non-avoidable mortality (Boys, Forster, & Jozan, 1991; Gaizauskiene 
& Gurevicius, 1995; Nolte, Scholz, Shkolnikov, et al., 2002; Treurniet, Boshuizen, & 
Harteloh, 2004). These mixed results suggest different patterns in health care 
improvements in different countries but may also be due to the application of 
different methods (e.g. conditions included, age limits and time periods studied). 
Moreover, three studies (Burcin, 2009; Burcin & Kucera, 2008; Jozan & 
Prokhorskas, 1997) analysed ‘avoidable’ mortality by separate conditions in both the 
Czech and the Slovak Republic at the regional level and one study only in Czech 
Republic at the aggregate level (Blazek & Dzurova, 2000), but neither has carried out 
a comparative analysis before and after the fall of the Communist regime and 
separation.   
 
In this chapter the indicators of ‘avoidable’ mortality are used to assess the 
performance of the Czech and Slovak health care systems before (1971 – 1989) and 
after (1989 – 2008) the fall of the Communist regime. The aim is to find out how the 
countries’ health care systems perform relative to each other in the latter period 
during which Czechoslovakia also split (1993) into two countries where each began to 
implement their own health policies and reforms likely to have influenced the 
performance of their health systems. To do so, national level mortality trends from a 
number of individual ‘avoidable’ causes of death in the two countries are examined, 
as well as trends of all ‘avoidable’ causes together compared to mortality from all the 
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other causes (also referred to as non-avoidable mortality). It is important to note that 
any observed trends in these two large groups of diseases are highly dependent on the 
selection of ‘avoidable’ causes of death.  For the period from 1996-2007, regional 
variations in mortality from selected ‘avoidable’ causes are also examined.  
 
3.2. Data and methods 
 
Raw mortality data classified by individual or small groups of diagnosis and age 
groups from 1971 – 2008 were obtained from the Statistical Office of the Slovak 
Republic and the Czech Statistical Office. Data for the early years (1971-1993) were 
not available electronically and had to be manually collected from annual mortality 
reports archived by the Statistical Office of the Slovak Republic in Bratislava, 
Slovakia. This process involved several visits (between November 2008 and May 
2010) to the Archive of the Statistical Office. Raw mortality data for these years were 
then transcribed and merged with mortality data available in electronic form.  
 
For both countries deaths are classified according to the 8th , 9th and 10th revisions of 
the International Classification of Diseases (ICD-8, ICD-9, ICD-10) between 1971-
1978,   1979-1993 and revision 1994-2008 respectively. ‘Avoidable’ causes of deaths 
within defined age groups have been selected based on the third edition of the EC 
Atlas of Avoidable Mortality (Holland, 1997), which defines ‘avoidable deaths’ as 
“deaths from specific diseases (within selected age groups) for which mortality should 
be wholly or substantially avoidable when appropriate medical care is sought and 
provided in good time”.  The general principle underlying the choice of each disease 
group applied in the EC Atlas was that each should have identifiable health care 
providers and effective interventions necessary to reduce mortality.  The EC Atlas list 
of conditions has been widely accepted and applied in many country studies to 
monitor the performance of the health care system (Alfonso Sanchez, Sanchis 
121 
Noguera, del Bano, et al., 1993; Barry, 1992; Kunst, Looman, & Mackenbach, 1988; 
Westerling & Smedby, 1992). The same list was also applied in another Atlas that 
focused on Eastern European countries including the Czech Republic and Slovakia 
between 1985-89 (Jozan & Prokhorskas, 1997). Using an extended list of conditions 
that other researchers have suggested without a more in depth analysis of its 
applicability to the Czech and Slovak context was not considered appropriate. 
Furthermore, it was important to study only those conditions that have been included 
as ‘avoidable’ for the entire period under study.   
 
The upper age limit was set at 64 years. While recent studies (Burcin, 2009; Gispert, 
Serra, Bares et al., 2008; Korda & Butler, 2006; Newey, Nolte, McKee et al., 2004; 
Nolte & McKee, 2004; Tobias & Jackson, 2001) have increased the age limit to 74 
years due to increased life-expectancy, setting a stricter age limit for every diagnosis 
should enhance the validity of mortality as an indicator of health service outcome. 
Especially, since avoidability of a death for an older person becomes more 
controversial due to frequent comorbidities and cause-of-death certification 
increasingly questionable at older ages (Logminiene, Nolte, McKee et al., 2004).  In 
fact, recent studies also chose to restrict their analysis to tighter age limits (James, 
Manuel, & Mao, 2006).   
 
Seventeen conditions from which deaths are considered to be ‘avoidable’ by timely 
and effective health care services are selected.  ‘Health care services’ are defined  to 
include primary care, hospital care and collective health services such as screening 
and public health programmes, e.g. immunisation (Holland, 1997).  Conditions 
whose control depends on primary prevention or health policies which are outside 
the direct control of health services, such as lung cancer or motor vehicle accidents 
are not included in our list. Also, it is important to note that the degree to which 
timely and effective health care service effect mortality from these conditions differs; 
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for some conditions, such as hypertensive & cerebrovascular diseases or ischaemic 
diseases other, non-health system factors are likely to play a much more important 
role than for appendicitis. Table 18 highlights the list of ‘avoidable’ conditions with 
the corresponding age limit.   
 
 
Table 18. ‘Avoidable’ causes of death selected for analysis 
 
Name of group Age ICD-8 ICD-9 ICD-10 
Tuberculosis 5-64 010-019 010-018, 137 A15-A19, B90 
Cancer of breast  25-64 174 174 C50 
Malignant neoplasm of cervix uteri 15-64 180 180 C53 
Malignant neoplasm of cervix uteri 
and body of uterus 
15-54 180, 182 180, 179,182 C53, C54,55 
Hodgkin’s disease 5-64 201 201 C81 
Chronic rheumatic heart disease 5-44 393-398 393-398 I05-I09 
Hypertensive & cerebrovascular 
diseases 
35-64 400-404, 
430-438 
401-405, 
430-438 
I10-I13, I15; 
I60-I69 
Ischaemic heart disease 35-64 410-414 410-414 I20-I25 
All respiratory diseases 1-14 460-519 460-519 J00-J99 
Asthma 5-44 493 493 J45-J46 
Peptic ulcers 25-64 531-533 531-533 K25-K27 
Appendicitis 5-64 540-543 540-543 K35-K38 
Abdominal hernia 5-64 550-553 550-553 K40-K46 
Cholelithiasis and cholecystitis 5-64 574-575 574-575 K80-K81 
Maternal mortality All 630-678 630-676 O00-O99 
Perinatal mortality <1 week  
+ still 
births 
760-779 760-779 Poo-P96 
Total ‘avoidable’ deaths 0-64    
Source:  Based on Holland, 1997 
 
Age-standardised mortality rates (per 100,000 population) for all the ‘avoidable’ 
mortality causes separately have been calculated for both countries from 1971-2008 
and all the regions from 1996-2007 by indirect standardisation to the total 
“Czechoslovakia” standard population. Perinatal mortality has been calculated per 
1,000 total births (live and still births) and maternal mortality per 100,000 live 
births.  Calculations were always confined to the appropriate age category. Perinatal  
123 
mortality rates were not standardised and deaths for gender- specific conditions (e.g. 
malignant neoplasm of cervix uteri) were age-standardised to the female population.  
Also, the analysis has been combined for the two sexes since avoidability of death 
should not depend on gender (Holland, 1997).  
 
The regional maps show standardised mortality ratios (SMRs) representing the 
percentage ratio of the number of deaths observed in a particular region to the 
number expected from the total “Czechoslovakia” standard age-specific death rate 
between 1996 and 2007; analysis is restricted to this period due to data availability at 
the regional level. Standardised mortality ratio for all of “Czechoslovakia” is equal to 
one hundred so the SMR for a region indicates the extent to which that area differs 
from the “Czechoslovakia” average.  Perinatal SMR is the percentage ratio of the 
crude perinatal death rate in the area studied to the crude perinatal death rate in the 
reference population.  
 
Overall, trends and maps for conditions with only a few deaths in the age range 
studied (e.g. chronic rheumatic heart disease, asthma, appendicitis, maternal deaths 
etc.) should be interpreted with caution due to the small number problem. The 
observed results are variable and a small difference between the number of deaths 
which occur and the expected number based on standard age-specific rates may yield 
extreme SMRs (Holland, 1997). 
 
3.3. Results  
 
Between 1971-2008 age-standardised mortality from ‘avoidable’ causes decreased in 
both the Czech Republic and Slovakia (by 62% and 39% respectively) by more than 
mortality from other causes (15% and 0.7% respectively) (Figure 17). During this 
period, ‘avoidable’ deaths accounted on average for 35% and 34% of total deaths in 
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the age group of 0-64 years in the Czech Republic and Slovakia respectively. While in 
1971 ‘avoidable’ deaths accounted for as much as 41% (15,586 out of 38,448) and 39% 
(6,109 out of 15,797) in the Czech Republic and Slovakia respectively, in 2008 it was 
only 24% (6,234 out of 26,185) and 27% (4,287 out of 15,663). Throughout the entire 
period, mortality from other causes is higher than ‘avoidable’ mortality in both 
countries and Slovakia is lagging behind the Czech Republic. However, for ‘avoidable’ 
mortality Slovakia performs better during the initial years, then the two countries 
have a period with similar rates and from the early 90s, after the change of the regime 
and separation of the countries, the rates begin to diverge with Slovakia lagging 
behind, mainly due to higher rates of ischaemic heart disease and hypertension & 
cerebrovascular disease mortality.  
 
Figure 17. Mortality from ‘avoidable’ and non-avoidable causes in the Czech 
Republic and Slovakia, 0-64 years 
 
 
 
Figure 18 shows the group of conditions for which community public health action or 
primary care is considered to be most important in preventing unnecessary deaths. 
The two countries often began with different mortality rates in 1971 with starting 
rates also varying greatly by condition, from 0.1 deaths per 100,000 for asthma in 
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Slovakia to 184.4 deaths per 100,000 for ischaemic heart disease in the Czech 
Republic (Table 19).   When looking more in-depth at individual conditions, mortality 
from cancer of breast and ischaemic heart disease appear to follow similar trends, 
where  most of the decline in both countries occurred between 1989 and 2008, while 
between 1971 and 1989 there is an actual increase in deaths per 100,000 (Table 19). 
For both conditions, Slovakia performs better at first while in the second period it 
begins to lag behind the Czech Republic.  
 
Mortality from malignant neoplasm of cervix and body of uterus in Slovakia 
improved only slightly over the entire period and somewhat more after 1989 (from 
6.3 to 5.1 deaths per 100,000).  On the other hand, in the Czech Republic a gradual 
and continuous decline can be observed by an overall 13% (from 7 to 6.1 deaths per 
100,000) before 1989 and between 1990-2008 an additional decline of 34.6% (from 
6.1 to 3.5 deaths per 100,000).  In the case of tuberculosis, the most significant 
decline can be observed during the first period (1971-1989) in both countries, with 
Slovakia performing worse but closing the gap by the early 80s; between 1990 and 
2008 mortality further declined by 72.5% in the Czech Republic.  While mortality for 
peptic ulcer has been declining between 1971 and 1989 in both countries, after 1989 it 
continued to decline only in the Czech Republic and began to increase in Slovakia 
(Figure 18 and Table 19).   
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Figure 18. Mortality from selected ‘avoidable’ causes where public health 
programmes or primary care are most important 
 
 
Maps in Figure 19 show that for the same conditions there are important regional 
variations.  The extent to which individual regions differ from the “Czechoslovakia” 
standard (equal to 100) can be observed. For example, for cerebrovascular & 
hypertensive diseases as well as malignant neoplasm of cervix uteri and body of 
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uterus, regions in Slovakia are performing worse than those in Czech Republic. On 
the other hand, for asthma Slovakia performs better, even though the overall national 
age-standardised mortality rate is only 0.17 deaths per 100,000.  Regions that show 
the worse performance for a number of conditions are Karlovarsky and Ustecky in the 
Czech Republic while in Slovakia the result differs across conditions.  
 
Figure 19. Regional SMRs from selected ‘avoidable’ causes where public health 
programmes or primary care are most important, 1996 to 2007 
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Figure 20 shows conditions for which health care services provided at the hospital 
level are considered to be most important in preventing unnecessary deaths. For 
most of the conditions mortality has been continuously declining throughout the 
entire period while for others the most important declines occurred  before 1989 (e.g. 
Hodgkin’s disease, chronic rheumatic heart disease, appendicitis, abdominal hernia, 
maternal mortality, perinatal mortality).  When comparing the two countries,  for 
some conditions Slovakia was initially performing worse (e.g. chronic rheumatic 
heart disease, abdominal hernia) while for others (e.g. Hodgkin’s disease, 
appendicitis or cholelithiasis and cholecystitis) it was the Czech Republic. Only for 
perinatal and respiratory disease mortality does Slovakia continuously throughout 
the entire period perform worse that the Czech Republic.  
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Figure 20. Mortality from ‘avoidable’ causes where most important 
interventions are provided at the hospital level 
 
 
Note: For Respiratory Diseases interventions are equally important at the primary care and 
hospital level 
 
Again, important regional variations for conditions where hospital care is considered 
to be most important can be noted (Figure 21). For example, for deaths for all 
respiratory diseases, two Eastern Slovak regions stand out with substantially worse 
performance, and SMRs more than double the “Czechoslovakia” rate. For 
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cholelithiasis and cholecystitis, it is the Southern Slovak regions where the mortality 
rates are double the “Czechoslovakia” rate. While there is some regional variation for 
appendicitis, only three western Czech regions perform much worse than the national 
average. Yet again it is important to note that the overall national rates for many of 
these conditions are already very low. Regions that show worse performance for 
several conditions are Ustecky and Liberecky in the Czech Republic and the Eastern 
and Southern regions in Slovakia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
131 
Figure 21. Regional standardised mortality ratios from selected ‘avoidable’ 
causes where public hospital care is most important, 1996-2007. 
 
 
 
 
 
Note: For Respiratory Diseases interventions are equally important at the primary care and 
hospital level 
 
Table 19 shows the overall and annual percentage changes by condition.  ‘Avoidable’ 
mortality in the Czech Republic declined from 173 to 131 (24%) between 1971-1989 
and down to 67 deaths per 100,000 (48%) by 2008; in Slovakia the decline was from 
162 to 138 (15%) between 1971-1989 and down to 99 deaths per 100,000 (29%) by 
2008. On the other hand, non-avoidable mortality in Slovakia increased by 5% (from 
132 
258 to 272 deaths per 100,000) before 1989 and only declined by 6% (from 275 in 
1990 to 257 deaths per 100,000) by 2008. In the Czech Republic, non-avoidable 
mortality also declined by 11% before 1989 (from 253 to 226 deaths per 100,000) and 
after 1989 similarly by 12% or 290 deaths per 100,000. Causes that made the largest 
contribution to total ‘avoidable’ mortality are ischaemic heart disease, 
cerebrovascular disease & hypertension, perinatal mortality and cancer of the breast.  
 
During the period before 1989, the largest average annual increase can be seen for 
asthma in both countries (7.3% and 4.0% in the Czech Republic and Slovakia 
respectively) and decline for chronic rheumatic heart disease (4.5%) in the Czech 
Republic and tuberculosis in Slovakia (4.8%).  After 1989 the largest average annual 
increase can be observed for peptic ulcers (1.8%) and abdominal hernia (1.5%) in 
Slovakia; annual decline is largest for chronic rheumatic heart disease (4.9%) in the 
Czech Republic and cholelithiasis and cholecystitis (4.1%) in  Slovakia. The largest 
overall percentage reductions in the Czech Republic between 1971-1989 as well as 
1990-2008 were made for chronic rheumatic heart disease (85% and 93% 
respectively). The largest overall percentage reductions in Slovakia between 1971-
1989 were made for tuberculosis (91%); between 1990-2008 it was for cholelithiasis 
and cholecystitis (79%).  
 
Overall, mortality from all ‘avoidable’ causes has been declining annually on average 
faster after 1989 with 2.5% in the Czech Republic and 1.5% in Slovakia compared to 
only 1.3% and 0.8% respectively before 1989.  This compares with smaller 
improvements for non-avoidable mortality, which has also been declining annually 
on average faster in the post-Communist period but overall less rapidly than 
‘avoidable’ mortality; in the Czech Republic it was declining annually on average by 
0.6% both before 1989 and after 1989 while in Slovakia it was actually increasing by 
0.3% before 1989 and afterwards declining by 0.3%. 
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3.4. Discussion and conclusion 
 
The results show an encouraging, declining pattern for most of the ‘avoidable’ 
conditions, especially since 1989, suggesting improvements in the performance of 
both health care systems since the fall of the communist regime. The analyses of 
trends is consistent with the findings of earlier studies (Burcin & Kucera, 2008; 
Charlton, Lakhani, & Aristidou, 1986; Mackenbach, Looman, Kunst, et al., 1988; Niti 
& Ng, 2001; Poikolainen & Eskola, 1988; Tobias & Jackson, 2001; Treurniet, 
Boshuizen, & Harteloh, 2004) where ‘avoidable’ mortality has been falling faster than 
mortality from other causes, pointing towards the potential positive impact of 
medical care (Nolte & McKee, 2004). While several studies of ‘avoidable’ mortality in 
Eastern Europe in the 1970s and 1980s found that ‘avoidable’ mortality declined 
slower than mortality from other conditions which has remained stable or even 
increased (Gaizauskiene & Gurevicius, 1995; Nolte, Scholz, Shkolnikov, et al., 2002), 
this cannot be confirmed in the Czech Republic and Slovakia between 1971 and 2008.  
 
Overall, divergence in total ‘avoidable’ mortality rates of the two countries (Figure 17) 
can be noted since the change of the regime in 1989 and the separation in 1993, when 
Slovakia began to lag behind the Czech Republic pointing towards potential 
deterioration in the performance of its health care system.  In particular, Slovakia is 
mainly lagging behind due to its higher mortality rates for ischaemic heart disease 
and hypertension & cerebrovascular disease mortality which make the largest 
contribution to ‘avoidable’ mortality but are also largely preventable with effective 
and timely prevention and primary care. For non-avoidable conditions, on the other 
hand, Slovakia was lagging behind the Czech Republic throughout the entire period 
under study. This gap can be explained by socio-economic, environmental and life-
style differences between the two countries.  Since non- health system factors such as 
socioeconomic changes, environment or life-style influence both ‘avoidable’ and non-
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avoidable conditions, any improvements or changes in ‘avoidable’ mortality  are likely 
to be explained by changes in the provision of timely and effective care (Korda & 
Butler, 2006).   
 
When studying the individual ‘avoidable’ mortality causes, however, the findings 
suggest that in a number of cases the two countries converge and Slovakia performs 
better than the Czech Republic. Analysis of individual conditions provides a more in 
depth understanding of how the respective health systems perform in specific areas; 
however, for some conditions, factors that are not part of the health care system may 
be equally or even more important.  In the group of conditions where public health 
programmes or primary care are considered to be most important, results across the 
conditions vary significantly.  It is especially important to study those conditions 
where mortality rates have been stagnant or the decline slowed down after 1989 (e.g. 
peptic ulcer or malignant neoplasm of cervix uteri and body of uterus in Slovakia). 
These findings raise questions about the medical care that is being provided for these 
conditions, what improvements can be made to prevent unnecessary deaths and 
whether other, non-medical care determinants, such as socio-economic, 
environmental or lifestyle need to be addressed instead.  
 
For peptic ulcer, for example, mortality rates in both countries have declined between 
1971-1989 but since 1990 they have increased in Slovakia (from 2.7 to 3.6 per 
100,000) and in the Czech Republic they hover around an average of 2.7 deaths per 
100,000. The initial declines may be explained by improvements in prevention, and 
diagnostic and therapeutic advancements since the 70s, as well as better and timely 
surgical interventions (Tesar, Foltan, & Huorka, 2002; Vecchia, Lucchini, Negri et al., 
1993). Yet the lack of further decline is a reason for concern and a more in-depth 
understanding of health services provided for this condition is required. However, 
other risk factors may also need to be considered, including the consumption of 
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alcohol and cigarettes (Holland, 1997).  Czech Republic followed by Slovakia ranked 
among the highest in alcohol consumption in 2002 and the proportion of unrecorded 
consumption of alcohol was also high (Popova, Rehm, Patra et al., 2007). In addition, 
a significant proportion of the population also smokes (Eurostat, 2004). Alcohol and 
smoking may therefore be some of the additional key factors explaining the observed 
trends apart from weaknesses in health service provision.   
 
The relatively high mortality rates for malignant neoplasm of cervix uteri and body of 
uterus could be attributed mainly to the deficiencies in the organisation and 
performance of cervical screening (Potancok & Sadovsky, 2004; Vlasak, Plesko, 
Dimitrova et al., 1991), which are also likely to explain the gap between the two 
countries.  While both countries have a nationwide organised screening programme 
since 2008, actual implementation remains an issue, especially getting the patients to 
show up for the visits.  Even before the passing of the new legislation in Slovakia, 
preventive gynaecological examinations were legally guaranteed but only about 20% 
of woman population took advantage of them (Hupkova, 2008).   
 
Until the early nineties some of the main factors behind unsatisfactory results in 
breast cancer mortality were late diagnosis, where patients sought medical care a few 
years after the first symptoms appeared (Konopasek, Novy, & Bauer, 1994). Overall, 
the importance of wide scale systematic education of the population, quick diagnosis 
with the necessary diagnostic equipment, a treatment strategy established by a 
multidisciplinary medical team, and respect for general onco-surgical guidelines have 
been stressed to avoid unnecessary deaths (Celko, 1996; Konopasek, Novy, & Bauer, 
1994).  Improvements in both countries since the early 90s are likely to be explained 
by early diagnosis, improved access to care, the introduction of new effective 
treatment (e.g. tamoxifen), shift toward more favourable stage distribution, and 
increased breast cancer awareness as national screening programmes were not in 
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place  (Botha, Bray, Sankila et al., 2003; Tyczynski, Plesko, Aareleid et al., 2004).  In 
addition, changes in other risk factors such as childbearing, breast-feeding, type of 
diet and obesity, use of alcohol and tobacco, oral contraceptives use and hormonal 
replacement therapy should be taken into consideration (Key, Verkasalo, & Banks, 
2001; McPherson, Steel, & Dixon, 2000; Tyczynski, Plesko, Aareleid, et al., 2004).   
 
Reductions in blood pressure related to diet, better control of hypertension, high 
cholesterol and smoking, enhanced access to pharmaceuticals and improvements in 
secondary cardiac care have resulted in declining hypertension and cerebrovascular 
mortality as well as mortality from ischaemic heart disease (Bruthans, Cífková, 
Lánská et al., 2012; Cífková, Škodová, Bruthans et al., 2010; Cifkova, Skodova, 
Lanska et al., 2004; Davídkovová, Kyselý, Kříž et al., 2013; Egnerova & Becezna, 
1997; Ginter, 1998; Newey, Nolte, McKee, et al., 2004; Skodova, Pisa, Poledne et al., 
1997). Also, increased consumption of anti-oxidants and decline in the consumption 
of animal fats, salt and spirits have been important (Bruthans, Cífková, Lánská, et al., 
2012; Ginter, 1995).  
 
However, further improvements can be made as treatment of hypertension is still not 
sufficient; between 1985 and 2001 less than 20% of those diagnosed in the Czech 
Republic had their blood pressure controlled (Cifkova, Skodova, Lanska, et al., 2004).  
Another study in Slovakia from 1995-2005 found that while mortality from the 
diseases of circulatory system, ischaemic heart disease and cerebrovascular disease in 
the age group between 25-64 have been declining, overall mortality from 
hypertension has doubled, largely due to the unfavourable prevalence of preventable 
risk factors such as untreated high blood pressure, overweight and obesity (Barakova 
& Riecansky, 2007) and deficiencies in the prevention and treatment of 
cardiovascular diseases (Bada, 2006; Jurkovicova, 2005). The same study suggests 
that only with better management of hypertension and interdisciplinary cooperation 
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can Slovakia close the gap with the Czech Republic and other EU countries. With 
respect to treatment, the number of angiograms, percutaneous coronary 
interventions, and stenting rates have been gradually increasing in both Slovakia and 
the Czech Republic but rates remain behind most Western European countries, 
especially in Slovakia (Cook, Walker, Hugli et al., 2007)  In addition, while the causes 
of the different developments may not be well recognized, lower level of education, 
worse composition of the diet, higher consumption of distillates and tobacco, lower 
level of health care, and higher proportion of the Roma population in Slovakia may 
require further attention  (Ginter, 2001).    
 
For all the conditions where hospital level care is considered more important (e.g. 
Hodgkin’s disease, appendicitis, maternal and perinatal mortality etc.), the declining 
mortality trends and convergence suggest improvements in the provision of timely 
and effective hospital care in both countries. These are encouraging trends likely to 
have resulted from significant improvements in the equipment of providers and 
available medicines since 1989 even though evidence on the changes in clinical 
aspects of quality are not available (Nemec & Lawson, 2005).   
 
When looking at individual conditions, substantial improvements in perinatal 
mortality can be attributed to developments in the quality of neonatal care in two 
areas:  prenatal diagnosis of congenital malformations and intensive care in 
newborns of extremely low birth weight (Stembera & Velebil, 2006).  The overall 
lower neonatal hospital and human resource capacity in Slovakia (Chovancova, 
2008) may explain the gap between the two countries.  Higher rates of perinatal 
mortality in the Eastern regions of Slovakia may be linked to the large presence of the 
Roma population, their lifestyle and attitudes to health and health care services 
(Ecohost/ Masaryk University, 2000).  
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Large presence of the Roma population may also explain the higher mortality rates 
for respiratory disease deaths for children aged 1 to 14 in the two Eastern regions. 
Other studies found that the most common diagnosis for hospitalized Roma infants 
and toddlers in Slovakia were respiratory tract infections, among others or that Roma 
children had twice as many respiratory diseases as ethnic Czech children (Ecohost/ 
Masaryk University, 2000).  As a result, specifically targeted prevention and 
treatment activities for this group may be necessary to make further reductions in 
mortality levels.  
 
Overall, aggregate studies of ‘avoidable’ mortality can only “point towards 
weaknesses or failures of the health system which require further investigation and 
not as an absolute measure of health care quality” (Kossarova, Holland, Nolte et al., 
2009). It is a tool to provide insights into the performance of the health system 
(James, Manuel, & Mao, 2006). Therefore, the next step for policy makers in both the 
Czech Republic and Slovakia would be to carry out in depth systematic investigations 
of the underlying reasons for observed trends according to existing and sound 
methodologies, as well understand local and central level policies, and how services 
targeted at the selected condition are being delivered and coordinated, starting from 
prevention, through diagnosis and treatment and management of the disease 
(Kossarova, Holland, Nolte, et al., 2009).  While for a number of conditions problems 
appear to be obvious and implementation is the issue (e.g. cancer of cervix), for 
others further research is necessary.  Also, in the future with regional level data 
becoming increasingly available, distribution of ‘avoidable’ mortality across socio-
demographic and ethnic groups may be particularly useful. Especially, when one 
considers, for example, the large presence of the Roma population in some regions of 
Slovakia and the Czech Republic whose health and access to care is worse than that of 
the general population and therefore health services at this group need to be better 
targeted ((Ecohost/ Masaryk University, 2000; Koupilová, 2001).  
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There are several limitations of using ‘avoidable’ mortality as an indicator of health 
system performance, many of which have been summarised in an in-depth review of  
the concept by Nolte et al (2004); the most important ones will be considered below.   
First, ‘avoidable’ mortality was originally intended to assess the quality of care 
(Holland & Breeze, 1985) but has also been used to measure the contribution of 
health systems to population health. Many authors have attempted to explain 
observed variations in ‘avoidable’ mortality using a range of potential explanatory 
variables of which health care resources has been one. However, given the weak 
association between variations in ‘avoidable’ mortality and measures of health care 
provision (Kunst, Looman, & Mackenbach, 1988; Mackenbach, Kunst, Looman et al., 
1988), some authors have questioned the usefulness of this indicator to measure the 
quality and effectiveness of health care services (Carr-Hill, Hardman, & Russell, 
1987). It is important to clarify that most of the variables studied to explain variations 
in ‘avoidable’ deaths such as health expenditure, number of health staff or hospital 
beds, presence of health care facilities tend to  only capture quantity but not quality of 
care (Nolte & McKee, 2004).  At the same time, evidence from analyses undertaken in 
the former communist countries of central and eastern Europe (Koupilová, McKee, & 
Holcik, 1998; Nolte, Scholz, Shkolnikov, et al., 2002; Telishevska, Chenet, & McKee, 
2001; Velkova, Wolleswinkel-van den Bosch, & Mackenbach, 1997) supports the link 
between health care resources and outcomes as measured by mortality. Overall, the 
weak or absent association with health care inputs may be attributable to (i) the use 
of variables which are measurable but not necessarily important; and/or ii) a time lag 
between changes in resources and changes in mortality and others (Nolte & McKee, 
2004).  However, the more frequently observed association with adverse 
socioeconomic factors has focused attention to timely access to medical care (Nolte & 
McKee, 2004).  
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Second, death from any particular condition, even if considered ‘avoidable’ is a result 
of many events (Rutstein, Berenberg, Chalmers, et al., 1976) and its prevention may 
not have been possible by the timely and effective provisions of health services. For 
example, severity of the disease at presentation to health services was not taken into 
account, which could be at a point when the death cannot be averted anymore. 
Severity of disease at presentation is a function of health seeking behaviour and thus 
partly outside the scope of health services; however it may also reflect access to care 
and should therefore, at least partially, be ‘avoidable’ by health services (Andreev, 
Nolte, Shkolnikov et al., 2003; Charlton, Hartley, Silver, et al., 1983).  Third, 
incidence of the disease may affect the observed trends and has not been 
incorporated in the analysis. However, studies that have taken into account incidence 
find that regional variations remain and cannot be explained by incidence (Bauer & 
Charlton, 1986; Treurniet, Looman, van der Maas et al., 1999). Also, as Charlton and 
colleagues stated, “there is no reason for more deaths to occur from conditions such 
as acute appendicitis or hernia in areas where the condition may be more common” 
(Charlton, Holland, Lakhani et al., 1987).  In other words, if there is higher incidence 
of a particular condition, the health system should adjust to the needs of the 
population.  
 
Fourth, while the conditions have been split into those where primary care or hospital 
care are more important, for many of these conditions both effective and timely 
primary care and hospital services are necessary to prevent deaths (Holland, 1997). 
In addition, other non-health system factors including socio-economic conditions, 
lifestyle, behavioural (e.g. smoking, alcohol, adherence), environmental and others 
should be considered. Attributing ‘avoidable’ mortality outcomes to health care 
services exclusively can be done for selected conditions only (e.g. appendicitis) (Nolte 
& McKee, 2004). As non-avoidable mortality rates may also be affected by all these 
different non-health system factors, the gradient in ‘avoidable’ mortality is best seen 
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relative to that in non-avoidable mortality (Korda & Butler, 2006).  Fifth, ‘avoidable’ 
mortality uses deaths but mortality may not always be the adequate indicator for the 
performance of the health system, especially for the elderly, where most of the focus 
is not on preventing death but on relieving pain and improving the quality of life 
(Holland, 2007). 
 
Sixth, some of the identified differences between the two countries may be due to 
differences in diagnostic patterns and habits (Reid, 1962; Reid & Rose, 1964), death 
certification or coding of causes of death, even though these may not be so severe 
given the countries’ common past and practices. In fact, these differences could even 
arise within one country in different regions. Problems in assigning ICD codes may 
result in misclassification of deaths and changes in trends; this is more likely to occur 
when new ICD coding is implemented. In both countries,  there was a change from 
ICD-8 to ICD-9 coding in 1979 and from ICD-9 to ICD-10 coding in1994 but these do 
not appear to be so important in the overall analysis of trends.  In general, assigning a 
single underlying cause of death for a person who has been suffering from multiple 
chronic conditions, particularly among older people, is often difficult and subject to 
variation even if the rules of certification and coding are well-understood and clearly 
formulated. Mortality data is also likely to underestimate the burden of disease for 
low-fatality conditions such as diabetes or other chronic disorders (Jougla, Papoz, 
Balkau et al., 1992; Ruzicka & Lopez, 1990). Thus, interpreting mortality statistics 
requires careful consideration of their limitations, and where possible, efforts should 
be made to improve their quality (Charlton in Hansluwka, Lopez, Porapakkham et al., 
1986).  
 
Next, most studies of ‘avoidable’ mortality have not addressed the potential negative 
impact of medical care. Iatrogenesis or medical errors, negligence and adverse effects 
have only recently become the focus of policy makers’ attention (Nolte & McKee, 
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2004). Estimates for the United States suggest that up to 98,000 deaths annually 
may result from medical errors (Kohn, Corrigan, & Donaldson, 1999). In the United 
Kingdom, since 2001 the National Patient Safety Agency also monitors information 
about incidents which may have led to harming a patient or even death.  However, 
incidents continue to be under-reported because the reporting and feedback 
environment is still one of “naming and shaming” (Cassidy, 2009; Health Committee, 
2009; Healthcare Commission, 2008) 
 
Finally, it should also be noted that there are certainly causes included in the category 
‘other’ or non-avoidable conditions that have become avoidable in the course of time 
(e.g. diabetes). However, since we were studying trends from as early as 1971 when 
deaths from these conditions were not yet considered to be avoidable, including them 
would have been incorrect.  Due to the changing concept of ‘avoidability’ (Nolte & 
McKee, 2004), it is important to revisit all the existing lists of ‘avoidable’ conditions 
and specify the date from which onwards a death from a particular condition has 
become avoidable, as has already been stressed by others earlier (Treurniet, Looman, 
van der Maas, et al., 1999).  Given the advances that have been made in medical care, 
there are now new conditions that may be considered ‘avoidable’ as effective 
prevention or treatment has become available; at the same time, some conditions 
which have been used earlier may no longer be a good indicator due to low incidence 
and prevalence. Therefore, deriving conclusions about the quality of health care 
based on small numbers may not be entirely appropriate (Westerling & Smedby, 
1992). At present the “AMIEHS” project - Avoidable mortality in the European 
Union: towards better indicators for the effectiveness of health systems –developed 
an agreed definition of ‘avoidable’ mortality for Europe, reviewed the evidence of how 
treatment has changed and derived a set of validated ‘avoidable’ mortality-based 
indicators of the effectiveness of health systems which can be used in routine 
surveillance systems.   
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Chapter 4.  Examining the relationship between health 
care inputs and ‘avoidable’ mortality  
 
4.1. Introduction 
 
One of the weaknesses of the ‘avoidable’ mortality indicator highlighted in Chapter 1 
more generally, as well as in Chapter 3 in more detail is the relationship with health 
care inputs, which led some to criticize it as an appropriate indicator for the quality 
and effectiveness of the health care system. However, the methodological weaknesses 
of the studies conducted to date using ‘avoidable’ mortality necessitate the re-
examination of this relationship. Before, however, it is important to highlight the 
continuing debate on the link between health care inputs and health outcomes. As 
was noted in Chapter 1, the literature mainly looks at standard health outcome 
measures - perinatal mortality, infant mortality, different life expectancy measures, 
age/sex specific mortality rates, physiological measures of health status, self-reported 
health, as well as summary measures of population health (PYLL, DALE) - and their 
relationship with health care expenditures or health care inputs, including number of 
physicians, nurses, beds and others. A comprehensive review of the relationship 
between health care expenditures and other health care resources finds that these do 
not consistently explain variations in health outcomes and that other variables such 
as income and life-style appear more important (Nixon & Ulmann, 2006). Number of 
other studies focusing on health care inputs, in particular physician supply equally 
fail to establish a clear relationship with health outcomes or instead suggest that 
more doctors are associated with increased mortality (Auster, Leveson, & Sarachek, 
1969; Cochrane, St Leger, & Moore, 1978; Newhouse & Friedlander, 1980; Prescott & 
Jamison, 1985; Starfield, Shi, Grover et al., 2005; Young, 2001), with the exception in 
rural areas where more doctors are associated with lower mortality levels (Robst & 
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Graham, 1997; Robst & Graham, 2004); the evidence similarly supports increased 
physician supply when the focus is on primary care physicians  (Ricketts & Holmes, 
2007; Shi, 1992, 1994; Shi, Macinko, Starfield et al., 2003; Starfield, Shi, & Macinko, 
2005).  
 
These findings suggest that health care expenditures or health care inputs may either 
not be true (or imperfect) determinants of health outcomes, or instead that health 
outcome measures used are not the most appropriate ones as health care provision is 
only one of the many determinants in any observed variations. Health expenditures 
are noisy measures of the economic use of health inputs (or activity indicators) as 
they not only vary with utilisation, but with prices. In contrast, risk adjusted 
expenditure measures, or price adjusted measures of utilisation are often difficult to 
estimate.  Hence, some of the variability in health expenditure might not be 
attributed to health care activity.  However, even when health expenditures are 
regarded as good proxies for activity, the question of how to measure health 
outcomes remains. This is where ‘avoidable’ mortality has been proposed as an 
indicator that should more accurately capture what happens in the health care system 
as opposed to standard health outcome measures that also capture the effect of non-
health care system determinants such as lifestyle or socioeconomic status (Kossarova, 
Holland, & Mossialos, 2012).  As ‘avoidable’ mortality has become an increasingly 
utilised indicator in the last decade, the debate surrounding the extent to which 
medical care truly contributes to variations in ‘avoidable’ mortality has also become 
more relevant. A review of a large number of studies (Nolte & McKee, 2004) found 
that socio-economic conditions appear to be the most important determinant. A 
recent large-scale European study14 (Plug, Hoffmann, & Mackenbach, 2011) aimed to 
                                                        
14 “Avoidable mortality in the European Union: Towards better indicators for the effectiveness 
of health systems” - AMIEHS 
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come up with amenable15 mortality indicators for routine surveillance purposes to 
identify problems in the delivery of health care. They looked at the link between an at 
least 30% decline in age-standardised mortality16 between 1979-2000 and the 
national introduction of a specific effective intervention that coincided with the 
identified decline during the same time, and found little or no association with only 
four conditions fulfilling all the criteria set out by the study. However, the criteria for 
the inclusion in the study were very strict17 and there is clear evidence for many of the 
conditions that health care (combination of different interventions) has made an 
important difference to mortality, even though the impact of individual interventions 
cannot be quantified. Overall, while the project did not come up with indicators of 
health care system performance to be used for routine surveillance purposes, it did 
conclude that care must be exercised when amenable mortality data is being 
interpreted, considering all the different determinants that drive changes in death 
rates, health care being one of them. Therefore, health care certainly makes a 
difference but the extent to which it does so at population level is difficult to 
determine.  
 
Most cross-section or time trend studies have been descriptive in nature, looking at 
trends in ‘avoidable’ mortality across countries (Holland, 1988, 1993; Kossarova, 
Holland, & Mossialos, 2012; Kunst, Looman, & Mackenbach, 1988; Mackenbach, 
1991; Newey, Nolte, McKee, et al., 2004; Nolte & McKee, 2008a; Nolte & Scholz, 
2004; Poikolainen & Eskola, 1988; Treurniet, Boshuizen, & Harteloh, 2004; Velkova, 
Wolleswinkel-van den Bosch, & Mackenbach, 1997; Weisz, Gusmano, Rodwin et al., 
                                                        
15 The study uses the term “amenable mortality” while this chapter uses ‘avoidable’ mortality. 
The two terms refer to the same concept.  
16 An indicator of amenable mortality is of little use of it causes no or only a few deaths each 
year. Therefore, the inclusion threshold selected in this study was at least 100 deaths in 
England and Wales in 2000. While it may be easy to identify conditions from which death 
rates are amenable to health care, it is more complicated to determine whether they make 
useful indicators (Plug, Hoffmann, & Mackenbach, 2011). 
17 Scientific evidence on the effectiveness of health care interventions and information about 
the time of national introduction was often lacking or inadequate. 
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2008) or variations within regions or smaller areas (Bauer & Charlton, 1986; Carr-
Hill, Hardman, & Russell, 1987; Charlton, Hartley, Silver, et al., 1983; Charlton, 
Lakhani, & Aristidou, 1986; Lagasse, Humblet, Lenaerts et al., 1990; Mackenbach, 
Kunst, Looman, et al., 1988; Nolasco, Melchor, Pina et al., 2009; Piers, Carson, 
Brown et al., 2007; Sundmacher & Busse, 2011; Treurniet, Looman, van der Maas, et 
al., 1999; Westerling, 1993; Westerling, Gullberg, & Rosen, 1996). Both individual 
‘avoidable’ causes (e.g. appendicitis, Hodgkin’s disease, breast cancer) and deaths 
from selected ‘avoidable’ causes grouped together and compared to non-avoidable 
deaths have been examined to evaluate the performance of a health care system. The 
underlying rationale for this comparison is that non-health system factors such as 
socioeconomic characteristics or life-style influence all types of mortality, both 
‘avoidable’ and non-avoidable, so any improvements in ‘avoidable’ mortality are 
likely to be due to changes in the provision of timely and effective care (Korda & 
Butler, 2006). 
 
A handful of studies have tried to explicitly identify determinants of variations in 
‘avoidable’ mortality.  Since the idea behind the concept of ‘avoidable’ mortality is 
that timely and effective health care should prevent unnecessary deaths, researchers 
have tried to demonstrate the link between health care system variables thought to be 
capturing high quality care and variations in ‘avoidable’ mortality rates. 
Epidemiologic studies have used health care inputs, including health expenditures 
(Poikolainen & Eskola, 1988), numbers of health professionals (Kunst, Looman, & 
Mackenbach, 1988; Poikolainen & Eskola, 1988; Sundmacher & Busse, 2011), 
hospital beds (Kunst, Looman, & Mackenbach, 1988; Pampalon, 1993), 
hospitalisation rates (Pampalon, 1993) or a combination of these (Schwierz & 
Wubker, 2009) as a proxy for “timely and effective health care”.  
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In the health economics literature, the concept of ‘avoidable’ mortality has only been 
applied to a limited extent (Heijink, Koolman, & Westert, 2012; Moreno-Serra & 
Wagstaff, 2010; Tang, Chin, & Rao, 2008).  Some of these studies use selected 
indicators of ‘avoidable’ mortality such as perinatal (Babazono & Hillman, 1994; 
Wolfe & Gabay, 1987) or maternal mortality (Cochrane, St Leger, & Moore, 1978)  as 
their dependent variable, even though the concept of ‘avoidable’ mortality is not 
explicitly referred to. Overall, all these studies suggest that the relationship between 
health care resources and ‘avoidable’ mortality is weak or inconsistent (Mackenbach, 
Bouvier-Colle, & Jougla, 1990; Nixon & Ulmann, 2006; Nolte & McKee, 2004) and 
that other socio-economic variables such as income and life-style appear more 
important. Some evidence of the relationship between health care inputs and 
‘avoidable’ mortality can be found, mainly in the Eastern European region and 
Germany (Koupilová, McKee, & Holcik, 1998; Nolte, Scholz, Shkolnikov, et al., 2002; 
Sundmacher & Busse, 2011; Telishevska, Chenet, & McKee, 2001; Velkova, 
Wolleswinkel-van den Bosch, & Mackenbach, 1997).  
 
However, most of these earlier studies in both disciplines have a number of 
weaknesses (Auster, Leveson, & Sarachek, 1969; Gravelle & Backhouse, 1987). First, 
many do not account for possible endogeneity between expenditures or other health 
care inputs and mortality (Anand & Bärnighausen, 2004; Cremieux, Ouellette, & 
Pilon, 1999; Or, 2000; Or, Wang, & Jamison, 2005), even though this is clearly vital 
to investigate.  For example, one study that did  allow for endogeneity found that 
health care expenditure had a strong impact on health outcomes in two programmes 
of care (cancer and circulatory diseases) (Martin, Rice, & Smith, 2008). Similarly, 
two studies in Germany that allowed for endogeneity of physician supply found that 
an increase in physician supply had a significantly positive effect on self-reported 
individual health (Gravelle, Morris, & Sutton, 2008) and on ‘avoidable’ cancer deaths 
(Sundmacher & Busse, 2011). Second, many studies are cross-sectional at the 
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national level and do not take into consideration dynamics, in other words the lag 
between expenditure and mortality (Gravelle & Backhouse, 1987).  One study that did 
use dynamic modeling and accounted for endogeneity between GP supply and 
mortality failed to find a significant relationship (Aakvik & Holmas, 2006). On the 
other hand, a longitudinal study of fourteen European countries that also accounted 
for dynamic effects found a significant relationship between health care spending and 
‘avoidable’ mortality (Heijink, Koolman, & Westert, 2012). 
 
This chapter has several goals. First, given the lack of a clear relationship between 
standard health outcome measures and health care inputs, it uses the improved 
indicator of ‘avoidable’ mortality to see whether the relationship with health care 
inputs holds. Second, given the available evidence of a link between health care 
inputs and ‘avoidable’ mortality in Eastern Europe, analysis is carried out in Slovakia 
and the Czech Republic, two countries that have been subjected to a range of health 
care reforms since the transition from communism in 1989. The results will nicely 
complement the handful of studies that have tried to assess the performance of the 
two health care systems using indicators of ‘avoidable’ mortality (Blazek & Dzurova, 
2000; Burcin, 2009; Burcin & Kucera, 2008; Jozan & Prokhorskas, 1997; Kossarova, 
Holland, & Mossialos, 2012). Generally these descriptive studies found that while 
there is still room for improvement, ‘avoidable’ mortality as measure of overall health 
care system performance has been gradually declining in both countries. Here the 
particular focus is on understanding regional variations in ‘avoidable’ mortality 
indicators and the association with health care inputs.  Finally, the chapter 
contributes to the literature by applying different modelling techniques to see 
whether the results are robust.  It has been shown in earlier studies that the 
application of different modelling techniques yields different results, and it is 
therefore necessary to be careful when interpreting these (Gravelle & Backhouse, 
1987). Panel data estimation techniques with instrumental variables are used to 
 150
account for potential endogeneity between health care inputs and mortality as well as 
dynamic models to account for the inter-temporal nature of mortality. 
 
4.2. Data and methods 
 
Data and variables 
 
Mortality data for 22 regions (8 regions in Slovakia; 14 regions in the Czech Republic) 
classified by individual or small groups of diagnosis and age groups between 1996 
and 2007 were obtained from the Statistical Office of the Slovak Republic and the 
Statistical Office of the Czech Republic. Deaths are classified according to the 10th 
revision of the International Classification of Diseases (ICD-10) in both countries.  
‘Avoidable’ causes of deaths within defined age groups have been selected based on 
the third edition of the EC Atlas of Avoidable Mortality (Holland, 1997). The Atlas 
defines ‘avoidable deaths’ as “deaths from specific diseases within selected age groups 
for which mortality should be wholly or substantially avoidable when appropriate 
medical care is sought and provided in good time”. The EC working group chose 
those disease groups and conditions that had identifiable effective interventions and 
health care providers.  For consistency purposes, the selected ‘avoidable’ causes of 
death (Table 20) are those included in Chapter 3.  Similarly, an upper age limit of 64 
years is applied and the  analysis for the two sexes is combined since avoidability of 
death should not depend on gender (Holland, 1997).  The remaining deaths not 
selected as ‘avoidable’ are classified as deaths from other causes or non-avoidable 
conditions. 
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Table 20. ‘Avoidable’ causes of death selected for analysis 
 
Name of group Age ICD 10th 
revision 
Tuberculosis 5-64 A15-A19, B90 
Cancer of breast  25-64 C50 
Malignant neoplasm of cervix uteri 15-64 C53 
Malignant neoplasm of cervix and body of uterus 15-54 C53, C54, C55 
Hodgkin’s disease 5-64 C81 
Chronic rheumatic heart disease 5-44 I05-I09 
Hypertensive & cerebrovascular diseases 35-64 I10-I13; I115; I60-
I69 
Ischaemic heart disease 35-64 I20-I25 
All respiratory diseases 1-14 J00-J99 
Asthma 5-44 J45-J46 
Peptic ulcers 25-64 K25-K27 
Appendicitis 5-64 K35-K38 
Abdominal hernia 5-64 K40-K46 
Cholelithiasis and cholecystitis 5-64 K80-K81 
Maternal mortality All O00-O99 
Perinatal mortality <1 Poo-P96 
Age range for total ‘avoidable’ deaths 0-64  
Age range for total mortality from other causes (non-
avoidable) 
0-64  
Source:  Based on (Holland, 1997) 
Notes: Perinatal mortality rates calculated per 1,000 total births (live and still births) and not 
standardised; maternal mortality calculated per 100,000 live births.   
 
Two rounds of analysis are carried out. First, all the conditions from which deaths are 
considered to be ‘avoidable’ are grouped together and used as the aggregated 
‘avoidable’ mortality dependent variable. In the second part of the analysis, the 
following disaggregated condition specific dependent variables are used: i) ischaemic 
heart disease; ii) hypertensive & cerebrovascular diseases; iii) remaining ‘avoidable’ 
mortality.  Only those conditions for which number of deaths in a particular year 
exceeded 30 are included. Hypertensive and cerebrovascular disease have been 
combined due to potential case transfer (coding) between hypertension and 
cerebrovascular disease (Holland, 1997).  In both rounds of analysis,  deaths from 
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other causes are grouped together (referred to as non-avoidable/other mortality) and 
used as a control dependent variable given that non-health system factors rather than 
timely and effective provision of medical care are considered to be more important in 
explaining variations in mortality.  
 
To measure timely and effective care, health care input variables are used as proxies. 
Number of physicians (docs), nurses (nurs) and beds (beds) - per 10,000 population - 
all of which have been used in earlier studies as important determinants of health 
outcomes (Cochrane, St Leger, & Moore, 1978; Dubois, McKee, & Nolte, 2006; 
Gerdtham, Søgaard, Andersson et al., 1992; World Health Organization, 2006) are 
used. These variables have been obtained from the Institute of Health Information 
and Statistics of the Czech Republic (IHIS) and the National Health Information 
Center of Slovakia (NHIC).  
 
While timely and effective medical care as proxied by health care inputs is expected to 
be the key explanatory variable of variations in ‘avoidable’ mortality, for some 
conditions (e.g. ischaemic heart disease, hypertensive & cerebrovascular diseases) 
additional non-health system determinants need to be considered as explanatory 
variables. Whitehead and Dahlgren (1991) suggest non-health system  determinants 
include socio-economic, cultural and environmental; living and working conditions 
(i.e. housing, health care services, water and sanitation, unemployment, work 
environment, education, agriculture and food production); social and community 
networks; individual lifestyle factors; and age, sex and constitutional factors 
(Whitehead & Dahlgren, 1991).  Due to data availability, only some of these will be 
controlled for in our analysis.  
 
Regional data on GDP per capita (GDP; adjusted to 2005 prices (OECD) and 
expressed in Czech crowns) and unemployment (to capture socio-economic 
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development), air pollution (in tons of basic pollutants per capita) to measure 
environmental influences have been obtained the Institute of Health Information and 
Statistics of the Czech Republic and the National Health Information Center of 
Slovakia.  A seminal piece found increases in per capita GDP having positive effects 
on health (Pritchett & Summers, 1996). Newer evidence suggests that this 
relationship is influenced by degree of inequality and poverty (Biggs, King, Basu et 
al., 2010). Also, the relationship between income and health is not linear and may be 
characterised by diminishing returns to scale in rich countries, explained by higher 
consumption of alcohol, cigarettes, pollution and stress (Or, 2000) and it may be 
desirable to control for these factors. Another variable used to capture socio-
economic development is unemployment (unem) where a positive relationship with 
mortality is expected. Finally, pollution (pol) is included, where again a positive 
relationship with mortality is anticipated. The relationship between pollution and 
health has been studied extensively in the recent years and the evidence suggests that 
more pollution is associated with worse health outcomes, in particular for respiratory 
and cardiovascular diseases (Brunekreef & Holgate, 2002; O'Neill, Jerrett, Kawachi 
et al., 2003; Ren & Tong, 2008).   
 
Model and estimation methods 
 
This chapter aims to examine the relationship between health care inputs and 
mortality from causes considered to be ‘avoidable’, controlling for a number of other 
factors. The starting model is an aggregate health production function where the 
health of the population at the regional level in Slovakia and the Czech Republic 
measured by ‘avoidable’ mortality is considered to be the outcome of the production 
process. Health care inputs measured by beds, doctors and nurses are the key 
variables of interest.  Given that the size of the panel is small (twelve time periods and 
twenty two cases/regions), a pooled OLS regression is considered first which assumes 
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no correlation across the regions or time periods. Time effects as well as the two 
capital regions are two sources of heterogeneity that are controlled for. However, a 
pooled regression may not make best use of our data as even if the unobserved 
individual effect was uncorrelated with our regressors, this individual effect would 
give unbiased but inefficient results with incorrect standard errors; Alternatively,  if 
the individual effect is correlated with the regressors, the pooled regression will be 
subject to the unobserved heterogeneity bias (Dougherty, 2007).  Therefore, the 
following empirical panel data model is explored for every condition or groups of 
conditions:  
 
++++++= ititititit
condition
it unemGDPnursdocsbedsAMR 543210 ββββββ    (1)
  
itiititit ucountrytimepol εβββ +++++ 876  
 
for i=1 ....N; t=1.....T, where i is the regional indicator and t the time indicator.  
condition
itAMR  is the health outcome variable. 
condition
itAMR  indicates regional age-
standardised mortality rates  per 100,000 population indirectly standardised to the 
total “Czechoslovakia” standard population for the following individual ‘avoidable’ 
conditions or groups of conditions: ischaemic heart disease, cerebrovascular & 
hypertension, all ‘avoidable’ causes, remaining ‘avoidable’ causes, non-avoidable 
causes. itε  is the random disturbance term, iu  is the unobserved region-specific time 
invariant effect, time represents time dummies which are included to capture 
unobserved effects of changes over time  and country is a  dummy variable to capture 
the difference in performance between the Czech Republic and Slovakia. In addition, 
using factor analysis, the three health care input variables of interest (doctors, nurses, 
beds) are reduced into a common factor, labelled ‘health activity’ (h_activ). This is 
our variable of interest capturing health activity in a given region.  
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The basic model suffers from a number of problems. First, while a selection of non-
health system factors is controlled for, there are other regional characteristics that 
cannot be measured but may be correlated with the explanatory variables. Therefore, 
regional fixed effects are used in this analysis.  Second, the model does not account 
for the potential problem of endogeneity which has been noted as a problem in earlier 
studies (Auster, Leveson, & Sarachek, 1969), in particular the direction of causality 
between number of physicians and mortality can run in both directions, which if not 
controlled for will lead to biased estimates.  
 
One solution to this problem is the use of instrumental variables (‘instruments’) 
through a within-groups instrumental variable model. It is important the instruments 
are properly selected both conceptually and technically. In other words, they need to 
be proper determinants of the endogenous explanatory variable being instrumented 
(physician supply), have the ability to predict the endogenous variable, and be 
uncorrolated with the error term so that they are related to the outcome of interest 
(‘avoidable’ mortality) or the dependent variable only through the variable being 
instrumented.  After having tested a range of potential instruments, number of 
dwellings completed in a given year and length of roads and motorways  were found 
to be both conceptually and statistically most appropriate and were used to 
instrument doctor supply.  With increased number of dwellings and roads the 
number if physicians is likely to increase; however ‘avoidable’ mortality is not 
necessarily expect to be affected. The instruments may not be as appropriate for non-
avoidable mortality. When using the reduced health activity as our explanatory 
variable, number of dwellings completed in a given year and car accidents per 
operated cars were chosen as most appropriate instruments.  These instruments 
predict physician supply in a region but do not predict ‘avoidable’ mortality.  The 
instruments have passed the relevance test using the Anderson canonical correlations 
likelihood-ratio test and the Sargan test of overidentifying restrictions in cases where 
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‘avoidable’ deaths are used as the dependent variable. An F-test of the first model in 
the two-stage regression was carried out to assess the validity of the instruments.  
 
Third, the assumption that mortality is static has been made, which is another 
potential source of omitted variable bias (Aakvik & Holmas, 2006). While mortality is 
determined by a range of present factors, it is likely that current levels of mortality 
are also determined by past levels of mortality. To take account of this problem a 
dynamic panel data model is used. The Arellano and Bond (1991) model addresses 
the problem of autocorrelation arising between the lagged dependent variable and the 
error term.  The third, dynamic model, for equation (1) can be specified as follows: 
 
tiititi
condition
ti
condition
ti uXHIAMRAMR ,,,11,0, εβαγβ +++++= −  
 
for i=1 ....N; t=1.....T, where again i is the regional indicator and t the time indicator.  
condition
tiAMR ,  is the ‘avoidable’ mortality rate in the region i and time t. 
condition
tiAMR 1, −  is 
the mortality rate in region i in the previous year so the model allows for today’s 
mortality levels to depend on past mortality.  tiHI ,  is a vector of the health care 
inputs and includes number of doctors, nurses and beds (or health activity in 
Equation (2)) which are all treated as endogenous. tiX ,  represents all the other 
variables as specified in equation (1) and (2) including GDP, unemployment, 
pollution and country, as well as the year specific intercept term common to all 
regions. iu  is again the unobserved region-specific time invariant effect and ti,ε  is the 
disturbance term. This equation is first- differenced to get rid of the regional fixed 
effect which may be correlated with our variables of interest but at the same time a 
new error term is obtained:  
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 ∆ ti,ε  = ti,ε - 1, −tiε   
 
This new error term is correlated with the lagged dependent variable  
 
condition
ti
condition
ti
condition
ti AMRAMRAMR 2,1,, −− −=∆ .  
 
However, conditionptiAMR −,  and ∆
condition
ptiAMR −,  are not correlated with ∆ ti,ε  and are 
therefore valid instruments for periods p ≥ 2. Also, the lagged values 2, −tiHI , 3, −tiHI  
of our endogenous variables are valid instruments for periods t = 3,4 ....T. The 
remaining variables are treated as exogenous.  
 
4.3. Results  
 
During the study period the mean age-standardised mortality rate for ischaemic heart 
disease was 102.973 per 100,000 inhabitants, followed by 46.665 per 100, 000 
inhabitants for hypertension & cerebrovascular diseases. Mortality from the 
remaining ‘avoidable’ causes was 16.575 per 100,000 inhabitants (see Table 20 for 
conditions included in this category). Finally, 231.677 per 100,000 died from non-
avoidable causes. Descriptive statistics of dependent and explanatory variables can be 
found in Table 21. 
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Table 21. Descriptive statistics of dependent and explanatory variables 
 
Variable name Description  Mean  Std. 
dev. 
Dependent variables   
ihdcr Age-standardised mortality rate for ischaemic heart disease 102.973 26.728 
hypcercr Age-standardised mortality rate for hypertension and cerebrovascular 
diseases  
46.665 15.533 
allcr Age-standardised mortality rate for all remaining avoidable causes  16.575 3.208 
other Age-standardised mortality rate for other mortality causes (non-
avoidable mortality)  
231.677 27.446 
avoid Age-standardised mortality rate for all avoidable causes 
(ihdcr+hypcercr+allcr) 
166.214 40.179 
Explanatory  variables   
doc Doctors per 10,000 inhabitants 35.919 10.169 
bed Hospital beds per 10,000 inhabitants 68.577 14.808 
nur Nurses per 10,000 inhabitants 74.216 14.557 
lgdp Log of Gross Domestic Product per capita adjusted to 2005 prices in 
Czech crowns 
12.228 0.338 
unem Unemployment rate 10.116 5.676 
pol Pollution in tons of pollutants per capita 0.638 0.772 
sl Slovakia = 1 Czech Republic = 0  0.364 0.482 
 
The purpose of Figure 22 is to highlight regional trends rather than identify 
particular regions. As expected, a declining trend for ‘avoidable’ mortality reflecting 
improvements in health system performance can be observed while regional 
mortality rates for other, other (non-avoidable) causes has remained around the 
same levels or slightly increased.  
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Figure 22. Regional mortality trends: age-standardised mortality rates per 
100,000 inhabitants for ‘avoidable’ and ‘other’ cause 
 
 
Note: Legend is omitted as the focus is on regional variation rather than the performance of 
individual regions 
 
Gradual increase in the number of physicians per 10,000 habitants can be observed 
over time.  In both capital cities, it is evident that there can be as much as three times 
the number of physicians than in other regions (Figure 23).  For nurses per 10,000 
inhabitants, there appears to be more variation both across regions and time. Finally, 
for beds per 10,000 inhabitants there is a continuous decline in all the regions. Again, 
the goal in this figure was to highlight general trends rather than the ability to 
identify trends in a particular region. 
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Figure 23. Regional trends - doctor, nurse and bed supply per 10,000 inhabitants 
 
 
Note: Legend is omitted as the focus is on regional variation rather than the performance of 
individual regions 
 
The maps in Figure 24 illustrate the regional variations of mean age-standardised 
‘avoidable’ mortality rates for the three different groups of ‘avoidable’ mortality and 
for mortality from other causes. Particular regions in both the Czech Republic 
(Ustecky and Karlovarsky) and in Slovakia (Banskobystricky for all groups, as well as 
Kosicky and Presovsky) are the worst performers. High rates of remaining ‘avoidable’ 
mortality in the Bratislava region should also be noted; yet mortality for all other 
causes in the Slovak capital is in the second lowest category.  
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Figure 24. Regional variations in average age-standardised ‘avoidable’ mortality 
rates for the period of 1996-2007 
 
 
 
 
Regression results 
 
Table 22 presents results from the static OLS, fixed effects (FE) and the dynamic 
GMM models for all ‘avoidable’ mortality causes grouped together, compared to other 
mortality.  First the OLS and FE models are discussed. Analysis for other cause 
mortality is used as control where a weaker effect of health care system inputs 
compared to socioeconomic variables on mortality was expected. The signs of 
coefficients do not differ as much as was expected a priori. For ‘avoidable’ mortality, 
the coefficients of interest do not show a significant relationship. Physician and bed 
supply display negative coefficients in the OLS model and positive coefficients in the 
fixed effects model, but are statistically not significant at conventional levels.  For 
nurse supply, the coefficients are positive in both models suggesting that mortality 
rate increases with the number of nurses. While GDP has a negative coefficient as was 
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expected, it is not significant. Unemployment and pollution are positively and 
significantly associated with ‘avoidable’ mortality in the OLS model but the sign of 
the coefficients change in the fixed effects model and the relationship becomes 
insignificant.   
 
However, as has already been suggested, these models are likely to be incorrectly 
specified due to endogeneity problems and possible dynamics that are not accounted 
for. Therefore, the instrumental variable model (see results of IV models for all 
dependent variables in Appendix C) with a reduced dataset was first examined.  The 
results of the Hausman test showed no significant evidence of endogeneity in 
physician supply and the Anderson test of relevance suggested a weak instrument 
problem. Therefore, an instrumental variable model does not appear to be more 
suited than the static models. Then a dynamic model (see GMM in Table 22) was 
used to account for possible dynamics in the mortality rates.  The specification tests 
in the dynamic models (Sargan test of over-identifying restrictions and test of serial 
correlation) were satisfactory.  However, neither of the two lags of the dependent 
variables are significant, contrary to earlier findings (Aakvik & Holmas, 2006) 
suggesting no persistence in mortality rate over time.  Further, there is no significant 
relationship between the combined health activity explanatory variable and 
‘avoidable’ mortality (see Appendix C).  
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Table 22. Results for ‘avoidable’ and other mortality 
 
 
 ‘Avoidable’ mortality Other mortality 
  OLS FE GMM OLS FE GMM 
L.avoid   -0.0288    
   (0.444)    
L.other      -0.0651 
      (0.385) 
doc -0.179 0.0311 -2.981 -0.610 1.371** -6.228 
 (0.879) (0.651) (18.47) (1.346) (0.578) (8.804) 
nur 0.672 0.351 0.306 0.766 -0.485 5.923 
 (0.687) (0.482) (9.989) (1.108) (0.429) (5.479) 
bed -0.734 0.0662 -0.781 -0.934** 0.193 0.381 
 (0.471) (0.300) (1.680) (0.409) (0.266) (2.427) 
lgdp -16.20 -13.99 1.485 -21.49 -7.386 -134.2 
 (16.83) (10.76) (36.06) (15.59) (9.561) (142.8) 
unem 2.612** -0.506 1.352 2.405** 0.110 -0.116 
 (1.034) (0.429) (5.113) (0.936) (0.382) (5.983) 
pol 13.80*** -0.274 168.6 8.840** 1.564 21.69 
 (2.856) (2.330) (218.7) (3.874) (2.071) (73.73) 
sl 45.25***   31.12**   
 (12.61)   (13.02)   
_Iyear_1997 -12.07** -10.85***  6.699* 4.624  
 (5.710) (3.611)  (3.755) (3.210)  
_Iyear_1998 -26.65*** -19.70*** 25.67 -1.236 0.894 4.650 
 (8.763) (4.143) (44.05) (5.568) (3.683) (21.61) 
_Iyear_1999 
-
34.90*** 
-
20.98*** 43.10 -8.994 -0.728 7.333 
 (10.26) (4.661) (64.71) (7.689) (4.143) (31.68) 
_Iyear_2000 -38.43*** -26.54*** 51.27 -10.20 -3.373 4.090 
 (10.03) (4.750) (89.78) (7.624) (4.222) (31.53) 
_Iyear_2001 -46.62*** -32.76*** 44.18 -9.848 -1.268 7.851 
 (11.25) (4.949) (87.36) (8.052) (4.399) (34.24) 
_Iyear_2002 -49.46*** -35.48*** 48.20 -6.985 1.020 17.93 
 (12.27) (5.230) (97.32) (8.763) (4.649) (44.59) 
_Iyear_2003 -53.07*** -39.14*** 38.00 3.841 10.76** 42.11 
 (12.49) (5.468) (101.4) (8.619) (4.861) (52.44) 
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_Iyear_2004 -51.85*** -41.66*** 37.25 2.237 3.581 60.11 
 (12.77) (6.165) (134.8) (10.08) (5.480) (72.08) 
_Iyear_2005 -54.94*** -47.46*** 35.28 11.85 10.25* 78.49 
 (13.80) (6.612) (152.7) (9.808) (5.877) (82.41) 
_Iyear_2006 -55.61*** -52.52*** 32.75 12.22 5.956 84.13 
 (13.54) (7.108) (171.8) (11.01) (6.318) (92.60) 
_Iyear_2007 -45.44*** -47.28*** 51.22 21.79 8.237 108.3 
 (15.01) (8.576) (211.2) (13.01) (7.623) (118.0) 
reg1 -4.060   52.56***   
 (22.16)   (15.47)   
reg15 2.580   40.42   
 (27.18)   (24.17)   
Constant 358.7* 342.0*** 133.6 476.2** 290.1*** 1,596 
 (202.0) (125.4) (640.0) (178.4) (111.5) (1,594) 
       
Observations 264 264 220 264 264 220 
R-squared 0.825 0.749   0.664 0.302   
*** p<0.01, ** p<0.05, * p<0.1     
Robust standard errors in parentheses    
 
 
Table 23 presents results from the static OLS and fixed effects models and the 
dynamic GMM model for the separate groups of ‘avoidable’ mortality causes: 
ischaemic heart disease, hypertension & cerebrovascular diseases, remaining 
avoidable causes.  We do not observe significant relationship between any of the 
three ‘avoidable’ mortality causes and the health care input coefficients of interest 
(doctors, nurses, beds).  The lagged dependent variables in the dynamic models are 
also not significant; however, given the results for aggregated ‘avoidable’ mortality 
above, these findings are not surprising.  
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Table 23. Results for selected ‘avoidable’ mortality conditions 
  IHD HYP&CER Remaining ‘avoidable’ causes 
VARIABLES OLS FE GMM OLS FE GMM OLS FE GMM 
L.ihdcr   0.0748        
   (0.285)        
L.hypcercr       -0.522    
       (0.404)    
L.allcr           -0.409 
           (1.745) 
Doc -0.376 -0.373 -1.224 0.263 0.421 1.818 -0.0656 -0.0166 0.417 
 (0.718) (0.596) (4.558) (0.317) (0.355) (5.108) (0.0954) (0.117) (8.900) 
Nur 0.636 0.240 -0.783 0.00921 0.133 -0.615 0.0261 -0.0220 -0.127 
 (0.552) (0.442) (2.295) (0.266) (0.263) (4.478) (0.0836) (0.0870) (4.502) 
Bed -0.357 0.287 -1.215 -0.364* -0.250 -0.385 -0.0128 0.0291 0.0865 
 (0.371) (0.274) (3.168) (0.196) (0.164) (0.656) (0.0418) (0.0540) (1.217) 
Lgdp -12.92 0.303 19.65 -2.092 -13.16** 12.35 -1.187 -1.128 -0.0469 
 (14.24) (9.851) (84.29) (6.021) (5.874) (88.54) (1.614) (1.940) (27.60) 
Unem 1.364 -1.265*** -0.0226 1.036*** 0.842*** 1.310 0.212** -0.0831 -0.388 
 (0.933) (0.393) (4.875) (0.341) (0.234) (2.264) (0.0860) (0.0775) (2.095) 
Pol 10.20*** 0.171 23.26 2.610 -0.291 0.891 0.990** -0.154 4.109 
 (2.772) (2.134) (99.66) (1.661) (1.272) (22.39) (0.360) (0.420) (18.47) 
Sl 21.69**    22.42***    1.140   
 (9.341)    (5.356)    (1.853)   
_Iyear_1997 -9.673** -7.958**   -2.212 -2.751   -0.184 -0.137  
 (4.166) (3.307)   (2.640) (1.972)   (0.661) (0.651)  
_Iyear_1998 -22.30*** -15.42*** -5.215 -3.393 -3.911* -4.594 -0.956 -0.368 1.014 
 (6.824) (3.795) (37.21) (3.157) (2.263) (12.17) (0.810) (0.747) (6.637) 
_Iyear_1999 -27.18*** -13.91*** -3.848 -6.840 -7.378*** -8.402 -0.881 0.313 2.385 
 (8.156) (4.269) (67.47) (4.085) (2.545) (17.09) (1.051) (0.841) (10.72) 
_Iyear_2000 -31.60*** -19.30*** -6.859 -5.665 -7.030*** -8.184 -1.162 -0.208 1.548 
 (7.597) (4.351) (75.46) (3.996) (2.594) (14.27) (1.033) (0.857) (12.21) 
_Iyear_2001 -36.77*** -23.03*** -10.83 -7.332 -8.336*** -9.492 -2.513** -1.395 0.306 
 (8.250) (4.532) (75.37) (5.124) (2.702) (15.84) (1.035) (0.893) (11.77) 
_Iyear_2002 -38.28*** -25.01*** -12.45 -8.657 -9.094*** -12.57 -2.517** -1.383 0.100 
 (8.611) (4.790) (85.24) (5.359) (2.856) (19.73) (0.950) (0.943) (11.58) 
_Iyear_2003 -40.88*** -28.28*** -20.63 -9.818* -9.546*** -16.24 -2.377* -1.315 -0.704 
 (9.277) (5.008) (89.81) (5.065) (2.986) (23.49) (1.181) (0.986) (16.62) 
_Iyear_2004 -38.65*** -30.17*** -25.83 -11.31** -10.21*** -20.80 -1.884 -1.272 -1.108 
 (10.29) (5.647) (94.90) (4.736) (3.367) (36.71) (1.158) (1.112) (23.62) 
_Iyear_2005 -40.37*** -34.79*** -32.08 -12.65** -11.05*** -24.05 -1.924 -1.621 -1.382 
 (11.06) (6.056) (101.7) (5.139) (3.611) (42.38) (1.220) (1.193) (27.69) 
_Iyear_2006 -39.20*** -37.78*** -35.14 -14.54** -12.73*** -28.17 -1.869 -2.014 -3.043 
 (10.54) (6.510) (102.9) (5.370) (3.882) (47.49) (1.282) (1.282) (35.38) 
_Iyear_2007 -29.62** -32.94*** -27.25 -13.69** -11.54** -32.93 -2.131 -2.797* -5.201 
 (11.48) (7.855) (115.0) (6.106) (4.683) (59.30) (1.405) (1.547) (52.95) 
reg1 -6.293    -1.836    4.069**   
 (21.22)    (7.444)    (1.867)   
reg15 2.021    -6.977    7.536***   
 (27.41)    (9.185)    (2.470)   
Constant 253.3 110.2 39.47 75.18 199.3*** -74.86 30.19 32.56 13.85 
 (171.0) (114.9) (880.4) (72.59) (68.48) (943.4) (18.84) (22.62) (326.1) 
Observations 264 264 220 264 264 220 264 264 220 
R-squared 0.703 0.691   0.795 0.388   0.537 0.300   
Robust standard errors in parentheses,  
*** p<0.01, ** p<0.05, * p<0.1                                                    
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4.4. Discussion and conclusions 
 
The goal of this chapter was to assess whether the relationship between ‘avoidable’ 
mortality as a methodologically more appropriate indicator of health outcome, and 
health care inputs holds in the context of Slovakia and the Czech Republic, given 
earlier evidence that supports this relationship. ‘Avoidable’ mortality refers to deaths 
which could have been avoided if timely and effective medical care had been 
provided.  Controlling for other factors, the chapter found no significant relationship 
between health care resources (measured by number of physicians, nurses and beds) 
and ‘avoidable’ mortality rates using:  a) pooled OLS regression controlling for years 
b) fixed effects that incorporate unmeasured regional factors c) instrumental variable 
model treating physician supply as endogenous d) dynamic GMM model which 
allows for time persistence in mortality rates. Despite taking into consideration 
potential endogeneity and dynamics, significant relationship was not found. 
 
These results contribute to the debate on the role of health care inputs in explaining 
variations in health outcomes in several ways. First, it is possible that a relationship 
cannot be established given that the supply of health services has reached a level 
where there are diminishing returns, mirroring Preston’s relationship between 
income and economic development (Bloom & Canning, 2007).  
 
Second, while health care inputs are an important element of the health care system, 
they do not seem to adequately capture what is happening in the health care system. 
Lack of a consistent association in numerous studies both with standard health 
outcome indicators and the results of this study confirm this finding. Capturing 
quality of care and not only quantity for the unit of interest (regions in this case) has 
been a challenge in earlier studies.  Using quantity of health care resources as a proxy 
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for quality can only tell us so much about the provision of timely and effective 
medical care. For example, while there is a minimum network requirement in 
Slovakia, health care capacities (beds and physicians) in the regions are calculated 
per capita and do not consider health care needs of the population and effective use 
of resources; adequate accessibility is not a requirement; only a minimum number of 
providers is (Szalay, Pažitný, Szalayová, et al., 2011).  In both countries, changes in 
bed, doctor and nurse supply were largely due to restructuring of health care facilities 
rather than a reflection of health needs (Rokosová M, 2005; Szalay, Pažitný, 
Szalayová, et al., 2011). Therefore, changes in supply can be observed while it cannot 
be concluded whether appropriate and timely care is being provided.  If other 
countries are considered, Canada for example, ‘avoidable’ deaths declined between 
1997 and 2002 (Nolte & McKee, 2008a) even though their physician-to-population 
ratio has been stable for over 20 years (Evans & McGrail, 2008), demonstrating that 
improvements in health care outcomes can be attained without increasing the 
physician-to-population ratio (Watson & McGrail, 2009). Under such circumstances, 
it is important to search for better indicators to capture timely access and provision of 
effective treatment for the group of ‘avoidable’ conditions. “Timely and effective 
medical care” has been difficult to measure with the data available in most countries, 
including the Czech Republic and Slovakia analysed in this study.   
 
Third, the evidence from the recent AMIEHS study shows that while for many 
conditions important key interventions are available to avoid deaths, it remains 
complicated to ascertain the exact proportion that can be attributed to the selected 
medical interventions. That may explain why establishing a link with health care 
inputs may have been difficult. The results of this study were preceded by a debate on 
this issue. For example, a comprehensive literature review by Nolte & McKee (2004) 
found that up to 70% of stroke mortality can be avoided through better management 
of high blood pressure and improved care after a stroke; the remaining 30% can be 
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attributed to smoking, diet and physical activity (Nolte & McKee, 2004).  The 
contribution of medical care to mortality from ischaemic heart disease is also 
controversial, although again available evidence suggests that its impact is 
considerable (Nolte & McKee, 2004), with about 45-70% of mortality  attributable to 
secondary and tertiary care such as post-infarction treatment or coronary bypass 
grafting (Beaglehole, 1986; Bots & Grobbee, 1996; Bruthans, Cífková, Lánská, et al., 
2012; Capewell, Beaglehole, Seddon et al., 2000; Capewell, Morrison, & McMurrey, 
1999; Hunink, Goldman, Tosteson et al., 1997; Tobias & Jackson, 2001; Tunstall-
Pedoe, Vanuzzo, Hobbs et al., 2000) and about 30-55% to primary prevention and 
risk factor mitigation such as smoking cessation, cholesterol reduction and control of 
high blood pressure (Bruthans, Cífková, Lánská, et al., 2012) (sometimes primary 
prevention was also included in the former category). These examples demonstrate, 
the difficulty in determining the exact contribution of health care, despite the broad 
understanding that it matters. The AMIEHS study (Plug, Hoffmann, & Mackenbach, 
2011) concluded stating that “we remain convinced, on the basis of the totality of the 
evidence, that improvements in health care have been associated with substantial 
declines in deaths from many conditions”. They further state that it is because apart 
from the timing of an innovation, the extent to which a population is covered by the 
innovation as well as the combined effect of the innovation with other health care 
factors need to also be considered. Therefore, the authors conclude that the ‘absence 
of evidence’ of the effectiveness of health care in reducing population-level mortality 
does not imply ‘evidence of absence’.  
 
Thus, even though ‘avoidable’ mortality is considered to better capture the 
contribution of health care systems and therefore have the potential to be used as 
indicator of the quality and performance of the health care system, range of other 
non-health system factors are still considered to be important determinants of 
changes in mortality rates (Plug, Hoffmann, & Mackenbach, 2011). Therefore, 
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variables that capture non-health determinants and may be key risk factors need also 
be included in future analysis. For example for cardiovascular mortality, risk factors 
such as nutrition  (Cremieux, Ouellette, & Pilon, 1999), alcohol and smoking  
(Cochrane, St Leger, & Moore, 1978; Cremieux, Ouellette, & Pilon, 1999), as well as 
high cholesterol and blood pressure (Bruthans, Cífková, Lánská, et al., 2012; Cífková, 
Škodová, Bruthans, et al., 2010),  physical inactivity, weight, hypertension control 
(Cífková, Škodová, Bruthans, et al., 2010), hyperlipidaemia and diabetes would all be 
important (Bruthans, Cífková, Lánská, et al., 2012; Cífková, Škodová, Bruthans, et al., 
2010; Mendis, Puska, & Norrving, 2011). Another example is malignant neoplasm of 
cervix uteri, for which it would be sexual habits and social class, and for peptic ulcer, 
alcohol and smoking (Holland, 1997). 
 
This chapter also used individual ‘avoidable’ mortality causes, in addition to 
aggregate ‘avoidable’ mortality as the key dependent variable.  Only a few studies 
have previously explored ‘avoidable’ mortality in this respect (Sundmacher & Busse, 
2011). The different conditions included in the analysis all have their specific health 
interventions at the primary or hospital care level which are essential to successfully 
prevent or treat the condition (Holland, 1997; Plug, Hoffmann, & Mackenbach, 2011). 
For example, in the case of malignant neoplasm of cervix uteri, it could be important 
to include variables that capture whether and how cervical cancer screening, cytology, 
surgery and radiation therapy have been provided. For peptic ulcer, anti-ulcer drugs 
and surgery for complications are important in preventing premature deaths18. 
Although important, explanatory variables that capture these key interventions were 
not included in our analysis due to data unavailability at the regional level. At the 
same time, due to insufficient numbers of deaths for these individual conditions, 
grouping them together makes the inclusion of condition specific quality of care 
                                                        
18 Evidence from the AMIEHS project which has updated the list of ‘avoidable’ mortality 
conditions and interventions that make these deaths avoidable (Plug, Hoffmann, & 
Mackenbach, 2011) should be consulted.  
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explanatory variables complicated. Overall one needs to consider the trade-off 
between analysing individual ‘avoidable’ causes versus all ‘avoidable’ causes grouped 
together and the best suited variables to be used to capture high quality health care 
provision. At the aggregate level, proxy variables may be used for effective 
prevention, integration of care, treatment and other elements of health care services. 
Thus ‘avoidable’ mortality conditions should be studied individually for those 
conditions where sufficient numbers of deaths exist, as the results obtained will be 
more informative to policy makers.  
 
Finally, contrary to earlier studies, this chapter has applied different analytical 
models to address problems, in particular endogeneity and dynamics. The analysis 
has shown that an instrumental variable model is not more appropriate than our 
fixed effects model. Even though earlier studies have suspected endogeneity of 
physician supply, in the case of Slovakia and the Czech Republic, endogeneity may 
not in fact be a problem as health care resource planning has not been based on 
health care needs (e.g. mortality, morbidity) of the population but per capita. 
Furthermore, the choice of instruments has always been a strongly contested topic 
(Angrist & Krueger, 2011). Using different and perhaps more appropriate 
instruments for physician supply instead of number of dwellings completed in a given 
year or length of roads and motorways may have led to different results. While these 
instruments have passed the Sargan test, conceptually there may be stronger and 
more appropriate instruments. However, due to data limitation no other suitable 
instruments could be identified for this analysis.  There are also a number of 
important variables missing in the analysis, such that the coefficients in the dynamic 
model may be biased.  
 
To conclude, health care inputs do not consistently explain health outcomes, even 
when an improved indicators such as ‘avoidable’ mortality is used. Variations in 
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‘avoidable’ mortality could possibly be explained when effective and high quality of 
care for individual conditions is captured with better quality data. Then with the use 
of more sophisticated analytical models accounting for endogeneity or dynamic 
influences, the existence of a significant negative relationship with ‘avoidable’ 
mortality may be shown. At the same time, non-health system determinants and 
other risk factors need to be better accounted for.  While it is difficult to determine at 
the aggregate level the extent to which health care interventions prevent unnecessary 
deaths, the most recent evidence from the AMIEHS project continues to point to the 
fact that ‘avoidable’ mortality indicators may be most useful for an initial 
understanding of how the health care system is performing. Therefore, unnecessary 
and potentially ‘avoidable’ deaths should be used as it was originally intended - as a 
tool to provide insights into the quality and weaknesses of the health care system 
where further systematic investigations for the underlying reasons are necessary 
(Holland & Breeze, 1985; James, Manuel, & Mao, 2006; Kossarova, Holland, Nolte, et 
al., 2009; Plug, Hoffmann, & Mackenbach, 2011).  In the future, applying more 
accurate explanatory variables to capture timely and effective interventions rather 
than health care inputs that do not sufficiently reveal to us how a health care system 
is working, is essential.  
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Chapter 5.  Examining the quality of ambulatory care in 
Slovakia using outcome and process indicators 
 
5.1. Introduction 
 
Chapters 2, 3 and 4 have focused on the macro level, using health outcomes to 
measure health system performance first and then health care performance more 
specifically.  This chapter moves to the assessment at the micro level by looking at the 
quality and effectiveness of one aspect of the health care system in Slovakia – 
ambulatory care – using individual patient level data.  Diabetes and asthma are two 
of the several chronic ACSCs, which if treated by timely and effective ambulatory care 
should not result in unnecessary hospitalisations. As highlighted in Chapter 1, 
hospitalisations for ACSCs (ACSHs) or preventable hospitalisations have been 
suggested and used as a population level indicator of access and quality of outpatient 
care. Therefore, one goal has been an attempt to describe trends in ACSHs. In 
addition, studies have also tried to assess and validate to what extent variations in 
preventable hospitalisations are associated with different factors, especially age, sex, 
socio-economic conditions, health system factors and others. This evidence is 
summarised against an analytical framework in Chapter 1.   
 
The evidence on the effectiveness of interventions aimed at reducing unplanned 
admissions on the population level remains limited (Ansari, 2007a; Purdy, 2010). 
Purdy (2010) identifies several interventions which may work in reducing avoidable 
admissions, including continuity and integration of care, patient self-management, 
acute assessment units or early review by a senior clinician in the emergency 
department, among others. The evidence on the association between higher quality of 
primary care, as measured by routine data and reduced rates of admission, is mixed 
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(Bottle, Gnani, Saxena et al., 2008; Downing, Rudge, Cheng et al., 2007; Purdy, 
2010; Saxena, George, Barber et al., 2006). However, these studies are carried out at 
the aggregate level for groups of conditions where certain important factors, 
including condition specific appropriate care, cannot be examined. Information about 
the quality and appropriateness of care of individual patients is essential in order to 
make quality of care improvements (Shekelle & Roland, 2000, p.172).  This chapter 
therefore aims to fill this gap in the literature using patient level data for diabetic and 
asthma patients. In particular, individual variations in potentially preventable 
diabetes and asthma hospitalisations will be analysed and whether the provision of 
(in)appropriate care can explain these variations.  
 
In 2011 United Nations General Assembly launched a global campaign to tackle the 
increasing burden of premature deaths from non-communicable diseases, including 
chronic respiratory diseases, diabetes, cardiovascular diseases and cancers (UN News 
Centre, 2011).  Diabetes and asthma are chronic conditions that can seriously affect a 
patient’s quality of life. In 2012, over 35 million people had diabetes in Europe which 
is about 7.9% of the adult population (European Diabetes Leadership Forum 
Copenhagen, 2012a); in Slovakia prevalence  in 2010 was 6.3% (National Health 
Information Centre, 2011). Asthma is the most common chronic disease among 
children and worldwide affects over 300 million people (Global Initiative for Asthma, 
2012); adult prevalence in Slovakia is between 3-5% and  among children as high as 
6-7% (Hrubisko & Ciznar, 2010). Given the high morbidity and mortality for these 
conditions, prevention, early diagnosis and appropriate treatment are fundamental.  
 
Parallel and in response to the UN global campaign, a number of disease specific 
initiatives have been emerging. In 2010 the Global Initiative for Asthma (GINA) 
embarked on the GINA Asthma Challenge which aims to reduce hospitalisations due 
to asthma by 50% by 2015, using the number of hospital admissions as the primary 
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marker of success (FitzGerald, Bateman, Hurd et al., 2011). Hospitalisations were 
selected as the main outcome measure as they are directly associated with mortality, 
are considered inconvenient for the patient, and together with medications are also a 
key driver of health care costs (Bahadori, Doyle-Waters, Marra et al., 2009; 
FitzGerald, Bateman, Hurd, et al., 2011). More importantly, asthma hospitalisations 
are highly responsive to interventions and decrease as access to care and controller 
treatment is provided (FitzGerald, Bateman, Hurd, et al., 2011). While emergency 
admissions are sometimes necessary for specialist management of severe 
exacerbation, about three quarters are preventable and usually represent a serious 
loss of control of a person’s asthma (NHS RightCare, 2011).  The hospitalisation 
reduction target may seem challenging but important reductions in admissions have 
already been achieved in Finland, through the coordination of access to a uniform 
package of care, involving education, pharmacotherapy and follow-up (Haahtela, 
Tuomisto, Pietinalho et al., 2006).  For diabetes, the Copenhagen Roadmap presents 
practical and concrete initiatives to improve prevention, early detection, control and 
treatment.  It is a result of  extensive political and policy efforts to provide detailed 
steps for the National Diabetes Guidelines (European Diabetes Leadership Forum 
Copenhagen, 2012b). Diabetes can be considered an illness upon which there is 
widespread consensus on good practice patterns and international convergence for 
processes and outcome of care (Nicolucci, Greenfield, & Mattke, 2006). As with 
asthma, experts agree that diabetes can and should be effectively managed and 
people should be ensured access to safe and effective treatments which improve 
control, reduce long-term complications and prevent hospitalisations (European 
Diabetes Leadership Forum Copenhagen, 2012b).  
 
Overall, there is consensus that the goal is to reduce the number of hospitalisations 
but as has been noted in Chapter 1, the appropriate number or rate of hospitalisations 
is not straightforward to determine. Especially, if detailed clinical information about 
 175
the patient is not available.  It is rather the observed variation in hospitalisations that 
this chapter is interested in explaining, as large fluctuations may suggest that some 
patients are not receiving the best recommended care, or that health care resources 
are not being used appropriately (Evans, 1990; Mercuri & Gafni, 2011). Variations in 
the quality of health care in the United States have been subject to debate for some 
time (Wennberg & Gittelsohn, 1973) and have increasingly led to quality 
improvement strategies.  A review of studies in the United States found that 
approximately 20% of patients received inappropriate care for their chronic condition 
(Schuster, McGlynn, & Brook, 1998). The Institute of Medicine (IOM) Committee on 
the Quality of Health Care in America also found that there is a large gap between the 
care patients should receive and the quality of care they actually receive (IOM, 2001). 
While the conclusions of the IOM Committee were for the United States, quality 
advocates largely agree that the same applies for other Western countries 
(Timmermans & Berg, 2003), and the European Union (Legido-Quigley, McKee, 
Nolte, et al., 2008).  A review of quality measurement and improvement concludes 
that in Slovakia “systematic approaches to quality of care are still at a basic stage of 
development”  (Legido-Quigley, McKee, Nolte, et al., 2008, p. 168) and securing 
quality of care while ensuring financial sustainability remains a challenge (Szalay, 
Pažitný, Szalayová, et al., 2011). While many clinical guidelines have been adopted, 
their uptake is sporadic and the extent to which quality of health care initiatives are 
implemented is not evaluated (Legido-Quigley, McKee, Nolte, et al., 2008).  A 2008 
report assessing the quality of diabetes care ranked Slovakia less favourable and 
showed that there is significant room for improvement (Health Consumer 
Powerhouse, 2008).  
 
More generally, the key tools proposed to address quality of care gaps, variations in 
medical care and rising health care costs are performance standards, information 
technology and evidence-based clinical guidelines (de Jong, Groenewegen, 
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Spreeuwenberg et al., 2010; IOM, 2001; Timmermans & Berg, 2003).  In particular, 
the focus is not on whether standards and evidence - based clinical guidelines should 
exist but what form they should take, and  how they should be implemented to 
improve quality of care (Timmermans & Berg, 2003). Clinical guidelines (“codified 
rules defining appropriate care or high quality medical care” (Nigam, 2012)) are 
designed to help physicians decide on the most appropriate form of care for the 
patient, especially when in doubt. Guidelines may also set the minimum required 
treatment. However, the existence of clinical guidelines does not necessarily 
guarantee their uptake or use. A range of factors determines whether physicians will 
treat according to guidelines, including: the type of health problem; how the 
guidelines were developed; content of the guideline; source of dissemination; format 
or layout (Grol & Grimshaw, 2003).  Evidence shows that most of the guidelines are 
just another source of reference for physicians about state-of-the-art practice and are 
often not adhered to.  As such, guidelines still have a long way to go in terms of 
changing the day to day practice of providers (Timmermans & Berg, 2003). 
Therefore, extensive efforts are being undertaken to learn about how physicians’ 
behaviour and medical practice can be changed (Grol & Grimshaw, 2003). Regardless 
of the extent of uptake, clinical guidelines can be used as baselines to assess the 
quality of care provided for a particular condition.  
 
Several studies have looked at the extent to which appropriate medical care, 
measured through selected indicators for asthma and diabetes, are associated with 
hospitalisations.  A systematic literature review on the extent to which quality 
indicators for diabetes care are related to patient outcomes presented mixed results 
(Sidorenkov, Haaijer-Ruskamp, de Zeeuw et al., 2011). The study found that while 
many structure and process indicators are widely accepted and may have content and 
face validity, and are feasible, they may not necessarily have predictive validity, i.e. 
high scores on process indicators may not necessarily be associated with better 
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patient outcomes (Sidorenkov, Haaijer-Ruskamp, de Zeeuw, et al., 2011). The authors 
grouped the papers according quality components. Studies that looked at structural 
indicators usually had a weak design and found no associations with outcomes or 
produced mixed results. Four studies considered to be of ‘high quality’ in the review 
measuring process indicators such as numbers of tests or visits showed mostly 
negative results. Overall, Sidorenkov et al (2011) argue that for many widely used 
quality indicators, there is insufficient evidence to conclude that they lead to better 
patient outcomes.  However, these results often rely on studies of insufficient quality, 
or limited geographic variation, especially as many are based on the US. Sidorenkov 
et al (2011) calls for more evidence to support the argument that there is relationship 
between quality of diabetes care - as currently assessed - and patient outcomes. In the 
same year a study using multiple regression analysis assessing the association 
between indicators of quality of diabetic management and emergency hospital 
admissions for short-term complications of diabetes in the United Kingdom found 
that GP practices with better quality of diabetes care had fewer emergency 
admissions (Dusheiko, Doran, Gravelle et al., 2011).  
 
For asthma, less evidence is available as quality of care indicators are not yet widely 
agreed on and applied. However, several studies found that adequate disease 
management and adherence to clinical guidelines by primary care providers is 
associated with less hospitalisations (Cloutier, Hall, Wakefield et al., 2005; 
FitzGerald & Quon, 2010; Fontes, Affonso, Calazans et al., 2011; Fuhrman, Dubus, 
Marguet et al., 2011; Rodrigo, Plaza, Bellido-Casado et al., 2009). Overall, two types 
of medication are used to treat asthma: i) controllers – used for everyday long term 
use with the goal of controlling asthma through anti-inflammatory effect; and ii) 
relievers – used when needed during  exacerbations to ensure fast relief from 
symptoms (Hrubisko & Ciznar, 2010). However, excessive amount of reliever 
medication, in particular short acting beta agonists (SABA) may also suggest 
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inappropriate treatment (Gilberg, Laouri, Wade et al., 2003; Walters, Walters, & 
Gibson, 2009). While SABA are considered to be the most effective reliever 
medication, utilisation that exceeds two times per week is a  warning that asthma 
control is worsening and there is need to begin or intensify anti-inflammatory 
treatment (Hrubisko & Ciznar, 2010). Furthermore, the use of oral corticosteroids 
and antibiotics (Breekveldt-Postmaa, Gerritsb, Lammersc et al., 2004) may suggest 
inappropriate care and be therefore positively associated with hospitalisations. If 
systemic glucocorticosteroids are taken for 5-10 days, they may prevent 
hospitalisation and reduce morbidity; however, if more than three treatments are 
given in a year, there is a need to consider and reassess the treatment plan as the 
patient may be receiving bad care (Hrubisko & Ciznar, 2010).  Therefore, these 
medications will also be included in the analysis.  
 
The goal of this chapter is to contribute to this body of evidence by examining both 
outcome and process quality of care indicators, and their relationship. This is done in 
three steps: first, by simply examining variations in ACSHs for diabetes and asthma; 
second, by analysing the extent to which appropriate treatment - measured through 
process indicators derived from clinical guidelines - is provided to asthma and 
diabetes patients. Process measures are direct measures of quality (Mant, 2001), 
especially those included in clinical guidelines.  Process measures used are simple to 
interpret - the more people without the contraindication who receive the therapy, the 
better; those who do not receive it yet, need to receive it (Mant, 2001). A third step 
involved an evaluation of the relationship between individual level variations in 
ACSHs (outcome indicator) and (in)appropriate care (process indicators) using panel 
data techniques.  Some argue that in order for process indicators to be valid, there 
must be a strong relationship between the process and outcome measures 
(Hammermeister, Shroyer, Sethi et al., 1995; Rubin, Pronovost, & Diette, 2001); 
however others state that such relationships are not necessary if process measures 
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are judged by clinical experts to be important to patient outcomes (Mant, 2001). 
Once the relationship is established, resources can be directed to those processes 
shown to have the greatest impact on patient outcomes (Hammermeister, Shroyer, 
Sethi, et al., 1995).  However, even if such a relationship is not established, 
understanding whether processes of care suggested in clinical guidelines are adhered 
to is important so that improvements in quality of care can be implemented.  
 
5.2. Data and methods 
 
Data 
 
This study uses nationally representative administrative data from the largest public 
health insurance company (the General Health Insurance Company (GHIC)) in 
Slovakia between 2001 and 2008. The individual patient level data was obtained after 
extensive personal negotiations with the GHIC.19 During this period GHIC covered 
about 70% of the national market with approximately 3.4 million people insured. 
Patients were included in the study population if they obtained outpatient or 
inpatient care, including diagnostic tests for diabetes (ICD-10 code E10) and asthma 
(ICD-10 code J45) in 2002 and had no such claim in 2001 (“disease free”). Given the 
limitations of administrative data, which do not collect information on the illness 
severity, choosing patients based on the ICD-10 diagnosis has provided us with a very 
large sample where not all the individuals may actually suffer from diabetes or 
asthma. Therefore, an additional criterion has been applied whereby only patients 
with at least two diabetic (referred to as “diabetes patients” throughout the chapter) 
or at least one asthma (referred to as “asthma patients” throughout the chapter) 
medication in any given year are included in the sample (Renard, Bocquet, Vidal-
Trecan et al., 2011).  For diabetic patients, this included drugs listed with the 
                                                        
19 The data was successfully obtained after 1 year. 
 180
Anatomical Therapeutic Chemical (ATC) code “A10”; for asthma patients the ATC 
code was “R03”.  Drugs were counted as prescriptions where some had multiple drug 
packages on them. Therefore, this study included a total of 10,561 diabetes patients 
with at least two anti-diabetic prescriptions in any given year; the total number of 
patients prior to the medication restriction with a diabetes ICD-10 code (E10) was 
49,982.  For asthma, there were a total of 2,508 asthma patients with at least one 
asthma prescription in any given year; the total number of patients prior to the 
medication restriction with an ICD 10 code (J45) for asthma was 67,128. 
 
By following this process, patients who have died or left the insurance company, or 
who may have been either the oldest or the sickest were automatically excluded. At 
the same time those patients who are treated with life-style changes only, so 
potentially the healthiest, were also excluded.  Patients with a unique identifier and 
their personal characteristics (age, sex, region of residence) were then followed for 
the period of 2002-2008 and data on all the medical care provided to them, including 
outpatient medical visits and procedures (primary or specialist care), 
hospitalisations, laboratory tests and medications, were collected. For each item the 
ICD-1o diagnosis is provided and the actual procedure or drug code could be 
identified through the GHIC’s code book of medical procedures. Services or drugs 
provided during the hospitalisation could not be identified. Finally, the database does 
not provide information on test results or other patient behaviour information. 
 
The dependent variable (hosp) is defined as the total number (a count variable) of 
ACSC diabetes or asthma admissions a patient has had in a given year (see Table 24 
for the relevant ICD-10 hospitalisation codes used by condition). Patients who were 
not hospitalised at all during the period of the study were excluded from the panel 
data analysis as the focus was on the relationship between hospitalisations and 
quality of care variables. All the hospitalisations for these two chronic conditions 
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were included and counted as an adverse outcome even though some of these may 
actually have been necessary hospitalisations. For example,  about 5-10% of asthma 
patients are classed as ‘complicated’,  with so called “difficult to treat asthma”, whose 
hospitalisations may be difficult to prevent (Hrubisko & Ciznar, 2010). Yet these 
patients cannot be identified in the dataset. As diabetic patients are likely to have first 
been diagnosed at hospital, these hospitalisation episodes were not counted within 
the main dependent variable.  
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Table 24. ICD-10 codes used for identifying hospitalisations 
 
Diagnosis ICD 10 
Code 
List of fourth character sub-divisions used 
Insulin dependent 
diabetes mellitus 
E10 .0 with coma 
.1 with ketoacidosis 
.2+ with renal complications 
Diabetic nephropathy (N08.3*)  
Intracapillary glomerulonephrosis (N08.3*) 
Kimmelstiel-Wilson syndrome (N08.3*) 
.3+ with ophthalmic complications 
cataract (H28.0*)  
retinopathy (H36.0*) 
.4+ with neurological complications  
amyotrophy (G73.0*)  
autonomic neuropathy (G99.0*)  
mononeuropathy (G59.0*)  
polyneuropathy (G63.2*)  
          autonomic (G99.0*) 
.5 with peripheral circulatory complications 
gangrene 
peripheral angiopathy+ (I79.2*)  
ulcer 
.6 with other specified complications 
Diabetic arthropathy+ (M14.2*)  
Neuropathic diabetic arthropathy+ (M14.6*) 
.7 with multiple complications 
.8 with unspecified complications 
.9 without complications 
Non-insulin dependent 
diabetes mellitus 
E11 
Malnutrition related 
diabetes mellitus 
E12 
Other specified diabetes 
mellitus 
E13 
Unspecified diabetes 
mellitus 
E14 
 
 
 
 
 
Asthma J45 .0  predominantly allergic asthma 
J45 .1  nonallergic asthma 
J45 .9 asthma, unspecified 
J46 
J47 
Status asthmaticus 
Bronchiectatis 
J81 Pulmonary oedema 
Source:  (NHS Institute for Innovation and Improvement, 2012; The NYU Center for Health 
and Public Service Research of the Robert F. Wagner Graduate School of Public Service) and 
ACSCs ICD 10 codes obtained from personal e-mail communication with prof. Billings, J. on 
May 6, 2009 
 
 183
Independent variables were constructed based on relevant clinical guidelines for each 
chronic disease (see Table 25 below) (Hrubisko & Ciznar, 2010; Uliciansky, Mokan, 
Nemethyova et al., 2007). A number of different international clinical guidelines are 
available for both conditions. Usually, countries adopt these guidelines directly or 
adjust them.  Slovakia first developed its own diabetes guidelines in 2007 (Uliciansky, 
Mokan, Nemethyova, et al., 2007) and asthma guidelines in 2010 (Hrubisko & 
Ciznar, 2010). In both cases the authors have built on widely used international 
clinical guidelines, translated certain sections directly and adjusted other parts to 
local circumstances.  The guidelines set out algorithms for how to proceed with a 
patient’s treatment depending on the severity of illness but also highlight basic steps 
for prevention or treatment for all patients regardless of severity of illness. These 
guidelines are used to construct process indicators of quality of care in our study. For 
diabetes, in addition to the existence of the clinical guidelines, there is international 
agreement and convergence on good practice and use of process and outcome 
indicators to assess and compare the quality of diabetes care (Health Consumer 
Powerhouse, 2008; Nicolucci, Greenfield, & Mattke, 2006). Asthma has received less 
attention in terms of quality of care process indicators, despite seemingly widespread 
agreement on appropriate treatment approaches within clinical guidelines. The 
predicted relationships between our dependent and independent variables are 
highlighted in Table 25.  
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Table 25. Patient level independent variables constructed based on clinical 
guidelines 
 
Condition Appropria
te care  
Source  Independe
nt 
variables 
Variable 
name 
Notes Predicted 
effect 
Diabetes Measure 
HbA1c at 
least 4/year 
 
Screening 
for 
nephropathy 
at least 
1/year 
 
Ophthalmol
ogic  exam 
at least 
1/year 
 
Doctor visit 
at least 
2/year  
 
Cholesterol 
test at least 
1/year 
 
Slovak 
Guidelines 
for Diabetes 
(2007) 
 
OECD 
Quality 
Indicators 
Project 
(2006) 
Dummy 
variables 
1 if at least 4 
HbA1c 
tests/year 
 
1 if at least 1 
urine 
test/year 
 
1 if at least 1 
ophthalmolo
gic  
exam/year 
 
1 if at least 2 
visits/year 
 
 
 
qual_hba1c 
 
 
qual_urine 
 
 
qual_eye 
 
 
 
qual_visit 
  
 
Negative 
 
 
 
Negative 
 
 
Negative 
 
 
 
Negative 
Asthma Flu 
vaccination 
every year 
 
Spirometry 
at least 
1/year 
 
Regular 
doctor visits 
(1-6 months; 
every 3 
months once 
asthma is 
controlled) 
 
Possibly 
inappropr
iate care: 
Excessive 
use of short 
acting beta 
agonists 
(SABA) 
Excessive 
use of 
corticosteroi
ds and 
antibiotics  
 
Slovak 
Guidelines 
for Asthma 
(2010) 
Dummy 
variables: 
1 if at least 1 
flu 
vaccine/year 
 
1 if at least 1 
spirometry/
year 
 
1 if at least 2 
visits/year 
 
 
 
Count 
variables: 
SABA 
Corticoids 
Antibiotics 
 
Dummy 
variables: 
1 if more 
than 3 
corticoid 
prescription
s/year 
 
 
 
qual_flu 
 
 
qual_tot_sp
ir 
 
 
qual_visit 
 
 
 
 
 
 
saba 
cort 
antib 
 
 
bad_cort 
 
 
 
While the 
Slovak 
Guidelines 
were only 
prepared in 
2010, the 
GINA 
guidelines 
from 2002 
also used in 
Slovakia 
already 
recommend
ed the same 
treatment 
 
 
Negative 
 
 
Negative 
 
 
Negative 
 
 
 
 
 
 
 
Positive 
Positive 
Positive 
 
 
 
Positive 
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Dummy variables were constructed, where the value ‘one’ was given if the 
appropriate care criterion recommended was fulfilled, ‘zero’ otherwise.  For all the 
variables, a negative association is expected between appropriate care and 
hospitalisations and a positive association between potentially inappropriate care and 
hospitalisations. Our variables of interest for diabetes are visits, glycated 
haemoglobin (HbA1c) tests, ophthalmologic exam and urinalysis. As has already been 
discussed above, the available evidence on the relationship between these process 
indicators and hospitalisations is mixed. For asthma our variables of interest are: 
number of visits, spirometry tests, whether or not the patient has received the flu 
vaccine in any given year. In line with the literature review in the previous section, 
the number of prescriptions for the following medications was also included in the 
analysis: SABA, antibiotics and corticoids. Finally, personal characteristics including 
age and sex (Melero Moreno, López-Viña, García-Salmones Martín et al., 2012), and 
comorbidities were controlled for. Comorbidities were defined as the total number of 
other (non-diabetes or asthma) ICD-10 codes for which the patient obtained any type 
of medical care.   Analysis was carried out separately for asthma and diabetes with 
the specific indicators of quality of care. Table 26 below summarises the relevant 
procedure or ATC codes used to identify the visits, procedures or drugs of interest.  
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Table 26. Summary of procedure and ATC codes used to design variables 
 
Variables Procedure/ATC codes 
Diabetes physician visits First, only visits with the diabetes ICD codes identified in 
Table 24 were used. Then the following procedure codes 
identified a visit: 1, 4, 8, 60, 62, 63, 25, 3439 and 3440.  
HbA1c tests 4587A 
Cholesterol 3674, 3674A, 3675, 3675A, 3676, 3676A, 3677, 3677A 
Ophthalmologic visit Ophthalmologic codes: 1200, 1201, 1202, 1203, 1204, 
1205, 1206, 1207, 1208, 1209, 1214,1215, 1216, 1217, 1218, 
1220, 1222, 1225, 1226, 1227, 1228, 1229, 1230, 1240, 
1241, 1242, 1244, 1246, 1246A, 1249, 1250, 1251, 1255, 
1256, 1257, 1262, 1265, 1266, 1271, 1273A, 1273B, 1273D, 
1273E, 1274, 1275, 1275A, 1275B, 1276, 1277, 1278, 1279, 
1282, 1293, 1294. These ophthalmologic codes had to be 
used in conjunction with the following visit codes: 1, 4, 8, 
60, 62, 63, 25, 3439 and 3440.  
Urinalysis 3525, 3526 
Insulin A10A 
Asthma physician visits First, only visits with the asthma ICD codes identified in 
Table 24 were used. Then the following procedure codes 
identified a visit: 1, 4, 8, 60, 62, 63, 25, 3439 and 3440. 
Spirometry 691, 690, 700, 723A, 723B, 3430, 5709, 5733A, 5766, 
5769, 5770, 5771 
Flu vaccine J07BB 
SABA R03AC 
Antibiotics J01 
Corticoids H02 
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Evidence from Chapter 1 indicates that the relationship between primary care 
encounters and hospitalisations at the aggregate level has been mixed.  However, 
some of the explanatory variables, especially visits or even tests, may be endogenous 
as sicker people may visit the doctor more often and therefore receive more tests, but 
they may also be hospitalized more often.  In light of this, some studies have included 
number of visits as a control variable indicating severity for diabetes patients which 
can therefore be positively associated with hospitalisation (Lin, Huang, Wang et al., 
2010). Other studies treat visits and tests as endogenous variables and use 
instruments to deal with the problem (Bech & Lauridsen, 2008; Fortney, Steffick, 
Burgess et al., 2005). These studies find that primary care encounters act as 
substitutes to inpatient services and are therefore negatively associated with 
hospitalisations. Our dataset is limited and does not provide for any suitable 
instruments, thus the approach that was taken to address endogeneity was to 
construct a variable that measures good or bad care from the predicted number of 
visits. Predicted visits have been estimated based on age, region, comorbidities and 
gender using a fixed effects model.  The values have been normalised, and the 
difference between the actual visits and predicted visit was calculated. More visits 
than predicted indicate potentially “good” care or overprovision and fewer visits than 
predicted indicate potentially “bad” care. This variable is referred to as “predicted 
visits” throughout the chapter.  
 
Estimation methods 
 
This chapter examines the relationship between hospitalisations for diabetes and 
asthma and lack of appropriate treatment as defined in the clinical guidelines. 
Poisson and negative binomial models for panel data are appropriate when the 
dependent variable is a count variable.  As count data are usually overdispersed, the 
use of panel-robust standard errors is required (Cameron & Trivedi, 2010).  
 188
The baseline model is as follows:  
 
itiititititi
condition
it uXcomorbsexcatagehosp εββββββ +++++++= '_)log( 43210  
    
for i=1 ....N; t=1.....T, where i is the individual indicator and t the time (year) 
indicator.  conditionitHosp  is the health outcome variable measuring the number of 
hospitalisations an individual had in a given year for the selected chronic condition ( 
diabetes or asthma) for patients who had at least one hospitalisation during the 
period of the study.  X’ denotes a vector of the appropriate care variables as presented 
in the section above.  Age_cat  is the age category that the individual falls within 
based on his or her age in the baseline year (2002), sex represents the sex of the 
individual and comorb the number of all unique ICD-10 codes for which the patients 
has received a drug, diagnostic test or treatment. itε  is the random disturbance term, 
iu  is the unobserved individual-specific time invariant effect.  In this model the main 
demographic characteristics are controlled for but there are several omitted variables 
which cannot be included.  Among others, for asthma these include: exposure to 
allergens, viral infections, indoor and outdoor pollutants and workplace pollutants; 
foods; drugs; obesity; emotional stress, behavioural and lifestyle factors that 
influence adherence to treatment (Global Initiative for Asthma, 2012; Hrubisko & 
Ciznar, 2010) or social deprivation (Purdy, 2010). For diabetes again these are mainly 
behavioural and lifestyle factors (e.g. exercise, obesity, diet) (Uliciansky, Mokan, 
Nemethyova, et al., 2007) as well as socioeconomic status and education (Smith, 
2007). Therefore, using individual fixed effects was considered to be the most 
appropriate method for the analysis even though this does not allow for examining 
the effect of variables that do not change over time (e.g. sex).  Results are reported as 
incidence rate ratios (IRR) where a change in the independent variable is associated 
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with a change in the estimated incidence rate of hospitalisations by a factor of the 
magnitude of the IRR reported. 
 
5.3. Results 
 
Summary statistics for all diabetes and asthma patients 
 
This study sample includes 10,561 diabetes patients and 2,508 asthma patients. The 
distribution of patients in  the sample shows that most of the diabetes patients fall 
into the three categories between ages 5o to 79 while for asthma it is children and 
then the three age groups between 40 to 69 (Figure 25). The average age of the 
diabetic population in 2002 was 62 years with 60.4% females compared to only 
39.6% males.  Females with diabetes were, on average, older (63.7 years) than males 
(59.4 years). The average age of the asthma patients was 40.8 years with somewhat 
more females than males (60.1% versus 39.8%).  Females were on average older (45.4 
years) than males (33.6 years) but overall the asthma sample was younger than the 
diabetic sample.  
 
 
Figure 25. Number of diabetes and asthma patients by age category in year 2002 
a. Diabetes                b. Asthma 
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Patients with diabetes had, on average, 4.8 visits per year and 10.5 comorbidities, 
while patients with asthma only had 3.15 visits but 11.9 comorbidities. With respect to 
condition specific medication prescriptions, patients with diabetes had, on average, 
6.7 while patients with asthma only 4.8 per year.  The average annual utilisation rate 
for ophthalmologic exams was 0.69, for HbA1c tests only 0.2, and for the flu 
vaccinations 0.03, all well below the recommended amount. However, for the 
spirometer tests it was around one annual test (1.02), consistent with the 
recommendations. In terms of inappropriate care, the average annual use of 
corticoids (0.12), antibiotics (0.12) and SABA (0.69) in the studied asthma population 
was low suggesting appropriate use. Finally, diabetes and asthma patients had an 
average of 0.04 hospitalisations in a year (Tables 27 and 28).  It should be noted that 
the mean figures in the tables below are for the number of services rather than 
appropriate care variables which are discussed later. 
 
Table 27. Diabetes -  number of services 
 
Variables  Mean Std. Dev  
HbA1c tests 0.21 0.64 
Urine test 1.78 2.19 
Ophthalmologic  exam 
Doctor visit 
0.69 
4.76 
1.67 
4.76 
Cholesterol 1.86 2.91 
Antidiabetic prescriptions 
Hospitalisations 
6.71 
0.04 
4.9 
0.38 
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Table 28. Asthma  -  number of services 
 
Variables  Mean Std. Dev  
Corticoids 
SABA 
Antibiotics 
Flu shot 
0.12 
0.69 
0.12 
0.03 
0.68 
1.66 
0.50 
0.15 
Spirometry 1.02 1.51 
Doctor visit 3.15 3.28 
Asthma prescriptions 
Hospitalisations 
4.77 
0.04 
4.77 
0.35 
 
The next two figures provide an overview of the mean number of hospitalisations by 
age groups and regions over the period of study.  An important variation can be 
observed within all age groups over the years. The mean number of hospitalisations is 
the highest in the youngest age group for both conditions. It should be noted that for 
diabetes, the youngest age group had the smaller number of patients while for asthma 
it had the largest number of patients. Overall, the mean number of hospitalisations 
for asthma patients (max 0.13 in 2004) is in a lower range than for diabetes patients 
(max 0.63 in 2006). 
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Figure 26. Mean number of hospitalisations by age category and year 
a. Diabetes                 b. Asthma 
 
 
Again, a substantial variation can be observed in all regions over the years.  For 
diabetes, the mean number of hospitalisations is the lowest in the Bratislava and 
Trencin region; for asthma, the mean number of hospitalisations is the highest in the 
Presovsky region.  
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Figure 27. Mean number of hospitalisations by region and year 
a. Diabetes                 b. Asthma 
 
 
Next, the variation in the appropriate care variables for diabetes and asthma is 
reviewed. The summary statistics in Table 29 suggest that for all variables, within 
variation for an individual over time is larger than variation between individuals. 
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Table 29. Summary statistics for appropriate care variables for all 
diabetes and asthma patients 
Variable  Mean Std. Dev. Min Max Observations 
       
Hospitalisations overall 0.037808 0.377507 0 81 N =   73927 
hosp between  0.171321 0 12.7143 n =   10561 
 within  0.336398 -12.6765 68.3235 T =       7 
       
Ophthalmologic 
exam 
overall 0.222003 0.415596 0 1 N =   73927 
qual_eye between  0.264497 0 1 n =   10561 
 within  0.320573 -0.63514 1.07915 T =       7 
       
HbA1c tests overall 0.005181 0.071792 0 1 N =   73927 
qual_hba1c between  0.040222 0 0.8571429 n =   10561 
 within  0.059467 -0.851962 0.862324 T =       7 
       
Cholesterol tests overall 0.394565 0.488760 0 1 N =   73927 
qual_chlst between  0.328398 0 1 n =   10561 
 within  0.362008 -
0.462578 
1.25171 T =       7 
       
Urine tests overall 0.845496 0.361433 0 1 N =   73927 
qual_urine between  0.260838 0 1 n =   10561 
 within  0.250206 -0.011647 1.70264 T =       7 
       
Flu shots overall 0.024892 0.155800 0 1 N =   17556 
qual_flu between  0.087609 0 0.857143 n =    2508 
 within  0.128844 -0.832251 0.882035 T =       7 
       
Spirometry overall 0.469013 0.499053 0 1 N =   17556 
qual_tot_spir between  0.353779 0 1 n =    2508 
 within  0.352047 -
0.388129 
1.32616 T =       7 
       
Corticoids overall 0.007405 0.085735 0 1 N =   17556 
bad_cort between  0.058837 0 0.857143 n =    2508 
 within  0.062368 -0.84974 0.864548 T =       7 
       
Visits overall 0.621611 0.484999 0 1 N =   17556 
qual_visit between  0.294242 0 1 n =    2508 
 within  0.385585 -0.23553 1.47875 T =       7 
 
The proportion of patients who received appropriate care according to the 
recommended clinical guidelines is also analysed. For diabetes patients (Table 30), 
there is a high percentage that received at least two visits per year (between 89% and 
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93%), and a similar proportion (between 80% to 88%) that had at least one urine test 
per year. Fewer patients received the recommended number of cholesterol tests 
(between 34% and 44%) and ophthalmologic exams (between 19% and 27%) during 
the study period.  There is a declining trend for both urine test and ophthalmologic 
exams. Less than one percent of patients with diabetes received the recommended 
minimum of four HbA1c tests in a year. As there are other methods of measuring 
glucose than the HbA1c test, the proportion of patients with a less strict criterion of at 
least one HbA1c test per year was assessed and the results suggest that the 
proportion, while still low, is significantly higher (from 6.5% in 2002 to 20% in 
2008).  
 
Table 30. Diabetes – percentage of all diabetic patients receiving appropriate 
care by year 
Variables 2002 2003 2004 2005 2006 2007 2008 
HbA1c tests 0.1 0.5 0.3 0.5 0.8 0.7 0.7 
Urine test 88 88 87 84 83 82 80 
Ophthalmologic  
exam 
27 23 24 23 21 20 19 
Doctor visit 89 90 90 93 92 93 92 
Cholesterol test 37 34 37 40 41 43 44 
 
For asthma patients (Table 31), between 47 and 73 percent received the 
recommended at least two visits per year. For spirometry test the proportion of 
patients who received at least one spirometer test per year was lower (between 36% 
and 53%).  As an indicator of potentially inappropriate care, patients who received 
three or more prescriptions of systemic corticoids in a year were analysed and the 
results show that only about one percent or less were treated in this way. However, 
very few patients received the recommend annual flu vaccination (between 0% and 
5%).  
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Table 31. Asthma – percentage of all asthma patients receiving appropriate care 
by year 
Variables 2002 2003 2004 2005 2006 2007 2008 
Flu shots 0 2 5 5 3 1 2 
Spirometry 36 46 50 53 51 46 46 
Doctor visit 47 65 69 73 66 58 57 
Corticoids 0 0.4 0.8 0.9 1 0.8 1 
Summary statistics for hospitalised patients 
 
Approximately 15% of the total studied population (both for asthma and diabetes) 
had at least one or more hospitalisations between 2002 and 2008 (Table 32 below); 
in some years some patients had more than one hospitalisation while in other years it 
could be zero. The 1622 diabetes patients hospitalized at least once had a total of 
2795 hospitalisations and the 393 hospitalized asthma patients had a total of 774 
hospitalisations. Figure 28 provides an overview of the number of patients who have 
had at least one hospitalisation by age category.  We can see that for diabetes it is 
people between age 60 and 69 while for asthma it is the youngest age group.  
 
Table 32. Overview of patients with and without hospitalisation between 2002 
and 2008 
 Zero hospitalisations 
 
At least 1 hospitalisation 
 
Diabetes patients (N) 8939 1622 
Proportion of total number of 
patients 
85% 15% 
Total number of 
hospitalisations 
0 2795 
Asthma patients (N) 2115 393 
Proportion of total number of 
patients 
84% 16% 
Total number of 
hospitalisations 
0 774 
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Figure 28. Number of patients with at least one hospitalisation by age 
category 
a. Diabetes     b. Asthma 
 
 
Diabetic patients with at least one hospitalisation had on average more visits and 
tests than patients with no hospitalisation; however, they had a very similar amount 
of Hba1c tests and were younger than patients without a hospitalisation. Asthma 
patients with at least one hospitalisation were slightly older than patients with no 
hospitalisation, had more tests, visits, medications and comorbidities (see Table 33 
below).  
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Table 33. Characteristics of patients with and without hospitalisation 
 
 Zero hospitalisations At least 1 hospitalisation 
 
DIABETES Mean Mean 
Hospitalisations 0 0.24 
Age 65.4 62.3 
Visits 4.5 6.4 
                Specialist 3.9 5.4 
                GP 0.55 1.1 
Antidiabetic prescriptions 6.5 7.9 
Eye  0.67 0.77 
Blood 0.86 1 
Urine  3.11 3.9 
Hba1c 0.21 0.23 
Cholesterol 1.75 2.43 
Comorbidities 10.2 11.8 
ASTHMA Mean Mean 
Hospitalisations 0 0.3 
Age 43.7 44.1 
Visits 2.9 4.4 
                Specialist 2.2 3.5 
                GP 0.7 1 
Antiasthma prescriptions 4.5 6.1 
Spirometry 1 1.4 
Flu 0.02 0.03 
Corticoids 0.1 0.3 
SABA 0.7 0.9 
Antibiotics 0.1 0.3 
Comorbidities 11.6 13.6 
 
 
The next figure (Figure 29) provides an overview of the mean number of 
hospitalisations by age groups over the period of study for patients who were 
hospitalised at least once. While variation can be observed within and between age 
categories, the mean number of hospitalisations for asthma is now more similar 
across age groups; for diabetes, it is difficult to observe a clear trend.  
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Figure 29. Mean number of hospitalisations by age category and year for 
patients with at least one hospitalisation 
a. Diabetes     b. Asthma 
 
 
Table 34 summarizes the within and between variation in the appropriate care 
variables for diabetes and asthma.  Apart from spirometry and overuse of corticoids, 
the results show that within variation for a patient over time is more important than 
variation between patients.  
 
 
 
 
 
 
 
 
 
 
0 .2 .4 .6 .8
80_98
70_79
60_69
50_59
40_49
30_39
18_29
0_17
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
0 .2 .4 .6 .8
80_98
70_79
60_69
50_59
40_49
30_39
18_29
0_17
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
2008
2007
2006
2005
2004
2003
2002
 200
Table 34. Summary statistics for appropriate care variables for diabetes 
and asthma patients with at least one hospitalisation 
Variable  Mean Std. 
Dev. 
Min Max Observations 
       
Hospitalisations overall 0.246169 0.936312 0 81 N =   11354 
hosp between  0.374008 0.142857 12.714290 n =    1622 
 within  0.858413 -12.46812 68.531880 T =       7 
       
Ophthalmologic 
exam 
overall 0.235776 0.424502 0 1 N =   11354 
qual_eye between  0.267433 0 1 n =    1622 
 within  0.329726 -0.621367 1.092919 T =       7 
       
HbA1c tests overall 0.007574 0.086705 0 1 N =   11354 
qual_hba1c between  0.053511 0 0.8571429 n =    1622 
 within  0.068233 -0.84957 0.864717 T =       7 
       
Cholesterol tests overall 0.489783 0.499918 0 1 N =   11354 
qual_chlst between  0.305502 0 1 n =    1622 
 within  0.395772 -0.36736 1.346926 T =       7 
       
Urine tests overall 0.844724 0.362183 0 1 N =   11354 
qual_urine between  0.236503 0 1 n =    1622 
 within  0.274359 -0.012419 1.701867 T =       7 
       
Flu shots overall 0.030171 0.171088 0 1 N =    2751 
qual_flu between  0.103427 0 0.714286 n =     393 
 within  0.136372 -0.684115 0.887314 T =       7 
       
Spirometry overall 0.531807 0.499078 0 1 N =    2751 
qual_tot_spir between  0.356615 0 1 n =     393 
 within  0.349545 -0.32534 1.388949 T =       7 
       
Corticoids overall 0.021810 0.146090 0 1 N =    2751 
bad_cort between  0.100716 0 0.857143 n =     393 
 within  0.105928 -0.83533 0.878953 T =       7 
       
Visits overall 0.725191 0.446499 0 1 N =    2751 
qual_visit between  0.249918 0 1 n =     393 
 within  0.370188 -0.131952 1.582334 T =       7 
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The final two graphs (Figure 30 and 31) provide an overview of the proportion of 
diabetes and asthma patients hospitalised at least once during the period of the study 
who received appropriate care as recommended in the clinical guidelines.  The focus 
is on variation in the proportion of patients (between variation) over time rather than 
within variation for particular patient, which will be the subject of the panel data 
analysis that follows. For diabetes, there is a declining trend for appropriate care in 
terms of urine and ophthalmologic tests, an increasing trend for cholesterol tests 
while the proportion of patients receiving HbA1c tests is very small. For asthma, there 
is declining trend of doctor visits and spirometries, with very few patients getting the 
flu vaccine. In terms of inappropriate care defined through excessive corticoid intake, 
very few patients appear to be treated inappropriately. 
 
 
Figure 30. Proportion (%) of hospitalised diabetes patients who received 
appropriate care 
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Figure 31. Proportion (%) of hospitalised asthma patients who received 
appropriate and inappropriate care 
 
 
 
The next section presents the analysis of the relationship between hospitalisations 
and appropriate care provided for diabetes and asthma.  
 
Poisson and Negative Binomial fixed effects regressions 
 
Below the results of the Poisson (PFE) and Negative Binomial (NBFE) fixed effects 
regressions results for diabetes are presented for the group of patients who were 
hospitalised at least once during the period of the study (Table 35). Coefficients are 
Incidence Rate Ratios and have a multiplicative effect on hospitalisations. For 
example, the coefficient for the quality of care in terms of HbA1c tests is 1.740, 
suggesting that those who received at least four HbA1c tests per year as opposed to 
those who have not are expected to have a hospitalisation rate 1.74 greater; similarly, 
for those who have received the appropriate amount of ophthalmologic tests as 
opposed to those who have not are expected to have a hospitalisation rate 0.612 
smaller (see Model 1). The output for the year dummies, for example, shows that the 
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hospitalisation incidence rate in year 2003 is 5.86 times the incident rate for the 
reference year (2002). 
 
Whether or not predicted visits or actual visits (which we suggested may be 
endogenous) are included, the results remain consistent.  In the first model (1&2), 
fewer actual visits than the predicted number of visits (potentially “bad” care) is 
negatively associated with hospitalisations which may suggest that these are the 
healthier patients and not necessarily those who receive inappropriate care. In the 
second model (3&4) this variable as well as visits are excluded, and the results are 
very similar. In the third model (5&6) a visits dummy variable (value 1 if the patient 
had at least two visits) was included and a positive association with hospitalisations 
was identified. Across the models, the results indicate that getting the recommend 
ophthalmologic exam is significantly negatively associated with hospitalisations. 
However, getting the recommended number of cholesterol and HbA1c tests is 
significantly positively associated with hospitalisations, while urine tests are also 
positively associated but only significant in the NBFE models.  As expected, the 
number of antidiabetic medication and comorbidities is also significantly positively 
associated with hospitalisations across the three models, as these suggest more severe 
diabetes patients. Age was included in age categories and the results showed that 
there is no significant difference, despite the youngest age group having the highest 
mean number of hospitalisations.  When age was included as a continuous variable, it 
was  positively associated with hospitalisations, but not significant (see Appendix D). 
Finally, hospital lag which indicates whether the patient was hospitalized in the 
previous 12 months is significantly negatively associated with hospitalisations, 
possibly to be explained by our sample that includes only newly diagnosed patients 
who may be hospitalised more frequently initially and less so as time passes and their 
condition is better managed.  
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Table 35. Relationship between (in)appropriate care and hospitalisations of 
diabetic patients 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE1 NBFE1 PFE2 NBFE2 PFE3 NBFE3 
              
comorb 1.056*** 1.054*** 1.054*** 1.051*** 1.053*** 1.051*** 
 
(0.00594) (0.00516) (0.00607) (0.00509) (0.00602) (0.00509) 
gender 
 
1.187 
 
1.124 
 
1.126 
  
(0.389) 
 
(0.369) 
 
(0.370) 
qual_eye 0.612** 0.777*** 0.619** 0.783*** 0.618** 0.779*** 
 
(0.147) (0.0527) (0.146) (0.0531) (0.144) (0.0529) 
qual_hba1c 1.740** 1.694** 1.743** 1.687** 1.723** 1.675** 
 
(0.471) (0.424) (0.475) (0.424) (0.467) (0.421) 
qual_chlst 5.164*** 6.721*** 5.360*** 7.002*** 5.325*** 6.956*** 
 
(0.804) (0.464) (0.859) (0.482) (0.848) (0.479) 
qual_urine 1.155 1.808*** 1.190 1.849*** 1.144 1.793*** 
 
(0.394) (0.170) (0.407) (0.174) (0.398) (0.170) 
badpred_visit 0.663** 0.541*** 
    
 
(0.121) (0.0437) 
    hosplag 0.601*** 0.503*** 0.602*** 0.506*** 0.599*** 0.505*** 
 
(0.115) (0.0311) (0.113) (0.0313) (0.111) (0.0313) 
antid 1.055*** 1.048*** 1.064*** 1.059*** 1.062*** 1.058*** 
 
(0.0119) (0.00813) (0.0103) (0.00806) (0.0103) (0.00807) 
insu 
 
3.786*** 
 
4.161*** 
 
3.998*** 
  
(1.804) 
 
(1.953) 
 
(1.842) 
_Iage_cat_2 0.783 0.868 0.804 0.883 0.805 0.884 
 
(0.292) (0.226) (0.302) (0.230) (0.300) (0.230) 
_Iage_cat_3 0.581 0.710 0.597 0.698 0.596 0.699 
 
(0.360) (0.340) (0.374) (0.332) (0.372) (0.332) 
_Iage_cat_4 0.367 0.431 0.375 0.406 0.377 0.408 
 
(0.273) (0.246) (0.282) (0.228) (0.283) (0.230) 
_Iage_cat_5 0.341 0.461 0.355 0.433 0.350 0.430 
 
(0.277) (0.273) (0.292) (0.252) (0.287) (0.249) 
_Iage_cat_6 0.241 0.402 0.255 0.374* 0.249 0.369* 
 
(0.210) (0.244) (0.226) (0.223) (0.221) (0.219) 
_Iage_cat_7 0.221 0.397 0.235 0.354* 0.231 0.351* 
 
(0.204) (0.247) (0.220) (0.216) (0.216) (0.213) 
_Iage_cat_8 0.227 0.533 0.247 0.467 0.244 0.467 
 
(0.231) (0.349) (0.256) (0.300) (0.252) (0.299) 
_Iyear_2003 5.842*** 6.239*** 5.523*** 5.790*** 5.523*** 5.781*** 
 
(1.057) (1.075) (0.985) (0.995) (0.988) (0.994) 
_Iyear_2004 7.116*** 8.246*** 6.692*** 7.386*** 6.701*** 7.374*** 
 
(1.633) (1.468) (1.391) (1.308) (1.401) (1.307) 
_Iyear_2005 7.405*** 8.041*** 6.905*** 7.297*** 6.856*** 7.249*** 
 
(1.540) (1.450) (1.372) (1.309) (1.372) (1.302) 
_Iyear_2006 8.199*** 8.794*** 7.602*** 7.986*** 7.562*** 7.931*** 
 
(1.803) (1.603) (1.580) (1.447) (1.587) (1.439) 
_Iyear_2007 6.810*** 5.775*** 6.438*** 5.388*** 6.393*** 5.338*** 
 
(1.629) (1.034) (1.644) (0.961) (1.623) (0.953) 
_Iyear_2008 5.568*** 5.902*** 5.025*** 5.155*** 5.034*** 5.152*** 
 
(1.187) (1.102) (1.028) (0.955) (1.035) (0.955) 
qual_visit 
    
1.712*** 1.529*** 
     
(0.324) (0.249) 
Constant 
 
0.0321*** 
 
0.0257*** 
 
0.0183*** 
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(0.0214) 
 
(0.0168) 
 
(0.0122) 
       Observations 11,266 11,266 11,266 11,266 11,266 11,266 
Number of v1 1,621 1,621 1,621 1,621 1,621 1,621 
Standard errors in parentheses. 
Coefficients are Incidence Rate Ratios. 
    *** p<0.01, ** p<0.05, * p<0.1 
 
     
Similarly for asthma (Table 36 below), results are broadly consistent across the 
different models. In the first model (1&2), fewer actual visits than the predicted 
number of visits is negatively associated with hospitalisations which may again 
suggest that it is the healthier patients who visit the doctor less and are also 
hospitalised less frequently. In the second model (3&4) this variable was excluded 
and the results remained very similar. In the third model (5&6) a visits dummy (value 
1 if the patient had at least 2 visits) was included and a positive association with 
hospitalisations was identified. Across the models, there is no significant association 
between hospitalisations and whether the patient gets the recommend flu vaccine or 
spirometer test or more than three corticoid prescriptions in a year.  However, 
excessive usage of SABA, antibiotics and corticoids is significantly positively 
associated with asthma hospitalisations. Comorbidities are positively associated with 
asthma hospitalisations but are not significant in any of the models.  Finally, hospital 
lag, which indicates whether the patient was hospitalized in the previous 12 months, 
is significantly negatively associated with hospitalisations.  
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Table 36. Relationship between (in)appropriate care and hospitalisations for 
asthma patients 
 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE1 NBFE1 PFE2 NBFE2 PFE4 NBFE4 
              
comorb 1.018* 1.018** 1.019* 1.019** 1.019* 1.020** 
 
(0.01000) (0.00884) (0.0104) (0.00880) (0.0103) (0.00882) 
gender 
 
1.089 
 
0.979 
 
0.994 
  
(0.523) 
 
(0.456) 
 
(0.465) 
qual_flu 0.769 0.914 0.724 0.860 0.735 0.896 
 
(0.234) (0.237) (0.233) (0.224) (0.235) (0.233) 
qual_tot_spir 0.906 0.918 0.987 1.018 0.962 0.928 
 
(0.119) (0.116) (0.132) (0.126) (0.133) (0.118) 
bad_cort 0.496 0.465 0.477 0.424* 0.478 0.440 
 
(0.285) (0.232) (0.278) (0.216) (0.279) (0.223) 
badpred_visit 0.595*** 0.548*** 
    
 
(0.0698) (0.0622) 
    saba 1.154*** 1.150*** 1.170*** 1.169*** 1.165*** 1.159*** 
 
(0.0484) (0.0357) (0.0502) (0.0362) (0.0476) (0.0358) 
cort 1.145** 1.152*** 1.152** 1.164*** 1.150** 1.155*** 
 
(0.0627) (0.0567) (0.0650) (0.0578) (0.0651) (0.0574) 
antib 1.073 1.052 1.094 1.069 1.091 1.067 
 
(0.0973) (0.0658) (0.108) (0.0666) (0.106) (0.0667) 
hosplag 0.601*** 0.583*** 0.594*** 0.576*** 0.596*** 0.580*** 
 
(0.0597) (0.0638) (0.0599) (0.0632) (0.0598) (0.0637) 
_Iage_cat_2 0.435 1.079 0.377 0.943 0.372 0.991 
 
(0.572) (0.630) (0.511) (0.553) (0.486) (0.568) 
_Iage_cat_3 0.364 1.415 0.299 1.153 0.291 1.268 
 
(0.547) (0.781) (0.461) (0.627) (0.435) (0.689) 
_Iage_cat_4 0.491 1.974 0.415 1.614 0.405 1.893 
 
(0.769) (0.950) (0.667) (0.755) (0.632) (0.890) 
_Iage_cat_5 0.725 2.762** 0.596 2.154* 0.581 2.596** 
 
(1.158) (1.310) (0.975) (0.988) (0.922) (1.201) 
_Iage_cat_6 0.645 1.652 0.561 1.333 0.533 1.565 
 
(1.071) (0.842) (0.955) (0.653) (0.884) (0.772) 
_Iage_cat_7 1.119 2.398 0.961 1.805 0.907 2.223 
 
(1.939) (1.429) (1.700) (1.045) (1.564) (1.277) 
_Iage_cat_8 1.583 2.730 1.409 2.100 1.285 2.214 
 
(2.983) (2.889) (2.686) (2.174) (2.398) (2.329) 
_Iyear_2003 33.59*** 37.89*** 36.57*** 42.95*** 35.42*** 38.78*** 
 
(21.06) (21.96) (22.91) (24.99) (22.27) (22.54) 
_Iyear_2004 40.86*** 40.21*** 45.69*** 47.42*** 44.52*** 41.99*** 
 
(26.89) (23.47) (29.96) (27.76) (29.79) (24.57) 
_Iyear_2005 38.51*** 37.81*** 43.60*** 45.52*** 42.24*** 39.66*** 
 
(25.33) (22.11) (28.51) (26.68) (28.22) (23.24) 
_Iyear_2006 26.45*** 30.96*** 29.20*** 35.91*** 28.76*** 32.73*** 
 
(16.92) (18.15) (18.67) (21.11) (18.44) (19.22) 
_Iyear_2007 14.30*** 15.66*** 15.14*** 17.11*** 15.21*** 16.51*** 
 
(9.256) (9.290) (9.802) (10.18) (9.855) (9.809) 
_Iyear_2008 10.96*** 11.68*** 11.34*** 12.76*** 11.46*** 12.31*** 
 
(7.231) (6.982) (7.469) (7.649) (7.538) (7.365) 
qual_visit 
    
1.199 1.667*** 
     
(0.308) (0.237) 
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Constant 
 
0.0388*** 
 
0.0283*** 
 
0.0196*** 
  
(0.0278) 
 
(0.0202) 
 
(0.0141) 
       Observations 2,751 2,751 2,751 2,751 2,751 2,751 
Number of v1 393 393 393 393 393 393 
seEform in parentheses 
    *** p<0.01, ** p<0.05, * p<0.1 
     
 
Sensitivity analysis 
 
For consistency purposes, the analysis was also run with independent variables 
constructed in several different ways considered to be appropriate as: i) dummy 
variables for “bad care” in the previous two, three of four years; ii) count variables 
(see Appendix D). “Bad care” is defined as the complete absence of tests or visits in 
the previous 2-3-4 years where a value of 1 is given if this condition is fulfilled. In this 
way, if a patient has not had any visits or tests done in the period of 4 years, it can be 
said the care is highly inappropriate.  Some of the results for diabetes when using a 
dummy variable for “bad care” in the previous 2-3-4 years are consistent with the 
results above while others are not. Furthermore, bad care in terms of ophthalmologist 
visits is significantly positively associated with hospitalisations as in our original 
analysis except for bad care in the previous 4 years. Bad care in terms of HbA1c and 
urine tests is mainly positively associated with hospitalisations but not significant. In 
our original analysis the provision of these according to clinical guidelines was 
actually positively associated with hospitalisations. Finally, bad care in terms of 
cholesterol and visits is negatively associated with hospitalisations, but is significant 
only for cholesterol. Again, these results differ from our original results. The effect of 
predicted visits, previous hospitalisations and other control variables were consistent 
with our original results, except age which is now significantly negatively associated 
with hospitalisations (again, except in the case of 4 years). When simple count 
variables are used, the number of HbA1c tests is positively but not significantly 
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associated with hospitalisations, while additional cholesterol and urine tests as well 
as visits are significantly positively associated with hospitalisations, similarly to the 
main results. It is also interesting to note that specialist visits are significantly 
positively associated with hospitalisations while GP visits are not significant, 
suggesting that GP visits may potentially be a substitute to hospital care but specialist 
visits are not. Only ophthalmologist visits are significantly negatively associated with 
hospitalisations, again as the main result. The remaining variables (predicted visits, 
previous hospitalisations, number of antidiabetic medications, insulin, comorbidities 
and age) again have the same relationship as in our original model.  
 
The results for asthma when using a dummy variable for “bad care” in the previous  
2-3-4 years are consistent with our results for the control variables but the effect of 
the variables of interest is somewhat different from those in the main body of the 
chapter. While the above results showed no association between appropriate care (flu 
vaccine, spirometry tests and more than 3 prescriptions of corticoids), here bad care 
in terms of flu vaccines is positively associated with hospitalisations, but the 
significant effect disappears with bad care in the last 4 years. Similarly, bad care for 
spirometry tests is positively associated with hospitalisations in the last 2 years but 
the significant effect disappears with 3 and 4 years. Finally, number of SABA is 
strongly positively associated with hospitalisations, while numbers of corticoids and 
antibiotics are all positively associated with hospitalisations, but not always 
significant.  When simple count variables are used, the association between flu 
vaccines, spirometer tests and hospitalisation is positive but usually not significant – 
results consistent with our analysis above. Number of antibiotics, corticoids and 
SABA show again a significant positive association with hospitalisations. The 
remaining variables have the same association. Thus overall, the sensitivity analysis 
suggests that for some variables the method of construction is important and has an 
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effect on the direction and significance of the association while for others results are 
robust across the models.  
 
5.4. Discussion and conclusion 
 
This study assessed elements of quality of care provided to asthma and diabetes 
patients in Slovakia in the post-transition period. The association between selected 
process indicators that capture appropriate care for these two conditions, as defined 
through clinical guidelines, and potentially preventable hospitalisations was 
reviewed. Overall, it was found that variables that capture inappropriate care are 
strongly positively associated with hospitalisations and as previous studies, mixed 
results for the relationship between appropriate care measured through number of 
visits and tests.  
 
Approximately 15% of the newly diagnosed patients followed during the period 
between 2002 and 2008 had one or more hospitalisation. Whether 15% of patients 
having at least one hospitalisation is appropriate or inappropriate is difficult to 
determine without further investigation and disaggregation. However, a substantial 
proportion of the patients (85%) do appear to have good access and receive 
appropriate medical care that does not result in potentially unnecessary 
hospitalisations.  The study also found that the mean number of selected tests 
(HbA1c, ophthalmologic exams, flu shot), regardless of the severity of a patient’s 
condition, is substantially lower than recommended in the clinical guidelines. This is 
despite the fact that patients have frequent and more than the recommended number 
of visits to physicians for both conditions. For diabetes, a large proportion is not 
receiving the recommended number of HbA1c tests, ophthalmologic exams and 
cholesterol tests. However, it should be noted that other methods of measuring 
glucose levels are being utilised, which are not explicitly recommended in clinical 
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guidelines and therefore not measured in this study. These should be reviewed in the 
future to determine whether care provided is truly inappropriate, there are issues 
with coding or the underlying reasons for discrepancies between the care 
recommended in clinical guidelines and the form of care actually provided. Similarly, 
for asthma, very few patients receive the recommended flu vaccination and 
spirometer tests. Therefore, while many patients frequently visit their provider, a 
large proportion of them are not receiving the appropriate selected tests as defined in 
the clinical guidelines. It cannot be concluded with certainty if due to coding issues 
the frequency of these procedures is underestimated. Also, it is possible that patients 
are being treated appropriately but with the selection of indicators, only what is 
measurable is assessed. For example, in the 2008 Health Consumer Powerhouse 
assessment of diabetes care, Slovakia ranked low, yet it was partially due to missing 
data in the “access to care” sub-discipline, including various tests such as 
microalbuminuria control, HbA1 control and foot examinations (Health Consumer 
Powerhouse, 2008).  A closer examination of why this data was not made available 
for the assessment (e.g. not tested, not coded or inappropriately coded, not easily 
reported) would be necessary.  
 
The relationship between process indicators constructed based on clinical guidelines 
for the two conditions and an outcome indicator of quality of care – preventable 
hospitalisations for diabetes and asthma – was assessed for patients who had at least 
one hospitalisation during the period of the study.  The results of the PFE and  NBFE 
models for diabetes show a significant, negative relationship with ophthalmologic 
exams, one of the variables for quality care, but a significantly positive relationship 
with the other variables for appropriate care (number of HbA1c tests, cholesterol tests 
and urine tests in the negative binomial model only). The positive relationship 
between HbA1c, cholesterol and urine tests, as well as physician visits, suggests that it 
is likely that the sicker patients who have many visits and tests are also more 
 211
frequently hospitalized. This suggests potential endogeneity which it was not possible 
to control for in this study as instruments were not available at the patient level due 
to data limitations. Studies that controlled for endogeneity of visits found that GP 
visits were a substitute to inpatient care. While not controlling for endogeneity, this 
result was also identified in the in the robustness checks where specialist visits were 
significantly positively associated with hospitalisations while GP visits were not. In 
other words, more intense primary care may prevent unnecessary hospitalisations, as 
suggested by the concept of ambulatory care sensitive conditions.  Similarly, for 
asthma, quality of care defined through the flu vaccination and spirometer test 
variables were not significantly associated with hospitalisations; however, excessive 
amount of SABA, corticoids and antibiotics were significantly positively associated 
with hospitalisations.  These results suggest that taking steps to monitor why some 
patients are disproportionately treated by these medications and a review their 
treatment plans may lead to better care and reductions in future hospitalisations.  
Again, it is possible that some of these are the sicker patients. The lack of relationship 
with the flu vaccination is not necessarily surprising; even though the flu vaccine has 
been recommended in the guidelines, it is also stated that is not likely to protect 
patients from exacerbations of asthma and does not improve asthma control 
(Hrubisko & Ciznar, 2010).  
 
While a stronger relationship between process and outcome measures gives greater 
validity, for some process measures that are considered important for the treatment 
of the patient, there is a weak relationship with outcomes. Nevertheless, providers  
consider these process indicators important as they have been included in their 
specializations’ clinical guidelines.  The relationship between good care and inferior 
outcomes is often identified because of confounding by indication – sicker patients 
with worse outcomes receive more or better care (Rubin, Pronovost, & Diette, 2001). 
This is particularly problematic for patients with chronic illnesses such as asthma, for 
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which measures of intrinsic disease severity are poor and it may therefore be difficult 
to find evidence to support valid process measures (Rubin, Pronovost, & Diette, 
2001). Also, most feasible process measures are usually indicators for a very specific 
element of the care process rather than comprehensive measures of how care is 
delivered (Rubin, Pronovost, & Diette, 2001). Care for both asthma and diabetes are 
highly complex and the indicators used are only capturing a small element of the 
appropriate care that should be provided. This study was limited to measuring only 
data that was available, not necessarily indicators which would cover in a complex 
way the most important elements of asthma and diabetes care. 
 
Several policy recommendations for the utilisation of preventable hospitalisations or 
quality of care process indicators for performance measurement are discussed. 
Firstly, preventable hospitalisations are an outcome indicator for the quality of 
ambulatory care. As per all outcome indicators, factors apart from quality of care 
determine whether or not a patient is hospitalized. Therefore, caution needs to be 
exercised when interpreting number of hospitalisations even though they provide an 
initial snapshot of the quality of ambulatory care provided. Excessive hospitalisations 
may be indicative of inappropriate care, result in unnecessary costs and require 
further investigation and analysis.  Our study suggests that while only 15% of newly 
diagnosed patients were hospitalized at least once during the period under study, 
many more did not receive appropriate treatment as defined by clinical guidelines.  
So the evidence of a gap between the best possible care and actual care accessed as 
measured by the process indicators should be taken as a basis for action by both 
purchasers and providers to improve adherence to clinical guidelines and improve 
overall care provided to patients. It is important to acknowledge that not all measures 
recommended in the clinical guidelines are necessarily directly related to reductions 
in hospitalisations. Yet, clinical evidence suggests that they are important and their 
use should be encouraged. While some indicators are easily measureable and there is 
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a direct relationship with outcomes (e.g. excessive use of SABA, antibiotics, 
corticoids), with others there is no direct relationship (e.g. flu vaccine, spirometer 
test) and there are also those that cannot presently be measured (e.g. adherence and 
appropriate dosage, lifestyle counselling, and other provider specific factors).  
 
Despite the availability of clinical guidelines, physician behaviour may not be simple 
to change and thus take a long time before full adherence to guidelines is reached. 
Explicit and implicit incentives in the system to provide treatment as well as 
physician practice style need to be reviewed and better understood to design 
appropriate interventions to improve quality of care provided.  Overall, there is more 
positive evidence on effectiveness of professional-oriented interventions (education, 
reminders, feedback) than on those aimed at the organisation or the patient (Grol & 
Grimshaw, 2003).  However, changes in clinical practice are only partly within 
doctors’ control; it is the prevailing professional and organisational culture towards 
quality that determines the outcome to a large extent (Grol & Grimshaw, 2003). In 
this sense, unless such changes are made in Slovakia, improvements in the quality of 
care will be difficult to achieve.  Overall, it is essential that physicians assume 
responsibility for quality improvement (Shekelle & Roland, 2000, p.171). 
 
The present study has several limitations. First, only newly diagnosed patients were 
considered whose condition may initially require hospitalisations and high amount of 
tests before they are stabilised. Therefore, those patients who have been living with 
their chronic condition for an extended period of time are not being captured.  By 
choosing only treated patients, the sick whose condition is managed without drug 
therapy were excluded as well as those who may have received highly inappropriate 
care and died. Second, the main focus of this analysis was on patients who were 
hospitalised at least once during the period of the study. However, there is also a 
large proportion of patients who were not hospitalised at all between 2002 and 2008.  
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Thus in the future additional analysis could be carried out attempting to understand 
the relationship between non-hospitalisations and potentially inferior quality of care 
provided to diabetes and asthma patients. Third, not all diabetes and asthma related 
hospitalisations are avoidable with high quality outpatient care but the data do not 
allow identifying the exact nature of the hospitalisation.  As a result, the number of 
hospitalisations, our dependent variable, may be overestimated. On the other hand, 
secondary diagnoses were not included so the number of hospitalisations may be 
underestimated.  
 
Fourth, issues surrounding data coding, recording and overall quality of the claims 
database should be highlighted. The data’s primary purpose is for billing where the 
payment mechanisms in place potentially incentivise physicians to inappropriate 
provision and coding of procedures to maximize payment. Also, physicians may be 
coding procedures inaccurately due to habit. For example, every visit of a diabetic 
patient will be coded under the diabetes ICD code, even though the visit may have 
been for hypertension or a sprained ankle. Also, not all the tests, medications or visits 
may always be recorded and coded correctly. Finally, as the dataset was not prepared 
for quality of care assessment, data handling was required which may have resulted 
in researcher bias.  It is also important to highlight again that the administrative data 
used lacked clinical and lifestyle information which made it difficult to adjust for 
important patient characteristics that could potentially influence hospitalisations For 
example, severity of illness which affects appropriate pharmacotherapy could not  be 
assessed, neither alcohol or smoking habits. Also, information on an important 
health outcome such as mortality was missing. However, given that our focus was on 
newly diagnosed patients, mortality may not have been an appropriate outcome to 
assess as it is likely to have been a rare event. In the future, improved features of the 
database should allow for the monitoring of different aspects of appropriate care and 
better risk adjustment.   
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To summarise, this chapter provides additional evidence on the link between 
appropriate/inappropriate care and hospitalisations. It also serves to initiate debate 
on the quality of care provided in Slovakia and how different process and outcome 
measures can be used to measure it.  While it is clear to most why it may be 
important to avoid unpleasant and costly hospitalisations, measuring quality of care 
at any level of the system is complex and highly controversial. However, small steps 
can be taken to reduce obvious deficiencies in quality.  Simply obtaining an overview 
on the proportions of patients who do not receive a particular form of therapy is 
essential. Then, breaking down these results by provider and reviewing the treatment 
of individual patients based on medical records may reveal what improvements 
should and could be implemented.  Finally, the wide availability of administrative 
data in Slovakia and other Eastern European countries call for their better 
utilisations for quality of care evaluations. While not without limitations, “current 
administrative data are probably most useful as screening tools that highlight areas in 
which quality should be investigated in greater depth.” (Iezzoni, 1997). However, at 
present the full potential of this administrative data is not being utilised.  
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Chapter 6. Conclusions and policy implications 
 
The goal of health system performance measurement is to ensure that health systems 
achieve their four key objectives: improve the health of their populations,  respond to 
the individual needs and preferences of patients, provide financial protection and 
productively utilise resources (Smith, Mossialos, Papanicolas, et al., 2009).  To reach 
these objectives, multiple other dimensions may be relevant, including access, quality 
of care or equity. Apart from using performance measurement to identify potential 
areas for improvement, it also serves to hold stakeholders accountable. Therefore, it 
is even more important in the times of fiscal constraint, rising health care 
expenditures coupled with ageing and increasing burden of chronic illnesses,  which 
require governments to be more accountable to patients  and provide effective and 
high quality care with limited resources (Papanicolas & Smith, 2013). Similarly, it is 
an essential tool for understanding the effect of major changes in any country’s health 
system so that negative consequences on the quality of the services and consequently 
the populations’ health and well-being can be averted. The key challenge remains 
how to best measure performance.  
 
The political and socio-economic transition in the Eastern European region where 
numerous changes occurred within a short period of time has been a unique area of 
interest to both academics and policy makers. Czechoslovakia makes a particularly 
interesting case study as not only did it transition from communism to democracy in 
1989 but in 1993 was also separated into two independent countries – the Czech 
Republic and Slovakia. The split of the countries provides for an excellent natural 
experiment to be studied as the two countries had very similar systems while being 
part of Czechoslovakia and embarked on increasingly different paths after the 
separation. During the period since the two transitions important health care reforms 
were implemented in each of the countries; however, there has been little concern 
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with a more in-depth assessment of health system performance.  Therefore, the main 
goal of this thesis was to identify changes in health system performance in Slovakia 
relative to the Czech Republic before and after the ‘double transition’ so that relevant 
lessons can be learned. Consequently, the two countries can take steps towards 
identifying existing problems and implementing strategies for improvements. While 
health systems have multiple goals, this thesis focuses on those that are often 
considered to be the most important and where evidence in the two countries is 
limited: overall health and well-being and quality of care. In particular, the goal was 
to contribute to the literature by better understanding how changes in the quality of 
care may have reflected on changes in population health.  
 
Assessing health system performance and quality of care can be done in multiple 
ways, using different structure, process and outcome indicators. This thesis applied a 
conceptual framework for health system performance assessment to guide the overall 
analysis, and a selection of methodologically more appropriate outcome and process 
indicators to evaluate the degree of progress the two countries have made before and 
since the fall of the communist regime and independence.  In the context of the Czech 
Republic and Slovakia only standard well-being and health outcome measures have 
been applied to date with a very limited focus on measuring quality of care. In the 
recent years more refined indicators that address some of the methodological 
weakness of these standard indicators have increasingly been applied but not yet in 
Slovakia and the Czech Republic. Therefore, this thesis employed some of these 
indicators (height, ‘avoidable’ mortality, hospitalisations for ACSCs) to assess 
performance, using different unique datasets and a range of methods from different 
disciplines for cross- sectional and panel data. 
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The individual chapters provided empirical evidence at the different levels of the 
health system.  Starting from the macro level, the first part of the analysis focused on 
measuring overall health system performance using the indicator of height to capture 
the health and well-being of the populations (Chapter 2).  Height was selected to 
measure overall system performance capturing all the different determinants of 
health and well-being highlighted in the conceptual framework, including the 
political, economic and social environments, different health risks, as well as the 
contribution of the health care system. Moving one level down, the thesis assessed 
health care performance by looking at overall quality of care with the indicators of 
‘avoidable’ mortality (Chapter 3). Here the goal was to capture the contribution of the 
quality of the health care system to changes in population health by applying 
indicators of ‘avoidable’ mortality. Consequently, given the improved properties of 
‘avoidable’ mortality as a health outcome indicator for capturing the contribution and 
quality of the health care system called for investigating its association with health 
care inputs using some more advanced analytical methods that previous studies have 
not employed (Chapter 4). The last part of the thesis consisted of an analysis of 
Slovakia at the micro level using hospitalisations for two ACSCs as an indicator of the 
quality of ambulatory care and the associations with selected process measures 
(Chapter 5).  
 
6.1 Overall answer to the research question and main 
contributions 
 
The overall research question of this thesis what: how have the health systems of 
Slovakia and the Czech Republic performed before and since the transition in 1989 
and independence in 1993? The thesis hypothesised that despite somewhat different 
socio-economic and health policies after the transition to democracy and separation, 
health system and health care system performance in the two countries has been 
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improving. The findings from Chapter 2 and Chapter 3 confirmed this hypothesis and 
also broadly reflected the results of how these countries have been performing on 
standard indicators (e.g. life expectancy, GDP per capita).  Height has continued to 
increase in both countries and while the transition period does not seem to have a 
significant positive effect, there were no signs of deterioration on overall population 
health and well-being. Interestingly, there was no significant country effect to suggest 
that one country fared better than the other, regardless of the existing evidence on 
Czech Republic performing better on numerous indicators. This means that despite 
the somewhat different socio-economic conditions in the two countries, the broad 
and immediate determinants of height were very similar. It was rather the significant 
interaction between country and years under democracy that showed how Slovakia 
had a larger capacity to benefit from democracy – a country that was worse off under 
communism and the initial years of democracy, confirming our hypothesis that those 
who start worse off have a larger capacity to benefit.  Finally, it was interesting to find 
that ultimately it was men who seemed to have benefited more from the transition 
than women.  
 
Following these broad system level findings, the thesis focused on the quality of the 
health care systems as measured by the ‘avoidable’ mortality indicators. Chapter 3 
hypothesised that improvements in the performance of the health care systems would 
be reflected in declining ‘avoidable’ mortality and the results confirmed this 
hypothesis. On the basis of the existing evidence the chapter further hypothesised 
that ‘avoidable’ mortality would decline slower than non-avoidable mortality but the 
findings contradicted this hypothesis; ‘avoidable’ mortality was actually declining 
faster than non-avoidable mortality in both countries.  Contrary to the findings from 
Chapter 2, Chapter 3 found that the trajectories of progress have not been the same in 
the two countries when measuring the quality of the health care systems since the 
double transition; there is evidence of divergence with Slovakia lagging behind the 
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Czech Republic in the quality of care provided. Analysis by individual condition 
allowed a more specific understanding of a country’s health care system performance. 
Here it became obvious that there are important differences across disease areas and 
lack of improvement or deterioration should lead to further investigation of the 
medical care provided and potential bottlenecks either in prevention, primary or 
hospital care. Depending on the condition, other risk factors such as smoking, alcohol 
consumption or diet should also be considered. However, while the analysis was 
condition specific, it was still carried out at the aggregate population level which can 
only point to initial weaknesses and further in-depth investigation and disaggregation 
is required, as will be highlighted in the policy recommendations section.   
 
Given the key advantages of ‘avoidable’ mortality as an improved health outcome 
indicator compared to those usually used for capturing the contribution of health care 
services, Chapter 4 hypothesised a negative relationship between increased health 
care inputs and ‘avoidable’ mortality. However, the thesis did not confirm this 
hypothesis and concluded that despite having employed more advanced analytical 
methods, timely and effective care cannot be adequately captured by measuring 
quantity of health care resources such as beds or human resources. Instead, better 
quality of care proxies together with non-health system determinants, as also 
highlighted in Chapter 3, need to be accounted for in models that consider 
endogeneity and dynamics in health care quality and outcomes. Finally, the thesis 
hypothesised that both appropriate and inappropriate care are associated with 
hospitalisations for ambulatory care sensitive conditions, and the findings from 
Chapter 5 showed mixed associations. Variations in hospitalisations do not provide 
conclusive findings about the quality of ambulatory care in Slovakia but instead 
suggest that in some cases inappropriate care may be provided. Thus these variations, 
similarly to variations in ‘avoidable’ mortality at the system level, need to be further 
investigated to see if any could be avoided by providing more appropriate care and 
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avoid unnecessary or even harmful care.  While there is little evidence of a strong 
relationship between appropriate processes of care and hospitalisations, there is 
nevertheless evidence that large proportions of patients do not receive appropriate 
care as recommended in the clinical guidelines both for asthma and diabetes.  
 
Before the empirical findings from each individual chapter and policy 
recommendations are presented, the main contributions of the thesis are 
summarised below. The thesis: 
 
• Demonstrated how population well-being, health and quality of care can be 
assessed to stimulate the country debate on health and quality improvement, 
applying various data sources, methods and indicators. This is especially 
important as it is an area that has been neglected in Slovakia and the Czech 
Republic during the post-transition period;   
• Revealed the relationship between the indicator of height as a measure of 
health and well-being and the political and economic transition.  Height has 
several advantages over traditional indicators of well- being and it was applied 
in an entirely new and unique country setting; 
• Demonstrated the usefulness of the indicator of ‘avoidable’ mortality for a 
more in-depth assessment of the quality of the two health care systems. The 
use of individual ‘avoidable’ mortality indicators to compare quality of care 
during the pre and post-transition period has not been previously undertaken;  
• Showed the absence of a relationship between ‘avoidable’ mortality, an 
improved health outcome indicator, and health care inputs using more 
advanced analytical methods that account for endogeneity and dynamics; 
• Demonstrated the usefulness of hospitalisations for two ACSCs as an outcome 
indicator for the quality of ambulatory care in Slovakia and explored whether 
there is an association with processes of care. It also demonstrated how 
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administrative data, while not perfect, can be used to assess the quality of 
ambulatory care; 
• Provided empirical evidence for population health and the quality of the 
Czech and Slovak health systems since transition and thus the necessary basis 
for further policy action in the area of quality assessment and improvement.  
 
6.2 Key findings of individual chapters 
 
6.2.1   Conclusions of Chapter 2  
 
Chapter 2 began by analysing height as an all-encompassing indicator of 
retrospective well-being and health, which accounts for all the broad determinants of 
these as highlighted in the conceptual framework in Chapter 1.  Height is an indicator 
that has been increasingly used to measure improvements in health and well-being. 
Therefore, this chapter started the assessment at the macro level where the quality of 
the health care system is only one of the many determinants of health and well-being. 
The goal of the chapter was to investigate whether the democratic transition and 
independence brought benefits or a deterioration in the health and well-being of the 
Slovak and Czech populations reflected in a change in adult heights.  The chapter 
used the World Health Survey data which contains individual height information.  
 
Using OLS regressions and controlling for a range of socio-economic factors as well 
as the “quality” of democracy, the main findings of this chapter indicated that with 
every additional year spent under democracy (or in independent Slovakia/Czech 
Republic while growing up in the first twenty years of an individual’s life) there is a 
positive effect on height. However, there was no significant cohort effect between the 
youngest population – those who mainly grew up under democracy/independent 
country – and the following two older cohorts. This finding suggests that the height 
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increase for the “transitional” generation was not significantly different from the 
generations growing up under communism. Therefore, the political and economic 
liberalisation that came with the transitions did not bring about a significant 
improvement in well-being as measured by height in neither of the two populations; 
however, there was also no evidence of visible deterioration There is an overall birth 
cohort effect, which showed that people have become on average taller over the 
course of time in both countries but the improvements are most noticeable for the 
oldest population born during the early 20th century. Furthermore, the Chapter found 
that there are social differences in well-being reflected in different height increases 
across the income terciles. Height increases from the poorest to the richest tercile for 
both genders.  In addition, there is also a significant education effect where the level 
of education achieved is an important determinant of the individual’s height.  
However, there was no consistent country effect across the models suggesting that 
both Slovakia and the Czech Republic were experiencing similar levels of well-being 
as measured by height.  
 
However, the findings also revealed that the effect of growing up under democracy 
was different for Slovakia and the Czech Republic as the interaction term was 
significant.  Thus while the Czechs were on average taller, Slovakia which was the 
poorer neighbour during communism and was under authoritarian rule after 
transition seemed to have benefited more from the transition to democracy.  
Furthermore, the results also showed that years spent under democracy had a 
different effect on height depending on the country and income tercile.  Existing 
evidence suggested that those benefiting from democracy were the same as those 
already benefiting during communism. However, the results suggest that while the 
transition years may have impacted negatively on the most disadvantaged, they were 
still able to benefit in height, and more so than the richer groups. Again, Slovaks in 
the bottom and mid tercile were benefiting more than the Czechs.  Finally, analysis by 
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gender revealed that the increase in height seems to be driven by men: for every 
additional year growing up under democracy for men, there was a significant height 
increase, including a significant difference between the youngest age cohorts, even 
after controlling for different factors; for women there was no significant effect. These 
findings are not surprising as evidence shows that women under communism already 
fared relatively well and thus the transition did not bring significant changes to their 
well-being.  
 
6.2.2   Conclusions of Chapter 3  
 
Chapter 3 aimed to measure the quality of the health care system using different 
indicators of ‘avoidable’ mortality between 1971 and 2008. ‘Avoidable’ mortality is 
defined as deaths which could have been avoided if timely and effective medical care 
had been provided.  Age-standardised mortality rates for mortality from ‘avoidable’ 
and other (non-avoidable) causes have been used to study national and regional 
trends. The chapter looked at overall trends but more importantly, condition specific 
mortality trends which provide more in-depth evidence about the quality of care 
provided in the two countries. Especially, given the results of Chapter 2 where the 
country effect was not a significant determinant of height difference, the goal was to 
see whether for specific ‘avoidable’ mortality indicators there is divergence or 
convergence between the two countries.  Regional within country differences were 
also examined.  
 
Overall, the results indicate that the quality of the health care system has been 
improving since 1989 and 1993 as reflected in declining ‘avoidable’ mortality. 
Furthermore, consistent with other studies ‘avoidable’ mortality has been declining 
faster than mortality from non-avoidable causes. As far as trends are concerned in the 
two countries, overall there has been divergence in aggregate ‘avoidable’ mortality 
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rates with Slovakia lagging behind the Czech Republic since the transition period 
suggesting the potential for improving the quality of care provided.  The main driver 
of ‘avoidable’ mortality in Slovakia has been ischaemic heart disease, hypertension 
and cerebrovascular disease, conditions for which deaths could be largely prevented 
with effective and timely prevention and primary care. Trends for non-avoidable 
mortality where factors outside the health care system (e.g. socio-economic, 
environmental, lifestyle etc.) are also important show that Slovakia has been lagging 
behind during the entire period of study.  Since these non- health care system factors 
affect both ‘avoidable’ and non-avoidable conditions, any improvements or changes 
in ‘avoidable’ mortality are likely to be explained by changes in the provision of timely 
and effective care (Korda & Butler, 2006).   
 
Analysis of individual ‘avoidable’ mortality conditions revealed that in several cases 
the two countries converge or Slovakia outperforms the Czech Republic. This type of 
in-depth analysis better demonstrated where there is bad performance that needs to 
be corrected. For example, in the group of conditions where public health 
programmes or primary care are considered to be most important, results across the 
conditions vary significantly and questions about the medical care provided for those 
where mortality rates have been stagnant or the decline slowed down after 1989 and 
1993 (e.g. peptic ulcer or malignant neoplasm of cervix uteri and body of uterus in 
Slovakia) should be raised to prevent unnecessary deaths. Among others, these 
include issues with screening, timely and effective diagnosis, treatment and 
coordination of care, but also non- health care  system factors that can be influenced 
such as lifestyles that include excessive alcohol and cigarette consumption or diets 
that lead to overweight and obesity. 
 
For all the conditions where hospital level care is considered essential (e.g. Hodgkin’s 
disease, appendicitis, maternal and perinatal mortality etc.), there have been 
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significant improvements in the provision of timely and effective hospital care in both 
countries reflected in declining and converging mortality trends. These can be 
explained by improvements in the equipment of providers and availability of more 
sophisticated medicines. For example, enhancements in neonatal care (e.g. prenatal 
diagnosis of congenital malformations and intensive care in newborns of extremely 
low birth weight) (Stembera & Velebil, 2006) have contributed to declining perinatal 
mortality while the overall lower neonatal hospital and human resource capacity in 
Slovakia (Chovancova, 2008) may explain the gap between the two countries.  
Regional variations showed higher rates of perinatal mortality and mortality rates for 
respiratory disease deaths for children aged 1 to 14 in the Eastern regions of Slovakia, 
potentially linked to the large presence of the Roma population and their lifestyle and 
attitudes to health and health care services (Ecohost/ Masaryk University, 2000). 
Thus upon further in depth investigation and analysis, targeted health care 
interventions may be more appropriate.  
 
6.2.3   Conclusions of Chapter 4  
 
Chapter 3 again used indicators of ‘avoidable’ mortality to measure the contribution 
of the health care system by analysing trends in mortality rates and their associations 
with health care inputs.  Extensive literature is dedicated to establishing a 
relationship between health care resources and health outcomes. Given that 
‘avoidable’ mortality is considered to be an improved health outcome indicator which 
better captures the quality of the health care system rather than the contribution of 
non-health system determinants, Chapter 4 of the thesis aimed to establish a 
relationship between health care resources and ‘avoidable’ mortality. Earlier studies 
have tried to establish this relationship but the evidence is mixed. However, the 
methods used previously have not accounted for potential endogeneity of physician 
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supply and time dependence of mortality rates. Therefore in Chapter 4 instrumental 
variable and dynamic panel modelling have been employed to address these issues.   
 
The chapter found no significant relationship between health care resources 
(measured by number of physicians, nurses and beds) and ‘avoidable’ mortality rates 
using:  a) pooled OLS regression controlling for years b) fixed effects that incorporate 
unmeasured regional factors c) instrumental variable models treating physician 
supply as endogenous d) dynamic GMM models which allows for time persistence in 
mortality rates. Despite taking into consideration potential endogeneity and 
dynamics, no significant relationship was found. In fact, in the context of Slovakia 
and the Czech Republic, endogeneity may not be a problem as health care resource 
planning is not based on health care needs (e.g. mortality, morbidity) of the 
population but per capita. Even though the choice of instruments is always 
controversial, using different and perhaps more appropriate instruments for 
physician supply may have led to different results.  
 
These results contribute to the debate on the role of health care inputs in explaining 
variations in health outcomes in several ways. First, it is possible that a relationship 
cannot be established given that the supply of health services has reached a level 
where there are diminishing returns. Second, while health care inputs are an 
important element of the health care system, confirming the findings of earlier 
studies, they do not seem to adequately capture what is happening in the health care 
system as they only measure quantity and not quality of care. Quantity of care does 
not seem to reveal sufficient information about the provision of timely and effective 
care and better indicators are necessary.  Furthermore, the evidence from the recent 
AMIEHS study shows that while for many conditions important key interventions are 
available to avoid deaths, it remains complicated to ascertain the exact proportion 
that can be attributed to the selected medical interventions, explaining the absence of 
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a clear link with health care inputs. There are several examples (e.g. stroke, ischaemic 
heart disease) where medical care explains between 45-70% of mortality while the 
remaining proportion can be attributed to inappropriate lifestyle. So even though 
‘avoidable’ mortality is considered to better capture the contribution of health care 
systems and therefore have the potential to be used as indicator of the quality of the 
health care system, range of other non-health system factors are still considered to be 
important determinants of changes in mortality rates (Plug, Hoffmann, & 
Mackenbach, 2011). Therefore, variables that capture non-health determinants and 
may be key risk factors (e.g. nutrition, alcohol, smoking, cholesterol, physical activity, 
weight and hypertension for cardiovascular mortality) need also be included in future 
analysis. 
 
This chapter also contributed to the literature by attempting to use individual 
‘avoidable’ mortality causes, in addition to aggregate ‘avoidable’ mortality as the key 
dependent variable.  Only a few studies have previously explored ‘avoidable’ mortality 
in this respect.  Such analysis allows for a more detailed specification of appropriate 
care and therefore a more precise analysis of the relationship between health care 
provision and mortality. For example, in the case of malignant neoplasm of cervix 
uteri, it could be important to include variables that capture whether and how 
cervical cancer screening, cytology, surgery and radiation therapy have been 
provided.  Due to lack of this type of data at the regional level, only some of the 
conditions could be analysed separately and the remaining had to be grouped 
together.  At the same time, insufficient numbers of deaths for these individual 
conditions made it necessary to group them together and thus impossible to include 
specific quality of care variables. The trade-off between individual condition specific 
analysis and aggregate ‘avoidable’ mortality should always be carefully considered.  
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6.2.4   Conclusions of Chapter 5  
 
Building on the findings from Chapter 2 and 3, Chapter 5 went further by assessing 
the quality of ambulatory care in Slovakia where evidence to date was limited. More 
specifically, it undertook the analysis of in/appropriate provision of care for two  
ACSCs (asthma and diabetes).  This was done by using selected process indicators as 
well as ACSHs as an outcome indicator to examine the quality and effectiveness of 
ambulatory care. The goal of this chapter was to also provide additional evidence on 
the link between appropriate/inappropriate care and hospitalisations. Anonymous 
country representative patient level data from the largest public health insurance 
company was used. The descriptive statistics together with the panel data regression 
results revealed interesting findings about the appropriateness of care provided. The 
findings below provide an insight into elements of quality of care provided for 
diabetes and asthma patients in Slovakia.  
 
Approximately 15% of the newly diagnosed asthma and diabetes patients followed 
during the period of the study had one or more hospitalisation. It is difficult to say 
whether this proportion is too high or too low but it is a baseline that should be 
monitored and further analysed to provide more detailed information for health 
purchasers and policy makers. Certainly a large proportion of the patients (85%) have 
not been hospitalised at all between 2002-2008 and thus have avoided unnecessary 
costs and discomfort resulting from a hospitalisation.  It should be further noted that 
all these patients are treated by medication as those who are only treated by lifestyle 
changes have been excluded from our sample. The results of Chapter 5 also indicate 
that the mean number of tests (HbA1c, ophthalmologic exams, flu shot) is 
substantially lower than recommended quantity in the clinical guidelines, even 
though patients appear to have an excessive number of visits to physicians for both 
conditions. These results either suggest that despite high number of physician 
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contacts appropriate care is not provided, or that the tests used in the analysis based 
on recommendations in clinical guidelines do not properly capture the provision of 
appropriate care.  
 
The results of the association between selected process indicators that capture 
appropriate care for these two conditions defined on the basis of clinical guidelines 
and potentially preventable hospitalisations were mixed, as in previous studies. It 
should be noted that the study used a selection of processes, not all of which would in 
a complex way cover all of the most important elements of asthma and diabetes care. 
Variables that capture inappropriate care were strongly positively associated with 
hospitalisations and there were mixed results for the relationship between 
appropriate care measured through number of visits and tests, and hospitalisations. 
Where a negative relationship was identified, the results suggest that more 
appropriate care at the ambulatory care level is associated with fewer adverse events.  
 
It is possible that where a positive relationship was identified, especially with visits, it 
was due to endogeneity problems as sicker patients are likely to have more tests and 
visits as well as hospitalisations.  However, these patients may actually be receiving 
appropriate care. While some studies have controlled for endogeneity and found a 
negative relationship with GP visits, others did not control for endogeneity and 
treated visits as a proxy for severity of illness.  Finally, potentially inappropriate care 
(e.g. excessive medications) was positively associated with hospitalisations, 
suggesting that further in depth inquires need to be undertaken to see whether these 
are the most severe patients or whether it is truly inappropriate care that results in 
further adverse events for the patient.  
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6.3 Limitations  
 
As the different chapters used different data sources and methods, the detailed 
limitations were highlighted in the individual chapters.  While some limitations could 
be overcome, others need to be acknowledged such that results are interpreted with 
care.  Limitations can be separated into data and methodological limitations, both of 
which are outlined below.   
 
Data limitations 
 
The first limitation is related to the quality of data, each dataset having some 
shortcomings.  In Chapter 2 the main limitation is the potentially low response rate 
identified for the WHS Czech data resulting in non-response bias. Furthermore, the 
use of self-reported height may have led to reporting bias. As was mentioned, 
overestimation of height may vary with a person’s age and gender (Cavelaars et al., 
2000; Ezzati, Martin, Skjold, Hoorn, & Murray, 2006; Giles & Hutchinson, 1991; Hill 
& Roberts, 1998) and the available evidence on the accuracy of self-reported height is 
mixed. In general, height is overestimated by shorter individuals, especially men and 
the error in reported height increases with age (Spencer, Appleby, Davey, et al., 
2002). Overall, there seems to be wide individual variation between reported and 
measured heights in both sexes (Cizmecioglu, Doherty, Paterson, et al., 2005) so 
using accurately measured heights in a clinical setting which have been recorded 
consistently would be most appropriate. As sensitivity analyses have shown, while 
representative samples were used, the results seemed to have been somewhat 
affected by the sample employed, especially with regards to the country and gender 
effect. Therefore, a cautious interpretation of some of the results was recommended 
and that potentially the same analysis is carried out with additional samples. Thus 
despite the potential for reporting error, the sample was not corrected for as precise 
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information on the magnitude of the bias was not available.  The key limitation of the 
mortality data used in Chapter 3 and 4 is related to the identification of the exact 
cause of death and the quality of death registration procedures.  Individuals usually 
die of multiple causes and countries differ in how these are interpreted and recorded. 
Often, only one cause is registered, either the underlying disease (e.g. diabetes) or the 
cause of the death (e.g. stroke). While it cannot be ascertained, given the common 
past of Slovakia and the Czech Republic, the coding and registration procedures can 
be expected to be similar. Finally, in Chapter 5 the thesis relied on secondary data, in 
particular an administrative (claims) data set whose primary purpose is for billing 
and not for measuring performance.  As such, it suffers from a number of limitations 
already discussed in Chapter 5.  During the course of the research no other 
publication was identified which would have discussed the quality of this data. As the 
data was not prepared for quality of care assessment and has undergone data 
manipulation, it will therefore be important to present and discuss the findings with 
the purchasing organisation. Nevertheless, despite these limitations the data overall 
has served well to provide an insight into the performance and quality of the Slovak 
and the Czech health systems.  
 
Methodological limitations 
 
The goal of the thesis was to provide an insight into the health system performance of 
Slovakia and the Czech Republic. While it provides some answers, there are still more 
questions which remain unanswered.  Especially, the ‘avoidable’ mortality indicators 
and ACSHs are indicators which require further investigation and disaggregation to 
provide definitive answers. It should also be mentioned again that while many deaths 
and hospitalisations are in theory avoidable, some will always occur as there are 
variations in medical need, use and implementation of the existing medical 
knowledge and the organisation health care across facilities or systems.  
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Nevertheless, these are outcome indicators which have improved properties 
compared to those previously used.  The thesis also acknowledges that many different 
outcome and process indicators can be employed to assess health system 
performance and quality of care more specifically.  
 
Overall, establishing a direct link between health care system activities and health 
outcomes continues to be a challenge, and this thesis has demonstrated this 
difficulty. While potential confounders have been risk adjusted for, it is important to 
acknowledge that due to data constraints it was not possible to control for all the 
important factors (e.g. lifestyle, clinical factors) and unobserved systematic variations 
may be causing the differences in health outcomes.  The other key limitation concerns 
the ability to control for endogeneity and the quality of the instruments used. It is 
therefore important to interpret all the findings in light of these limitations and 
acknowledge that the results of this thesis are another step towards better quality 
assessment. Despite these limitations, the thesis answered the overall research 
question and the individual chapters met their research objectives.  
 
6.4 Policy and future research recommendations  
 
All the findings from the different chapters lead to some common general and 
country specific policy recommendations. These should be viewed in light of the 
limitations discussed in the previous section and the individual chapters.  The 
following section highlights the key policy recommendations from this thesis, starting 
with the general ones and followed by a few country specific ones.  
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1. Employ improved health outcome indicators to capture the quality of the 
health care system  
 
Overall, research in the area of performance assessment in Eastern Europe, and 
quality of care in particular, falls behind that of other countries. Chapter 3 
demonstrated the utility of using ‘avoidable’ mortality indicators to obtain a clearer 
picture of the health care system performance.  These are indicators that will provide 
an initial well-rounded snapshot of the health care system and can then be further 
disaggregated. ‘Avoidable’ mortality has advantages compared to standard mortality 
indicators and as such policy makers in Slovakia, the Czech Republic and other 
countries should utilise these to obtain a better understanding of the quality of care 
provided. While in this thesis the indicator was used at the national and regional 
level, the indicator can also be applied at the provider level (e.g. hospital).  Similarly, 
hospitalisations for ACSCs can be used to monitor variations at regional or small area 
level, as well as for individual patients to identify weaknesses in the provision of 
outpatient care in selected areas or for groups of patients. Chapter 5 used patient 
level data and focused on several process of care indicators; however with a small 
area level analysis the relationship of preventable hospitalisations with broader 
health care system level factors as well as non-health system factors (e.g. prevalence 
of smoking, alcohol or inappropriate diets) can be explored, as highlighted in the 
conceptual framework.  Large variations in ACSHs should serve as the warning flag, 
requiring more in-depth investigations of factors associated with such preventable 
hospitalisations.  Collecting information on severity of illness, adherence to 
medication, information about smoking or eating habits or provider level 
characteristics (e.g. size of practice, type of contract, years of experience etc.) is 
therefore essential to better understand the true determinants of preventable 
hospitalisations. These types of analysis will then allow for improving access and 
quality of care provided at the system or provider level. 
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2. Outcome measures have their limitations and should be used together with 
process measures to assess quality of care 
 
There is not one perfect outcome or process indicator.  The strengths and weaknesses 
of any indicator need to be well-understood before it can be used for routine 
surveillance of quality of care and any action is taken to avoid potential negative 
consequences.  For example, Chapter 2 and Chapter 3 have nicely demonstrated that 
while overall Slovakia seems to perform worse than the Czech Republic, for selected 
conditions in Chapter 3 the two countries perform very similarly or Slovakia even 
better. These results demonstrate that one should not easily jump to general 
conclusions about the quality of the health care system, as problems may be specific 
to a particular area.   
 
In general, outcome and process indicators should be used together to obtain a more 
accurate picture of population health in the country, especially quality of care.  Both 
outcome and process measures have their weaknesses. The main weakness of 
outcome measures is that even though risk adjustment is carried out, perfect risk 
adjustment is difficult and variations are not entirely due to variation in the quality of 
care provided. Therefore, using health outcome indicators to make regional 
representatives or providers accountable where factors outside their control 
determine variations is controversial. Based on trends in ‘avoidable’ deaths countries, 
regions or providers should be encouraged to actively take steps towards reducing 
mortality rates by improving the timeliness and effectiveness of medical services.  
Similarly, trends and variations in preventable hospitalisations should be understood 
so that the unnecessary ones are prevented where possible. However, these outcome 
measures provide only an insight into the performance of the health care system and 
will always capture the contribution of many different factors apart from the quality 
of care provided. Therefore, as demonstrated in Chapter 5, a range of process 
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measures that reveal a more detailed picture of actual care provided should also be 
used. Monitoring processes of care will ensure that these are carried out. However, it 
is essential that processes not monitored (and rewarded in an incentive scheme) are 
not neglected. It is important to note that depending on the choice of process 
measures, these may or may not comprehensively capture the quality of care 
provided. A stronger relationship between process and outcome measures gives 
process measures greater validity. Nevertheless, for some process measures that are 
considered important for the treatment of the patient there may be a weak 
relationship with outcomes. The selection of process measures to hold stakeholders 
accountable should therefore be carefully considered.   
 
3. Carry out further analysis at each level of the system to better identify 
quality problems and ensure action 
 
Designing an indicator to measure health system performance and collecting 
information without an appropriate follow up is futile. Therefore, the next step for 
policy makers in both the Czech Republic and Slovakia would be to carry out in depth 
systematic investigations of the underlying reasons for observed trends according to 
existing and sound methodologies, as well understand local and central level policies, 
and how services targeted at the selected condition are being delivered and 
coordinated, starting from prevention, through diagnosis and treatment and 
management of the disease.  For example, as Chapter 3 indicated, for some 
conditions problems appear to be obvious and implementation is the issue (e.g. 
cancer of cervix), for others further research is necessary.  Also, in the future with 
regional level data becoming increasingly available, distribution of ‘avoidable’ 
mortality across socio-demographic and ethnic groups may be particularly useful 
(e.g. Roma, retired).  
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Apart from maternal and perinatal mortality, there are few examples of systematic 
investigation, at local or national level, to identify the possible causes of failure of 
health care and what can be done to improve outcomes (Holland, 2003). It is this 
type of follow up that should be encouraged in the countries. To date, when data was 
used to improve services, it often resulted in identifying and a culture of blaming the 
individual practitioner rather than considering system deficiencies; other ‘side-
effects’ tend to include inappropriate policy responses, lack of resources, lack of 
coordination of care as well as individual errors (Holland, 2009).  For these reasons, 
it is highly recommended that systematic investigations of ‘avoidable’ deaths are 
carried out, following existing and sound methodologies. Methods of enquiry have 
been proposed for maternal mortality and summarised in the 2004 World Health 
Organization Report (World Health Organization, 2004). The WHO Report (2004) 
provides a range of approaches the applicability of which depends on the level of 
investigation, i.e. facility, community, district, regional or national level. Confidential 
enquiries comprise a systematic multi-disciplinary anonymous investigation of all or 
a representative sample of deaths occurring at an area, district, regional or national 
level; they aim to identify the numbers, causes and avoidable or remediable factors 
associated with deaths so identified (Lewis, 2003). Through lessons learned from 
each death and through aggregating the data, they provide evidence of where the 
main problems lie and what can be done in practical terms. Thus, confidential 
enquiries have the potential to highlight the key areas requiring recommendations for 
health sector and community action and can so guide the improvement of clinical 
outcomes (World Health Organization, 2004).  
 
4. Use existing data for performance assessment  
 
There is no doubt that health system performance assessment, in particular quality 
assessment, is an extremely challenging task. However, these difficulties should not 
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deter policy makers and purchasers from attempting to measure and understand 
what is happening in a country’ health system and what is the quality of care 
provided. For this purpose, different data are available, which though not perfect as 
this thesis has demonstrated, can be a useful starting point. Certainly caution needs 
to be exercised when the results are interpreted, however, only if analysis is 
undertaken, can one identify where improvements in data need to be made to allow 
for better measurement and ultimately quality improvement in the future.  It has 
been noted that “data on health status, quality and performance of health care 
providers do not meet the needs of policy-makers to make informed decision” (SK 
HiT). Only these types of analysis and conclusions that emerge from them will allow 
those in charge of data collection to collect data that will be of best use to policy 
makers.  
 
The wide availability of administrative data in Slovakia and other Eastern European 
countries call for their utilisation for quality of care evaluations. “Current 
administrative data are probably most useful as screening tools that highlight areas in 
which quality should be investigated in greater depth.” (Iezzoni, 1997). However, at 
present the full potential of this administrative data is not being utilised. ACSCs rely 
on easily accessible administrative data available from purchasing organisations or 
discharge data from hospitals which makes this indicator appealing and easy to use.  
Patient level panel data allows for the examination of variations in ACSHs and the 
factors influencing ACSHs over an extended period of time. While most 
administrative databases may lack clinical information about the patient (e.g. severity 
of the disease at presentation, behavioural risk factors), Chapter 5 has demonstrated 
that already basic demographic data, information about physician contacts and 
services provided (e.g. types of drugs prescribed, diagnostic tests carried out etc) may 
reveal some information about the quality of care provided to patients. In the future, 
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potential data linkages with other databases or survey could be considered as patients 
in Slovakia have a unique identifier.   
 
5. Make available disaggregated mortality data 
 
Mortality data is routinely collected in all the European Union countries. However, in 
order to be able to monitor ‘avoidable’ death rates and make international 
comparisons, detailed data on mortality by ICD codes on the regional level needs to 
be made available. Standardisation of data collection, diagnosis and coding, both 
between and within countries is necessary. Furthermore, appropriate analyses of 
comparability both between and within countries is needed on all these aspects at 
regular intervals. Care must be then taken to ensure the appropriate certification and 
coding of multiple causes of deaths, e.g. diabetes and arthrosclerosis.  Since 1994, 
Eurostat has been collecting regional mortality statistics from member states for a 
total of 65 individual or groups of causes of death.  This data cover several of the 
conditions that have been considered as ‘avoidable’ such as selected treatable cancers, 
ischaemic heart disease and cerebrovascular disease (Appendix B). However, much of 
the Eurostat mortality data set is not sufficiently disaggregated to allow for detailed 
analysis of ‘avoidable’ mortality. Thus, Eurostat data will not allow separate 
monitoring of conditions such as Hodgkin’s disease (C81), appendicitis (K35-38), 
epilepsy (G40-G41), or medical errors resulting in patient death (Y60-69, Y83-84). If 
‘avoidable’ mortality is to be monitored at European level drawing on Eurostat data, 
it will be necessary for Eurostat to collect mortality data that are sufficiently 
disaggregated. 
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6. Use major reforms as an opportunity to reassess what is good/bad 
 
While policy makers may be tempted to conclude that the transition has only had a 
positive effect across the different conditions, chapter 3 has identified conditions 
where deterioration or lack of improvement was noted in the recent years.  This 
finding has a much broader policy implication suggesting that not everything “old” 
was necessarily bad and everything “new” is entirely good. End of communism and 
political and economic liberalisation may have certainly brought many positive 
opportunities but did not remove all the problems in the health care systems. At the 
same time numerous reforms were implemented but these have also brought new 
challenges. For example, new provide payment mechanisms introduced may 
encourage a particular negative behaviour by the provider which needs to be 
corrected for. It is essential to continuously reassess performance and aim to 
maintain the good elements of the system while changing only those that 
underperform.  
 
7. Do not seek to establish a relationship between ‘avoidable’ mortality and 
health care inputs without better data  
 
Findings from Chapter 4 have shown that health care inputs do not consistently 
explain health outcomes, even when an improved indicator such as ‘avoidable’ 
mortality is used.  While it is difficult to determine at the aggregate level the extent to 
which health care interventions prevent unnecessary deaths, the most recent 
evidence from the AMIEHS project continues to point to the fact that ‘avoidable’ 
mortality indicators may be most useful for an initial understanding of how the 
health care system is performing. However, there are many other important 
determinants (e.g. lifestyle) of ‘avoidable’ mortality that lie outside of the health care 
system which would need to be better accounted for in future research and analysis as 
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the exact contribution of medical care cannot be established. Also, quantity of 
resources cannot always be used as proxy for timely and effective care and therefore 
better data is required. Variations in ‘avoidable’ mortality, especially by individual 
conditions with sufficiently high number of deaths (i.e. ischaemic heart disease) 
could possibly be explained if quality of care, but especially other important 
determinants of mortality are captured with better data and then analytical models 
that account for endogeneity or dynamic influences are employed. Nevertheless, it is 
important to acknowledge that even with better data, not all variations in ‘avoidable’ 
mortality will be explained as there will be determinants of deaths which are difficult 
to identify or measure at the aggregate level.  
 
8. Use existing clinical guidelines as a basis for quality of care assessment   
 
Preventable hospitalisations are an outcome indicator for the quality of ambulatory 
care. As all outcome indicators, factors apart from quality of care determine whether 
or not a patient is hospitalized. Therefore, caution needs to be exercised when 
interpreting number of hospitalisations even though they provide an initial snapshot 
of the quality of ambulatory care provided. Excessive hospitalisations may be 
indicative of inappropriate care, result in unnecessary costs and require further 
investigation and analysis.  Our study suggests that while only 15% of newly 
diagnosed patients were hospitalized at least once during the period under study, 
many more did not receive appropriate treatment as defined by clinical guidelines.  
Results also indicated higher rates in selected regions. So the evidence of a gap 
between the best possible care for asthma and diabetes patients and actual care 
provided as measured by the process indicators should be taken as a basis for action 
for a further review of care currently provided and strategies to improve it. It is 
important to acknowledge that not all steps recommended in the clinical guidelines 
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are necessarily directly related to reductions in hospitalisations. Yet, clinical evidence 
suggests that they are important and their use should be encouraged.  
 
Another issue concerns the actual adherence to clinical guidelines. Associations of 
specialists have prepared clinical guidelines for both asthma and diabetes; clinical 
guidelines are available for other diseases as well. Physicians involved in the 
preparation of these guidelines together with representatives of purchasing 
organisations and other policy makers should decide on how to ensure that all 
providers concerned adhere to these guidelines.  Overall, it is essential that 
physicians assume responsibility for quality improvement (Shekelle & Roland, 2000, 
p.171). Evidence shows that despite the availability of clinical guidelines, physician 
behaviour may not be simple to change and thus take a long time before full 
adherence to guidelines is reached. Explicit and implicit incentives in the system to 
provide treatment as well as physician practice style need to be reviewed and better 
understood to design appropriate interventions to improve quality of care provided.  
Overall, there is more positive evidence on effectiveness of professional-oriented 
interventions (education, reminders, feedback) than on those aimed at the 
organisation or the patient (Grol & Grimshaw, 2003).  However, changes in clinical 
practice are only partly within doctors’ control; it is the prevailing professional and 
organisational culture towards quality that determines the outcome to a large extent 
(Grol & Grimshaw, 2003). In this sense, unless such changes are made in Slovakia, 
improvements in the quality of care will be difficult to achieve.   
 
9. Review risk factors and care provided for peptic ulcer 
 
Analysis of individual ‘avoidable’ conditions provides a more in depth understanding 
of how the respective health systems perform in specific areas. Peptic ulcer is one of 
the conditions where mortality rates have been stagnant or the decline slowed down 
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after 1989 in both the Czech Republic and Slovakia. It is therefore essential to 
understand how prevention and treatment is provided to patients with peptic ulcer so 
that improvement strategies can be implemented. At the same time an analysis of 
important risk factors such as alcohol and cigarettes in this context should be 
undertaken.  
 
10. Review risk factors and care provided for malignant neoplasm of cervix 
uteri and body of uterus 
 
The relatively high mortality rates for malignant neoplasm of cervix uteri and body of 
uterus could be attributed mainly to the deficiencies in the organisation and 
performance of cervical screening (Potancok & Sadovsky, 2004; Vlasak, Plesko, 
Dimitrova, et al., 1991), which are likely to explain the gap between Slovakia and the 
Czech Republic. While both countries have a nationwide organised screening, uptake 
of screening is unsatisfactory, as in Slovakia only about 20% of woman population 
took advantage of these preventive examinations (Hupkova, 2008).  Therefore the 
underlying reasons for low uptake should be better understood in both countries so 
that effective interventions to address this problem can be designed.  
 
11. Encourage further improvements in the prevention and treatment of 
hypertension 
 
While significant improvements have already been made, further progress is 
necessary in the treatment of hypertension. In the Czech Republic, large proportion 
of the patients do not have their blood pressure controlled (Cifkova, Skodova, Lanska, 
et al., 2004).  In Slovakia,  mortality from hypertension also remains a problem due 
to deficiencies in the prevention and treatment of cardiovascular diseases broadly 
(Bada, 2006; Jurkovicova, 2005), and untreated high blood pressure, overweight and 
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obesity more specifically (Barakova & Riecansky, 2007). With respect to treatment, 
the number of angiograms, percutaneous coronary interventions, and stenting rates 
have been gradually increasing in both Slovakia and the Czech Republic but rates 
remain behind most Western European countries, especially in Slovakia (Cook, 
Walker, Hugli, et al., 2007)  Therefore, the design of effective strategies to better 
manage the risk factors, uptake of prevention and treatment in the different risk 
groups need to be a top priority in both the Czech Republic and Slovakia.  
 
12. Design specific strategies for the uptake of care by the Roma population 
 
This thesis found higher rates of perinatal and respiratory disease mortality for 
children in the two Eastern regions of Slovakia. These are regions where there is a 
significantly higher presence of the Roma population than in the remaining of the 
country. Previous evidence suggests that these unfavourable mortality rates may 
result from the lifestyle, attitudes to health and health care services of this ethnic 
group (Ecohost/ Masaryk University, 2000).   Therefore, identifying the risk factors, 
as well as reasons for low uptake of prevention and treatment by the Roma 
population and then designing specifically targeted interventions may be necessary to 
make further reductions in mortality levels.  
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Appendix A – Appendix to Chapter 1 
Table 37. Development of the concept of ‘avoidable’ mortality 
 
Authors Definition of 
Health Services 
Number of 
conditions 
Contribution Upper age 
Limit 
Rutstein et 
al. 
1976  
Includes 
“application of all 
relevant medical 
knowledge, the 
basic and applied 
research to increase 
that knowledge and 
make it more 
precise, the services 
of all medical and 
allied health 
personnel, 
institutions and 
laboratories, the 
resources of 
governmental, 
voluntary, and 
social agencies, and 
the co-operative 
responsibilities of 
the individual 
himself” 
Over 90 
conditions as 
‘sentinel 
health events’ 
 
Conditions divided into: 
i) even a single death justifies 
immediate enquiry (split to 
preventable/treatable) 
ii) not every single case is 
preventable or manageable 
but where appropriate care 
should be associated with 
lower incidence of that 
condition (split to 
preventable/treatable) 
Stresses that for each 
unnecessary untimely death 
the physician has the initial 
and some continuing 
responsibility.  
None 
Charlton et 
al. 
1983 
Excludes conditions 
which considered to 
be outside the scope 
of medical care 
(primary care, 
hospital care, public 
health programmes) 
 
14 disease 
groups  
First to apply concept 
empirically at the population 
level to analyse area variation 
in mortality in England & 
Wales (1974-78)  
Examines national and 
international trends between 
1956 and 1978.  
65 for some 
conditions 
and less for 
others  
Poikolainen 
and Eskola  
1986,1988 
Excludes conditions 
which depended 
mainly on efforts 
outside the health 
services (e.g. lung 
cancer)  
Extend by 
more than 70 
amenable and 
20 partly-
amenable 
conditions 
Analyse trends in Finland 
between 1969 - 1981 
Drew up explicit list of “not 
amenable” conditions 
Age limit 
set for all 
conditions; 
 
65 for some 
conditions 
and less for 
others 
European 
Community 
Atlas  
(Holland) 
1988/91; 
1993; 1997 
 
Health care services 
include primary 
care, hospital care 
and collective 
health services such 
as screening and 
public health 
programmes, e.g. 
immunisation. 
 
Initially also 
includes conditions 
whose control 
depends on primary 
prevention (health) 
policies with action 
outside the direct 
control of health 
services; these were 
later excluded.  
 
1st edition/1st 
volume of 2nd 
edition: 17 
disease 
groups  
 
2nd volume/ 
2nd edition: 
expands by 8 
conditions 
where role of 
health 
services in the 
reduction of 
mortality less 
certain  
 
3rd edition:  
combination 
of causes 
from previous 
editions (total 
Conditions that “provide 
warning signals of potential 
shortcomings in health care 
delivery” and conditions for 
which at least a proportion of 
deaths can be prevented.  
Stimulated a range of country 
–specific studies. Apply a 
range of causes of deaths. 
 
Age limit 
set for all 
conditions;  
 
In the last 
edition:   
65 for some 
conditions 
and less for 
others 
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Authors Definition of 
Health Services 
Number of 
conditions 
Contribution Upper age 
Limit 
of 16) 
Mackenbach, 
1980s 
Used a more 
restricted definition 
of medical care as 
“the application of 
biomedical 
knowledge through 
a personal service 
system”;  exclude 
conditions for 
which effective 
intervention is 
outside the direct 
control of medical 
care system, 
including many 
forms of primary 
prevention 
  
Based on EC 
project  
Link trends in mortality to 
specific innovations in medical 
care 
 
Could not 
identify 
clear 
evidence for 
age limits 
except for a 
few 
conditions 
Westerling, 
1992, 1993 & 
1996 
Indicators reflecting 
the outcome of 
medical care and 
those mainly 
reflecting the effect 
of national health 
policy 
Based on 
Rutstein and 
EC  project 
First explicit comparison of 
"preventable conditions” vs 
“treatable conditions” and 
empirical application  
65  
Simonato, 
1998 
Primary prevention, 
reduction of 
exposures (includes 
measures outside 
the health services); 
secondary 
prevention, early 
detection and 
treatment; and 
tertiary prevention, 
improvement in 
treatment and 
medical care 
Based on 
Rutstein, 
Charlton and 
EC project 
and 
additional 
new causes 
Presents the following 
differentiation:  
1) amenable to primary 
prevention 2) amenable to 
early detection and treatment  
3) amenable to improved 
treatment and medical care 
65  
Tobias and 
Jackson, 
2001 
The concept of 
avoidability was 
extended to cover 
not only causes of 
death amenable to 
therapeutic 
intervention but 
also those 
responsive to 
individual and 
population-based 
preventive 
interventions 
 
56 conditions 
Broadened 
list of 
conditions by 
reviewing 
literature of 
advances in 
health care 
since 1980s 
Distinguishes 3 categories: 
(primary/secondary/tertiary 
prevention) with relative 
weights for each derived 
through expert consensus.  
 
Substantially broadened list of 
potentially “‘avoidable’” 
conditions. 
 
75 
Nolte & 
McKee, 2004 
Health care services 
include primary 
care, hospital care 
and collective 
health services such 
as screening and 
public health 
programmes, e.g. 
immunisation. 
34 conditions  
Based on 
Charlton et 
al., Tobias 
and Jackson, 
Mackenbach 
Updates list based on most 
recent advances in medical 
knowledge and technology 
 
Conditions selected 
considered indicators of the 
impact of health care 
75 
Source: Based on (Nolte & McKee, 2004 and Charlton, Hartley, Silver, et al., 1983; Holland, 
1997; Poikolainen & Eskola, 1988; Simonato, Ballard, Bellini et al., 1998; Tobias & Jackson, 
2001; Westerling, 1993) 
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Table 38. Eurostat list of conditions and their use in some lists of ‘avoidable’ 
deaths 
Eurostat List of Causes of death ICD 10 EC/ 
Holland 
Nolte 
& 
McKee 
Infectious and parasitic diseases  
Tuberculosis  
Meningococcal infection  
AIDS (HIV-disease)  
Viral hepatitis 
Neoplasms  
Malignant neoplasms  
Malignant neoplasm of lip, oral cavity, pharynx  
Malignant neoplasm of oesophagus  
Malignant neoplasm of stomach  
Malignant neoplasm of colon  
Malignant neoplasm of rectum and anus  
Malignant neoplasm liver and the intrahepatic 
bile ducts  
Malignant neoplasm of pancreas  
Malignant neoplasm of larynx and 
trachea/bronchus/lung  
Malignant melanoma of skin  
Malignant neoplasm of breast  
Malignant neoplasm of cervix uteri  
Malignant neoplasm of other parts of uterus 
Malignant neoplasm of ovary  
Malignant neoplasm of prostate  
Malignant neoplasm of kidney 
Malignant neoplasm of bladder  
Malignant neoplasm of 
lymphatic/haematopoietic tissue  
Dis. of the blood(-forming organs), 
immunological disorders  
Endocrine, nutritional and metabolic diseases  
Diabetes mellitus  
Mental and behavioural disorders  
Alcoholic abuse (including alcoholic psychosis)  
Drug dependence, toxicomania  
Diseases of the nervous system and the sense 
organs  
Meningitis (other than 03)  
Diseases of the circulatory system  
Ischaemic heart diseases  
Other heart diseases  
Cerebrovascular diseases 
Diseases of the respiratory system  
Influenza  
Pneumonia  
Chronic lower respiratory diseases  
Asthma  
Diseases of the digestive system  
Ulcer of stomach, duodenum and jejunum  
Chronic liver disease  
Diseases of the skin and subcutaneous tissue  
Diseases of the musculoskeletal 
system/connective tissue Rheumatoid arthritis 
and osteoarthrosis  
Diseases of the genitourinary system  
Diseases of kidney and ureter  
Complications of pregnancy, childbirth and 
A00-B99 
A15-A19,B90 
A39 
B20-B24 
B15-B19 
C00-D4 
C00-C97 
C00-C14 
C15 
C16 
C18 
C19-C21 
C22 
 
C25  
C32-C34 
 
C43 
C50 
C53 
C54-C55 
C56 
C61 
C64 
C67  
C81-C96 
 
D50-D89 
 
E00-E90 
E10-E14 
F00-F99 
F10 
F11-F16,F18-F19 
G00-H95 
 
G00-G03 
I00-I99 
I20-I25 
I30-I33,I39-I52 
I60-I69 
J00-J99 
J10-J11 
J12-J18 
J40-J47 
J45-J46 
K00-K93 
K25-K28 
K70, K73-K74 
L00-L99 
M00-M99 
M05-M06,M15-M19 
 
N00-N99 
N00-N29 
O00-O99 
 
X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X 
X 
X 
X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X 
 
X 
X 
X 
X 
 
X 
 
 
 
 
 
 
 
 
 
X 
 
X 
 
 
 
 
 
 
 
 
X 
X 
 
 
 
 
 
X 
X 
X 
X 
 
 
 
 
 
 
 
 
 
X 
 
 
 
 
 
 
 
X 
 
X 
X 
X 
X 
 
 
 
 
 
 
 
 
 
 
 
X 
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Eurostat List of Causes of death ICD 10 EC/ 
Holland 
Nolte 
& 
McKee 
puerperium  
Certain conditions originating in the perinatal 
period  
Congenital malformations and chromosomal 
abnormalities  
Congenital malformations of the nervous system  
Congenital malformations of the circulatory 
system  
Symptoms, signs, abnormal findings, ill-defined 
causes  
Sudden infant death syndrome  
Unknown and unspecified causes 
External causes of injury and poisoning  
Accidents  
Transport accidents  
Accidental falls  
Accidental poisoning  
Suicide and intentional self-harm  
Homicide, assault  
Events of undetermined intent 
TOTAL  All causes of death  
 
P00-P96 
 
Q00-Q99 
 
Q00-Q07 
Q20-Q28 
 
R00-R99 
 
R95 
R96-R99 
V01-Y89 
V01-X59 
V01-V99 
W00-W19 
X40-X49 
X60-X84 
X85-Y09 
Y10-Y34 
A00-Y89 
 
 
 
 
 
 
X 
 
 
 
 
 
 
 
 
 
 
X 
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Table 39. Ambulatory care sensitive and marker conditions 
 
Condition ICD – 9 – CM 
Codes 
Comments 
Ambulatory Care Sensitive Conditions 
Congenital syphilis 090 Secondary diagnosis for newborns only 
Immunisation-related 
and preventable 
conditions   
033, 037, 045, 
320.0, 390, 391 
 
Grand mal status and 
other epileptic 
convulsions   
345  
Convulsions "A"   780.3 Age 0-5 
Convulsions "B"   780.3 Age >5 
Severe ENT infections   382, 462, 463, 
465, 472.1 
Exclude otitis media cases [382] with myringotomy 
with insertion of tube [20.01] 
Pulmonary tuberculosis   011  
Other tuberculosis 012-018  
Chronic obstructive 
pulmonary disease 
491, 492, 494, 
496, 466.0 
Acute bronchitis [466.0] only with secondary 
diagnosis of 491, 492, 494, 496 
Bacterial pneumonia   481, 482.2, 
482.3, 482.9, 
483, 485, 486 
Exclude case with secondary diagnosis of sickle cell 
[282.6] and patients < 2 months 
Asthma 493  
Congestive heart failure   428, 402.01, 
402.11, 402.91,  
518.4 
Exclude cases with the following surgical 
procedures:  36.01, 36.02, 36.05, 36.1, 37.5, or 37.7 
Hypertension 401.0, 401.9, 
402.00, 402.10, 
402.90 
Exclude cases with the following procedures:  
36.01, 36.02, 36.05, 36.1, 37.5, or 37.7 
Angina 411.1, 411.8, 413 Exclude cases with a surgical procedure [01-86.99] 
Cellulitis 681, 682, 683, 
686 
Exclude cases with a surgical procedure [01-86.99], 
except incision of skin and subcutaneous tissue 
[86.0] where it is the only listed surgical procedure 
Skin grafts with cellulitis   DRG 263, DRG 
264 
Exclude admissions from SNF/ICF 
Diabetes "A" 250.1, 250.2, 
250.3 
 
Diabetes "B"   250.8, 250.9  
Diabetes "C"   250.0  
Hypoglycemia 251.2  
Gastroenteritis   558.9  
Kidney/urinary infection 590, 599.0, 
599.9 
 
Dehydration - volume 
depletion   
276.5 Examine principal and secondary diagnoses 
separately 
Iron deficiency anemia 280.1, 280.8, 
280.9 
Age 0 - 5 only, and examine principal and 
secondary diagnoses separately 
Nutritional deficiencies   260, 261, 262, 
268.0, 268.1 
Examine principal and secondary diagnoses 
separately 
Failure to thrive   783.4 Age < 1 only 
Pelvic inflammatory 
disease   
614 Women only denominator - exclude cases with a 
surgical procedure of hysterectomy [68.3-68.8] 
Dental Conditions   521, 522, 523, 
525, 528 
 
“Marker’ Conditions 
Appendicitis with 
appendectomy   
540, 541, 542 With principal procedure of 47.0 or 47.1 
Acute myocardial 
infarction   
410 Only cases with LOS > 5 days or disposition of 
death 
 250
Gastrointestinal 
Obstruction   
560  
Fracture hip/femur   820 Age 45+ only 
Source:  The NYU Center for Health and Public Service Research (CHPSR) of the Robert F. 
Wagner Graduate School of Public Service; http://wagner.es.its.nyu.edu/chpsr/ 
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Table 40. Summary of assessment of ACSC admissions indicator 
 
Criterion Definition Summary for ACSCs in general 
Face validity Indicator must have sound clinical 
or empirical rationale for its use and 
should measure an important aspect 
of quality that is subject to provider 
or health care system control. 
Early diagnosis and management for most 
conditions reduces ACSC admissions. 
Precision  An adequate quality indicator should 
have relatively large variation among 
providers or areas that is not due to 
random variation or patient 
characteristics. This criterion 
measures the impact of chance on 
apparent provider or community 
health system performance. 
All ACSC indicators are measured relatively 
precisely but also involve complications. 
The precision of avoidable hospitalisation 
rates is likely to depend on the size of the 
denominator.  
Minimum bias 
 
The indicator should not be affected 
by systematic differences in patient 
case-mix, including disease severity 
and comorbidity. In cases where 
such systematic differences exist, an 
adequate risk adjustment system 
should be possible using available 
data. 
Previous studies have documented several 
characteristics that are associated with 
either the risk of an avoidable 
hospitalisation (at the individual level) or 
the avoidable hospitalisation rate (at the 
area level), including prevalence of the 
condition, race, socioeconomic status (SES), 
chronic disease and health of the 
population. These characteristics may be 
confounding factors, but also might be 
measuring subtle aspects of access to care. 
Overall, while a range of factors (SES, 
environmental, other) influence ACSHs, 
substantial part of the variation in rates 
across areas is unexplained by these factors.  
Construct 
validity 
 
The indicator should be related to 
other indicators or measures 
intended to measure the same or 
related aspects of quality. In general, 
better outpatient care (including, in 
some cases, adherence to specific 
evidence-based treatment 
guidelines) can reduce patient 
complication rates.  
Most previous studies have assessed the 
validity of an entire set of ACSCs, rather 
than each condition alone, and have used 
SES as a marker of access to care. These 
studies have repeatedly shown strong 
correlations between household income and 
ACSHs, both at the individual level and the 
area level. Fewer studies have tested true 
measures of access to care.   
Fosters true 
quality 
improvement 
 
The indicator should be robust to 
possible provider manipulation of 
the system. In other words, the 
indicator should be insulated from 
perverse incentives for providers to 
improve their reported performance 
by avoiding difficult or complex 
cases, or by other responses that do 
not improve quality of care.  
 
Despite the relationships demonstrated at 
the patient level between higher-quality 
ambulatory care and lower rates of 
admission with subsequent complication, 
there is generally little evidence on whether 
improvements in access to high-quality care 
can reduce ACSHs in an area. Such 
relationships are difficult to elucidate, 
because of the many intervening factors that 
also affect ACSH rates (see above). Yet, 
there is also little evidence that use of these 
quality indicators would have any 
undesirable effects on hospital activities. 
Prior use, 
application 
The indicator should have been used 
in the past or have high potential for 
working well with other indicators. 
Sometimes looking at groups of 
indicators together may provide a 
more complete picture of quality. 
Application of indicators in a number of 
different settings 
Source: AHRQ, 2001 and 2007 
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Systematic Literature Review 
 
A systematic review has been carried out to bring together the existing body of 
evidence on the factors that explain ACSH rates. Applying a conceptual framework, 
such evidence should enable the better application of this indicator for the 
measurement of performance of outpatient care.  Improvements in the access and 
quality of care should not only save costs but also avoid unnecessary hospital stays for 
patients.  In the process of carrying out the initial literature search of the systematic 
review in the Medline and Embase databases, a comprehensive literature review20 
(Ansari, 2007) has been identified. The Ansari review covers evidence from 1970 till 
August, 2005; it explores the validity of ACSC admissions as proxy indicators of 
access to primary health care, and summarises all the different factors that are 
associated with ACSHs rates across geographic areas and population groups. The 
author of the review grouped the evidence along several areas. The results and main 
effects are summarised below (Table 41) and further details can be found in the 
original article (Ansari, 2007).  
                                                        
20 From here onwards this literature review may be referred to as “Ansari review” only.   
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Ansari concludes that ACSC admissions are valid proxy indicators of access to 
primary health care. ACSHs result from a number of key reasons including 
insufficiency and mal-distribution of primary health care resources, evidence of the 
existence of barriers to accessing primary care services (e.g. socioeconomic), 
problems with continuity of care and inefficient use of resources (e.g. may occur if the 
patient finds it easier or cheaper to go directly to the hospital instead of getting care 
in an ambulatory setting) (Ansari, 2007). Overall, the review reveals that 
socioeconomic factors seem to be the most important predictors of ACSHs. While 
some factors are addressed much more extensively (e.g. supply of physicians), others 
such as lifestyle, prevalence, adherence to medication, and in more general terms, 
utilisation and clinical quality of care that patients are covered to a more limited 
extent.  
 
The Ansari review was systematically updated to encompass new evidence from 2005 
until March 2009 to see whether an effect of any additional factors that influence 
ACSHs has since been identified.  
 
Objectives 
 
This review looks at available evidence on factors that explain ACSHs from August 
2005 to date.  
 
Criteria for selecting studies for the review  
 
The following main question will be explored in this systematic review:  What factors 
explain ACSHs in the adult population? 
 
In addition, the following sub- question, which is of prime interest in the general 
framework of my research, will be explored:  Have any utilisation and quality of 
outpatient care variables been explored as factors influencing ACSHs in the adult 
population? 
 
The main question can be broken down into the following components:  
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Table 42. Main criteria for study inclusion 
 
Types of participants   General population 
Adults over 18 years old 
Types of interventions/tools All risk factors 
Types of outcome measures Hospitalisations for groups of ACSCs 
Type of study design All study designs 
 
 
Search strategy for identification of studies 
 
The search strategy described in the Ansari review was partially reproduced. It 
searched Medline, Australasian Medical Index (AMI), grey literature on the World 
Wide Web and relevant references; however in this systematic review Medline, 
Embase and Econlit have been searched instead. AMI was not searched because of its 
exclusive focus on Australian studies and its replacement by two databases with a 
worldwide coverage was found to be more appropriate. A citation search for the 
Ansari review has been done in the Web of Sciences; however, no additional articles 
have been identified. These databases are expected to provide a solid coverage of the 
material for the purpose of this systematic review.  
 
In the Ansari review the following free text phrases have been searched: 
“preventable/avoidable hospitalisation(s)/admission(s)/hospital admission(s), 
together with the phrase ambulatory care sensitive’“. Details of how these search 
terms were applied are as follows: 
 
In the literature review the following free text phrases have been searched in titles 
and abstracts: “preventable/avoidable hospitalisation(s)/admission(s)/hospital 
admission(s), together with the phrase ambulatory care sensitive’“. However, the 
literature review did not provide further information about how these free text 
phrases are to be combined nor did it give the search results. The provided 
description suggests the following search strategy: 
 
1. Preventable or avoidable 
2. Hospitalisation(s) OR admission(s) OR hospital admission(s) 
3. 1 AND 2 
4. Ambulatory care sensitive 
5. 3 AND 4 
6. Limit 5 to year 2005-2009 
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However, this search strategy limited the results too much and excluded important 
studies when compared to broader searches. Then the following strategy was tested: 
 
1. Preventable OR avoidable OR ambulatory care sensitive 
2. Hospitalisation(s) OR admission(s) OR hospital admission(s) 
3. 1 AND 2 
4. Limit 3 to year 2005-2009 
 
However, this search strategy yielded too many results instead. Finally, the following 
search strategy seemed most appropriate and was applied in the three databases:  
 
1. Hospitali?ation*  
2. Admission*  
3. Hospital admission*  
4. 1 OR 2 OR 3  
5. Ambulatory care sensitive  
6. 4 AND 5  
7. Limit 6 to years 2005 – 2009 
 
MESH terms have not been used because for most free text terms these were not 
available. Also, using free text terms for this search was likely to pick up a larger 
number of studies. Finally, search of the World Wide Web and review of references of 
the relevant articles have not been carried out due to time limitations.  
 
The results of every search step in the Medline, Embase and Econlit databases are as 
follows: 
 
I. MEDLINE 
 
1. Hospitali?ation* - 99740 
2. Admission* - 99466 
3. Hospital admission* - 14567 
4. 1 OR 2 OR 3 - 182134 
5. Ambulatory care sensitive – 135 
6. 4 AND 5 – 131 
7. Limit 6 to years 2005 – 2009 – 59 
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II. EMBASE 
 
1. Hospitali?ation* - 93379 
2. Admission* - 108551 
3. Hospital admission* - 59760 
4. 1 OR 2 OR 3 - 185398 
5. Ambulatory care sensitive – 96 
6. 4 AND 5 – 94 
7. Limit 6 to years 2005 – 2009 – 44 
8. Of these 44 studies, 8 were not identified by MEDLINE 
 
III. ECONLIT 
 
1. Hospitali?ation* - 209 
2. Admission* -  685 
3. Hospital admission* - 184 
4. 1 OR 2 OR 3 - 874 
5. Ambulatory care sensitive - 11 
6. 4 AND 5 - 9 
7. Limit 6 to years 2005 – 2009 - 4 
8. Of these  studies, 1 was not identified by MEDLINE or EMBASE 
  
Methods of the review 
 
The general criteria for the literature search have been specified earlier. The following 
additional exclusion criteria have been applied: 
 
1. Only English language studies  
2. Only studies focusing on a set of ACSC conditions. This review looks at ACSHs 
as a set of indicators together since most of the evidence has the same focus. 
However, in future reviews it may be useful to look individual conditions as 
well depending on the purpose of the research being carried out. 
3. Only studies for the general adult population. Application of this indicator for 
children requires specific adjustments. Also studies focusing on a highly 
specific population group or minority were excluded. 
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4. Only studies using administrative or billing data. Studies using medical 
records or other sources of data were excluded because these result in 
different data analysis and results.  
 
Overall, 107 studies were identified through the search. After excluding duplicate 
articles and applying the strict inclusion criteria, 14 studies were included in this 
systematic review (Figure 32).  
 
Figure 32. Search results 
 
 
 
 
The review of the studies has been carried out using tools of the narrative synthesis 
method developed by the University of York. This method is usually used when 
quantitative synthesis is not applicable due to the heterogeneity of the studies. The 
Narrative Synthesis Methods Guidance has been requested from the University of 
York and obtained through personal correspondence. The framework and tools 
applied are summarised below: 
 
 
 
 
 
 
Medline
N = 59
Embase
N = 44
Comparison of 
results for 
duplication
Title & abstract 
search
N = 68
Medline = 59
Embase = 8
Econlit = 1
Excluded
N = 52
Full text search
N = 16
Excluded
N = 2
Total included
N = 14
Econlit
N = 4
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Table 43. Narrative synthesis approach 
 
Source: Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, , Roen K, 
Duffy S. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews: A Product 
from the ESRC Methods Programme. April 2006. 
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The main elements of the narrative synthesis framework are: 
 
1. Developing a theory of how the intervention works, why and for whom 
2. Preliminary synthesis: Data extraction and some quality assessment 
3. Data analysis and results: Explore relationships within and across studies 
4. Assess robustness of synthesis, comment on heterogeneity  
 
The results from the Ansari review as well as the systematic review can be 
summarised in light of a conceptual framework adapted from models for access to 
care, in particular earlier behavioural models (Andersen, 1995; Andersen, 
McCutcheon, Aday, et al., 1983), supply-demand models (Basu, Friedman, & Burstin, 
2004), Chang’s model (Chang, Mirvis, & Waters, 2008) and the World Bank’s health 
outcome model21. This framework does not, however, only focus on ACSCs as a 
measure of access since other variables not associated with access may have an effect 
on preventable hospitalisations. Figure 33 below summarises the conceptual 
framework that has been applied when reviewing the literature and shows which 
factors, and how these factors are likely to influence ACSHs.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                        
21 The World Bank, www.worldbank.org 
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Figure 33. Conceptual framework for ACSHs 
 
 
Source: Adjusted based on Chang et al, 2008; Anderson, 1983 and 1995; Basu et al, 2004; 
World Bank 
 
Any individual begins with the onset of a certain condition (need) which is influenced 
by the environment, behavioural and risk factors, as well as the person’s predisposing 
factors such as genetic characteristics, age, gender or ethnicity. Then there are the 
behavioural and risk factors which include the person’s lifestyle (e.g. exercise, eating 
and smoking habits), attitude towards taking medication and propensity to seek care. 
These are influenced both by predisposing as well enabling personal factors (e.g. 
insurance status, income) and enabling community factors (e.g. community poverty 
level); both provide the “means” to utilise services (Chang, Mirvis, & Waters, 2008). 
Depending on the person’s perception of the health care system, its availability, 
quality and accessibility, individuals utilise health care. Finally, the number of times 
the person comes into contact with the outpatient health system (primary and/or 
specialist care), as well as the quality of care he or she receives, determine ACSH 
rates.  
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Therefore, while ACSH rates may be used as a measure of access to effective 
outpatient care, it is important to take into account all the different factors that may 
confound this relationship, to the extent that this is possible. Some of these variables 
(e.g. age, gender, ethnicity) may capture differences in preferences for and utilisation 
of outpatient treatment, or quality of treatment offered by providers and not just 
biological predispositions. For example, ethnicity may not be an important factor 
after additional variables such as patient attributes, lifestyle, level of poverty and 
others are included. Therefore, instead of risk adjustment, which may hide important 
gender or ethnic differences, these may be better accounted for through a stratified 
analysis where the results are examined separately; i.e., for women and men, 
different ethnic groups, etc.   
 
In addition, some variables in the framework, for example genetics, may not only 
explain access to care, but through the concept of health need, may have a direct 
relationship to ACSHs (see dashed line in Figure 33).  These are hospitalisations 
which are not preventable but need to be accounted for.  
 
Fourteen new studies have been included and analysed as part of the systematic 
review.  Information on key aspects which are relevant for analysis has been extracted 
and can be found in Table 44:  
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The findings of the reviewed studies are summarised in Table 45. The table highlights 
the variables of interest22 that have been selected on the basis of the factors identified 
in the Ansari review; newly identified factors are included as well. The table also 
shows whether studies applied a conceptual framework as a starting point for 
analysing the effects of different variables of interest.  
 
Table 45. Summary of results 
 
Study 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Association 
with ACSHs 
Demographics 
               
Age     X          YES 
Gender   X            YES 
Race X      X      X  MIXED 
Socioeconomic 
status 
               
Insurance status X X  X     X   X   YES 
Poverty among 
elderly 
          X    YES 
Managed care 
penetration 
          X    YES 
Availability of 
supplemental 
coverage 
          X    YES 
Rurality                
Urban sprawl           X    YES 
Health System 
Factors 
               
Self-rate access      X         YES 
Continuity of 
care/regular source 
of care 
       X      X YES 
Presence of rural 
clinic 
         X     YES 
Physician supply 
(providers other 
than GPs) 
          X    YES  
Physician visits           X    YES 
Prevalence, lifestyle 
factors, 
environment, 
adherence to 
medication, 
propensity to seek 
care, severity of 
illness 
               
                                                        
22 Variables controlled for/confounding variables are not included. 
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The literature search yielded highly heterogeneous studies which may partially be 
explained by the search strategy which did not focus only on certain variables of 
interest. A broad search may be more informative and useful for researchers or policy 
makers who are interested in the general application and use of the ACSH indicator. 
This is also suggested by the way the Ansari review was carried out, which did not 
include an in depth comparison of the studies but instead focused on the results of 
the studies.  
 
Overall, the variety of settings and chosen variables of interest, differences in ACSCs 
used, the target population, number and type of confounders, study designs, methods 
and data sources made it difficult to compare and assess the quality of studies. 
Therefore, it was difficult to draw sound conclusions about the overall effects and 
strengths of associations of the different factors and ACSHs. However, despite these 
limitations, this systematic review together with the Ansari review provide interesting 
findings for future research and policy application of the ACSHs indicator.  
 
Having carried out this review with the application of the conceptual framework 
described earlier revealed that most studies do not apply a structured approach to 
their analysis, which may impact on the overall quality of the study and its results. 
Similar to earlier studies, the newly identified studies have again been focusing on 
demographic, socioeconomic and a few health system factors. Also, the focus was on 
factors which are easier to assess and measure. This may not be a problem as such, 
but may lead to incomplete conclusions about ACSHs as a measure of the quality of 
care.  When the results are analysed against the factors included in the conceptual 
framework, the literature predominantly deals with predisposing factors, personal 
enabling factors and health system factors and how these explain ACSH rates, while 
other factors are not addressed.  
 
Besides one study which included physician visits, no new evidence has been 
identified which would consider health services utilisation (intensity) and clinical 
quality of care variables, such as appropriate drug treatment for a specific condition23 
or adherence to the treatment prescribed.  Yet it is important to acknowledge that 
including these types of variables may only be possible if ACSCs are monitored 
individually at the patient level which has been done in condition specific studies, for 
e.g. diabetes or asthma, where it has been established that hospitalisations for these 
                                                        
23 Literature on determinants of hospitalisations for individual conditions has not been 
reviewed 
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conditions can be controlled with appropriate care. Also, none of the studies looked 
at the relationship between all the key factors together - predisposing (e.g. age, 
gender), enabling (e.g. income, insurance), behaviour and risk (e.g adherence, 
smoking), utilisation (e.g. primary and specialist visits) and quality of care (e.g. type 
of drug treatment) – and ACSHs.  Finally, the indicator of ACSHs continued to be 
applied mainly in the United States, as well as Canada, Australia and Spain but not in 
an entirely new country context.  
 
Implications of the review and conclusions 
 
This chapter has highlighted the importance of measuring the quality of ambulatory 
care with the indicator of preventable hospitalisations. The systematic literature 
review revealed that the application of this indicator requires additional in depth 
research, especially, studies that focus on the effect of variables whose association 
with ACSHs is not well understood. Also, it would be important if future studies 
carried out a more in depth review of the study designs, methods, data sources and 
ASCSs included in the available literature in order to allow for better evidence to 
policy makers. This chapter did not review the condition specific literature (e.g. 
diabetes, asthma, and hypertension) which may identify a range of additional, 
especially clinical, factors associated with preventable hospitalisations. These may 
include for example, appropriateness of clinical care according to evidence-based 
guidelines, adherence or others.  
 
In order to make this indicator useful for policy makers on the country level, it is 
important that future studies focus on factors that are specific to the country’s health 
system context in countries where to-date little or no research has been carried out. 
For example, in systems of social health insurance where entire populations are 
covered, exploring the association of insurance status with hospitalisations may not 
be relevant. Instead, coordination of care or adherence and their association with 
preventable hospitalisations may need to be measured. In addition, it is important to 
understand the hospital payment scheme which may influence the admission 
threshold and patient management of the admitting physicians.  
 
Overall, hospitalisations for ACSCs can be useful to policy-makers in several ways. 
Hospitalisations for ambulatory care sensitive conditions can be used as an 
information and evaluation tool for planners and policy-makers for continuous 
monitoring of health services (Ansari, 2007a). ACSHs can also be used as an outcome 
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indicator for small area analysis as it provides researchers and policy-makers with a 
valuable tool for identifying communities or regions with greater problems in 
accessing primary health care compared to a reference (either state average or rates 
of ACSH admission in communities with similar demographics) (Ansari, 2007a). The 
indicator does not only reveal problems in accessing primary health care, but in fact, 
problems with the quality of the entire ambulatory care area of the health system. 
Large variations in ACSHs should serve as the warning flag, requiring more in depth 
investigations of factors associated with such preventable hospitalisations and careful 
consideration of future actions.  Better understanding of country specific 
determinants of ACSHs will allow the countries to take necessary quality 
improvement actions at the provider or system level -  actions related to barriers to 
accessing primary care in the community (Ansari, 2007a), access to specialist or 
other types of services, as well as the clinical quality of care provided by the different 
providers. As Ansari also noted (2007a), it is important to bear in mind the respective 
contributions and interplay between all facets of the health care system and how it 
influences hospitalisations rates. In addition, non-health system determinants of 
preventable hospitalisations as highlighted in the conceptual framework (e.g. 
behavioural and risk factors) may need to be addressed as well.  
 
ACSCs can rely on easily accessible administrative or billing data available from 
purchasing organisations or discharge data from hospitals which makes this indicator 
more appealing and easy to use. Analysing patient level panel data allows for the 
examination of the factors influencing ACSHs over an extended period of time. While 
most administrative and billing databases may lack clinical information about the 
patient (e.g. severity of the disease at presentation, behavioural risk factors), basic 
demographic data, information about physician contacts and services provided (e.g. 
types of drugs prescribed, diagnostic tests carried out etc) may reveal a wealth of 
information about the quality of care provided to patients. If necessary, additional 
databases and surveys (e.g. censuses) may be used for supplementing the missing 
information.  
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Appendix B – Appendix to Chapter 2 
 
 
Robustness Checks using Eurobarometer 2005 data 
 
 
Figure 34. Height by age group, and gender and country, 2005 
 
 
Table 46. Descriptive statistics 
 
      
Variable Obs Mean Std. Dev. Min Max 
      
height 1986 170.721 9.127407 130 201 
age 2024 46.11117 16.18186 18 89 
co 2024 .4916008 .500053 0 1 
gend 2024 .4204545 .493754 0 1 
geog 2024 .6205534 .4853692 0 1 
demd 2024 .31917 .4662702 0 1 
indd 2024 .2534585 .4350986 0 1 
demage 2024 2.670949 4.760962 0 16 
indage 2024 1.777174 3.656839 0 13 
age18_29 2024 .1912055 .3933477 0 1 
age30_39 2024 .1902174 .3925696 0 1 
age40_49 2024 .1867589 .3898142 0 1 
age50_59 2024 .1956522 .3967999 0 1 
age60_69 2024 .1590909 .3658512 0 1 
age70_98 2024 .0770751 .2667765 0 1 
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Table 47. Democracy as a dummy variable 
 
 (1) 
VARIABLES Eq.1 
  
demd 0.310 
 (0.682) 
co 1.332*** 
 (0.277) 
gend 12.92*** 
 (0.277) 
age30_39 -0.501 
 (0.478) 
age40_49 -0.901 
 (0.803) 
age50_59 -3.609*** 
 (0.813) 
age60_69 -4.601*** 
 (0.827) 
age70_98 -6.176*** 
 (0.874) 
Constant 166.7*** 
 (0.755) 
  
Observations 1,986 
R-squared 0.563 
 
Table 48. Democracy as a continuous variable 
 
 (1) 
VARIABLES Eq.1 
  
demage 0.184** 
 (0.0752) 
co 1.341*** 
 (0.277) 
gend 12.91*** 
 (0.277) 
age30_39 1.268 
 (0.872) 
age40_49 1.091 
 (1.029) 
age50_59 -1.618 
 (1.037) 
age60_69 -2.612** 
 (1.048) 
age70_98 -4.186*** 
 (1.085) 
Constant 164.7*** 
 (0.992) 
  
Observations 1,986 
R-squared 0.564 
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Table 49. Democracy as a continuous variable – male 
 
 (1) 
VARIABLES Eq.1 
  
demage 0.0402 
 (0.124) 
co 1.679*** 
 (0.454) 
age30_39 -0.00854 
 (1.445) 
age40_49 -0.278 
 (1.713) 
age50_59 -3.907** 
 (1.728) 
age60_69 -4.765*** 
 (1.767) 
age70_98 -5.906*** 
 (1.832) 
Constant 179.3*** 
 (1.644) 
  
Observations 842 
R-squared 0.121 
 
 
Table 50. Democracy as a continuous variable – female 
 
 (1) 
VARIABLES Eq.1 
  
demage 0.313*** 
 (0.0922) 
co 1.049*** 
 (0.341) 
age30_39 2.293** 
 (1.064) 
age40_49 2.231* 
 (1.251) 
age50_59 0.420 
 (1.260) 
age60_69 -0.822 
 (1.261) 
age70_98 -2.680** 
 (1.305) 
Constant 163.3*** 
 (1.197) 
  
Observations 1,144 
R-squared 0.134 
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Table 51. Independence as a dummy variable 
 
 (1) 
VARIABLES Eq.1 
  
indd -0.0434 
 (0.686) 
co 1.332*** 
 (0.277) 
gend 12.92*** 
 (0.277) 
age30_39 -0.633 
 (0.628) 
age40_49 -1.254 
 (0.806) 
age50_59 -3.963*** 
 (0.817) 
age60_69 -4.954*** 
 (0.830) 
age70_98 -6.530*** 
 (0.877) 
Constant 167.1*** 
 (0.759) 
  
Observations 1,986 
R-squared 0.563 
 
 
Table 52. Independence as a continuous variable 
 
 (1) 
VARIABLES Eq.1 
  
indage 0.224*** 
 (0.0840) 
co 1.344*** 
 (0.277) 
gend 12.90*** 
 (0.277) 
age30_39 1.375 
 (0.852) 
age40_49 0.916 
 (0.901) 
age50_59 -1.793** 
 (0.910) 
age60_69 -2.787*** 
 (0.922) 
age70_98 -4.361*** 
 (0.964) 
Constant 164.9*** 
 (0.858) 
  
Observations 1,986 
R-squared 0.564 
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Table 53. Independence as a continuous variable – male 
 
 (1) 
VARIABLES Eq.1 
  
indage 0.0630 
 (0.141) 
co 1.677*** 
 (0.454) 
age30_39 0.143 
 (1.435) 
age40_49 -0.178 
 (1.525) 
age50_59 -3.807** 
 (1.542) 
age60_69 -4.664*** 
 (1.586) 
age70_98 -5.806*** 
 (1.658) 
Constant 179.2*** 
 (1.446) 
  
Observations 842 
R-squared 0.121 
 
 
Table 54. Independence as a continuous variable – female 
 
 (1) 
VARIABLES Eq.1 
  
indage 0.357*** 
 (0.101) 
co 1.066*** 
 (0.341) 
age30_39 2.255** 
 (1.027) 
age40_49 1.696 
 (1.079) 
age50_59 -0.116 
 (1.089) 
age60_69 -1.358 
 (1.091) 
age70_98 -3.214*** 
 (1.141) 
Constant 163.8*** 
 (1.017) 
  
Observations 1,144 
R-squared 0.134 
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Appendix C – Appendix to Chapter 4 
 
Table 55. IV results for ‘avoidable’ and other (non-avoidable) mortality 
 
  ‘Avoidable’ mortality Other mortality 
VARIABLES OLS IV FE FE IV OLS IV FE FE IV 
                  
doc -0.291 -1.887 -0.705 11.62 -0.513 -0.433 0.969 26.93 
 (0.708) (1.817) (1.043) (10.06) (0.735) (1.852) (1.068) (17.18) 
nur 0.537 1.328 0.637 -4.091 0.260 0.221 -0.794 -10.45 
 (0.445) (0.938) (0.557) (3.790) (0.462) (0.956) (0.583) (6.469) 
Bed -0.669** -0.559** -0.0572 2.209 -0.712*** -0.717** 0.307 4.914 
 (0.261) (0.277) (0.384) (1.848) (0.271) (0.283) (0.397) (3.154) 
Lgdp 0.471 11.37 18.28 27.69 -13.29 -13.84 15.35 28.41 
 (14.44) (18.06) (19.37) (27.43) (14.99) (18.41) (19.83) (46.82) 
Unem 2.358*** 2.120*** -0.417 -1.261 2.868*** 2.880*** -0.263 -2.098 
 (0.515) (0.556) (0.516) (1.002) (0.535) (0.567) (0.525) (1.711) 
Pol 1.932*** 2.046***  -4.745 0.881*** 0.875*** -0.734 -5.263 
 (0.281) (0.297)  (2.943) (0.292) (0.303) (1.747) (5.023) 
Sl 53.90*** 63.21***    26.21*** 25.74**   
 (7.989) (12.48)    (8.292) (12.72)   
_Iyear_2002 -3.569 -4.021 -4.807 -8.420* 2.567 2.590 0.838 -4.428 
 (4.912) (4.758) (2.946) (4.667) (5.098) (4.850) (3.095) (7.967) 
_Iyear_2003 -8.069 -7.861 -9.370*** -15.20** 12.92** 12.91*** 9.655*** -1.296 
 (4.993) (4.817) (3.374) (6.313) (5.182) (4.911) (3.466) (10.78) 
_Iyear_2004 -8.408 -6.758 -13.34*** -33.01** 10.81* 10.72* 0.221 -39.03 
 (5.306) (5.403) (4.798) (16.50) (5.507) (5.508) (4.960) (28.16) 
_Iyear_2005 -12.38** -10.31* -20.12*** -44.28** 20.14*** 20.04*** 5.190 -42.04 
 (5.535) (5.767) (5.673) (19.83) (5.745) (5.879) (5.933) (33.85) 
_Iyear_2006 -14.05** -11.68* -25.96*** -57.72** 20.69*** 20.57*** -0.460 -63.47 
 (5.805) (6.128) (6.706) (25.97) (6.025) (6.247) (6.991) (44.33) 
_Iyear_2007 -5.328 -1.582 -22.55** -78.30* 30.68*** 30.49*** 0.0317 -111.8 
 (6.611) (7.499) (9.181) (44.84) (6.862) (7.644) (9.616) (76.54) 
reg1 -9.730 -9.679    65.44*** 65.43***   
 (16.90) (16.29)    (17.54) (16.61)   
reg15 -19.22 -13.52    48.20** 47.91**   
 (18.41) (18.73)    (19.11) (19.10)   
Constant 117.7 -26.05 -70.44   382.1** 389.3* 52.70  
 (180.1) (230.5) (233.0)   (187.0) (235.0) (237.7)  
          
Observations 154 154 154 154 154 154 154 154 
R-squared 0.838 0.832 0.503 -0.037 0.685 0.685 0.256 -3.405 
Number of v1     22 22     22 22 
Standard errors in parentheses       
*** p<0.01, ** p<0.05, * p<0.1       
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Table 57. IV results for ‘avoidable’ and other (non-avoidable) mortality using 
health activity as the dependent variable 
 ‘Avoidable’ mortality Other mortality 
VARIABLES OLS IV FE FE IV OLS IV FE FE IV 
                  
h_activ -0.244 5.234*** 0.478 -4.135 -0.847*** 4.943** -0.331 -9.231 
 (0.299) (1.984) (0.681) (5.723) (0.310) (2.084) (0.692) (7.696) 
lgdp 10.42 -10.68 19.66 46.53 -2.518 -24.82 11.16 60.41 
 (13.21) (24.34) (18.97) (37.75) (13.67) (25.57) (19.26) (50.77) 
unem 2.127*** -1.035 -0.362 1.102 2.607*** -0.735 -0.249 2.584 
 (0.488) (1.398) (0.496) (1.888) (0.505) (1.469) (0.503) (2.539) 
pol 1.892*** 1.983***  -4.118 0.855*** 0.952*  -3.010 
 (0.281) (0.494)  (2.541) (0.290) (0.519)  (3.417) 
sl 46.33*** 85.80***    20.00*** 61.71***   
 (5.900) (17.24)    (6.105) (18.11)   
_Iyear_2002 -3.714 -3.854 -4.978* -6.856** 2.377 2.229 1.344 -0.207 
 (4.990) (8.761) (2.933) (3.470) (5.164) (9.203) (2.978) (4.667) 
_Iyear_2003 -8.510* -6.366 -10.07*** -13.55*** 12.52** 14.78 10.55*** 4.756 
 (5.073) (8.938) (3.302) (5.196) (5.250) (9.389) (3.353) (6.988) 
_Iyear_2004 -9.875* -9.268 -15.39*** -20.02*** 9.562* 10.20 2.826 -4.791 
 (5.314) (9.333) (4.391) (6.870) (5.499) (9.804) (4.460) (9.239) 
_Iyear_2005 -14.46*** -13.08 -22.64*** -30.17*** 18.35*** 19.81* 8.530 -3.614 
 (5.492) (9.653) (5.152) (9.608) (5.683) (10.14) (5.232) (12.92) 
_Iyear_2006 -16.86*** -19.67* -29.05*** -35.14*** 18.21*** 15.24 3.700 -5.547 
 (5.716) (10.08) (6.017) (8.907) (5.915) (10.59) (6.110) (11.98) 
_Iyear_2007 -8.602 -23.20* -27.32*** -27.43*** 27.85*** 12.42 6.434 10.43 
 (6.442) (12.41) (7.968) (9.368) (6.666) (13.03) (8.092) (12.60) 
reg1 -14.55 -212.0***    60.07*** -148.6*   
 (16.80) (74.98)    (17.38) (78.76)   
reg15 -31.07* -252.6***    36.53* -197.6**   
 (18.11) (83.63)    (18.74) (87.85)   
Constant 0.386 22.96 -92.75   252.6 276.5 111.7  
 (162.7) (285.8) (225.2)   (168.4) (300.2) (228.7)  
          
Observations 154 154 154 154 154 154 154 154 
R-squared 0.830 0.425 0.499 0.337 0.672 -0.147 0.246 -0.748 
Number of v1     22 22     22 22 
Standard errors in parentheses       
*** p<0.01, ** p<0.05, * p<0.1       
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Table 58. Results for ‘avoidable’ and other (non-avoidable) mortality using 
health activity as the explanatory variable 
 
  ‘Avoidable’ mortality Other mortality 
VARIABLES OLS FE GMM OLS FE GMM 
L.avoid   -0.247    
   (0.818)    
L.other       0.0611 
       (1.659) 
h_activ 0.0817 0.477* -3.848 -0.290 0.562** 1.981 
 (0.477) (0.243) (3.710) (0.418) (0.218) (7.627) 
lgdp -9.857 -11.28 21.45 -13.09 
-
20.38*** -79.10 
 (21.31) (8.446) (88.43) (17.64) (7.585) (190.2) 
unem 2.082** -0.453 1.421 1.831* -0.0257 -0.347 
 (0.936) (0.411) (1.297) (0.915) (0.369) (7.408) 
pol 13.55*** -0.213 89.99 8.378* 1.686 6.465 
 (3.112) (2.293) (87.31) (4.246) (2.060) (48.18) 
sl 36.95***    19.80*   
 (9.628)    (10.66)   
_Iyear_1997 -9.443** -11.44***   9.412*** 7.127** -1.656 
 (4.377) (3.356)   (2.790) (3.013) (35.75) 
_Iyear_1998 
-
21.49*** 
-
20.62*** 6.407 4.274 4.394 -7.060 
 (5.533) (3.648) (16.06) (4.414) (3.276) (19.08) 
_Iyear_1999 
-
27.36*** 
-
22.08*** 10.71 -0.845 3.022 -4.592 
 (6.707) (4.035) (22.37) (6.668) (3.623) (14.75) 
_Iyear_2000 
-
29.18*** 
-
27.68*** 18.69 0.0716 0.115 -10.67 
 (6.096) (4.064) (30.04) (6.245) (3.649) (20.86) 
_Iyear_2001 
-
36.36*** 
-
34.01*** 11.48 1.662 2.268 -7.913 
 (6.341) (4.120) (29.72) (6.140) (3.700) (11.70) 
_Iyear_2002 
-
39.04*** 
-
36.93*** 9.285 4.659 5.394  
 (7.775) (4.196) (30.63) (6.621) (3.768)  
_Iyear_2003 
-
42.83*** 
-
40.85*** -1.630 15.11** 16.30*** 13.31** 
 (7.412) (4.112) (29.43) (6.331) (3.692) (6.538) 
_Iyear_2004 
-
42.72*** 
-
43.83*** -9.021 11.83* 11.63*** 13.88 
 (7.641) (4.142) (34.61) (6.223) (3.720) (19.12) 
_Iyear_2005 
-
46.48*** 
-
49.86*** -16.21 20.51*** 19.41*** 23.09 
 (8.985) (4.256) (40.92) (5.717) (3.822) (15.77) 
_Iyear_2006 
-
48.16*** 
-
55.09*** -21.88 19.57*** 16.17*** 21.99 
 (9.787) (4.518) (48.35) (5.688) (4.058) (17.90) 
_Iyear_2007 
-
38.63*** 
-
50.33*** -9.183 28.06*** 21.10*** 29.84 
 (11.31) (5.334) (54.69) (7.321) (4.790) (26.86) 
reg1 -11.52    42.20**   
 (26.43)    (18.20)   
reg15 -18.77    12.74   
 (29.12)    (22.17)   
Constant 272.1 314.0*** 90.97 365.5* 438.7*** 1,063 
 288
 (257.9) (98.77) (822.0) (210.2) (88.70) (1,760) 
        
Observations 264 264 220 264 264 220 
R-squared 0.815 0.748   0.629 0.287   
Robust standard errors in parentheses    
*** p<0.01, ** p<0.05, * p<0.1     
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Appendix D – Appendix to Chapter 5 
 
 
Table 59. Diabetes: using “bad care” variables in the previous 2 years 
 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE1 PFE1 PFE2 PFE2 PFE3 PFE3 
              
age 0.939** 0.949*** 0.927*** 0.938*** 0.926*** 0.936*** 
 
(0.0248) (0.0187) (0.0246) (0.0160) (0.0247) (0.0166) 
gender 
 
1.086 
 
1.009 
 
1.073 
  
(0.561) 
 
(0.451) 
 
(0.510) 
comorb 1.058*** 1.056*** 1.054*** 1.053*** 1.054*** 1.053*** 
 
(0.00700) (0.00532) (0.00679) (0.00522) (0.00678) (0.00523) 
eye_bad 1.723* 1.246** 1.757* 1.267** 1.760* 1.269** 
 
(0.518) (0.120) (0.548) (0.123) (0.548) (0.122) 
hba1c_bad 1.093 1.108 1.109 1.116 1.109 1.116 
 
(0.131) (0.127) (0.134) (0.128) (0.134) (0.128) 
urine_bad 0.920 0.917 0.938 0.923 0.955 0.937 
 
(0.0776) (0.0788) (0.0778) (0.0791) (0.0798) (0.0809) 
chlst_bad 0.535*** 0.445*** 0.520*** 0.434*** 0.522*** 0.435*** 
 
(0.0892) (0.0319) (0.0890) (0.0312) (0.0891) (0.0313) 
badpred_visit 0.448*** 0.442*** 
    
 
(0.0483) (0.0463) 
    hosplag 0.506*** 0.403*** 0.511*** 0.409*** 0.508*** 0.407*** 
 
(0.112) (0.0262) (0.114) (0.0266) (0.114) (0.0265) 
antid 1.065*** 1.069*** 1.074*** 1.079*** 1.073*** 1.079*** 
 
(0.00948) (0.00840) (0.00953) (0.00839) (0.00953) (0.00839) 
insu 
 
3.422 
 
3.140 
 
3.439 
  
(3.591) 
 
(2.548) 
 
(3.096) 
visit_bad 
    
0.736 0.774 
     
(0.145) (0.138) 
Constant 
 
47.35*** 
 
52.40*** 
 
60.91*** 
  
(67.38) 
 
(65.15) 
 
(78.03) 
       Observations 7,062 7,062 7,062 7,062 7,062 7,062 
Number of v1 1,421 1,421 1,421 1,421 1,421 1,421 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 60. Diabetes: using “bad care” variables in the previous 3 years 
 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE1 PFE1 PFE2 PFE2 PFE3 PFE3 
              
age 0.964* 0.978** 0.949*** 0.962*** 0.948*** 0.961*** 
 
(0.0190) (0.0103) (0.0187) (0.0105) (0.0189) (0.0106) 
comorb 1.057*** 1.059*** 1.054*** 1.055*** 1.054*** 1.055*** 
 
(0.00737) (0.00523) (0.00720) (0.00517) (0.00720) (0.00517) 
gender 
 
0.755 
 
0.734 
 
0.747 
  
(0.268) 
 
(0.248) 
 
(0.255) 
eye_bad 2.012* 1.388*** 2.073* 1.447*** 2.078* 1.450*** 
 
(0.765) (0.173) (0.808) (0.180) (0.809) (0.181) 
hba1c_bad 1.157 1.173 1.168 1.179 1.166 1.179 
 
(0.161) (0.167) (0.163) (0.167) (0.162) (0.167) 
urine_bad 1.018 1.025 1.026 1.026 1.040 1.035 
 
(0.0934) (0.0918) (0.0937) (0.0911) (0.0961) (0.0929) 
chlst_bad 0.773* 0.673*** 0.769* 0.667*** 0.772* 0.668*** 
 
(0.104) (0.0540) (0.106) (0.0534) (0.107) (0.0536) 
badpred_visit 0.453*** 0.442*** 
    
 
(0.0535) (0.0486) 
    hosplag 0.530*** 0.430*** 0.535*** 0.438*** 0.534*** 0.437*** 
 
(0.0949) (0.0280) (0.0953) (0.0283) (0.0952) (0.0283) 
antid 1.071*** 1.072*** 1.079*** 1.080*** 1.078*** 1.080*** 
 
(0.00964) (0.00838) (0.00960) (0.00837) (0.00961) (0.00837) 
insu 
 
1.636 
 
1.733 
 
1.734 
  
(0.752) 
 
(0.740) 
 
(0.744) 
visit_bad 
    
0.840 0.895 
     
(0.141) (0.136) 
Constant 
 
3.380 
 
5.483** 
 
5.625** 
  
(2.810) 
 
(4.659) 
 
(4.817) 
       Observations 7,062 7,062 7,062 7,062 7,062 7,062 
Number of v1 1,421 1,421 1,421 1,421 1,421 1,421 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 61. Diabetes: using “bad care” variables in the previous 4 years 
 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE1 PFE1 PFE2 PFE2 PFE3 PFE3 
              
age 0.968 0.989 0.962 0.978** 0.962 0.978** 
 
(0.0246) (0.0105) (0.0238) (0.0103) (0.0239) (0.0103) 
gender 
 
0.470* 
 
0.485** 
 
0.482** 
  
(0.186) 
 
(0.174) 
 
(0.173) 
comorb 1.042*** 1.047*** 1.044*** 1.049*** 1.044*** 1.049*** 
 
(0.00886) (0.00615) (0.00866) (0.00604) (0.00865) (0.00605) 
eye_bad 1.811 1.264 1.800 1.286 1.801 1.283 
 
(0.773) (0.227) (0.757) (0.227) (0.756) (0.227) 
hba1c_bad 1.196 1.126 1.245 1.147 1.245 1.148 
 
(0.270) (0.241) (0.285) (0.246) (0.286) (0.246) 
urine_bad 1.040 1.073 1.061 1.103 1.061 1.095 
 
(0.140) (0.134) (0.140) (0.133) (0.142) (0.133) 
chlst_bad 0.674*** 0.640*** 0.681*** 0.624*** 0.681*** 0.622*** 
 
(0.0710) (0.0703) (0.0747) (0.0677) (0.0749) (0.0677) 
badpred_visit 0.388*** 0.378*** 
    
 
(0.0403) (0.0348) 
    hosplag 0.475*** 0.368*** 0.501*** 0.392*** 0.501*** 0.393*** 
 
(0.100) (0.0281) (0.103) (0.0296) (0.103) (0.0297) 
antid 1.059*** 1.052*** 1.081*** 1.074*** 1.081*** 1.074*** 
 
(0.0146) (0.00981) (0.0140) (0.00968) (0.0140) (0.00968) 
insu 
 
1.161 
 
1.475 
 
1.480 
  
(0.548) 
 
(0.632) 
 
(0.635) 
visit_bad 
    
0.991 1.077 
     
(0.177) (0.190) 
Constant 
 
3.802 
 
2.857 
 
2.832 
  
(3.438) 
 
(2.522) 
 
(2.495) 
       Observations 4,683 4,683 4,683 4,683 4,683 4,683 
Number of v1 1,178 1,178 1,178 1,178 1,178 1,178 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 62. Using count variables – Poisson and NB fixed effects 
 
  (1) (2) (3) (4) (5) (6) (7) (8) 
VARIABLES PFE1 NBFE1 PFE2 NBFE2 PFE3 NBFE3 PFE4 NBFE4 
                  
age 1.030 1.006 1.037* 1.013 1.030 1.005 1.019 1.001 
 
(0.0236) (0.00870) (0.0225) (0.00867) (0.0237) (0.00866) (0.0245) (0.00887) 
gender 
 
0.654 
 
0.704 
 
0.594* 
 
0.600* 
  
(0.197) 
 
(0.213) 
 
(0.178) 
 
(0.181) 
comorb 1.045*** 1.045*** 1.047*** 1.048*** 1.044*** 1.044*** 1.041*** 1.041*** 
 
(0.00628) (0.00486) (0.00642) (0.00491) (0.00636) (0.00487) (0.00614) (0.00490) 
eye 0.903* 0.951*** 0.901* 0.949*** 0.902* 0.950*** 0.898* 0.943*** 
 
(0.0524) (0.0148) (0.0525) (0.0146) (0.0519) (0.0147) (0.0511) (0.0147) 
hba1c 1.042 1.038 1.046 1.042 1.045 1.041 1.027 1.024 
 
(0.0523) (0.0417) (0.0520) (0.0418) (0.0522) (0.0416) (0.0515) (0.0408) 
chlst 1.190*** 1.207*** 1.186*** 1.203*** 1.186*** 1.204*** 1.178*** 1.195*** 
 
(0.0157) (0.00961) (0.0153) (0.00960) (0.0160) (0.00962) (0.0161) (0.00964) 
tot_urine 1.080** 1.086*** 1.074** 1.078*** 1.077** 1.083*** 1.062* 1.067*** 
 
(0.0352) (0.00780) (0.0341) (0.00769) (0.0352) (0.00780) (0.0328) (0.00769) 
hosplag 0.636** 0.533*** 0.634** 0.527*** 0.641** 0.537*** 0.623** 0.518*** 
 
(0.117) (0.0332) (0.120) (0.0329) (0.118) (0.0335) (0.120) (0.0325) 
antid 1.101*** 1.107*** 1.095*** 1.100*** 1.098*** 1.104*** 1.088*** 1.093*** 
 
(0.00841) (0.00655) (0.00806) (0.00654) (0.00864) (0.00656) (0.00863) (0.00658) 
insu 
 
3.515*** 
 
3.329*** 
 
3.458*** 
 
2.558** 
  
(1.544) 
 
(1.482) 
 
(1.491) 
 
(1.035) 
badpred_vis
it 
  
0.685** 0.585*** 
    
   
(0.113) (0.0460) 
    
visit 
    
1.013 1.012*** 
  
     
(0.0123) (0.00324) 
  
sasvisit 
      
1.090*** 1.092*** 
       
(0.0124) (0.00915) 
pasvisit 
      
1.000 1.000 
       
(0.00419) (0.00303) 
 293
Constant 
 
0.0926*** 
 
0.0796*** 
 
0.0972*** 
 
0.119*** 
  
(0.0582) 
 
(0.0498) 
 
(0.0609) 
 
(0.0764) 
         Observation
s 11,266 11,266 11,266 11,266 11,266 11,266 11,266 11,266 
Number of 
v1 1,621 1,621 1,621 1,621 1,621 1,621 1,621 1,621 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 63. Asthma: using “bad care” variables in the previous 2 years 
 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE2 NBFE2 PFE1 NBFE1 PFE3 NBFE3 
              
age 0.818*** 0.995 0.828*** 1.002 0.843*** 1.002 
 
(0.0212) (0.00807) (0.0226) (0.00877) (0.0228) (0.00877) 
comorb 1.015 1.004 1.014 1.004 1.012 1.003 
 
(0.0105) (0.00841) (0.0102) (0.00850) (0.0107) (0.00849) 
gender 
 
1.038 
 
1.214 
 
1.149 
  
(0.475) 
 
(0.585) 
 
(0.587) 
flu_bad 13.56*** 8.230*** 11.40*** 6.642*** 10.82*** 6.659*** 
 
(4.395) (2.508) (3.684) (2.023) (3.545) (2.033) 
tot_spir_bad 1.541** 1.300** 1.661*** 1.470*** 1.696*** 1.503*** 
 
(0.278) (0.173) (0.291) (0.198) (0.288) (0.203) 
saba 1.166*** 1.187*** 1.144*** 1.155*** 1.143*** 1.151*** 
 
(0.0482) (0.0355) (0.0463) (0.0348) (0.0469) (0.0346) 
cort 1.098** 1.063 1.095** 1.059 1.033 0.996 
 
(0.0479) (0.0432) (0.0465) (0.0427) (0.0407) (0.0386) 
antib 1.178* 1.137** 1.143 1.108* 1.123 1.078 
 
(0.114) (0.0697) (0.102) (0.0680) (0.0875) (0.0748) 
hosplag 0.799** 0.669*** 0.787** 0.665*** 0.800* 0.682*** 
 
(0.0902) (0.0672) (0.0888) (0.0670) (0.0961) (0.0686) 
badpred_visit 
  
0.533*** 0.466*** 
  
   
(0.0601) (0.0513) 
  visit 
    
1.093*** 1.115*** 
     
(0.0191) (0.0137) 
Constant 
 
0.155*** 
 
0.191*** 
 
0.0911*** 
  
(0.0893) 
 
(0.112) 
 
(0.0548) 
       Observations 2,751 2,751 2,751 2,751 2,751 2,751 
Number of v1 393 393 393 393 393 393 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 64. Asthma: using “bad care” variables in the previous 3 years 
 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE2 NBFE2 PFE1 NBFE1 PFE3 NBFE3 
              
age 0.780*** 1.003 0.797*** 1.009 0.810*** 1.009 
 
(0.0435) (0.00762) (0.0458) (0.00854) (0.0479) (0.00867) 
comorb 1.015 1.004 1.013 1.005 1.010 1.003 
 
(0.00987) (0.00832) (0.00962) (0.00840) (0.0102) (0.00839) 
gender 
 
1.175 
 
1.340 
 
1.298 
  
(0.474) 
 
(0.581) 
 
(0.588) 
flu_bad 2.931*** 1.293* 2.481*** 1.126 2.511*** 1.215 
 
(0.796) (0.177) (0.688) (0.154) (0.715) (0.168) 
tot_spir_bad 1.103 0.936 1.158 1.027 1.158 1.026 
 
(0.176) (0.131) (0.185) (0.144) (0.189) (0.145) 
saba 1.236*** 1.239*** 1.206*** 1.199*** 1.202*** 1.200*** 
 
(0.0487) (0.0365) (0.0454) (0.0353) (0.0459) (0.0353) 
cort 1.089* 1.068 1.088* 1.069* 1.016 0.999 
 
(0.0515) (0.0429) (0.0496) (0.0423) (0.0410) (0.0384) 
antib 1.173 1.167** 1.134 1.133** 1.141* 1.130* 
 
(0.125) (0.0718) (0.102) (0.0688) (0.0805) (0.0747) 
hosplag 0.645*** 0.714*** 0.645*** 0.706*** 0.653*** 0.710*** 
 
(0.0612) (0.0755) (0.0603) (0.0747) (0.0639) (0.0750) 
badpred_visit 
  
0.490*** 0.427*** 
  
   
(0.0557) (0.0460) 
  visit 
    
1.104*** 1.121*** 
     
(0.0174) (0.0133) 
Constant 
 
0.610 
 
0.786 
 
0.357** 
  
(0.249) 
 
(0.336) 
 
(0.158) 
       Observations 2,751 2,751 2,751 2,751 2,751 2,751 
Number of v1 393 393 393 393 393 393 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 65. Asthma: using “bad care” variables in the previous 4 years 
 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE2 NBFE2 PFE1 NBFE1 PFE3 NBFE3 
              
age 0.934* 1.012 0.940 1.018* 0.940 1.017* 
 
(0.0351) (0.00861) (0.0361) (0.0101) (0.0362) (0.0104) 
comorb 1.007 1.008 1.007 1.009 1.004 1.006 
 
(0.0110) (0.00842) (0.0109) (0.00850) (0.0113) (0.00850) 
gender 
 
1.134 
 
1.277 
 
1.228 
  
(0.474) 
 
(0.578) 
 
(0.576) 
flu_bad 1.065 0.868 1.019 0.820 1.079 0.870 
 
(0.204) (0.120) (0.198) (0.115) (0.212) (0.123) 
tot_spir_bad 0.976 0.909 0.985 0.954 1.020 0.982 
 
(0.150) (0.139) (0.152) (0.147) (0.153) (0.152) 
saba 1.238*** 1.241*** 1.201*** 1.199*** 1.204*** 1.204*** 
 
(0.0479) (0.0359) (0.0445) (0.0348) (0.0448) (0.0349) 
cort 1.095** 1.080** 1.092** 1.081** 1.021 1.010 
 
(0.0499) (0.0424) (0.0470) (0.0417) (0.0413) (0.0385) 
antib 1.245** 1.204*** 1.189* 1.159** 1.197** 1.156** 
 
(0.137) (0.0738) (0.110) (0.0701) (0.0840) (0.0761) 
hosplag 0.853 0.806** 0.826* 0.778** 0.832 0.789** 
 
(0.0926) (0.0822) (0.0885) (0.0790) (0.0950) (0.0803) 
badpred_visit 
  
0.450*** 0.421*** 
  
   
(0.0492) (0.0450) 
  visit 
    
1.111*** 1.119*** 
     
(0.0182) (0.0133) 
Constant 
 
0.571 
 
0.750 
 
0.348** 
  
(0.230) 
 
(0.318) 
 
(0.152) 
       Observations 2,751 2,751 2,751 2,751 2,751 2,751 
Number of v1 393 393 393 393 393 393 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 66. Astma: using count variables – Poisson and NB fixed effects 
 
  (1) (2) (3) (4) (5) (6) (7) (8) 
VARIABLES PFE2 NBFE2 PFE1 NBFE1 PFE3 NBFE3 PFE4 NBFE4 
                  
age 0.942*** 1.004 0.941*** 1.010 0.960** 1.014 0.962* 1.015 
 
(0.0184) (0.00730) (0.0196) (0.00823) (0.0192) (0.00908) (0.0195) (0.00953) 
comorb 1.008 1.006 1.008 1.006 1.004 1.005 1.006 1.006 
 
(0.0110) (0.00830) (0.0109) (0.00839) (0.0113) (0.00841) (0.0111) (0.00848) 
gender 
 
1.178 
 
1.318 
 
1.212 
 
1.173 
  
(0.466) 
 
(0.563) 
 
(0.562) 
 
(0.560) 
flu 1.045 1.210 1.152 1.330 1.401 1.586* 1.383 1.569* 
 
(0.371) (0.309) (0.370) (0.337) (0.342) (0.397) (0.336) (0.392) 
antib 1.233* 1.160** 1.183* 1.125* 1.193** 1.140** 1.206*** 1.154** 
 
(0.133) (0.0723) (0.111) (0.0692) (0.0869) (0.0748) (0.0842) (0.0753) 
cort 1.094** 1.074* 1.091** 1.070* 1.016 1.001 1.001 0.990 
 
(0.0487) (0.0417) (0.0466) (0.0417) (0.0415) (0.0379) (0.0438) (0.0382) 
saba 1.226*** 1.228*** 1.198*** 1.196*** 1.202*** 1.202*** 1.203*** 1.202*** 
 
(0.0469) (0.0358) (0.0439) (0.0349) (0.0447) (0.0350) (0.0450) (0.0351) 
tot_spir 1.090** 1.116*** 1.038 1.055* 0.984 0.991 0.965 0.974 
 
(0.0380) (0.0335) (0.0339) (0.0326) (0.0374) (0.0323) (0.0364) (0.0331) 
hosplag 0.843* 0.761*** 0.820** 0.734*** 0.834 0.753*** 0.828* 0.751*** 
 
(0.0850) (0.0765) (0.0826) (0.0738) (0.0922) (0.0755) (0.0889) (0.0752) 
badpred_visit 
  
0.461*** 0.439*** 
    
   
(0.0506) (0.0482) 
    visit 
    
1.114*** 1.123*** 
  
     
(0.0188) (0.0141) 
  sasvisit 
      
1.137*** 1.140*** 
       
(0.0236) (0.0184) 
pasvisit 
      
1.072** 1.093*** 
       
(0.0334) (0.0234) 
Constant 
 
0.545 
 
0.741 
 
0.355** 
 
0.354** 
  
(0.212) 
 
(0.307) 
 
(0.156) 
 
(0.159) 
         Observations 2,751 2,751 2,751 2,751 2,751 2,751 2,751 2,751 
Number of v1 393 393 393 393 393 393 393 393 
Standard errors in parentheses  
*** p<0.01, ** p<0.05, * p<0.1 
Note: Coefficients are Incidence Rate Ratios 
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Table 67. Diabetes: including age as a continuous variable – Poisson and NB 
fixed effects 
         (1) (2) (3) (4) (5) (6) 
VARIABLES PFE1 NBFE1 PFE2 NBFE2 PFE3 NBFE3 
              
age 1.022 1.005 1.016 0.997 1.015 0.996 
 
(0.0187) (0.00846) (0.0198) (0.00841) (0.0196) (0.00836) 
comorb 1.054*** 1.052*** 1.052*** 1.049*** 1.052*** 1.049*** 
 
(0.00623) (0.00503) (0.00635) (0.00499) (0.00628) (0.00498) 
gender 
 
1.128 
 
1.074 
 
1.076 
  
(0.353) 
 
(0.337) 
 
(0.336) 
qual_eye 0.596** 0.760*** 0.600** 0.763*** 0.598** 0.759*** 
 
(0.150) (0.0510) (0.149) (0.0511) (0.147) (0.0509) 
qual_hba1c 1.746* 1.678** 1.750* 1.680** 1.734* 1.671** 
 
(0.500) (0.426) (0.504) (0.426) (0.496) (0.423) 
qual_chlst 5.006*** 6.456*** 5.173*** 6.691*** 5.141*** 6.648*** 
 
(0.794) (0.438) (0.839) (0.453) (0.829) (0.450) 
qual_urine 1.143 1.765*** 1.173 1.807*** 1.124 1.749*** 
 
(0.397) (0.164) (0.408) (0.167) (0.399) (0.164) 
badpred_visit 0.694** 0.588*** 
    
 
(0.106) (0.0467) 
    hosplag 0.660** 0.550*** 0.661** 0.555*** 0.657** 0.553*** 
 
(0.121) (0.0333) (0.119) (0.0336) (0.117) (0.0335) 
antid 1.107*** 1.113*** 1.114*** 1.120*** 1.112*** 1.118*** 
 
(0.00839) (0.00666) (0.00871) (0.00666) (0.00879) (0.00666) 
insu 
 
4.400*** 
 
4.322*** 
 
4.132*** 
  
(2.081) 
 
(1.967) 
 
(1.845) 
qual_visit 
    
1.761*** 1.582*** 
     
(0.336) (0.252) 
Constant 
 
0.0374*** 
 
0.0462*** 
 
0.0326*** 
  
(0.0234) 
 
(0.0289) 
 
(0.0207) 
       Observations 11,266 11,266 11,266 11,266 11,266 11,266 
Number of v1 1,621 1,621 1,621 1,621 1,621 1,621 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1    
      Note: Coefficients are Incidence Rate Ratios 
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Table 68. Asthma: including age as a continuous variable – Poisson and NB fixed 
effects 
  (1) (2) (3) (4) (5) (6) 
VARIABLES PFE1 NBFE1 PFE2 NBFE2 PFE3 NBFE3 
              
age 0.943*** 1.012 0.941*** 1.006 0.952** 1.014* 
 
(0.0198) (0.00844) (0.0185) (0.00754) (0.0193) (0.00835) 
comorb 1.007 1.006 1.008 1.006 1.008 1.009 
 
(0.0109) (0.00843) (0.0111) (0.00836) (0.0117) (0.00842) 
gender 
 
1.322 
 
1.163 
 
1.192 
  
(0.569) 
 
(0.464) 
 
(0.501) 
qual_flu 1.154 1.347 1.071 1.256 1.105 1.326 
 
(0.374) (0.343) (0.390) (0.323) (0.379) (0.338) 
qual_tot_spir 1.013 1.047 1.194 1.267** 1.081 1.008 
 
(0.123) (0.127) (0.145) (0.149) (0.153) (0.124) 
bad_cort 0.542 0.452 0.490 0.384* 0.503 0.422* 
 
(0.347) (0.231) (0.324) (0.206) (0.332) (0.220) 
saba 1.200*** 1.198*** 1.231*** 1.232*** 1.213*** 1.206*** 
 
(0.0445) (0.0351) (0.0476) (0.0361) (0.0434) (0.0351) 
cort 1.135** 1.129** 1.148** 1.146*** 1.140* 1.133** 
 
(0.0732) (0.0574) (0.0777) (0.0593) (0.0771) (0.0581) 
antib 1.182* 1.125* 1.233* 1.163** 1.214* 1.152** 
 
(0.110) (0.0682) (0.134) (0.0711) (0.124) (0.0702) 
badpred_visit 0.452*** 0.427*** 
 
  
  
 
(0.0494) (0.0465) 
 
  
  hosplag 0.821* 0.727*** 0.840* 0.749*** 0.833* 0.727*** 
 
(0.0846) (0.0733) (0.0858) (0.0755) (0.0902) (0.0735) 
qual_visit 
 
  
 
  1.669* 2.446*** 
  
  
 
  (0.471) (0.330) 
Constant 
 
0.760 
 
0.545 
 
0.246*** 
  
(0.317) 
 
(0.214) 
 
(0.104) 
  
  
 
  
  Observations 2,751 2,751 2,751 2,751 2,751 2,751 
Number of v1 393 393 393 393 393 393 
Standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1     
     Note: Coefficients are Incidence Rate Ratios 
 
  
 300
Bibliography 
 
Aakvik, A., & Holmas, T. H. (2006). Access to primary health care and health 
outcomes: the relationship between GP characteristics and mortality rates. 
Journal of Health Economics, 25, 1139-1153. 
Aday, L. A., Begley, C. E., Lairson, D. R., & Slater, C. H. (1993). Evaluating the 
Medical Care System: Effectiveness,efficiency, and equity (Vol. 1st). Chicago: 
Health Administration Press. 
Aday, L. A., Begley, C. E., Lairson, D. R., & Slater, C. H. (1998). Evaluating the 
Health Care System: Effectiveness,efficiency, and equity (Vol. 2nd). Chicago: 
Health Administration Press. 
Aday, L. A., Begley, C. E., Lairson, D. R., & Slater, C. H. (2004). Evaluating the 
Health Care System: Effectiveness,efficiency, and equit (Vol. 3rd). Chicago: 
Health Administration Press. 
Aday, L. A., Begley, C. E., Lairson, D. R., Slater, C. H., Richard, A. J., & Montoya, I. D. 
(1999). A framework for assessing the effectiveness, efficiency, and equity of 
behavioral healthcare. The American journal of managed care, 5, 25-44. 
Alfonso Sanchez, J., Sanchis Noguera, B., del Bano, M. J., Sabater Pons, A., Saiz 
Sanchez, C., & Cortina Greus, P. (1993). Testing a new health indicator: using 
avoidable causes of death and life expectancy for Spain between 1975-1986. 
Eur J Epidemiol, 9, 33-39. 
Almeida, C., Braveman, P., Gold, M. R., Szwarcwald, C. L., Ribeiro, J. M., Miglionico, 
A., et al. (2001). Methodological concerns and recommendations on policy 
consequences of the World Health Report 2000. Lancet, 357(9269), 1692-
1697. 
Anand, S., & Bärnighausen, T. (2004). Human resources and health outcomes: cross-
country econometric study. The Lancet, 364(9445), 1603-1609. 
 301
Andersen, R. M. (1995). Revisiting the behavioral model and access to medical care: 
Does it matter? Journal of Health and Social Behavior, 36(3), 1-10. 
Andersen, R. M., McCutcheon, A., Aday, L. A., Chiiu, G. Y., & Bell, R. (1983). 
Exploring dimensions of access to medical care Health Serv Res, 18(1), 49-74. 
Andreev, E. M., Nolte, E., Shkolnikov, V. M., Varavikova, E., & McKee, M. (2003). 
The evolving pattern of avoidable mortality in Russia. Int. J. Epidemiol., 
32(3), 437-446. 
Angrist, J. D., & Krueger, A. B. (2011). Instrumental Variables and the Search for 
Identification: From Supply and Demand to Natural Experiments Journal of 
Economic Perspectives, 15(4), 69-85. 
Ansari, Z. (2007a). The Concept and Usefulness of Ambulatory Care Sensitive 
Conditions as Indicators of Quality and Access to Primary Health Care. 
Australian Journal of Primary Health, 13(3), 91-110. 
Ansari, Z. (2007b). A Review of Literature on Access to Primary Health Care. 
Australian Journal of Primary Health, 13(2), 80-95. 
Ansari, Z., Laditka, J. N., & Laditka, S. B. (2006). Access to health care and 
hospitalization for ambulatory care sensitive conditions. Med Care Res Rev, 
63(6), 719-741. 
Arah, O. A., Westert, G. P., Hurst, J., & Klazinga, N. S. (2006). A conceptual 
framework for the OECD Health Care Quality Indicators Project. 
International Journal for Quality in Health Care, 18(suppl 1), 5-13. 
Atun, R., & Menabde, N. (2008). Health systems and systems thinking. In R. Cooker, 
R. Atun & M. McKee (Eds.), Health systems and the challenge of 
communicable diseases: Experience from Europe and Latin America. 
Buckingham: Open University Press (European Observatory on Health 
Systems and Policies). 
Auster, R., Leveson, I., & Sarachek, D. (1969). The Production of Health, an 
Exploratory Study. The Journal of Human Resources, 4(4), 411-436. 
 302
Babazono, A., & Hillman, A. L. (1994). A Comparison of International Health 
Outcomes and Health Care Spending. International Journal of Technology 
Assessment in Health Care, 10(03), 376-381. 
Bada, V. (2006). Po 20 rokoch novy terapeuticky princip v liecbe ischemickej choroby 
srdca. Via pract., 3(11), 530-533. 
Bahadori, K., Doyle-Waters, M., Marra, C., Lynd, L., Alasaly, K., Swiston, J., et al. 
(2009). Economic burden of asthma: a systematic review. BMC Pulmonary 
Medicine, 9(1), 24. 
Barakova, A., & Riecansky, I. (2007). Development of hypertensive diseases in the 
context of mortality and morbidity of the circulatory system diseases in Slovak 
Republic. Lek. Obzor, 56(3), 94-102. 
Barry, J. (1992). “Avoidable mortality” as an index of health care outcome: results 
from the European Community Atlas of “Avoidable death”. Ir J Med Sci, 160, 
490-492. 
Basu, J., Friedman, B., & Burstin, H. (2004). Managed care and preventable 
hospitalization among Medicaid adults. Health Serv Res, 39(3), 489-510. 
Bauer, R. L., & Charlton, J. R. H. (1986). Area variation in mortality from diseases 
amenable to medical intervention: The Contribution of differences in 
morbidity. Int. J. Epidemiol., 15(3), 408-412. 
Beaglehole, R. (1986). Medical management and the decline in mortality from 
coronary heart disease. Br Med J (Clin Res Ed), 292(6512), 33-35. 
Bech, M., & Lauridsen, J. (2008). Exploring the spatial pattern in hospital 
admissions. Health Policy, 87(1), 50-62. 
Biggs, B., King, L., Basu, S., & Stuckler, D. (2010). Is wealthier always healthier? The 
impact of national income level, inequality, and poverty on public health in 
Latin America. [Article]. Social Science & Medicine, 71(2), 266-273. 
Billings, J., Anderson, G. M., & Newman, L. S. (1996). Recent findings on preventable 
hospitalizations. Health Affairs, 15(3), 239-249. 
 303 
Billings, J., Zeitel, L., Lukomnik, J., Carey, T. S., Blank, A. E., & Newman, L. (1993). 
Impact of socioeconomic status on hospital use in New York City. Health Aff, 
12, 162 - 173. 
Bindman, A. B., Chattopadhyay, A., & Auerback, G. M. (2008). Interruptions in 
medicaid coverage and risk for hospitalization for ambulatory care-sensitive 
conditions: Annals of Internal Medicine. 149(12)(pp 854-860), 2008. Date of 
Publication: 16 Dec 2008. 
Bindman, A. B., Chattopadhyay, A., Osmond, D. H., Huen, W., & Bacchetti, P. (2005). 
The impact of Medicaid managed care on hospitalizations for ambulatory care 
sensitive conditions. Health Serv Res, 40(1), 19-38. 
Bjerregaard, P., & Juel, K. (1990). Avoidable deaths in Greenland 1968-1985: 
Variations by region and period. Arct Med Res, 49, 119-127. 
Blazek, J., & Dzurova, D. (2000). The Decline of Mortality in the Czech Republic 
during the Transition: A Counterfactual Case Study. In G. A. Cornia & R. 
Paniccià (Eds.), The mortality crisis in transitional economies. Oxford: 
Oxford University Press. 
Bloom, D. E., & Canning, D. (2007). Commentary: The Preston Curve 30 years on: 
still sparking fires. International Journal of Epidemiology, 36(3), 498-499. 
Bobak, M., & Feachem, R. (1992). Health status in the Czech and Slovak Federal 
Republic. Health Plicy and Planning, 7(3), 234-242. 
Bobak, M., Skodova, Z., Pisa, Z., Poledne, R., & Marmot, M. (1997). Political changes 
and trends in cardiovascular risk factors in the Czech Republic, 1985-92. 
Journal of Epidemiology and Community Health, 51(3), 272-277. 
Bojan, F., Hajdu, P., & Belicza, E. (1991). Avoidable mortality. Is it an indicator of 
quality of medical care in Eastern European countries? Int J Qual Health 
Care, 3(3), 191-203. 
Bookman, M. Z. (1992). The Economics of Secession. New York: St. Martin's Press. 
 304
Botha, J. L., Bray, F., Sankila, R., & Parkin, D. M. (2003). Breast cancer incidence 
and mortality trends in 16 European countries. European Journal of Cancer, 
39(12), 1718-1729. 
Bots, M. L., & Grobbee, D. E. (1996). Decline of coronary heart disease mortality in 
The Netherlands from 1978 to 1985: contribution of medical care and changes 
over time in presence of major cardiovascular risk factors. European Journal 
of Cardiovascular Prevention & Rehabilitation, 3(3), 271-276. 
Bottle, A., Gnani, S., Saxena, S., Aylin, P., Mainous, A., & Majeed, A. (2008). 
Association Between Quality of Primary Care and Hospitalization for 
Coronary Heart Disease in England: National Cross-sectional Study. Journal 
of General Internal Medicine, 23(2), 135-141. 
Boys, R. J., Forster, D. P., & Jozan, P. (1991). Mortality from causes amenable and 
non-amenable to medical care: the experience of Eastern Europe. BMJ, 303, 
879-883. 
Bozzoli, C., Deaton, A., & Quintana-Domeque, C. (2009). Adult height and childhood 
disease. Demography, 46(4), 647-669. 
Breekveldt-Postmaa, N. S., Gerritsb, C. M. J. M., Lammersc, J. W. J., Raaijmakersb, 
J. A. M., & Heringsa, R. M. C. (2004). Persistence with inhaled corticosteroid 
therapy in daily practice. Respiratory Medicine, 98, 752-759. 
Brook, R. H., McGlynn, E. A., & Cleary, P. D. (1996). Quality of Health Care. Part 2: 
Measuring Quality of Care. New England Journal of Medicine 335(13), 966-
970. 
Brunekreef, B., & Holgate, S. T. (2002). Air pollution and health. The Lancet, 
360(9341), 1233-1242. 
Bruthans, J., Cífková, R., Lánská, V., O’Flaherty, M., Critchley, J. A., Holub, J., et al. 
(2012). Explaining the decline in coronary heart disease mortality in the 
Czech Republic between 1985 and 2007. European Journal of Preventive 
Cardiology. 
 305
Bryndova, L., Pavlokova, K., Roubal, T., Rokosova, M., Gaskins, M., & van Ginneken, 
E. (2009). Czech Republic: Health system review. . Health Systems in 
Transition, 11(1), 122. 
Burcin, B. (2009). Avoidable mortality in the Czech Republic in 1990-2006. Czech 
Demography, 50(1), 15-31. 
Burcin, B., & Kucera, T. (2008). Structural changes in mortality in the Czech 
Republic and Slovakia between 1991 and 2006. Demografie, 50, 173-185. 
Cameron, A. C., & Trivedi, P. K. (2010). Microeconometrics Using Stata. Texas: A 
Stata Press Publication, StataCorp LP. 
Caminal, J., Starfield, B., Sanchez, E., Casanova, C., & Morales, M. (2004). The role 
of primary care in preventing ambulatory care sensitive conditions. European 
Journal of Public Health, 14(3), 246-251. 
Campbell, S. M., Roland, M. O., & Buetow, S. A. (2000). Defining quality of care. 
Social Science & Medicine, 51(11), 1611-1625. 
Capewell, S., Beaglehole, R., Seddon, M., & McMurray, J. (2000). Explanation for the 
decline in coronary heart disease mortality rates in Auckland, New Zealand, 
between 1982 and 1993. Circulation, 102, 1511-1516. 
Capewell, S., Morrison, C. E., & McMurrey, J. J. (1999). Contribution of modern 
cardiovascular treatment and risk factor changes to the decline in coronary 
heart disease mortality in Scotland between 1975 and 1994. . Heart, 81, 380-
386. 
Carr-Hill, R., Hardman, G., & Russell, I. (1987). Variations in avoidable mortality and 
variations in health care resources. Lancet, 1, 1789-1792. 
Carstairs, V. (1989). Avoidable mortality in European countries - 1974-1978. Scot 
Med J, 34, 391-392. 
Carter, M. W., Datti, B., & Winters, J. M. (2006). ED visits by older adults for 
ambulatory care-sensitive and supply-sensitive conditions: American 
 306
Journal of Emergency Medicine. 24(4)(pp 428-434), 2006. Date of 
Publication: Jul 2006. 
Cassidy, J. (2009). Name and shame. BMJ, 339, 264-267. 
Celko, A. M. (1996). Breast cancer epidemiology in Czech Republic. Central 
European Journal of Public Health, 4(2), 106-109. 
Center for Systemic Peace. (2013). Polity IV Annual Time Series 1800-2011. 
Integrated Network for Societal Conflict Research Data Page  Retrieved 
February, 2013, from http://www.systemicpeace.org/polity/polity4.htm; 
http://www.systemicpeace.org/inscr/inscr.htm 
Chang, C. F., Mirvis, D. M., & Waters, T. M. (2008). The effects of race and insurance 
on potentially avoidable hospitalizations in Tennessee: Medical Care 
Research and Review. 65(5)(pp 596-616), 2008. Date of Publication: October 
2008. 
Charlton, J. R. H., Hartley, R., Silver, R., & Holland, W. (1983). Geographical 
variation in mortality from conditions amenable to medical intervention in 
England and Wales. Lancet, 1(8326 ), 691-696. 
Charlton, J. R. H., Holland, W., Lakhani, A., & Paul, E. A. (1987). Variations in 
avoidable mortality and variations in health care. Lancet, 1, 858. 
Charlton, J. R. H., Lakhani, A., & Aristidou, M. (1986). How have 'avoidable death' 
indices for England and Wales changed? 1974-78 compared with 1979-83. J 
Public Health, 8(4), 304-314. 
Chovancova, D. (2008). Ako je to so starostlivostou o novorodencov na Slovensku? 
Pediatria Pre Prax, 3. 
Chu, C. M., Chan, V. L., Lin, A. W. N., Wong, I. W. Y., Leung, W. S., & Lai, C. K. W. 
(2004). Readmission rates and life threatening events in COPD survivors 
treated with non-invasive ventilation for acute hypercapnic respiratory 
failure. Thorax, 59(12), 1020-1025. 
 307
CIFHI. (2008). Health indicators. Ottawa: Canadian Institute for Health 
Information. 
Cífková, R., Škodová, Z., Bruthans, J., Holub, J., Adámková, V., Jozífová, M., et al. 
(2010). Longitudinal trends in cardiovascular mortality and blood pressure 
levels, prevalence, awareness, treatment, and control of hypertension in the 
Czech population from 1985 to 2007/2008. Journal of Hypertension, 28(11), 
2196-2203 2110.1097/HJH.2190b2013e32833d34451. 
Cifkova, R., Skodova, Z., Lanska, V., Adamkova, V., Novozamska, E., Petrzilkova, Z., 
et al. (2004). Trends in blood pressure levels, prevalence, awareness, 
treatment, and control of hypertension in the Czech population from 1985 to 
2000/01. Journal of Hypertension, 22(8), 1479-1485. 
Cizmecioglu, F., Doherty, A., Paterson, W. F., Young, D., & Donaldson, M. D. C. 
(2005). Measured versus reported parental height. Archives of Disease in 
Childhood, 90(9), 941-942. 
Cloutier, M. M., Hall, C. B., Wakefield, D. B., & Bailit, H. (2005). Use of asthma 
guidelines by primary care providers to reduce hospitalizations and 
emergency department visits in poor, minority, urban children. The Journal 
of Pediatrics, 146(5), 591-597. 
Cochrane, A., St Leger, A., & Moore, F. (1978). Health service'input'and 
mortality'output'in developed countries. Journal of Epidemiology and 
Community Health, 32(3), 200-205. 
Collins, S. M., & Rodrik, D. (1991). Eastern Europe and the Soviet Union in the 
World Economy. Washington DC: Institute for International Economy. 
Commonwealth Fund. (2006). Framework for a high performance health system for 
the United States. New York: The Commonwealth Fund. 
Cook, S., Walker, A., Hugli, O., Togni, M., & Meier, B. (2007). Percutaneous coronary 
interventions: prevalence, numerical estimates, and projections based on data 
up to 2004. Clinical Research in Cardiology, 96(6), 375-382. 
 308
Cornia, G. A., & Paniccià, R. (2000). The Mortality Crisis in Transitional Economies. 
Oxford: Oxford University Press. 
Costa-Font, J., & Gil, J. (2008). Generational effects and gender height dimorphism 
in contemporary Spain. Economics & Human Biology, 6(1), 1-18. 
Council of Europe. (1998). The development and implementation of quality 
improvement systems (QIS) in health care. Recommendation No. R (97) 17 
adopted by the Committee of Ministers of the Council of Europe on 30 
September 1997 and explanatory memorandum Strasbourg Council of 
Europe Publishing. 
Cox, T., & Mason, B. (1999). Social and Economic Transformation in East Central 
Europe: Institutions, Property Relations and Social Interests. Cheltenham: 
Edward Elgar Publishing Limited. 
Cremieux, P.-Y., Ouellette, P., & Pilon, C. (1999). Health Care Spending as 
Determinants of Health Outcomes. Health Economics, 8(7), 627-639. 
Cvrcek, T. (2006). Seasonal anthropometric cycles in a command economy: The case 
of Czechoslovakia, 1946–1966. Economics & Human Biology, 4(3), 317-341. 
Davídkovová, H., Kyselý, J., Kříž, B., Vojtíšek, P., & Bobák, M. (2013). Trends in 
cardiovascular mortality and hospitalisations, and potential contribution of 
inhospital case-fatality rates to changes in national mortality in the Czech 
Republic 1994–2009. Heart, 99(6), 409-416. 
de Jong, J. D., Groenewegen, P. P., Spreeuwenberg, P., Schellevis, F., & Westert, G. P. 
(2010). Do guidelines create uniformity in medical practice? Social Science 
&amp; Medicine, 70(2), 209-216. 
Deaton, A. (2007). Height, health, and development. Proceedings of the National 
Academy of Sciences, 104(33), 13232-13237. 
Delgado-Rodríguez, M., & Llorca, J. (2004). Bias. Journal of Epidemiology and 
Community Health, 58(8), 635-641. 
 309
Department of Health. (1997). A first class service - quality in the new NHS. London: 
Department of Health. 
Donabedian, A. (1980). Explorations in quality assessment and monitoring. The 
definition of quality and approaches to its assessment. Ann Arbor, MI: 
Health Administration Press. 
Donabedian, A. (1988). The quality of care. How can it be assessed? JAMA, 260(12), 
1743-1748. 
Donabedian, A. (1993). Quality in Health Care: Whose Responsibility Is It? American 
Journal of Medical Quality, 8(2), 32-36. 
Donabedian, A. (2003). An Introduction to Quality Assurance in Health Care. New 
York: Oxford University Press. 
Donabedian, A. (2005). Evaluating the Quality of Medical Care. The Milbank 
Quarterly, 83(4), 691-729. 
Dougherty, C. (2007). Introduction to Econometrics (3 ed.). New York: Oxford 
University Press. 
Downing, A., Rudge, G., Cheng, Y., Tu, Y. K., Keen, J., & Gilthorp, M. S. (2007). Do 
the UK government's new Quality and Outcomes Framework (QOF) scores 
adequately measure primary care performance? A cross-sectional survey of 
routine healthcare data BMC Health Services Research, 7. 
Dubois, C., McKee, M., & Nolte, E. (Eds.). (2006). Human resources for health in 
Europe: European Observatory on Health Systems and Policies. Open 
University Press. 
Dusheiko, M., Doran, T., Gravelle, H., Fullwood, C., & Roland, M. (2011). Does higher 
quality of diabetes management in family practice reduce unplanned hospital 
admissions? Health Services Research, 46(1 Pt 1), 27-46. 
Ecohost/ Masaryk University. (2000). Health needs of the Roma population in the 
Czech and Slovak Republics. London: London School of Hygiene and Tropical 
Medicine. 
 310
Economic and Social Data Service. (2005). SN 5526 -Eurobarometer 64.3: Foreign 
Languages, Biotechnology, Organized Crime, and Health Items.   Retrieved 
February 12, 2013, from 
http://www.esds.ac.uk/findingData/snDescription.asp?sn=5526 
Egnerova, A., & Becezna, A. (1997). Trendy predcasnej umrtnosti na 
kardiovaskularne choroby na Slovensku. Lek. Obzor, 46(1-2), 4-5. 
European Diabetes Leadership Forum Copenhagen. (2012a). 
European Diabetes Leadership Forum Copenhagen. (2012b). Copenhagen Roadmap: 
outcomes of the European Diabetes Leadership Forum from 
http://www.diabetesleadershipforum.eu/ 
Evans, R., & McGrail, K. (2008). Richard III, Barer-Stoddart and the Daughter of 
Time. Healthcare Policy, 3(3), 18-28. 
Evans, R. G. (1990). The dog in the night-time: medical practice variations and health 
policy. In T. F. Andersen & G. Mooney (Eds.), The challenges of medical 
practice variations (pp. 117-152). London: Macmillan Press. 
Eveleth, P. B., & Tanner, J. M. (1976). Worldwide variation in human growth: 
Cambridge University Press. 
Eveleth, P. B., & Tanner, J. M. (1990). World-Wide Variation in Human Growth 
(2nd ed.). Cambridge: Cambridge University Press. 
Falik, M., Needleman, J., Herbert, R., Wells, B., Politzer, R., & Benedict, M. B. 
(2006). Comparative Effectiveness of Health Centers as Regular Source of 
Care: Application of Sentinel ACSC Events as Performance Measures. The 
Journal of Ambulatory Care Management, 29(1), 24-35. 
Figueras, J., McKee, M., Cain, J., & Lessof, S. (Eds.). (2004). Health systems in 
transition: learning from experience: World Health Organization on behalf of 
the European Observatory on Health Systems and Policies. 
Fisher, S., Gould, J., & Haughton, T. (2007). Slovakia's neoliberal turn. Europe-Asia 
Studies, 59(3), 977-998. 
 311
FitzGerald, J. M., Bateman, E., Hurd, S., Boulet, L.-P., Haahtela, T., Cruz, A. A., et al. 
(2011). The GINA Asthma Challenge: reducing asthma hospitalisations. 
European Respiratory Journal, 38(5), 997-998. 
FitzGerald, J. M., & Quon, B. S. (2010). The impact of asthma guidelines. The Lancet, 
376(9743), 751-753. 
Fontes, M. J., Affonso, A. G., Calazans, G. M., de Andrade, C. R., Lasmar, L. M., 
Nader, C. M., et al. (2011). Impact of an asthma management program on 
hospitalizations and emergency department visits. J Pediatr 87(5), 412-418. 
Fortney, J. C., Steffick, D. E., Burgess, J. F., Maciejewski, M. L., & Petersen, L. A. 
(2005). Are primary care services a substitute or complement for specialty 
and inpatient services? [Article; Proceedings Paper]. Health Services 
Research, 40(5), 1422-1442. 
Fuhrman, C., Dubus, J. C., Marguet, C., Delacourt, C., Thumerelle, C., de Blic, J., et 
al. (2011). Hospitalizations for asthma in children are linked to 
undertreatment and insufficient asthma education. J Asthma, 48(6), 565-571. 
Gaizauskiene, A., & Gurevicius, R. (1995). Avoidable mortality in Lithuania. Journal 
of Epidemiology and Community Health, 49, 281-284. 
Gerdtham, U. G., Søgaard, J., Andersson, F., & Jönsson, B. (1992). An econometric 
analysis of health care expenditure: a cross-section study of the OECD 
countries. Journal of health economics, 11, 63-84. 
Gilberg, K., Laouri, M., Wade, S., & Isonaka, S. (2003). Analysis of medication use 
patterns: apparent overuse of antibiotics and underuse of prescription drugs 
for asthma, depression and CHF. Journal of Managed Care Pharmacy, 9(3), 
232-237. 
Ginter, E. (1995). Cardiovascular risk factors in the former communist countries. Eur 
J Epidemiol, 11, 199-205. 
Ginter, E. (1996). The development of premature cardiovascular mortality in various 
regions of Europe. Period 1961-1990. Noninvas Cardiol, 5(4), 171-176. 
 312
Ginter, E. (1998). Vyvoj vcasnej kardiovaskularnej mortality v strednej Europe v 
poslednom desatroci. Cardiol, 7(3), 199-122. 
Ginter, E. (2001). [Different trends in cardiovascular mortality in the Czech and 
Slovak Republics after the partition of Czechoslovakia in 1993]. Cas Lek Cesk, 
140(20), 624-628. 
Ginter, E., Simko, V., & Wsolova, L. (2009). Fall of the iron curtain: male life 
expectancy in Slovakia, in the Czech Republic and in Europe. Central 
European Journal of Public Health, 17(4), 171-174. 
Gispert, R., Serra, I., Bares, M. A., Puig, X., Puigdefabregas, A., & Freitas, A. (2008). 
The impact of avoidable mortality on life expectancy at birth in Spain: 
changes between three periods, from 1987 to 2001. Journal of Epidemiology 
and Community Health, 62(9), 783-789. 
Giuffrida, A., Gravelle, H., & Roland, M. (1999). Measuring quality of care with 
routine data: avoiding confusion between performance indicators and health 
outcomes. British Medical Journal, 319(7202), 94-98. 
Global Initiative for Asthma. (2012). Pocket Guide for Asthma Prevention and 
Treatment: Global Initiative for Asthma. 
Gravelle, H., & Backhouse, M. E. (1987). International cross-section analysis of the 
determination of mortality. Social Science & Medicine, 25(5), 427-441. 
Gravelle, H., Morris, S., & Sutton, M. (2008). Are family physicians good for you? 
Endogenous doctor supply and individual health. Health Services Research, 
43(4). 
Grol, R., & Grimshaw, J. (2003). From best evidence to best practice: effective 
implementation of change in patients' care. The Lancet, 362(9391), 1225-
1230. 
Haahtela, T., Tuomisto, L. E., Pietinalho, A., Klaukka, T., Erhola, M., Kaila, M., et al. 
(2006). A 10 year asthma programme in Finland: major change for the better. 
Thorax, 61(8), 663-670. 
 313
Hammermeister, K. E., Shroyer, A. L., Sethi, G. K., & Grover, F. L. (1995). Why It Is 
Important to Demonstrate Linkages between Outcomes of Care and Processes 
and Structures of Care. Medical Care, 33(10), OS5-OS16. 
Hansluwka, H., Lopez, A. D., Porapakkham, Y., & Prasartkul, P. (Eds.). (1986). New 
developments in the analysis of mortality and causes of death. Bangkok: 
Mahidol University - Institute of Population and Social Research; World 
Health Organization. 
Hatton, T. J. (2013). How have Europeans grown so tall? Oxford Economic Papers. 
Health Committee. (2009). Patient safety: Sixth report of session 2008-09. 
Retrieved from 
http://www.publications.parliament.uk/pa/cm200809/cmselect/cmhealth/1
51/151i.pdf. 
Health Consumer Powerhouse. (2008). Euro Consumer Diabetes Index: Health 
Consumer Powerhouse. 
Healthcare Commission. (2008). State of Healthcare 2008. London: Stationary 
Office. 
Heijink, R., Koolman, X., & Westert, G. (2012). Spending more money, saving more 
lives? The relationship between avoidable mortality and healthcare spending 
in 14 countries. The European Journal of Health Economics, 1-12. 
Hiermeyer, M. (2008). The trade-off between a high and an equal biological standard 
of living—Evidence from Germany. Economics & Human Biology, 6(3), 431-
445. 
Hlavačka, S., Wágner, R., & Riesberg, A. (2004). Health care systems in transition: 
Slovakia: WHO Regional Office for Europe on behalf of the European 
Observatory on Health Systems and Policies. 
Holland, W. (1986). The 'avoidable death' guide to Europe. Health Policy, 6, 115-117. 
Holland, W. (2003). Commentary: Should we not go further than description of 
avoidable mortality? Int J Epidemiol, 32, 447-448. 
 314
Holland, W. (2007). Tackling assessment of the performance of health services. 
Eurohealth, 13(4). 
Holland, W. (2009). Measuring the quality of medical care. Journal of Health Service 
Research and Policy, 14, 183-185. 
Holland, W. (Ed.). (1988). European Community atlas of 'avoidable death'. 
Commission of the European Communities Health Services Research Series 
No.3. Oxford: Oxford University Press. 
Holland, W. (Ed.). (1991). European Community atlas of 'avoidable death' (2nd ed. 
Vol. I). Commission of the European Communities Health Services Research 
Series No.6. Oxford: Oxford University Press. 
Holland, W. (Ed.). (1993). European Community atlas of 'avoidable death' (2nd ed. 
Vol. II). Commission of the European Communities Health Services Research 
Series No.9. Oxford: Oxford University Press. 
Holland, W. (Ed.). (1997). European Community atlas of 'avoidable death' 1985-89. 
Oxford: Oxford University Press. 
Holland, W., & Breeze, E. (1985). The performance of health services. In M. Keynes, 
D. A. Coleman & N. H. Dimsdale (Eds.), The Political Economy of Health and 
Welfare: Proceedings of the twenty-second annual symposium of the 
Eugenics Society, London (pp. 149-169): MacMillan Press. 
Howard, D. L., Hakeem, F. B., Njue, C., Carey, T., & Jallah, Y. (2007). Racially 
disproportionate admission rates for ambulatory care sensitive conditions in 
North Carolina. Public Health Reports, 122(3), 362-372. 
Hrubisko, M., & Ciznar, P. (2010). Asthma Bronchiale: national guidelines for 
treatment. Bratislava. 
Hsiao, W. C. (2003). What is a health system? Why should we care? Cambridge: 
Harvard School of Public Health. 
 315 
Hunink, M. G. M., Goldman, I., Tosteson, A. N. A., Mittleman, M. A., Goldman, P. A., 
Williams, L. W., et al. (1997). The recent decline in mortality from coronary 
heart disease, 1980-1990. JAMA, 277, 535-543. 
Hupkova, H. (2008). Cervical cancer screening in Slovakia. Central European 
Journal of Public Health, 16(suppl.), S35-S36. 
Hurst, J., & Jee-Hughes, M. (2001). Performance measurement and performance 
management in OECD health systems. Paris: Organisation for Economic Co-
operation and Development Publishing (OECD Labour Market and Social 
Policy Occasional Paper, no.47). 
Iezzoni, L. (1997). Assessing Quality Using Administrative Data. Annals of Internal 
Medicine, 127(2), 666-674. 
Iezzoni, L. (2003). Risk adjustment for measuring health care outcomes (3 ed.). 
Chicago: Health Administration Press. 
IHP. (2008). Monitoring performance and evaluating progress in the scale-up for 
better health: A proposed common framework: Document prepared by the 
monitoring and evaluating working group of the International Health 
Parternship and Related Initiative (IHP+), led by the WHO and World Bank. 
Inglot, T. (2009). Czech Republic, Hungary, Poland and Slovakia: Adaptation and 
Reform of the Post-Communist 'Emergency Welfare States'. In A. Cerami & P. 
Vanhuysse (Eds.), Post-communist welfare pathways : theorizing social 
policy transformations in Central and Eastern Europe Basingstoke: Palgrave 
Macmillan. 
Institute of Health Information and Statistics Czech Republic. (2004). World Health 
Survey in the Czech Republic (Světové šetření o zdraví v České republice) by 
Mgr. Jiří Holub, Ing. Jakub Hrkal, Ing. Vlasta Pázlerová. 
Institute of Health Information and Statistics Czech Republic. (2006). Trends in 
evolution of health data in the Slovak Republic and Czech Republic, 1994-
2004. Prague: Institute of Health Information and Statistics Czech Republic. 
 316
Institute of Medicine. (1990). Medicare: A strategy for quality assurance (Vol. 1). 
Washingont DC: National Academy Press. 
Institute of Research and Digital Education. (2013). STATA FAQ: How can I use 
margins to understand a categorical by categorical by continuous 3-way 
interaction? (Stata 11). 2013, from 
http://www.ats.ucla.edu/stat//stata/faq/catcatcon.htm 
IOM. (2001). Crossing the quality chasm: a new health system for the 21st century. 
Washington DC: National Academy of Sciences. 
James, P. D., Manuel, D. G., & Mao, Y. (2006). Avoidable mortality across Canada 
from 1975 to 1999., 6(137). 
Janik, Z. (2010). Twenty Years after the Iron Curtain: The Czech Republic in 
Transition. Juniata voices 10(2010). 
Jougla, E., Papoz, L., Balkau, B., Maguin, P., Hatton, F., & The Eurodiab Subarea, C. 
S. G. (1992). Death Certificate Coding Practices Related to Diabetes in 
European Countries--The 'EURODIAB Subarea C' Study. Int. J. Epidemiol., 
21(2), 343-351. 
Jozan, P., & Prokhorskas, R. (Eds.). (1997). Atlas of leading and 'avoidable' causes of 
death in countries of Central and Eastern Europe. Budapest: Hungarian CSO 
Publishing House. 
Jurkovicova, J. (2005). Vieme zdravo zit? Zdravotny stav slovenskej populacie 1999-
2004 a prevencia kardiovaskularnych a civilizacnych ochoreni. Bratislava: 
Lekarska Fakulta, Univerzita Komenskeho  
Karanikolos, M., Khoshaba, B., Nolte, E., & McKee, M. (2013). Comparing Population 
Health. In I. Papanicolas & P. C. Smith (Eds.), Health System Performance 
Comparison: an Agenda for Policy, Information and Research. Berkshire: 
Open University Press. 
Key, T. J., Verkasalo, P. K., & Banks, E. (2001). Epidemiology of breast cancer. The 
Lancet Oncology, 2(3), 133-140. 
 317
Koch, D. (2012). Four Essays on the Biological Standard of Living in Europe and 
America in Historical Perspective. Ludwig Maximilians University Munich, 
Munich. 
Kohn, L. T., Corrigan, J. M., & Donaldson, M. S. (Eds.). (1999). To err is human. 
Building a safer health system. Washington DC: National Academic Press. 
Komlos, J. (2009). Anthropometric history: an overview of a quarter century of 
research. Anthropol Anz., 67(4), 341-356. 
Komlos, J., & Baten, J. (Eds.). (1998). The Biological Standard of Living in 
Comparative Perspective. Stuttgart: Franz Steiner Verlag. 
Komlos, J., & Baur, M. (2004). From the tallest to (one of) the fattest: the enigmatic 
fate of the American population in the 20th century. Economics & Human 
Biology, 2(1), 57-74. 
Komlos, J., & Kriwy, P. (2002). Social status and adult heights in the two Germanies. 
Annals of Human Biology, 29(6), 641-648. 
Komlos, J., & Kriwy, P. (2003). The Biological Standard of Living in the Two 
Germanies. German Economic Review, 4(4), 459-473. 
Komlos, J., & Snowdon, B. (2005). Measures of Progress and Other Tall Stories. 
World Economics, 6(2), 87-135. 
Konopasek, B., Novy, F., & Bauer, J. (1994). Nedostatky v diagnostice a lecbe 
karcinomu prsu. Prakticky Lekar, 74(9). 
Korda, R. J., & Butler, J. R. G. (2006). Effect of healthcare on mortality: Trends in 
avoidable mortality in Australia and comparisons with Western Europe. 
Public Health, 120(2), 95-105. 
Kossarova, L., Holland, W., & Mossialos, E. (2012). 'Avoidable' mortality: a measure 
of health system performance in the Czech Republic and Slovakia between 
1971 and 2008. Health Policy and Planning. 
Kossarova, L., Holland, W., Nolte, E., & McKee, M. (2009). Measuring 'avoidable' 
mortality: Research Note, European Observatory on the Social Situation  
 318
Koupilová, I. (2001). Health needs of the Roma population in the Czech and Slovak 
Republics. Social Science & Medicine, 53, 1191-1204. 
Koupilová, I., McKee, M., & Holcik, J. (1998). Neonatal mortality in the Czech 
Republic during the transition. Health Policy, 46, 43-52. 
Kovner, A. R., & Knickman, J. R. (2008). Jonas & Kovner's Health Care Delivery in 
the United States (9th ed.). New York: Springer Publishing Company. 
Kunst, A. E., Looman, C. W., & Mackenbach, J. P. (1988). Medical care and regional 
mortality differences within the countries of the European Community. 
European J Population, 4, 223-245. 
Laditka, J. N., & Laditka, S. B. (2006). Race, ethnicity and hospitalization for six 
chronic ambulatory care sensitive conditions in the USA. Ethnicity & Health, 
11(3), 247-263. 
Lagasse, R., Humblet, P. C., Lenaerts, A., Godin, I., & Moens, G. F. G. (1990). Health 
and social inequities in Belgium. Social Science & Medicine, 31(3), 237-248. 
Leff, C. S. (1996). The Czech and Slovak Republics: Nation Versus State. Boulder: 
Westview Press. 
Legido-Quigley, H., McKee, M., Nolte, E., & Glinos, I. (2008). Assuring the quality of 
health care in the European Union: European Observatory on Health Systems 
and Policies. 
Lester, H., & Roland, M. (2009). Performance measurement in Primary Care. In P. C. 
Smith, E. Mossialos, I. Papanicolas & S. Leatherman (Eds.), Performance 
Measurement for Health System Improvement: Experiences, Challenges and 
Prospects. Cambridge: Cambridge University Press. 
Lewis, G. (2003). Beyond the Numbers: reviewing maternal deaths and 
complications to make pregnancy safer. Br Med Bull, 67(1), 27-37. 
Lin, W., Huang, I.-C., Wang, S.-L., Yang, M.-C., & Yaung, C.-L. (2010). Continuity of 
diabetes care is associated with avoidable hospitalizations: evidence from 
 319
Taiwan's National Health Insurance scheme. International Journal for 
Quality in Health Care, 22(1), 3-8. 
Logminiene, Z., Nolte, E., McKee, M., Valius, L., & Gaizauskiene, A. (2004). 
Avoidable mortality in Lithuania: 1991-1999 compared with 1970-1990. Public 
Health, 118(3), 201-210. 
Lohr, K. N., Eleazer, K., & Mauskopf, J. (1998). Health policy issues and applications 
for evidence-based medicine and clinical practice guidelines. Health Policy, 
46(1), 1-19. 
Mackenbach, J. P. (1991). Health care expenditure and mortality from amenable 
conditions in the European community. Health Policy, 19(2-3), 245-255. 
Mackenbach, J. P., Bouvier-Colle, M. H., & Jougla, E. (1990). "Avoidable” mortality 
and health services: a review of aggregate data studies. Journal of 
Epidemiology and Community Health, 44, 106-111. 
Mackenbach, J. P., Kunst, A. E., Looman, C. W., Habbema, J. D., & van der Maas, P. 
J. (1988). Regional differences in mortality from conditions amenable to 
medical intervention in The Netherlands: a comparison of four time periods. J 
Epidemiol Community Health, 42(4), 325-332. 
Mackenbach, J. P., Looman, C., Kunst, A., Habbema, J., & van der Maas, P. (1988). 
Post-1950 mortality trends and medical care: gains in life expectancy due to 
declines in mortality from conditions amenable to medical interventions in 
the Netherlands. Social Science Medicine, 27, 889-894. 
Magan, P., Otero, A., Alberquilla, A., & Ribera, J. M. (2008). Geographic variations in 
avoidable hospitalizations in the elderly, in a health system with universal 
coverage. BMC Health Serv Res, 8, 42. 
Malcolm, M. (1994). Avoidable mortality and life expectancy in New Zealand. J 
Epidemiol Comm Health, 48, 211. 
 320
Mant, J. (2001). Process versus outcome indicators in the assessment of quality of 
health care. International Journal for Quality in Health Care, 13(6), 475-
480. 
Manuel, D. G., & Mao, Y. (2002). Avoidable mortality in the United States and in 
Canada, 1980-1996. Am J Public Health, 92, 1481-1484. 
Martin, S., Rice, N., & Smith, P. C. (2008). Does health care spending improve health 
outcomes? Evidence from English programme budgeting data. Journal of 
Health Economics, 27(4), 826-842. 
McCall, N., Harlow, J., & Dayhoof, D. (2001). Rates of hospitalization for ambulatory 
care sensitive conditions in the Medicare+Choice population. Health Care 
Financ Rev, 22, 127-145. 
McGlynn, E. A. (2009). Measuring Clinical Quality and Appropriateness. In P. C. 
Smith, E. Mossialos, I. Papanicolas & S. Leatherman (Eds.), Performance 
Measurement for Health System Improvement: Experiences, Challenges and 
Prospects. Cambridge: Cambridge University Press. 
McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., et al. 
(2003). The Quality of Health Care Delivered to Adults in the United States. 
The New England Journal of Medicine, 348(26), 2635-2645. 
McKee, M. (2004). Winners and losers: the consequences of transition for health. In 
J. Figueras, M. McKee, J. Cain & S. Lessof (Eds.), Health systems in 
transition: learning from experience: World Health Organization on behalf of 
the European Observatory on Health Systems and Policies. 
McKee, M., Bain, C., & Nolte, E. (2009). Chronic care. In P. C. Smith, E. Mossialos, I. 
Papanicolas & S. Leatherman (Eds.), Performance Measurement for Health 
System Improvement: Experiences, Challenges and Prospects. Cambridge: 
Cambridge University Press. 
McKee, M., & Healy, J. (Eds.). (2002). Hospitals in a changing Europe: European 
Observatory on Health Care Systems Series. Open University Press. 
 321
McPherson, K., Steel, C. M., & Dixon, J. M. (2000). Breast cancer - epidemiology, risk 
factors, and genetics. British Medical Journal, 321, 624-628. 
Melero Moreno, C., López-Viña, A., García-Salmones Martín, M., Cisneros Serrano, 
C., Jareño Esteban, J., & Ramirez Prieto, M. T. (2012). Factors related with 
the higher percentage of hospitalizations due to asthma amongst women: the 
FRIAM study. Arch Bronconeumol., 48(7), 234-239. 
Mendis, S., Puska, P., & Norrving, B. (Eds.). (2011). Global Atlas on Cardiovascular 
Disease Prevention and Control. . Geneva: World Health Organization. 
Menec, V. H., Sirski, M., Attawar, D., & Katz, A. (2006). Does continuity of care with 
a family physician reduce hospitalizations among older adults? : Journal of 
Health Services Research and Policy. 11(4)(pp 196-201), 2006. Date of 
Publication: Oct 2006. 
Mercuri, M., & Gafni, A. (2011). Medical practice variations: what the literature tells 
us (or does not) about what are warranted and unwarranted variations. 
Journal of Evaluation in Clinical Practice, 17(4), 671-677. 
Meszaros, A. I. (1999). Divergent neighbors: The Czech Republic and Slovakia since 
independence. Harvard International Review, 21(2), 30-33. 
Milanovic, B. (1998). Income, Inequality, and Poverty during the Transition from 
Planned to Market Economy. Washington, D.C.: World Bank. 
Millman, M. (1993). Access to health care in America. Washington, D.C.: Institute of 
Medicine, National Academy Press. 
Mobley, L. R., Root, E., Anselin, L., Lozano-Gracia, N., & Koschinsky, J. (2006). 
Spatial analysis of elderly access to primary care services: International 
Journal of Health Geographics. 5, 2006. Article Number: 19. Date of 
Publication: 15 May 2006. 
Moreno-Serra, R., & Wagstaff, A. (2010). System-wide impacts of hospital payment 
reforms: Evidence from Central and Eastern Europe and Central Asia. 
Journal of Health Economics, 29(4), 585-602. 
 322
Murray, C. J., & Frenk, J. (2000). A framework for assessing the performance of 
health systems. Bulletin of the World Health Organisation, 78(6), 717-731. 
National Health Information Centre. (2011). Health Statistics Yearbook of the Slovak 
Republic 2010. Bratislava: National Health Information Centre  
Navarro, V. (2000). Assessment of the World Health Report 2000. Lancet, 
356(9241), 1598-1601. 
Nemec, J., & Lawson, C. (2005). Health policy in Slovakia and the outcomes of health 
care reforms: 1989 - 2003. Journal of Comparative Policy Analysis, 7(1), 49-
71. 
New York Academy of Medicine. (1933). Maternal Mortality in New York: a study of 
all puerperal deaths 1930-32. New York: New York Academy of Medicine: 
Committee on Public Health Relations. The Commonwealth Fund. 
Newey, C., Nolte, E., McKee, M., & Mossialos, E. (2004). Avoidable mortality in the 
enlarged European Union. Brussels: In ISS Statistics 2-meeting. Inproving 
the performance of health systems in the enlarged European Union. 
Newhouse, J. P., & Friedlander, L. J. (1980). The Relationship between Medical 
Resources and Measures of Health: Some Additional Evidence. The Journal 
of Human Resources, 15(2), 200-218. 
NHS Institute for Innovation and Improvement. (2012). Indicator Construction: 
Managing Variation in Emergency Admissions. from 
http://www.productivity.nhs.uk/Indicator/608/For/National/And/25th/Per
centile 
NHS RightCare. (2011). The NHS Atlas of Variation in Healthcare: Reducing 
unwaranted variation to increase value and improve quality: NHS Righcare. 
Nicolucci, A., Greenfield, S., & Mattke, S. (2006). Selecting indicators for the quality 
of diabetes care at the health systems level in OECD countries. International 
Journal for Quality in Health Care, 18(suppl 1), 26-30. 
 323
Nigam, A. (2012). Changing health care quality paradigms: The rise of clinical 
guidelines and quality measures in American medicine. Social Science & 
Medicine, 1-5. 
Niti, M., & Ng, T. P. (2001). Temporal trends and ethnic variations in amenable 
mortality in Singapore 1965-1994: the impact of health care in transition. Int 
J Epidemiol, 30, 966-973. 
Nixon, J., & Ulmann, P. (2006). The relationship between health care expenditure 
and health outcomes. The European Journal of Health Economics, 7(1), 7-18. 
Nolasco, A., Melchor, I., Pina, J. A., Pereyra-Zamora, P., Moncho, J., Tamayo, N., et 
al. (2009). Preventable avoidable mortality: Evolution of socioeconomic 
inequalities in urban areas in Spain, 1996-2003. Health & Place, 15(3), 732-
741. 
Nolte, E., & McKee, M. (2004). Does health care save lives? Avoidable mortality 
revisited. London: The Nuffield Trust. 
Nolte, E., & McKee, M. (2008a). Measuring The Health Of Nations: Updating An 
Earlier Analysis. Health Aff, 27(1), 58-71. 
Nolte, E., & McKee, M. (Eds.). (2008b). Caring for people with chronic conditions: A 
health system perspective: Open University Press. 
Nolte, E., & Scholz, R. (2004). Progress in health care, progress in health? Patterns of 
amenable mortality in Central and Eastern Europe before and after political 
transition. Demographic research special collections, 2(6), 139-162. 
Nolte, E., Scholz, R., Shkolnikov, V., & McKee, M. (2002). The contribution of 
medical care to changing life expectancy in Germany and Poland. Social 
Science Medicine, 55, 1907-1923. 
North, D. C. (1991). Institutions. The Journal of Economic Perspectives, 5(1), 97-112. 
O'Neill, M. S., Jerrett, M., Kawachi, I., Levy, J. I., Cohen, A. J., Gouveia, N., et al. 
(2003). Health, wealth, and air pollution: advancing theory and methods. 
Environ Health Perspect, 111(16), 1861-1870. 
 324
OECD. (2010). OECD Health Data 2010. 
http://stats.oecd.org/Index.aspx?DataSetCode=HEALTH_PROC 
Or, Z. (2000). Determinants of health outcomes in industrialised countries: a pooled, 
cross-country, times-series analysis. OECD Economic Studies, 30. 
Or, Z., Wang, J., & Jamison, D. (2005). International differences in the impact of 
doctors on health: multilevel analysis of OECD countries. Journal of Health 
Economics, 24, 531-560. 
Organization for Economic Cooperation and Development. (2011). How's Life?: 
Measuring well-being: OECD Publishing. 
Pampalon, R. (1993). Avoidable mortality in Québec and its regions. Soc Sci Med, 37, 
823-831. 
Papanicolas, I. (2013). International Frameworks for Health System Comparison. In 
I. Papanicolas & P. C. Smith (Eds.), Health System Performance 
Comparison: an Agenda for Policy, Information and Research (pp. 31-74). 
Berkshire: Open University Press. 
Papanicolas, I., & Smith, P. C. (2013). Health System Performance Comparison: an 
Agenda for Policy, Information and Research 
Pavlínek, P. (1995). Regional development and the disintegration of Czechoslovakia. 
Geoforum, 26(4), 351-372. 
Peracchi, F. (2008). Height and Economic Development in Italy, 1730-1980. 
American Economic Review, 98(2), 475-481. 
Persico, N., Postlewaite, A., & Silverman, D. (2004). The Effect of Adolescent 
Experience on Labor Market Outcomes: The Case of Height. National Bureau 
of Economic Research Working Paper Series, No. 10522. 
Piers, L. S., Carson, N. J., Brown, K., & Ansari, Z. (2007). Avoidable mortality in 
Victoria between 1979 and 2001 Australian and New Zealand Journal of 
Public Health 31(1), 5-12. 
 325
Plug, I., Hoffmann, R., & Mackenbach, J. e. (2011). AMIEHS. Avoidable mortality in 
the European Union: Towards better indicators for the effectiveness of 
health systems. EU Public Health Program 2007106. 
Poikolainen, K., & Eskola, J. (1988). Health services resources and their relation to 
mortality from causes amenable to health care intervention: a cross-national 
study. Int J Epidemiol, 17, 86-89. 
Popova, S., Rehm, J., Patra, J., & Zatonski, W. (2007). Comparing alcohol 
consumption in central and Eastern Europe to other European countries. 
Alcohol & Alcoholism, 42(5), 465-473. 
Potancok, B., & Sadovsky, O. (2004). Current state of cervical carcinoma screening in 
Slovakia and proposal of mass screening practice. Prakticka Gynekologia, 
11(1), 4-11. 
Potucek, M., & Radicova, I. (1997). Splitting the welfare state: the Czech and Slovak 
cases. Social Research, 64(4), 1449-1587. 
Prescott, N., & Jamison, D. T. (1985). The distribution and impact of health resource 
availability in China. The International Journal of Health Planning and 
Management, 1(1), 45-56. 
Pritchett, L., & Summers, L. H. (1996). Wealthier is Healthier. The Journal of Human 
Resources, 31(4), 841-868. 
Purdy, S. (2010). Avoiding hospitali admissions: what does research evidence say? : 
The King's Fund. 
Rechel, B., Wright, S., Edwards, N., Dowdeswell, B., & McKee, M. (Eds.). (2009). 
Investing in hospitals of the future: World Health Organization, on behalf of 
the European Observatory on Health Systems and Policies. 
Reid, D. D. (1962). Diagnostic standardization in geographic comparisons of 
morbidity. American Review of Respiratory Diseases, 86, 850-854. 
Reid, D. D., & Rose, G. A. (1964). Assessing the comparabiity of mortality statistics. 
British Medical Journal, 2, 1437-1439. 
 326
Ren, C., & Tong, S. (2008). Health effects of ambient air pollution--recent research 
development and contemporary methodological challenges. Environ Health, 
7(56). 
Renard, L., Bocquet, V., Vidal-Trecan, G., Lair, M.-L., Couffignal, S., & Blum-
Boisgard, C. (2011). An algorithm to identify patients with treated type 2 
diabetes using medico-administrative data. BMC Medical Informatics and 
Decision Making, 11(1), 23. 
Ricketts, T. C., & Holmes, G. M. (2007). Mortality and Physician Supply: Does Region 
Hold the Key to the Paradox? Health Services Research, 42(6p1), 2233-2251. 
Rizza, P., Bianco, A., Pavia, M., & Angelillo, I. (2007). Preventable hospitalization and 
access to primary health care in an area of Southern Italy. BMC Health 
Services Research, 7(1), 134. 
Roberts, M. J., Hsiao, W., Berman, P., & Reich, M. R. (2004). Getting Health Reform 
Right: a Guide to Improving Performance and Equity. New York: Oxford 
University Press. 
Robst, J., & Graham, G. G. (1997). Access to health care and current health status: do 
physicians matter? Applied Economics Letters, 4(1), 45-48. 
Robst, J., & Graham, G. G. (2004). The relationship between the supply of primary 
care physicians and measures of health. Eastern Economic Journal, 30(3), 
467-486. 
Rodrigo, G. J., Plaza, V., Bellido-Casado, J., Neffen, H., Bazús, M. T., Levy, G., et al. 
(2009). The study of severe asthma in Latin America and Spain (1994-2004): 
characteristics of patients hospitalized with acute severe asthma. J Bras 
Pneumol, 35(7), 635-644. 
Rokosová M, H. P., Schreyögg J, Busse R. (2005). Health care systems in transition: 
Czech Republic: Copenhagen, WHO Regional Office for Europe on behalf of 
the European Observatory on Health Systems and Policies. 
 327
Rubin, H. R., Pronovost, P., & Diette, G. B. (2001). The advantages and disadvantages 
of process‐based measures of health care quality. International Journal for 
Quality in Health Care, 13(6), 469-474. 
Rutstein, D. D., Berenberg, W., Chalmers, T. C., Child, C. G., Fishman, A. P., & Perrin, 
E. B. (1976). Measuring the quality of medical care. A clinical method. N Engl 
J Med, 294(11), 582-588. 
Ruzicka, L. T., & Lopez, A. D. (1990). The use of cause-of-death statistics for health 
situation assessment: national and international experiences. World Health 
Stat Q, 43(4), 249-258. 
Saha, S., Solotaroff, R., Oster, A., & Bindman, A. B. (2007). Are preventable 
hospitalizations sensitive to changes in access to primary care? The case of the 
Oregon Health Plan. Med Care, 45(8), 712-719. 
Saxena, S., George, J., Barber, J., Fitzpatrick, J., & Majeed, A. (2006). Association of 
population and practice factors with potentially avoidable admission rates for 
chronic diseases in London: cross sectional analysis. JRSM, 99(2), 81-89. 
Schuster, M. A., McGlynn, E. A., & Brook, R. H. (1998). How Good Is the Quality of 
Health Care in the United States? The Milbank Quarterly, 76(4), 517-563. 
Schwierz, C., & Wubker, A. (2009). Determinants of avoidable deaths from ischaemic 
heart diseases in East and West Germany. Rheinisch-Westfalisches Institut 
fur Wirtschaftsforschung, Ruhr-Universitat Bochum, Universitat Dortmund, 
Universitat Duisburg-Essen. 
Sen, A. K. (1999). Democracy as a universal value. Journal of democracy, 10(3). 
Shekelle, P. G., & Roland, M. (2000). Measuring Quality in Health Care. In N. D. 
Finkelstein (Ed.), Transparency in Public Policy: Great Britain and the 
United States. London: MacMillan Press LTD. 
Shi, L. (1992). The relationship between primary care and life chances. Journal of 
health care for the poor and underserved, 3(2), 321-335. 
 328 
Shi, L. (1994). Primary care, specialty care, and life chances. International Journal of 
Health Services, 24(3), 431-458. 
Shi, L., Macinko, J., Starfield, B., Wulu, J., Regan, J., & Politzer, R. (2003). The 
relationship between primary care, income inequality, and mortality in US 
States, 1980–1995. The Journal of the American Board of Family Practice, 
16(5), 412-422. 
Sicotte, C., Champagne, F., Contandriopoulos, A. P., Barnsley, J., Béland, F., Leggat, 
S. G., et al. (1998). A conceptual framework for the analysis of health care 
organizations' performance. Health services management research : an 
official journal of the Association of University Programs in Health 
Administration / HSMC, AUPHA, 11(1), 24-41; discussion 41-28. 
Sidorenkov, G., Haaijer-Ruskamp, F. M., de Zeeuw, D., & Denig, P. (2011). A 
Longitudinal Study Examining Adherence to Guidelines in Diabetes Care 
According to Different Definitions of Adequacy and Timeliness. [Article]. 
PLoS ONE, 6(9). 
Silventoinen, K., Kaprio, J., Lahelma, E., & Koskenvuo, M. (2000). Relative effect of 
genetic and environmental factors on body height: differences across birth 
cohorts among Finnish men and women. American Journal of Public Health, 
90(4), 627-630. 
Simai, M. (2006). Poverty and Inequality in Eastern Europe and the CIS Transition 
Economies. Working Papers, United Nations, Department of Economics and 
Social Affairs,  
Simonato, L., Ballard, T., Bellini, P., & Winkelmann, R. (1998). Avoidable mortality in 
Europe 1955-1994: a plea for prevention. J Epidemiol Community Health, 
52(10), 624-630. 
Skodova, Z., Pisa, Z., Poledne, R., Berka, L., Cicha, Z., Emrova, R., et al. (1997). 
Decline of the cardiovascular mortality rate in the Czech Republic in 1984 -
1993 and its possible causes. Casopis Lekaru Ceskych, 136 (12). 
 329
Smith, J. (2007). Diabetes and the Rise of the SES Health Gradient. Cambridge: 
NATIONAL BUREAU OF ECONOMIC RESEARCH. 
Smith, P. C., Mossialos, E., Papanicolas, I., & Leatherman, S. (2009). Performance 
Measurement for Health System Improvement: Experiences, Challenges and 
Prospects. Cambridge: Cambridge University Press. 
Spencer, E. A., Appleby, P. N., Davey, G. K., & Key, T. J. (2002). Validity of self-
reported height and weight in 4808 EPIC–Oxford participants. Public Health 
Nutrition, 5(04), 561-565. 
Starfield, B., Shi, L., Grover, A., & Macinko, J. (2005). The effects of specialist supply 
on populations’ health: assessing the evidence. Cancer, 103(20.93), 23.18. 
Starfield, B., Shi, L., & Macinko, J. (2005). Contribution of Primary Care to Health 
Systems and Health. Milbank Quarterly, 83(3), 457-502. 
Steckel, R. H. (1995). Stature and the Standard of Living. Journal of Economic 
Literature, 33(4), 1903-1940. 
Steckel, R. H. (2009). Heights and human welfare: Recent developments and new 
directions. Explorations in Economic History, 46(1), 1-23. 
Stembera, Z., & Velebil, P. (2006). [Analysis of stagnation of perinatal mortality in 
the Czech Republic]. Ceska Gynekol, 71(2), 87-91. 
Stunkard, A. J., Foch, T. T., & Hrubec, Z. (1986). A twin study of human obesity. 
Journal of American Medical Association (JAMA), 256, 51-54. 
Sunder, M. (2003). The making of giants in a welfare state: the Norwegian experience 
in the 20th century. Economics & Human Biology, 1(2), 267-276. 
Sundmacher, L., & Busse, R. (2011). The impact of physician supply on avoidable 
cancer deaths in Germany. A spatial analysis. Health Policy, 103, 53-62. 
Szalay, T., Pažitný, P., Szalayová, A., Frisová, S., Morvay, K., Petrovič, M., et al. 
(2011). Slovakia: Health system review. Health Systems in Transition, 13(2), 
1-200. 
 330 
Tang, K. K., Chin, J. T. C., & Rao, D. S. P. (2008). Avoidable mortality risks and 
measurement of wellbeing and inequality. Journal of Health Economics, 
27(3), 624-641. 
Tanner, J. M. (1981). A history of the study of human growth. Cambridge: 
Cambridge University Press. 
Tanner, J. M. (1986). Growth as a mirror for the conditions of society: Secular trends 
and class distinctions. In A. Demirjian (Ed.), Human Growth: A 
Multidisciplinary Review (pp. 3-34). London: Taylor and Francis. 
Tavares, J., & Wacziarg, R. (2001). How democracy affects growth. European 
Economic Review, 45, 1341-1378. 
Telishevska, M., Chenet, L., & McKee, M. (2001). Towards an understanding of the 
high death rate among young people with diabetes in Ukraine. Diab Med, 
18(3-9). 
Tesar, T., Foltan, V., & Huorka, M. (2002). Pharmacoeconomics in the therapy of 
peptic ulcer. Ceska Slov Farm., 51(2), 78-83. 
The NYU Center for Health and Public Service Research of the Robert F. Wagner 
Graduate School of Public Service.   Retrieved April 8, 2013, from 
http://wagner.nyu.edu/faculty/billings/acs-algorithm.php 
The World Bank. from www.worldbank.org 
The World Bank. (2002). Poverty and welfare of Roma in the Slovak Republic. 
Bratislava. 
Timmermans, S., & Berg, M. (2003). The gold standard: the challenge of evidence-
based medicine and standardization in health care Philadelphia: Temple 
University Press. 
Tobias, M., & Jackson, G. (2001). Avoidable mortality in New Zealand, 1981-97. Aust 
N Z J Public Health 25, 12-20. 
Tomasik, T. (2012). We don’t know if health system changes in eastern Europe have 
improved quality. BMJ, 344. 
 331
Treurniet, H. F., Boshuizen, H. C., & Harteloh, P. P. M. (2004). Avoidable mortality 
in Europe (1980-1997): a comparison of trends. J Epidemiol Community 
Health, 58(4), 290-295. 
Treurniet, H. F., Looman, C. W., van der Maas, P. J., & Mackenbach, J. P. (1999). 
Variations in 'avoidable' mortality: a reflection of variations in incidence? Int. 
J. Epidemiol., 28(2), 225-232. 
Tunstall-Pedoe, H., Vanuzzo, D., Hobbs, M., Mähönen, M., Cepatis, Z., Kuulasmaa, 
K., et al. (2000). Estimation of contribution of changes in coronary care to 
improving survival, event rates, and coronary heart disease mortality across 
the WHO MONICA Project populations. Lancet, 355, 688-700. 
Tyczynski, J. E., Plesko, I., Aareleid, T., Primic-Zakelj, M., Dalmas, M., Kurtinaitis, J., 
et al. (2004). Breast cancer mortality patterns and time trends in 10 new EU 
member states: Mortality declining in young women, but still increasing in the 
elderly. International Journal of Cancer, 112(6), 1056-1064. 
Uliciansky, V., Mokan, M., Nemethyova, Z., Tkac, I., Galajda, P., & Vozar, J. (2007). 
Guidelines of the Slovak Diabetology Association for the Diagnosis and 
Treatment of Diabetes Mellitus Type II. 
UN News Centre. (2011). UN launches global campaign to curb death toll from non-
communicable diseases. 
http://www.un.org/apps/news/story.asp?NewsID=39600&Cr=non+commun
icable+diseases 
United Nations Development Programme. (2013). International Human 
Development Indicators.   Retrieved February 14, 2013, from 
http://hdrstats.undp.org/en/tables/ 
Vecchia, C. L., Lucchini, F., Negri, E. V. A., Reggi, V., & Levi, F. (1993). The impact of 
therapeutic improvements in reducing peptic ulcer mortality in Europe. Int. J. 
Epidemiol., 22(1), 96-106. 
 332
Velkova, A., Wolleswinkel-van den Bosch, J., & Mackenbach, J. P. (1997). The east-
west life expectancy gap: Differences in mortality from conditions amenable 
to medical intervention. Int J Epidemiol, 26. 
Vignerová, J., Brabec, M., & Bláha, P. (2006). Two centuries of growth among Czech 
children and youth. Economics & Human Biology, 4(2), 237-252. 
Vlasak, V., Plesko, I., Dimitrova, E., & Hudakova, G. (1991). Recent trends in uterine 
cervix cancer in Slovakia, 1968-1987. Neoplasma, 38(5), 533-540. 
Walters, E. H., Walters, J. A. E., & Gibson, P. G. (2009). Regular treatment with long 
acting beta agonists versus daily regular treatment with short acting beta 
agonists in adults and children with stable asthma (Review). London: The 
Cochrane Collaboration. 
Watson, D., & McGrail, K. (2009). More Doctors or Better Care? Healthcare Policy, 
5(1), 26-31. 
Weissman, J. S., Gatsonis, C., & Epstein, A. M. (1992). Rates of avoidable 
hospitalization by insurance status in Massachusetts and Maryland. Jama, 
268(17), 2388-2394. 
Weisz, D., Gusmano, M. K., Rodwin, V. G., & Neuberg, L. G. (2008). Population 
health and the health system: a comparative analysis of avoidable mortality in 
three nations and their world cities. Eur J Public Health, 18(2), 166-172. 
Wennberg, J. E. (1999). Understanding Geographic Variations in Health Care 
Delivery. New England Journal of Medicine, 340(1), 52-53 <53>. 
Wennberg, J. E. (2004). Practice variations and health care reform: connecting the 
dots. Health Aff (Millwood), Suppl Web Exclusives, VAR140-144. 
Wennberg, J. E., Fisher, E. S., Stukel, T. A., & Sharp, S. M. (2004). Use of Medicare 
claims data to monitor provider-specific performance among patients with 
severe chronic illness. Health Aff (Millwood), Suppl Web Exclusives, VAR5-
18. 
 333
Wennberg, J. E., & Gittelsohn, A. (1973). Small area variations in health care delivery: 
a population-based health information system can guide planning and 
regulatory decision-making. Science, 182, 1102-1108. 
Westerling, R. (1993). Indicators of "Avoidable" Mortality in Health Administrative 
Areas in Sweden 1974-1985. Scand J Public Health, 21(3), 176-187. 
Westerling, R., Gullberg, A., & Rosen, M. (1996). Socio-economic differences in 
'avoidable mortality' in Sweden 1986-1990. Int J Epidemiol, 25, 560 - 567. 
Westerling, R., Gullberg, A., & Rosén, M. (1996). Socioeconomic Differences in 
'Avoidable' Mortality in Sweden 1986-1990. Int. J. Epidemiol., 25(3), 560-
567. 
Westerling, R., & Smedby, B. (1992). The European Community ‘avoidable death 
indicators’ in Sweden 1974-1985. Int J Epidemiol, 21, 502-510. 
Whitehead, M., & Dahlgren, G. (1991). What can be done about inequalities in 
health? The Lancet, 338(8774), 1059-1063. 
Wolfe, B., & Gabay, M. (1987). Health status and medical expenditures: More 
evidence of a link. Social Science & Medicine, 25(8), 883-888. 
World Health Organization. (2000). The World Health Report 2000: Health 
Systems: Improving Performance. Geneva: World Health Organization. 
World Health Organization. (2003). World Health Survey.    
World Health Organization. (2004). Beyond the Numbers. Reviewing maternal 
deaths and complications to make pregnancy safer. Geneva: WHO. 
World Health Organization. (2006). The World Health Report 2006: working 
together for health. Geneva. 
World Health Organization. (2012). Measurement of and target-setting for well-
being: an initiative by the WHO Regional Office for Europe. Second meeting 
of the expert group, Copenhagen, Denmark, 8-9 February 2012. 
Copenhagen: WHO Regional Office for Europe. 
 334
World Health Organization. (2013). The European health report 2012: charting the 
way to well-being: World Health Organization Regional Office for Europe. 
Young, F. W. (2001). An explanation of the persistent doctor-mortality association. 
Journal of Epidemiology and Community Health, 55(2), 80-84. 
Zeng, F., O'Leary, J. F., Sloss, E. M., Lopez, M. S., Dhanani, N., & Melnick, G. (2006). 
The effect of medicare health maintenance organizations on hospitalization 
rates for ambulatory care-sensitive conditions. Medical Care, 44(10), 900-
907. 
Zhang, W., Mueller, K. J., Chen, L.-W., & Conway, K. (2006). The role of rural health 
clinics in hospitalization due to ambulatory care sensitive conditions: a study 
in Nebraska. Journal of Rural Health, 22(3), 220-223. 
 
 
